{
  "experiment_metadata": {
    "model": "nemotron-nano-30b",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 453.85,
    "timestamp": "2026-02-03T20:33:35.768011"
  },
  "results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT’s nonqualified defined benefit pension plans remained essentially unchanged, holding at $1.0 billion in both 2023 and 2024, while the related assets set aside increased modestly from $615 million to $658 million over the same period. Consequently, actuarial losses recorded in accumulated other comprehensive loss declined from $347 million at the end of 2023 to $303 million at the end of 2024, reflecting a modest reduction in the unrecognized loss component despite the stable gross obligation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49092,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12493,
        "completion_tokens": 133,
        "total_tokens": 12626
      }
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "Between 2022 and 2024, General Motors reduced its long-term rate of return assumptions for U.S. pension plan assets from 5.6% to 5.4% (2021) and then increased it to 6.5% by December 31, 2024, reflecting updated capital market assumptions and strategic asset allocation shifts. This evolution indicates a deliberate adjustment toward a more aggressive asset mix—particularly increasing equity exposure from 9% to 11% and shifting debt allocations to better align with liability management goals—aimed at improving funded positions while managing volatility, consistent with the company’s stated strategy to de-risk and optimize pension funding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 63666,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16149,
        "completion_tokens": 161,
        "total_tokens": 16310
      }
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy shifted from a strategic acquisition to full integration, resulting in measurable operational and financial impacts. Operationally, Chevron incorporated PDC's legacy assets into its U.S. upstream segment, boosting net oil-equivalent production by 250,000 barrels per day (19% increase) and adding $2.2 billion in sales volumes, while eliminating decommissioning charges from previously divested assets. Financially, the acquisition drove a $3.5 billion increase in U.S. upstream earnings and contributed to the company's $15.2 billion in 2024 common stock repurchases, though it also introduced higher integration costs reflected in elevated operating expenses and net charges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 109506,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 27600,
        "completion_tokens": 179,
        "total_tokens": 27779
      }
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Southern Company’s treatment of energy-related derivatives remained consistent in methodology between 2022 and 2024, continuing to account for them primarily as regulatory hedges, cash flow hedges, or non-designated derivatives, with gains and losses initially recorded in regulatory liabilities/assets or AOCI depending on hedge designation. However, the scale of unrealized gains and their presentation shifted significantly: in 2024, the company reported substantially higher net regulatory hedge gains ($155 million total across subsidiaries) compared to 2022 (which showed smaller gains of $12–$44 million depending on subsidiary), with these gains increasingly recognized in the balance sheet through \"Other regulatory assets/liabilities\" and offset by gross amounts offset (e.g., $44 million offset in 2024 vs. $8–$503 million in prior years). The 2024 disclosures also expanded to include detailed maturity dates and volumes of outstanding contracts, reflecting a more transparent but structurally similar approach to prior years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 324,
          "pages": [
            322,
            323,
            324,
            325,
            326
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 283,
          "pages": [
            281,
            282,
            283,
            284,
            285
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53692,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13661,
        "completion_tokens": 259,
        "total_tokens": 13920
      }
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Between 2022 and 2024, Chevron's investment carrying value in Tengizchevroil increased from $22,685 million to $27,368 million, while its equity earnings from TCO rose from $1,238 million in 2020 to $3,375 million in 2024 (reflecting higher earnings in 2024 versus $1,140 million in 2020). This growth corresponds with the upward trend in total upstream equity earnings, which grew from $(1,140) million in 2020 to $3,580 million in 2024, underscoring a strengthening financial relationship with Tengizchevroil.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58656,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14889,
        "completion_tokens": 127,
        "total_tokens": 15017
      }
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart's ownership stake in Alert Innovation changed from a variable interest entity (VIE) to 100% ownership during fiscal 2023. This occurred through a $0.4 billion acquisition that resulted in the Company becoming a 100% owner, as disclosed in Note 3 (Shareholders' Equity) for fiscal 2023. The entity was previously consolidated as a VIE before this transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59098,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15003,
        "completion_tokens": 91,
        "total_tokens": 15095
      }
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks' foreign currency derivative asset and liability positions shifted significantly from fiscal 2022 to 2023, with the net asset position decreasing from $1,269 million to $920 million and the related liability declining from $1,009 million to $750 million. This reduction reflects the company’s active management of foreign exchange risk—using forwards, swaps, and hedged debt to offset currency volatility—while maintaining a substantial portion of its hedged exposure to protect earnings from adverse currency movements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64331,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16317,
        "completion_tokens": 132,
        "total_tokens": 16449
      }
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Between fiscal years 2022 and 2024, Medtronic’s treatment of A Preferred Shares shifted from having 1,872 shares outstanding at the start of 2022 to being fully redeemed during the third quarter of fiscal 2022, after which no A Preferred Shares remained outstanding. In 2022, the Company specifically redeemed those 1,872 A Preferred Shares for $0.075 million, effectively retiring the entire series.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48184,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12270,
        "completion_tokens": 100,
        "total_tokens": 12370
      }
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Based on the provided SEC 10-K filings, Comcast's financial relationship with Atairos evolved such that equity income (losses) driven by fair value adjustments on underlying investments shifted from a $286 million loss in 2020 to $1.8 billion of income in 2021, as disclosed in the 2022 10-K (page 46-47). This significant swing was primarily attributed to fair value adjustments on Atairos's underlying investments, which contributed $1.8 billion in income during 2021 compared to $(64) million in 2019 and $(286) million in 2020. The 2023 10-K (page 37-38) further notes that Atairos generated $1.1 billion in income and $(434) million in losses in 2023 and 2022, respectively, with fair value adjustments continuing to drive these results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40389,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10330,
        "completion_tokens": 185,
        "total_tokens": 10515
      }
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP's proved reserves in the Asia Pacific/Middle East region increased from 936 million barrels of oil equivalent in 2023 to 940 million barrels in 2024, reflecting upward revisions and additions that underscore the company's strategic focus on expanding its presence in this high‑growth geographic area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 75381,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19080,
        "completion_tokens": 76,
        "total_tokens": 19156
      }
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL revenue in Canada declined sharply from $73 million in 2022 to $47 million in 2023, a drop of roughly 36%, and is projected to continue falling in 2024 due to lower net selling prices and seasonal first‑quarter weakness. This downward trend signals a weakening market position for ENBREL in Canada, with sales expected to keep decreasing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40038,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10228,
        "completion_tokens": 86,
        "total_tokens": 10314
      }
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "From fiscal 2023 to fiscal 2024, Qualcomm’s executive‑compensation framework shifted to explicitly tie human‑capital progress to pay: the HR and Compensation Committee now uses “human‑capital advancements” as a non‑financial performance modifier that can adjust the fiscal‑2024 executive bonus by a multiplier of **0.9 to 1.1**. In fiscal 2024, the applicable performance‑modifier range for that human‑capital factor was **0.9 – 1.1**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61027,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15493,
        "completion_tokens": 108,
        "total_tokens": 15601
      }
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Based on the provided 2022 and 2024 SEC filing excerpts, Breyanzi's therapeutic scope expanded significantly between 2022 and 2024. In 2022, it was approved for relapsed/refractory multiple myeloma (Phase III), but by 2024, it received FDA accelerated approvals for three additional hematologic indications: relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), relapsed/refractory follicular lymphoma (FL), and relapsed/refractory mantle cell lymphoma (MCL), as documented in the 2024 pipeline and approval tables. This broadened its use beyond its initial myeloma indication to target multiple B-cell malignancies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45084,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11491,
        "completion_tokens": 162,
        "total_tokens": 11654
      }
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "The Disney Resorts and Vacations segment showed strong growth in 2024, with total revenues increasing 5% to $34,151 million from $32,549 million in 2023, driven by growth in theme park admissions (7% increase), resorts and vacations (5% increase), and merchandise/food and beverage sales (4% increase). This segment's operating income also rose 4% to $9,272 million, reflecting growth particularly at international parks. This performance contrasts with the broader Parks & Experiences segment, which reported 5% overall revenue growth to $34,151 million (from $32,549 million in 2023), indicating that the Resorts and Vacations component is a key driver of the segment's overall revenue expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 35614,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9136,
        "completion_tokens": 174,
        "total_tokens": 9310
      }
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "The structure of CVS's forward contracts tied to ASR transactions remained consistent through 2024, continuing to involve fixed-dollar agreements with banks (e.g., Morgan Stanley, Citibank, Barclays) where an initial share purchase was made, followed by a forward contract for the remaining notional amount. The key evolution is in the timing and completion of these contracts: the $3.0 billion ASR with Morgan Stanley, announced in 2023, was finalized in March 2024 after receiving the remaining 15% of shares, while the $2.0 billion ASR with Citibank and $1.5 billion ASR with Barclays were completed in early 2023 and 2022, respectively, with their forward contracts reclassified from capital surplus to treasury stock upon final settlement. The forward contracts were always classified as equity instruments initially recorded in capital surplus, but their reclassification to treasury stock occurred upon receipt of the final share allocations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 175,
          "pages": [
            173,
            174,
            175,
            176,
            177
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39069,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9990,
        "completion_tokens": 237,
        "total_tokens": 10228
      }
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "Duke Energy’s 2024 disclosure shows a more transparent and refined approach to pension asset valuation compared to 2023, particularly in the categorization of fair value measurements. The 2024 filing explicitly details the fair value hierarchy (Level 1, Level 2, Level 3) for all major asset classes within the Master Retirement Trust, including the disclosure of assets measured using the net asset value practical expedient (Not Categorized), which was not clearly labeled in 2023. Additionally, the 2024 valuation tables provide clearer reconciliation of Level 3 assets and more granular breakdowns of actual vs. target allocations, enhancing transparency around how assets are classified and measured. This represents a meaningful evolution in disclosure practices, improving clarity around fair value categorization without altering the underlying methodology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 228,
          "pages": [
            226,
            227,
            228,
            229,
            230
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67556,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17127,
        "completion_tokens": 216,
        "total_tokens": 17343
      }
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Pfizer recorded a $3.5 billion non‑cash revenue reversal in Q4 2023 related to the expected return of about 6.5 million EUA‑labeled Paxlovid courses purchased by the U.S. government, and later converted that liability into a volume‑based credit for a U.S. Strategic National Stockpile of 1 million treatment courses that will be provided at no cost through 2028. The reversal reduced 2023 revenue and shifted the remaining undelivered courses into a credit that will generate future revenue as the courses are delivered, while the newly created stockpile has no cash consideration attached.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 98369,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24837,
        "completion_tokens": 147,
        "total_tokens": 24984
      }
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "Between 2022 and 2023, ERLEADA sales grew by 26.9% (from $1.881 billion to $2.387 billion), driven by continued market share gains and growth in metastatic castration-resistant prostate cancer. This strong performance contributed to the Oncology segment's 10.5% overall sales increase, underscoring ERLEADA's expanding role within J&J's oncology portfolio as a key growth driver alongside other newer agents like CARVYKTI and TECVAYLI.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42310,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10797,
        "completion_tokens": 108,
        "total_tokens": 10906
      }
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA's global sales grew dramatically from $760 million in 2022 to $1,291 million in 2023—a 70% increase—indicating a strong upward market trajectory for the product. This surge reflects both expanding market share and growing demand for the drug across regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38283,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9787,
        "completion_tokens": 66,
        "total_tokens": 9853
      }
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "The company repaid the $1.25 billion 0.584% Notes Due 2024 in fiscal 2025, removing that tranche from its long‑term debt schedule, and the remaining notes continue to be reported as unsecured senior obligations with maturities extending from 2026 through 2060. Consequently, the 0.584% Notes Due 2024 no longer appear on the balance sheet, and the debt‑management strategy shifted to maintaining the longer‑dated notes while managing covenant compliance and interest‑rate exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41174,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10507,
        "completion_tokens": 120,
        "total_tokens": 10627
      }
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Based on the provided document pages, Honeywell's investment in Mortgage/Asset-backed securities within its U.S. pension plan assets **decreased significantly** between 2022 and 2023. Specifically, the fair value of these securities fell from **$1,072 million in 2021** (as reported in the 2022 10-K for 2021 assets) to **$676 million in 2023** (as reported in the 2023 10-K for 2023 assets), representing a **$400 million reduction** (approximately a 37% decline) over the two-year period. This reduction is explicitly documented in the asset allocation tables for both U.S. and non-U.S. pension plans across the 2021–2023 timeframe.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57599,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14621,
        "completion_tokens": 158,
        "total_tokens": 14779
      }
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Capital One's use of securitized debt obligations remained a key funding source, with $6.25 billion of securitized debt issued in 2021 (up from $1.25 billion in 2020) and $3.44 billion of maturities that year, reflecting continued reliance on these structures within its diversified funding mix. The fair value of these securitized obligations was classified as Level 2 in the company's fair‑value hierarchy, indicating they are primarily valued using observable market inputs rather than significant unobservable inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48310,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12311,
        "completion_tokens": 130,
        "total_tokens": 12441
      }
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "From 2023 to 2024 the firm’s CECL‑related capital benefit declined materially.  In the 2023 capital roll‑forward the CECL transition provision contributed roughly $1.4 bn to CET1 capital (shown as a $1.4 bn benefit in Note 27), whereas in the 2024 roll‑forward the same provision was fully phased in and contributed only a $720 m benefit, resulting in a net reduction of about $0.7 bn in the CECL‑related capital benefit.  Consequently, the quantitative change in the CECL‑related capital benefit was a decrease of approximately $0.7 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56645,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14399,
        "completion_tokens": 135,
        "total_tokens": 14535
      }
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "Based on the provided SEC 10-K filings, Salesforce's Revolving Loan Credit Agreement evolved between fiscal 2023 and fiscal 2024 as follows: In fiscal 2023 (prior to October 2024), the company had a $3.0 billion unsecured revolving credit facility under the Prior Credit Agreement dated December 2020, which matured in December 2025. In fiscal 2024, this was superseded by a new $5.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement executed in October 2024, which extends the maturity to October 2029. The new agreement replaced the prior facility and increased borrowing capacity from $3.0 billion to $5.0 billion, with no outstanding borrowings under either facility as of January 31, 2024. (Document references: CRM_10k_2023.pdf pages 51-55; CRM_10k_2024.pdf pages 49-53)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48416,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12318,
        "completion_tokens": 203,
        "total_tokens": 12521
      }
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "UPS's relationship with Coyote evolved through a strategic divestiture that was completed in the third quarter of 2024, after which Coyote was no longer part of UPS's ongoing operations. This transaction generated a pre-tax gain of $156 million ($152 million after tax) that was excluded from UPS's non-GAAP financial measures as it was deemed non-recurring. The divestiture was part of UPS's broader transformation strategy (Transformation 2.0), which included workforce reductions and portfolio realignment to improve efficiency and focus on core growth areas like healthcare logistics. The financial impact of this change was a one-time gain recognized in 2024, but the strategic shift aimed to streamline operations and redirect resources toward higher-growth segments such as Supply Chain Solutions, ultimately supporting long-term profitability and reducing complexity in UPS's global network.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44248,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11277,
        "completion_tokens": 224,
        "total_tokens": 11502
      }
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Based on the provided 2023 and 2024 document pages, Union Pacific's relationship with chassis evolved in terms of ownership structure and total units as follows:\n\n1.  **Ownership Structure:** The 2024 document shows a significant increase in leased chassis units (17,705 leased vs. 9,474 owned in 2023), resulting in a total of 48,340 chassis (up from 30,635 owned + 17,705 leased = 48,340 total in 2023? Wait, 2023 total was 30,635 owned + 17,705 leased = 48,340, but 2024 shows 4,356 owned + 1,197 leased = 5,553 total for chassis? Actually, the 2024 table shows \"Chassis\" as 4,356 owned and 1,197 leased, totaling 5,553. However, the 2023 table showed 30,635 owned and 17,705 leased, totaling 48,340. This indicates a massive reduction in total chassis units from 48,340 in 2023 to 5,553 in 2024, but the ownership structure shifted heavily toward ownership (4,356 owned vs. 30,635 owned previously) and away from leasing (1,197 leased vs. 17,705 leased previously). The key point is the substantial decrease in total chassis units and a shift toward more ownership.\n\n2.  **Total Units:** The total number of chassis units decreased dramatically from 48,340 in 2023 (30,635 owned + 17,705 leased) to 5,553 in 2024 (4,356 owned + 1,197 leased), reflecting a significant reduction in the overall chassis fleet size, likely due to operational adjustments and fleet management strategies. The 2024 data shows a much smaller total chassis count compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34965,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8960,
        "completion_tokens": 365,
        "total_tokens": 9325
      }
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing's aluminum agreements transitioned from being classified as derivatives requiring hedge accounting treatment to being explicitly noted as derivatives not receiving hedge accounting treatment in its 2024 10-K. Previously in 2022, these agreements were described as derivatives for accounting purposes but not designated for hedge accounting, with fair value changes recorded immediately in earnings. By 2024, this classification remained consistent, but the disclosure became more explicit in Note 20, emphasizing they are \"derivatives not receiving hedge accounting treatment\" with fair value changes recorded in earnings immediately. The time horizon for these agreements was not newly specified in 2024, but the 2022 filing noted they offset quantities priced at prevailing market prices to address long-term strategic sourcing objectives and non-U.S. business requirements, with no explicit multi-year term disclosed beyond the general context of strategic sourcing. The 2024 filing also reaffirmed that these agreements are not designated for hedge accounting, maintaining the same accounting treatment as in prior years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39693,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10157,
        "completion_tokens": 288,
        "total_tokens": 10446
      }
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Based on the provided 10-K pages for fiscal 2023 and 2024, Procter & Gamble's exposure to currency rate risk has evolved such that its hedging instruments and confidence in mitigating near-term exchange rate fluctuations remain consistent with prior periods. The company continues to primarily use forward contracts and currency swaps with maturities under 18 months to manage currency exposure, and it explicitly states that a near-term change in currency rates, at a 95% confidence level based on historical movements, would not materially affect its financial statements. While the company acknowledges currency volatility (e.g., citing currency devaluation impacts on the Gillette indefinite-lived intangible asset impairment), it maintains that its diversified portfolio of exposures acts as a natural hedge, and no significant changes to its hedging strategy or confidence levels were disclosed between the fiscal years ended June 30, 2023 and June 30, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63110,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16022,
        "completion_tokens": 241,
        "total_tokens": 16263
      }
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Adobe's integration of Frame.io has expanded its functional scope from a standalone collaboration platform to a tightly embedded component of its Creative Cloud ecosystem, with deep integration into key Adobe applications such as Premiere Pro, After Effects, Photoshop, Lightroom, and Express. This integration enables seamless workflows like frame-accurate commenting, Camera to Cloud uploads, and direct asset access within Adobe apps, while also supporting broader use cases such as video production, design collaboration, and enterprise content workflows through Adobe GenStudio. Frame.io’s capabilities now complement Adobe’s generative AI (Firefly) and Document Cloud offerings, reinforcing Adobe’s positioning as a unified platform for end-to-end creative and document workflows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 38721,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9908,
        "completion_tokens": 196,
        "total_tokens": 10105
      }
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between fiscal years 2022 and 2023, AMD's investment in the ATMP joint venture increased from a carrying value of $69 million to $99 million, reflecting higher equity‑method earnings and larger receivables/payables with the JV. The company continues to disclose the investment using the equity‑method, with no funding obligation, and reports related‑party transactions (purchases, resales, and receivables/payables) in its consolidated balance sheets and income statement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42794,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10934,
        "completion_tokens": 118,
        "total_tokens": 11052
      }
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Based on the provided financial data, Honeywell's revenue from Commercial Aviation Original Equipment increased from $2,397 million in 2023 to $2,223 million in 2024 (as reported in the 2024 filing), representing a 7.2% decline year-over-year. This decrease suggests a potential softening in the commercial aviation original equipment market, though the company maintains a significant position in the aerospace sector through its broad portfolio of products, services, and aftermarket revenue (which grew to $7,144 million in 2024). The decline contrasts with overall aerospace segment growth (net sales of $15,458 million in 2024 vs. $13,624 million in 2023), indicating Honeywell's aerospace business remains resilient but faces specific headwinds in OEM equipment demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51860,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13192,
        "completion_tokens": 193,
        "total_tokens": 13386
      }
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, reflecting a $118 million rise. This represents a 10.2 % growth (or approximately a 10 % change) in the segment’s total revenue over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47176,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12019,
        "completion_tokens": 67,
        "total_tokens": 12086
      }
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "Based on the provided document pages, there is no information about IBM's treatment of the 0.300% Notes due 2028 in the 2022 or 2023 filings. The documents focus on executive compensation plans (e.g., 2001 Plan, PWCC Plan, Red Hat Plan, DCEAP), board governance, and financial disclosures, but do not discuss the specific terms, modifications, or treatment of the 0.300% Notes due 2028 between the 2022 and 2023 filings. The question cannot be answered using the given sources.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35923,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9187,
        "completion_tokens": 119,
        "total_tokens": 9306
      }
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region showed a decline in both net sales and operating income from 2022 to 2023. In 2022, the region generated $66.952 billion in net sales with an operating income of $27.082 billion, which decreased to $66.952 billion in net sales and $27.082 billion in operating income for 2023, indicating a year-over-year reduction in both metrics. This trend reflects weaker performance in the region compared to the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42659,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10887,
        "completion_tokens": 119,
        "total_tokens": 11006
      }
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed from a five‑year pro‑rata schedule for grants made before 2022 to a four‑year pro‑rata schedule for grants made after December 31, 2021, as disclosed in the 2022 and 2024 10‑K filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61319,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15571,
        "completion_tokens": 68,
        "total_tokens": 15640
      }
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "CVS Health's approach to validating fair value estimates for Level 2 debt securities remained consistent between 2022 and 2023, relying on observable market inputs through matrix pricing models and quarterly price comparisons with secondary sources to ensure accuracy. The company did not adjust Level 2 debt security prices during 2023, continuing its practice of obtaining one price per security from primary sources and validating them against internal estimates and secondary benchmarks without material changes to methodology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 153,
          "pages": [
            151,
            152,
            153,
            154,
            155
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49609,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12638,
        "completion_tokens": 132,
        "total_tokens": 12770
      }
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "CVS Health's classification and valuation methodology for privately-placed equity securities remained consistent between 2022 and 2023, with these securities consistently classified as Level 3 due to the absence of active markets and reliance on internal valuation models using unobservable inputs like earnings multiples and marketability discounts. The fair value determination process for Level 3 assets, including privately placed equity securities, continued to involve internal analysis of financial statements and cash flow projections, with changes in unobservable inputs directly impacting the measured fair value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 153,
          "pages": [
            151,
            152,
            153,
            154,
            155
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49609,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12638,
        "completion_tokens": 155,
        "total_tokens": 12794
      }
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue from Alphagan/Combigan declined 21.4% at actual currency rates and 19.1% at constant currency rates between 2023 and 2024. International revenue for Alphagan/Combigan grew 4.9% at actual currency rates and 10.4% at constant currency rates during the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16290,
        "completion_tokens": 71,
        "total_tokens": 16361
      }
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "From 2023 to 2024, Chevron's relationship with PDC Energy evolved from acquisition to full integration, as evidenced by the 2023 business combination that made PDC Energy a wholly‑owned subsidiary. This change directly boosted Chevron's worldwide oil‑equivalent production, contributing to a 7 % year‑over‑year increase to 3.3 million barrels per day in 2024, with the Permian Basin and other PDC assets driving the growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61387,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15574,
        "completion_tokens": 105,
        "total_tokens": 15679
      }
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "UPS expanded its cold-chain logistics capabilities in 2024 by acquiring healthcare logistics firms Bomi Group and MNX Global Logistics in 2023, and by acquiring Frigo-Trans and Biotech & Pharma Logistics in January 2025 to strengthen its international cold-chain network. These acquisitions, reported within Supply Chain Solutions, were part of UPS's strategy to enhance its complex healthcare logistics services and cold-chain capabilities globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38770,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9913,
        "completion_tokens": 112,
        "total_tokens": 10025
      }
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Based on the provided SEC filing exhibits, Linde plc's non-employee director restricted stock unit (RSU) award program has been updated to align with long-term shareholder interests through governance enhancements and performance-linked incentives. The 2021 Long-Term Incentive Plan (Exhibit 10.02) introduced performance metrics tied to Return on Capital and Total Shareholder Return for RSUs, replacing prior plans (e.g., 2009 Amended Plan) to ensure director compensation is directly linked to sustained shareholder value creation. This evolution reflects a strategic shift toward stricter governance oversight and performance accountability, as evidenced by the 2024 amendments to the plan (Exhibit 10.03e) and the adoption of a formal Director Indemnification Agreement (Exhibit 10.14) to reinforce fiduciary alignment with shareholders. The program now emphasizes multi-year performance metrics and deferred compensation structures to mitigate short-termism and strengthen enduring shareholder confidence.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60527,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15367,
        "completion_tokens": 252,
        "total_tokens": 15620
      }
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors’ financial relationship with Stellantis evolved through the termination of its indemnification obligations tied to the 2017 sale of Opel/Vauxhall to PSA Group (now Stellantis), which had previously required GM to cover certain losses, including emissions-related claims and recalls. While GM had accrued minimal amounts for these indemnifications by 2024, the legal exposure remained contingent and unresolved, particularly regarding potential future liabilities from emissions lawsuits in Europe. Additionally, GM Financial’s EBT-adjusted growth in 2021 was partly driven by gains related to Stellantis warrants, reflecting ongoing financial ties, though by 2024, GM’s focus had shifted to its own EV and financial strategies, with reduced direct reliance on Stellantis-linked gains or obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59935,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15211,
        "completion_tokens": 209,
        "total_tokens": 15420
      }
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "Southern Company's treatment of energy-related derivatives shifted from 2022 to 2024 in both financial presentation and categorization. In the 2022 filing (pages 325-329), energy-related derivatives were primarily presented as regulatory hedges with gains/losses initially recorded in regulatory liabilities/assets and later recognized in fuel expense, while cash flow hedges were disclosed in OCI with specific line-item reclassifications. By 2024 (pages 281-285), the company expanded its derivative disclosures to include more detailed categorization across regulatory, cash flow, and non-designated hedges, with explicit reporting of net volumes hedged (e.g., 431 mmBtu net purchased for Southern Company), longer hedge horizons (up to 2030), and enhanced balance sheet presentation showing gross and offset amounts for all derivative types. Crucially, the 2024 filing also clarified that energy-related derivatives not designated as hedges were now separately tracked for income statement impacts (e.g., $117 million gain/loss in natural gas revenues), and the company emphasized its netting agreements and collateral policies to mitigate credit risk, reflecting a more structured and transparent approach to derivative accounting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 283,
          "pages": [
            281,
            282,
            283,
            284,
            285
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52276,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13300,
        "completion_tokens": 309,
        "total_tokens": 13609
      }
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, GILD’s strategic relationship with Arcus evolved from a 2020 collaboration agreement into a deepened partnership marked by significant equity increases and governance influence. In May 2023, GILD amended the Collaboration Agreement to expand research into inflammatory disease targets and made an additional $320 million equity investment, raising its ownership stake from approximately 19.9% to 33%. This was followed by an April 2024 amendment where GILD paid a $100 million anniversary option fee and increased its board representation from two to three designees, solidifying its governance role while maintaining shared development cost structures and U.S. profit-splitting terms for optioned programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56440,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14331,
        "completion_tokens": 182,
        "total_tokens": 14513
      }
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "Based on the provided documents, the maturity date of the 2021 Multicurrency Credit Facility was extended to **July 1, 2026** (from June 30, 2025) through amendments finalized on June 29, 2023, as stated in the \"Amendments to Bank Facilities\" section of the 2023 filing. The borrowing capacity under this facility remained unchanged at **$6.0 billion** (including a $3.5 billion sublimit for multicurrency borrowings), with no adjustments to the maximum commitments or sublimits noted between 2022 and 2023. Thus, the maturity date evolved to July 1, 2026, while the borrowing capacity stayed at $6.0 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46133,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11747,
        "completion_tokens": 152,
        "total_tokens": 11899
      }
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron’s U.S. refinery crude inputs remained heavily reliant on imported oil, accounting for roughly 60 % of feedstock in both 2023 and 2024, while overall refinery utilization stayed near 90 % (88.6 % in 2023, 87.9 % in 2024).  The company continued modest capacity expansions—such as the Pasadena refinery upgrade aimed at boosting light‑crude throughput to 125,000 bbl/d by 2025—but did not signal a major shift in imported‑crude share; instead, utilization trends showed a slight dip in 2024 versus the 2023 peak.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52469,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13347,
        "completion_tokens": 129,
        "total_tokens": 13476
      }
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS reduced its notional exposure to British Pound Sterling hedges from $663 million in 2023 to $536 million in 2024, reflecting a deliberate scaling back of its currency‑risk program. This shift signals a more measured approach to foreign‑exchange risk, relying less on active hedging and more on natural offsets and market monitoring.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 137,
          "pages": [
            135,
            136,
            137,
            138,
            139
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47166,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12021,
        "completion_tokens": 84,
        "total_tokens": 12105
      }
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "Between 2023 and 2024 the fair‑value of Bank of America’s money‑market investments rose from roughly $868 million to about $1.3 billion, reflecting a modest increase in short‑term cash holdings. This shift suggests the company is allocating slightly more of its liquid assets to higher‑yielding, short‑duration instruments, indicating a cautious but proactive stance toward managing its short‑term investment strategy amid changing market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 93821,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23689,
        "completion_tokens": 112,
        "total_tokens": 23802
      }
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell‑back options is 26 million mmBtu for Southern Company overall, broken down as 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power and 8 million mmBtu for Southern Power. This figure is presented in the 2021 notes and is not updated in the 2024 disclosures, indicating that the volume has remained essentially unchanged between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 319,
          "pages": [
            317,
            318,
            319,
            320,
            321
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54699,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13905,
        "completion_tokens": 121,
        "total_tokens": 14027
      }
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "Between 2023 and 2024, Adobe integrated Firefly Vector Model more deeply into its Creative Cloud suite, embedding it natively into Photoshop (with Generative Fill and Expand), Illustrator (Generative Recolor), and Express, while expanding its commercial safety via Content Credentials and enterprise indemnification. The model’s capabilities were enhanced through dedicated Firefly paid plans, increased Generative Credit allocations, and broader AI-driven features across products like Acrobat AI Assistant, reinforcing Adobe’s strategy to make generative AI a core, trusted component of its ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11225,
        "completion_tokens": 150,
        "total_tokens": 11376
      }
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "From 2023 to 2024, Biktarvy's sales grew from $9,692 million to $11,850 million—a 22% increase—reflecting stronger market uptake and continued demand for GILD’s HIV regimen. This commercial momentum reinforces GILD’s HIV strategy of leveraging Biktarvy as a cornerstone product while expanding its pipeline and seeking label extensions to maintain growth and competitive advantage in the HIV market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74061,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18740,
        "completion_tokens": 99,
        "total_tokens": 18839
      }
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "Based on the provided documents, the Series 2018-1A Securities (Secured Tower Revenue Securities, Series 2018-1, Subclass A) had an outstanding principal amount of **$496.8 million as of December 31, 2023**, compared to **$496.1 million as of December 31, 2022**. The interest rate for this series was **3.652%**, with a maturity date of **March 15, 2028** (anticipated repayment date), and the final legal maturity is March 15, 2048. The document indicates no significant change in outstanding principal between 2022 and 2023, with the slight increase reflecting routine accounting adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58485,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14850,
        "completion_tokens": 148,
        "total_tokens": 14999
      }
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "UPS's relationship with Coyote evolved from a significant strategic asset in 2023 to a divested business by 2024, resulting in a $156 million gain on divestiture and $111 million goodwill impairment charge related to the Coyote trade name. This strategic exit, completed in September 2024, reduced Supply Chain Solutions revenue by $976 million (primarily due to lower volumes and market rates) but improved overall operating performance, as evidenced by a $178 million increase in total operating profit and a 150 basis point rise in operating margin to 7.3% in 2024. The divestiture allowed UPS to refocus resources on higher-growth areas like Logistics and digital businesses within Supply Chain Solutions, while the $111 million impairment reflected the trade name's declining fair value amid market headwinds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38404,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9814,
        "completion_tokens": 203,
        "total_tokens": 10017
      }
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "Based on the provided SEC filing excerpts, Linde plc's Performance Share Unit Awards under its Long Term Incentive Plan underwent structural evolution between 2022 and 2024, particularly regarding performance metrics for grants beginning in 2019. The 2021 Long Term Incentive Plan (referenced in Exhibit 10.02c and 10.03c of the 2021 filings) established two distinct performance metrics: Return on Capital (ROIC) and Total Shareholder Return (TSR), which were used for awards beginning in 2019 under the amended 2009 Praxair, Inc. Long Term Incentive Plan (Exhibits 10.11k–10.11m in the 2018 Annual Report). By 2024, as evidenced by the First Amendment to the 2021 Long Term Incentive Plan (Exhibit 10.03e), Linde updated its Performance Share Unit Award framework to incorporate these metrics, reflecting a refined approach to aligning executive compensation with strategic financial outcomes. The evolution underscores a continuity in performance-based equity design, transitioning from legacy Praxair-era structures to a unified Linde plc framework that emphasizes capital efficiency and shareholder value creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 107,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60287,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15301,
        "completion_tokens": 279,
        "total_tokens": 15580
      }
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, Trodelvy’s regulatory trajectory shifted from initial approvals to expanded indications and accelerated development pathways. In 2023, the FDA approved Trodelvy for metastatic HR+/HER2- breast cancer and provided Breakthrough Therapy designation for small cell lung cancer, signaling its growing clinical relevance. By 2024, it gained additional Breakthrough Therapy status for extensive-stage small cell lung cancer and received expanded approvals in breast cancer and other indications, underscoring its evolving role in oncology and accelerating its development trajectory toward broader therapeutic applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58877,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14935,
        "completion_tokens": 159,
        "total_tokens": 15094
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "From 2023 to 2024, Vertex AI’s role within Google Cloud expanded significantly as Google’s primary platform for developers to build, deploy, and manage generative AI applications. In 2023, Vertex AI provided access to foundational models like Gemini and Imagen, enabling tasks such as model training, tuning, and deployment. By 2024, Vertex AI became deeply integrated with Gemini 2.0, Google’s most advanced multimodal model, allowing developers to leverage Gemini’s capabilities (text, code, audio, image, video) for more sophisticated applications. Key enhancements included Gemini for Google Cloud, which offers pre-packaged AI agents for coding, cybersecurity, and workflow automation, as well as tighter integration with Google Cloud’s AI-optimized infrastructure and data platforms. This evolution positioned Vertex AI as the central hub for enterprises to adopt generative AI at scale, directly supporting Google’s broader strategy to make AI accessible across its ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49470,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12593,
        "completion_tokens": 245,
        "total_tokens": 12839
      }
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "The treatment of weather derivatives in Southern Company’s financial disclosures has shifted from being explicitly excluded as immaterial in 2022 to being formally incorporated into the derivative valuation framework in 2024, where they are now disclosed as part of energy-related derivatives with immaterial premiums and intrinsic values, though still not material to the overall hedge portfolio. While 2022 documentation noted immaterial weather-related exposures and omitted specific quantification, the 2024 filings include structured disclosures of weather derivatives within Level 2 fair value measurements and note their inclusion in regulatory hedging programs, indicating a formalization of their treatment rather than a change in materiality status.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 122,
          "pages": [
            120,
            121,
            122,
            123,
            124
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 285,
          "pages": [
            283,
            284,
            285,
            286,
            287
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55153,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14028,
        "completion_tokens": 189,
        "total_tokens": 14217
      }
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Based on GILD's 2023 and 2024 disclosures, Biktarvy's regulatory positioning evolved with a key label expansion: the FDA approved an **expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance** (a common resistance mutation), alongside an updated label reinforcing its safety and efficacy in pregnant individuals with HIV-1. This marked a strategic shift toward addressing a specific, high-need patient population within HIV treatment, enhancing its clinical value proposition. Commercially, Biktarvy remained a cornerstone product, maintaining strong market presence as reflected in its continued patent protection (expiring in 2033 in both U.S. and EU) and inclusion in GILD's portfolio strategy to \"build a sustainable and diverse portfolio\" through targeted therapeutic advancements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58903,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14937,
        "completion_tokens": 215,
        "total_tokens": 15153
      }
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "Based on the provided document pages, AMT's utilization of the 2021 Multicurrency Credit Facility changed between 2022 and 2023 as follows:  \n- In 2022 (as of December 31, 2022), the facility had $1,611.6 million available under the 2021 Multicurrency Credit Facility (with $6.0 billion total commitment).  \n- In 2023, the facility was amended to extend maturities to July 2026/2028, with $6.0 billion commitment (including $3.5 billion sublimit for multicurrency borrowings), and borrowings under it were used to repay $6.1 billion in revolving indebtedness (including $919.1 million EUR repayments) and repay the 2021 USD Two-Year Delayed Draw Term Loan.  \n- Subsequent to December 31, 2023, an additional $850 million was borrowed under the facility for general corporate purposes, following $3.0 billion borrowings in 2023.  \n- The facility's borrowing capacity remained at $6.0 billion, but utilization increased significantly in 2023 compared to 2022, with net borrowings of $3.0 billion during 2023 and $850 million in subsequent 2024 borrowings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52037,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13234,
        "completion_tokens": 263,
        "total_tokens": 13497
      }
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Based on the provided SEC 10-K filings, Google Ad Manager's role in Alphabet's advertising revenue recognition strategy has evolved significantly between 2023 and 2024, particularly regarding its integration with revenue reporting models. The key evolution is the increased reliance on Google Ad Manager as the primary platform for managing advertising inventory across Google's network, which directly impacts how advertising revenue is recognized. Specifically, Alphabet continues to report advertising revenue on a **gross basis** for ads placed on Google Network properties (including those managed through Ad Manager), meaning the full amount billed to customers is recorded as revenue, with payments to network partners (TAC) recorded as cost of revenue. This model remains consistent, but the 2023 filing highlights that Ad Manager's role has become even more central to managing this gross revenue recognition, especially as it supports the allocation of revenue across multiple performance obligations (e.g., performance vs. brand advertising) and handles variable consideration like customer incentives. The 2024 filing further reinforces this by detailing that Ad Manager's infrastructure enables the efficient processing of ad inventory, ensuring accurate revenue recognition when control transfers to customers—whether through user engagement (performance ads) or ad display (brand ads)—while maintaining the gross basis for network property revenue. This integration ensures that advertising revenue is systematically tracked, allocated, and reported in alignment with GAAP, with Ad Manager serving as the operational backbone for these processes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51576,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13127,
        "completion_tokens": 415,
        "total_tokens": 13543
      }
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "UPS's financial exposure and strategic positioning regarding Roadie evolved significantly between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment. In 2023, UPS recorded $56 million in goodwill impairment related to Roadie, reflecting limited excess fair value and heightened vulnerability to performance shortfalls. By 2024, Roadie remained one of three reporting units (alongside Global Freight Forwarding and Global Logistics and Distribution) with limited excess fair value above carrying value, retaining approximately $1.1 billion of the company's $4.3 billion consolidated goodwill balance. While no impairment was recorded in 2024, UPS explicitly highlighted that these units are at heightened risk of future impairment if actual cash flows fall short of projections or cost of capital increases by 100 basis points. This progression underscores a strategic shift from initial acquisition-driven investment to active, ongoing risk monitoring of Roadie's contribution within the Supply Chain Solutions segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35749,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9165,
        "completion_tokens": 262,
        "total_tokens": 9427
      }
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "Linde's helium relationship shifted from a major growth driver in 2022 to a more constrained, cost-impacted element by 2024, with helium-related costs now acting as a headwind rather than a tailwind. This change directly reduced operating profit by $19 million in the \"Other\" segment (which includes global helium wholesale) in 2024, driven by higher costs that partially offset insurance recoveries for LAMT, while helium volumes declined due to lower demand in the global helium wholesale business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37873,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9692,
        "completion_tokens": 125,
        "total_tokens": 9817
      }
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long‑term credit protection agreements with FNMA and FHLMC rose from $8.7 billion at the end of 2023 to $8.0 billion at the end of 2024 (the document notes the agreements cover $8.0 billion of loans at December 31 2024 and $8.7 billion at December 31 2023). This increase reflects a modest expansion of the protected loan portfolio, but because all of these loans are fully insured, the Corporation does not record an allowance for credit losses, indicating that its exposure to credit risk on residential mortgage loans remains limited and is effectively mitigated by the guarantees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 112466,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 28361,
        "completion_tokens": 155,
        "total_tokens": 28517
      }
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Adobe's strategic positioning of Adobe Firefly evolved from a foundational generative AI offering in 2023 to a more integrated, enterprise-grade capability by 2024, emphasizing commercial safety and IP indemnification to differentiate from competitors like Midjourney and Stable Diffusion. This differentiation is underscored by its native integration into Creative Cloud apps (e.g., Photoshop’s Generative Fill/Expand) and expanded use in Adobe Express and Firefly for Enterprise, which includes IP indemnification for business users. However, this strategy introduces regulatory risks, particularly from evolving AI governance frameworks such as the EU AI Act, which could impose compliance costs, restrict model training data, or limit deployment models, potentially disrupting Adobe’s monetization and requiring significant R&D adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50383,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12822,
        "completion_tokens": 211,
        "total_tokens": 13033
      }
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Between 2023 and 2024, Trodelvy’s sales grew 56% year-over-year to $1.06 billion, driven by increased demand across new and existing geographies, while its regulatory trajectory advanced with FDA approval for HR+/HER2- metastatic breast cancer and EC approval for monotherapy use in that indication. The drug also received Breakthrough Therapy designation for small cell lung cancer and saw expanded use in liver disease settings, though its overall revenue contribution remained modest compared to HIV and oncology pillars.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61649,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15621,
        "completion_tokens": 131,
        "total_tokens": 15752
      }
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "From 2022 to 2024 Chevron’s equity stake in Angola LNG remained roughly constant at about 36 % of the project, but the company’s financial involvement deepened through larger capital commitments and stronger cash‑flow contributions.  In the 2022 10‑K (p. 40‑44) Chevron disclosed a $1.7 bn investment in Angola LNG Limited and highlighted the project as a key growth driver, while the 2024 filing (p. 83‑87) shows a $3.6 bn cumulative equity investment and reports $1.2 bn of cash‑flow‑related advances to the venture, underscoring a strategic shift toward greater upstream exposure and enhanced financing support for the LNG expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58046,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14744,
        "completion_tokens": 159,
        "total_tokens": 14903
      }
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, the value of META's Fixed-Rate Senior Unsecured Notes increased from $18.50 billion to $29.00 billion, reflecting the issuance of $10.50 billion of new notes in August 2024 in addition to the existing $8.50 billion May 2023 issuance and $10.00 billion August 2022 issuance.  The total face amount of long‑term debt rose to $29 billion, with future principal payments scheduled as $2.75 billion in 2027, $1.5 billion in 2028, $1.0 billion in 2029 and $23.75 billion thereafter.  Interest expense on these notes was $683 million in 2024, up from $420 million in 2023 and $160 million in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45476,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11582,
        "completion_tokens": 152,
        "total_tokens": 11734
      }
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "Based on the provided 10-K disclosures, LIN's financial exposure to helium shifted from being treated as a \"supply\" (2023) to a \"dependency\" (2024) due to explicit sourcing and cost disclosures in the 2024 filing. Specifically, the 2024 document (page 61, Note 6) states that helium is now a \"critical raw material\" with \"significant supply chain dependencies,\" and the company discloses \"increased reliance on external helium suppliers\" and \"potential cost volatility\" due to constrained global supply. In contrast, the 2023 filing (page 71) only categorizes helium as a \"supply\" without highlighting dependency or sourcing risks. The 2024 disclosure explicitly links helium to \"raw material cost pressures\" and \"supply chain disruptions,\" confirming its transition from a routine supply to a strategic dependency. (298 characters)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 29305,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7560,
        "completion_tokens": 208,
        "total_tokens": 7768
      }
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "Between 2022 and 2023, the amount of European customer balances approved for credit activities declined from $3.8 billion to $3.0 billion, reflecting a reduction of roughly 21 %. This decrease corresponds to the percentage change in the approved credit amount, which fell by about 21 % over the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44156,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11270,
        "completion_tokens": 76,
        "total_tokens": 11347
      }
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Based on the provided 10-K disclosures, Starbucks' exposure to foreign currency derivatives designated as hedging instruments (specifically \"Foreign currency - other\" under cash flow hedges) shows a significant evolution in fair value and reclassification impact between 2023 and 2024. The net gains/(losses) included in AOCI for foreign currency - other decreased from $39.6 million (as of Oct 1, 2023) to $11.5 million (as of Sep 29, 2024), and the amount expected to be reclassified into earnings within 12 months declined from $23.6 million to $9.5 million. This indicates a reduction in the anticipated earnings impact from reclassifying these hedging gains/losses, though the remaining $9.5 million will still affect earnings in the near term. The reclassification amounts are tied to specific line items like licensed stores revenues, with the foreign currency - other component showing a clear downward trend in both AOCI balances and expected reclassification amounts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 54781,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13928,
        "completion_tokens": 244,
        "total_tokens": 14172
      }
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "Based on the provided fair value hierarchy tables for 2022 and 2023, Alabama Power's energy-related derivatives shifted from a $18 million liability (2022) to a $15 million asset (2023), reflecting a directional change from liability to asset. Georgia Power's energy-related derivatives similarly transitioned from a $124 million liability (2022) to a $13 million asset (2023), indicating a comparable shift from liability to asset position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83041,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20995,
        "completion_tokens": 110,
        "total_tokens": 21105
      }
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "The U.S. Retiree Health Care Plan’s asset allocation remained heavily weighted toward fixed‑income securities, with roughly 64‑65 % of its assets in fixed‑income and cash equivalents and about 36 % in equities in both 2022 and 2023, indicating little change in the fixed‑income versus equity distribution over that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54882,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13956,
        "completion_tokens": 80,
        "total_tokens": 14037
      }
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy evolved from having received accelerated FDA approval in 2020 (with continued approval contingent on confirmatory trials) to gaining full FDA approval in 2023 for an expanded indication in unresectable or metastatic HR+/HER2- breast cancer after prior endocrine therapy and at least two systemic treatments. In 2023, Trodelvy also received EC approval as monotherapy for the same breast cancer indication and was further approved in Japan for relapsed/refractory LBCL. Additionally, a Phase 3 trial of Trodelvy in metastatic non-small cell lung cancer did not meet its primary survival endpoint, though a trend was observed in a subgroup.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58361,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14805,
        "completion_tokens": 176,
        "total_tokens": 14981
      }
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Between 2023 and 2024, Meta’s disclosure regarding user perception as a risk factor evolved from a general warning about user retention and engagement to a more specific emphasis on how declining user trust, sentiment, and platform usage—driven by competition, regulatory pressures, and product changes—could materially harm revenue and business operations. In 2024, the risk is framed more explicitly around user disengagement due to privacy concerns, content quality, algorithmic changes, and regulatory actions (e.g., GDPR, DMA), with greater focus on the vulnerability of ad revenue if users reduce engagement or cease using Facebook and Instagram. The 2024 filing also underscores that perceived erosion of platform integrity or trust could trigger user attrition, reduce ad impressions, and weaken marketer demand, directly threatening financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47184,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12032,
        "completion_tokens": 216,
        "total_tokens": 12248
      }
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "Based on the provided document pages, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million at December 31, 2021 and $572 million at December 31, 2020. This indicates a reduction in the notional amount over the period, reflecting a potential shift in the company's interest rate risk management strategy toward fixed-rate debt or reduced reliance on variable rate hedging instruments. The decline suggests Lockheed Martin is managing interest rate exposure through alternative mechanisms or adjusting its hedging approach as market conditions or financing needs evolve.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41549,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10619,
        "completion_tokens": 150,
        "total_tokens": 10769
      }
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "PayPal’s approach to its Seller Protection Programs evolved between 2022 and 2023 primarily through changes in the financial provisions for transaction losses. In 2022, the company recorded a provision for transaction and credit losses of $1.7 billion, which was adjusted in operating cash flow by changes in other assets and liabilities reflecting actual cash losses incurred. By 2023, the allowance for transaction losses was $64 million (down from $66 million in 2022) and the provision for transaction and credit losses was incorporated into the $1.1 billion adjustment to cash from operating activities, indicating a more refined estimation and reporting of expected credit losses. This shift reflects a tighter integration of loss provisions into cash‑flow adjustments and a reduced reliance on large non‑cash provisions, as evidenced by the lower allowance balance and the increased focus on actual cash transaction losses in the cash‑flow statement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49966,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12717,
        "completion_tokens": 239,
        "total_tokens": 12956
      }
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "The foreign currency‑other derivative asset and liability positions shifted from $1.9 million (asset) and $4.7 million (liability) on September 29 2024 to $32.0 million (asset) and $2.0 million (liability) on October 1 2023, reflecting a net increase of roughly $30 million in assets and a $2.7 million decrease in liabilities. Consequently, the overall change in the balance‑sheet exposure was about a $33 million swing toward a larger net asset position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 63021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15990,
        "completion_tokens": 114,
        "total_tokens": 16104
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "The financial impact of energy-related derivatives on natural gas cost and revenue hedging positions shifted significantly from 2022 to 2023, with gains in AOCI declining from $34 million (2022) to $(81) million (2023) for Southern Company’s energy‑related cash‑flow hedges, and a corresponding reduction in the amount reclassified into earnings from $17 million (2022) to $(44) million (2023). This evolution reflects a marked decrease in the pre‑tax gains recognized in OCI and a reversal of those gains into earnings over the two‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 295,
          "pages": [
            293,
            294,
            295,
            296,
            297
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64108,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16246,
        "completion_tokens": 136,
        "total_tokens": 16382
      }
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Based on the provided 10-K filings, Walmart's Deferred Compensation Matching Plan was amended and restated effective November 8, 2023, as documented in Exhibit 10.1 of both the 2023 and 2024 filings. The plan's effective date remained November 8, 2023, with no indication of a change to this date between the two filings. The documentation status confirms it was properly restated and filed as part of the annual reports, with the 2024 filing referencing the November 8, 2023 effective date as the current governing version.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70915,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17959,
        "completion_tokens": 131,
        "total_tokens": 18090
      }
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, the dilutive effect and accrual policy for LTIP Units remained consistent: no potentially dilutive securities, including LTIP Units, had a material dilutive impact on earnings per share or per unit for the years ended December 31, 2024, 2023, and 2022. The Company continues to accrue dividends on LTIP Units when declared, and these units are exchangeable into common stock (or operating partnership units) on a one‑for‑one basis, but they did not materially affect diluted earnings per share/unit calculations in either period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48991,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12471,
        "completion_tokens": 138,
        "total_tokens": 12609
      }
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta’s compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) has evolved significantly between 2023 and 2024 in direct response to regulatory pressures and enforcement actions. In 2023, Meta faced a landmark €1.2 billion fine from Ireland’s Data Protection Commission (IDPC) over unlawful data transfers under GDPR, specifically related to its reliance on Standard Contractual Clauses (SCCs) after the Schrems II ruling invalidated Privacy Shield. This forced Meta to accelerate its transition to the newly established EU-U.S. DPF, which the European Commission formally adopted in July 2023 as an adequacy decision to enable lawful data transfers. By November 2023, Meta had implemented compliance measures to align with the DPF’s requirements, including updating data transfer mechanisms and engaging with regulators to address the IDPC’s corrective orders. However, the company continues to appeal the IDPC’s ruling and navigate ongoing scrutiny, as a further invalidation of the DPF by the CJEU could disrupt its core services in Europe. The 2024 annual report underscores that Meta’s compliance strategy now hinges on the DPF’s stability, with heightened focus on adhering to both the DPF and evolving regulations like the DMA and DSA, which impose new obligations on data practices and competition. This shift reflects a proactive, regulatory-driven adaptation to mitigate legal risks while maintaining operational continuity in the EU.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55938,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14213,
        "completion_tokens": 365,
        "total_tokens": 14578
      }
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Linde’s 2024 10‑K shows a clear shift toward renewable‑energy‑driven hydrogen production.  In the 2024 filing the company emphasizes that “green hydrogen is produced by electrolysis using renewable energy” and that it is expanding low‑carbon (blue) and green hydrogen projects, whereas the 2023 filing focused mainly on gray hydrogen from natural‑gas reforming and described blue hydrogen only as carbon‑capture‑enabled processes.  Consequently, the 2024 approach places far greater emphasis on renewable‑energy sources and on scaling electrolytic, green‑hydrogen production methods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44930,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11456,
        "completion_tokens": 145,
        "total_tokens": 11602
      }
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company's relationship with Sequent evolved significantly between 2022 and 2023, culminating in the sale of Sequent to Williams Field Services Group on July 1, 2021 (with final adjustments completed later), which generated a pre-tax gain of approximately $121 million ($92 million after tax) and resulted in $85 million of additional tax expense due to changes in state apportionment rates. This transaction marked the end of Southern Company Gas's involvement with Sequent, removing it from their consolidated financial statements and eliminating related equity method investments and associated impairments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 302,
          "pages": [
            300,
            301,
            302,
            303,
            304
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39844,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10180,
        "completion_tokens": 154,
        "total_tokens": 10335
      }
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Walmart's relationship with the Allswell brand has remained consistent as part of its broader private brand strategy, with Allswell continuing to be marketed under the company's portfolio of private-label brands. This reflects Walmart's strategic focus on expanding its range of value-oriented, quality merchandise across categories like home, apparel, and general merchandise, reinforcing its positioning as a one-stop retailer that leverages private brands to enhance profitability and customer trust.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48245,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12290,
        "completion_tokens": 125,
        "total_tokens": 12416
      }
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "Based on the provided financial data, the strategic importance of Embedded Processing products has increased from 2022 to 2023. While Embedded Processing revenue grew 3% year-over-year (from $3.261B to $3.368B), its operating profit margin declined significantly (from 38.4% to 29.9%), indicating higher investment and cost pressures. However, its revenue share within the total semiconductor business remained stable at approximately 18-19% of total revenue ($3.049B in 2022 vs. $3.368B in 2023), and it continues to represent a critical growth area within the company's core strategy, as emphasized in management's discussion of focusing on \"analog and embedded processing products\" as one of the four sustainable competitive advantages. This strategic emphasis is further validated by the company's continued capital allocation toward Embedded Processing, including $5.07B in capital expenditures (primarily for manufacturing capacity expansion) and $1.35B in free cash flow generation, which supports its long-term growth objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41909,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10698,
        "completion_tokens": 259,
        "total_tokens": 10957
      }
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "Chevron’s involvement in Angola LNG has deepened significantly from 2022 to 2024, transitioning from a major equity stakeholder to a leading operator. In 2022, Chevron held a 36.4% interest in Angola LNG Limited, which it expanded through strategic investments and operational leadership, including the $4.5 billion Wellhead Pressure Management Project and Future Growth Project. By 2024, this partnership solidified Chevron’s role as the primary operator, enabling it to drive production growth and secure long-term gas delivery commitments (e.g., 2.9 trillion cubic feet to global markets through 2024). This evolution reflects Chevron’s strategic focus on leveraging high-margin, long-term LNG projects to strengthen its position in the global LNG market, emphasizing operational control, reserve development, and stable revenue streams amid energy transition pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63701,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16145,
        "completion_tokens": 218,
        "total_tokens": 16363
      }
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "The CH-53K program’s financial contribution grew steadily from 2021 through 2024, with net sales rising 5% in 2024 to $1.1 billion and operating profit climbing 11% year‑over‑year, driven by higher production volume and increased risk retirements on the Sikorsky helicopter line. This upward trend reflects the program’s expanding role within Lockheed Martin’s RMS division, positioning CH‑53K as a key growth engine for the segment despite overall RMS sales being expected to decline slightly in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46257,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11796,
        "completion_tokens": 125,
        "total_tokens": 11921
      }
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "Based on the provided document pages, PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolved significantly between 2022 and 2023. In 2022, the company relied on externally sourced macroeconomic forecasts (such as U.S. credit card charge-off rates and U.K. unemployment projections) to generate loss curves, with a reasonable and supportable forecast period of approximately 2 years for revolving consumer products. By 2023, the forecast period was extended to approximately 5 years for revolving products and 7 months to 3.5 years for installment products, incorporating more granular macroeconomic factors like forecasted household disposable income trends and retail e-commerce sales, while still using externally sourced data to supplement limited historical credit product experience. This refinement allowed for more tailored macroeconomic modeling across different loan segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49337,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12552,
        "completion_tokens": 233,
        "total_tokens": 12785
      }
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "The foreign‑currency‑related gains and losses that were recorded in AOCI declined markedly from fiscal 2023 to fiscal 2024 – the net amount of such gains that remained in AOCI at the end of 2024 was essentially zero (down from a net gain of roughly $11 million in 2023), indicating that the company’s foreign‑currency hedging program generated only modest net gains in 2024 and that most prior gains had been reclassified into earnings. This shift suggests that Starbucks’ exposure to foreign‑currency fluctuations is now largely offsetting, with little net residual gain remaining in AOCI.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50644,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12895,
        "completion_tokens": 147,
        "total_tokens": 13042
      }
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "Based on the provided SEC 10-K pages for Alabama Power and Georgia Power (within Southern Company), the fair value of energy-related derivatives for Alabama Power **decreased from $18 million (2022) to $15 million (2023)**, while Georgia Power's fair value **decreased from $13 million (2022) to $13 million (2023)**. However, the combined liabilities related to these derivatives **increased from $110 million (2022) to $124 million (2023)**, indicating a net rise in their overall liability position despite the decrease in Alabama Power and Georgia Power's individual fair values. This trend reflects a broader increase in their combined derivative liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67550,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17125,
        "completion_tokens": 166,
        "total_tokens": 17291
      }
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Walmart moved from a 49% stake to 100% ownership of Alert Innovation by completing a $0.4 billion acquisition in fiscal 2023 and subsequently settling related liabilities, while later in fiscal 2024 it paid $3.5 billion to acquire additional Flipkart shares and settle non‑controlling interests. The company’s later fiscal 2024 actions involved acquiring shares from Flipkart’s non‑controlling holders and receiving equity funding for PhonePe, but there was no subsequent disposition of Alert Innovation itself.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59994,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15228,
        "completion_tokens": 137,
        "total_tokens": 15365
      }
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy evolved from receiving FDA accelerated approval in April 2021 and full approval in November 2021 for metastatic TNBC, followed by additional approvals in Canada (September 2021) and expanded indications in Europe and other markets. By 2023, Trodelvy had received multiple new approvals, including for hormone receptor-positive/HER2-negative breast cancer (EC approval in September 2023) and as monotherapy for HR+/HER2- breast cancer after prior systemic therapies. This expansion underscores Gilead's strategic focus on broadening its oncology portfolio, particularly in high-need solid tumors, and reinforces Trodelvy's role as a key growth driver in the company's oncology franchise, supporting its ambition to deliver 10+ transformative therapies by 2030.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52866,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13436,
        "completion_tokens": 206,
        "total_tokens": 13642
      }
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's financial relationship with ABG underwent significant evolution through strategic capital transactions and restructuring of ownership stakes. The company reduced its ownership in ABG from approximately 11.8% to 9.6% via a 2023 capital transaction, recognizing a non-cash pre-tax gain of $12.4 million from the deemed disposal, while simultaneously recording deferred tax expenses. This followed earlier transactions where ABG completed multiple capital transactions diluting Simon's stake, including a 2022 transaction that generated $36.4 million in non-cash gains. Most notably, Simon completed a full exit from ABG in early 2024, selling its remaining interest for $1.2 billion in cash, which generated a $414.8 million pre-tax gain, and subsequently dissolved the SPAC entity that had been a key vehicle for these investments. These transactions reflect a deliberate strategic shift to monetize its ABG investment and redeploy capital toward core retail real estate development and repurchase programs, while reducing exposure to the joint venture's operational risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49970,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12718,
        "completion_tokens": 279,
        "total_tokens": 12997
      }
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Between 2022 and 2024, Chevron's financial relationship with Chevron Phillips Chemical Company LLC remained consistent in reporting structure and investment value, as evidenced by its continued inclusion in Note 8 (Summarized Financial Data) and Note 15 (Investments and Advances) across all three 10-K filings. The company's equity investment in Chevron Phillips Chemical Company LLC grew from $7,765 million (2022) to $8,571 million (2024), reflecting increased capital allocation to lower-carbon initiatives, while its share of earnings from the entity remained a key component of downstream segment performance, contributing $1,010 million in 2024 (up from $1,003 million in 2022). This steady investment aligns with Chevron's broader strategy to grow lower-carbon businesses, though the financial reporting of the relationship maintained its traditional segmentation and disclosure framework without structural changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47910,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12204,
        "completion_tokens": 231,
        "total_tokens": 12435
      }
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Based on the provided 10-K pages, Meta's Facilities Consolidation Strategy evolved significantly between the end of 2023 and the end of 2024. In 2023, the company recorded $2.51 billion in restructuring charges related to facilities consolidation (primarily under the 2022 Restructuring plan), with $352 million allocated to general and administrative costs. By the end of 2024, the company had substantially completed the 2022 restructuring initiatives, as noted in Note 3: \"As of December 31, 2024, we have completed the data center initiatives and the 2022 employee layoffs, and substantially completed the facilities consolidation initiatives.\" The 2024 restructuring charges related to facilities consolidation were minimal ($31 million in cost of revenue, $50 million in general and administrative), reflecting the near-completion of the strategy, whereas 2023 had seen significant ongoing charges ($352 million in G&A for 2022 restructuring). The financial impact shifted from active, large-scale implementation in 2023 to minimal residual charges in 2024, indicating the strategy was largely executed by year-end 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40096,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10244,
        "completion_tokens": 281,
        "total_tokens": 10526
      }
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "From 2022 to 2024 Lockheed Martin’s hypersonics effort shifted from early‑stage development to more concrete program execution and production focus.  In the 2022 filing the company highlighted its “hypersonics programs” as part of a broader advanced‑technology portfolio but did not detail a specific production schedule.  By 2024 the same filings note that hypersonics work is being pursued “with the U.S. Air Force and U.S. Army to design, develop and build hypersonic strike weapons,” and the firm references “the Transport Layer programs, small‑satellite capabilities … and advancing hypersonic capabilities” as part of its growth pillars.  This indicates a strategic move toward maturing hypersonic strike weapons for potential acquisition and fielding rather than solely research‑level activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49425,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12576,
        "completion_tokens": 200,
        "total_tokens": 12777
      }
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "From 2022 to 2023, Southern Company’s treatment of energy-related derivatives shifted from explicit regulatory hedging disclosures in 2022 to a more detailed breakdown of unrealized gains/losses and balance sheet impacts in 2023, particularly for Southern Company Gas and Southern Power. The 2023 disclosures show expanded use of regulatory hedging instruments with clearer separation of current vs. deferred regulatory assets/liabilities, while 2022 data lacked such granularity. Additionally, 2023 reflects increased non-designated derivative activity (e.g., $59M gain/loss in natural gas revenues), though the core hedging framework remained consistent. (Based on SO_10k_2022.pdf pp. 322-326 and SO_10k_2023.pdf pp. 293-297)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 324,
          "pages": [
            322,
            323,
            324,
            325,
            326
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 295,
          "pages": [
            293,
            294,
            295,
            296,
            297
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65524,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16610,
        "completion_tokens": 181,
        "total_tokens": 16791
      }
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Based on the provided SEC 10-K filings, Gilead's patent disclosures regarding Truvada did not show a significant evolution in strategy between 2022 and 2023. The 2022 filing (page 37) noted that Truvada's composition-of-matter patent had expired in the EU, with U.S. patent protection for key components like tenofovir alafenamide (TAF) extending to 2031 (with potential extensions), while the 2023 filing (page 36) continued to reference the same patent expirations and highlighted ongoing reliance on patent term extensions and pediatric exclusivity (e.g., Veklury's 2036 U.S. expiration with six-month pediatric extension). Crucially, the 2023 filing emphasized that Truvada's U.S. exclusivity was already lost in October 2020 due to generic competition, and the company's patent strategy focused on protecting next-generation products (e.g., Biktarvy, Descovy) rather than Truvada itself. No new patent filings or strategic shifts for Truvada were disclosed in 2023, confirming its patent protection had effectively ended.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53304,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13544,
        "completion_tokens": 256,
        "total_tokens": 13801
      }
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "SPG increased its borrowing under the Supplemental Facility from $1.05 billion in 2021 to $1.05 billion drawn in December 2021 and then fully repaid that amount on January 12 2022 using proceeds from a new $500 million floating‑rate note and a $700 million fixed‑rate note issuance.  Subsequent 2022‑2024 activity shows continued use of the Supplemental Facility for refinancing and early‑extinguishment of mortgages, but the facility’s outstanding balance was effectively reduced and replaced by new note issuances and direct repayments, indicating a shift from reliance on the Supplemental Facility toward capital‑market debt to fund repayments and acquisitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50958,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12957,
        "completion_tokens": 166,
        "total_tokens": 13123
      }
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife’s capital management strategy has increasingly prioritized maintaining robust liquidity buffers to support capital allocation decisions amid evolving market conditions. While the 2022 disclosures emphasized liquidity management frameworks and capital adequacy under regulatory frameworks like RBC, the 2024 filing underscores heightened focus on stress testing, counterparty risk mitigation in derivatives hedging, and the role of cash buffers in constraining dividend payments and share repurchases. The evolution reflects a strategic shift toward proactive liquidity resilience, ensuring capital allocation aligns with both regulatory requirements and market volatility, particularly through enhanced monitoring of cash flow forecasts, collateral requirements, and risk management actions in dynamic markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 122,
          "pages": [
            120,
            121,
            122,
            123,
            124
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52084,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13255,
        "completion_tokens": 209,
        "total_tokens": 13464
      }
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Between 2022 and 2023, Starbucks' \"Foreign currency - other\" derivatives shifted from a small net gain position to a significantly larger net gain, with the amount expected to be reclassified from AOCI into earnings increasing from $32.5 million to $32.5 million (though the table shows $32.5M as the expected reclassification amount for 2022, the 2023 figure reflects a substantial increase in the underlying position). The derivatives were classified as part of cash flow hedges, with the foreign currency - other component showing a net gain of $55.3 million in AOCI as of October 2, 2022, which contributed to the $32.5 million expected to be reclassified into earnings within 12 months. This evolution reflects the company's ongoing use of derivatives to manage foreign currency exposure, particularly related to anticipated transactions, with the liability side of the balance sheet also showing increased derivative liabilities tied to these positions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 71130,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18007,
        "completion_tokens": 239,
        "total_tokens": 18247
      }
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "From 2023 to 2024, Coca‑Cola’s strategic engagement with Coca‑FEMSA remained anchored in its bottling‑investment model: the Company retained a significant equity stake (approximately 28 % of Coca‑FEMSA’s shares) and continued to rely on FEMSA as one of its five largest independent bottlers, accounting for about 42 % of global unit‑case volume.  The partnership deepened through expanded incidence‑based concentrate pricing, joint marketing initiatives, and continued supply‑chain financing support, while the Company’s bottling‑investment segment saw a modest reduction in its equity stake due to divestitures and impairment charges.  Financially, the relationship contributed to steady net operating revenue growth for Coca‑Cola, with Coca‑FEMSA’s volume and revenue gains offsetting the slight decline in the Company’s consolidated bottling‑investment carrying value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54864,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13939,
        "completion_tokens": 217,
        "total_tokens": 14156
      }
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Intel's strategic positioning of FPGAs has evolved from a niche, adjacent product to a core component of its broader platform strategy. By 2024, FPGAs are integrated into Intel's adjacent product portfolio (e.g., AIPC, networking, and edge solutions) and support its focus on AI, 5G, and specialized workloads, while the company simultaneously restructured its production focus toward cost efficiency and capital discipline under its 2024 restructuring plan. This shift reflects a move to leverage FPGAs as part of comprehensive platform solutions rather than standalone offerings, aligning with Intel's expanded focus on AI-driven and high-growth markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 70808,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17932,
        "completion_tokens": 164,
        "total_tokens": 18096
      }
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips' Lower 48 operations saw a significant increase in proved reserves, rising from 1,273 million barrels of oil equivalent (MMBOE) at the end of 2022 to 2,775 million barrels of oil equivalent (MMBOE) at the end of 2021 (as shown in the 2021 10-K tables, though note the 2021 data reflects year-end 2021 balances). This growth was driven primarily by extensions and discoveries (508 MMBOE added in 2021) and purchases related to the Concho acquisition (1,169 MMBOE), offset by production (289 MMBOE) and revisions (168 MMBOE downward). Consequently, depreciation, depletion, and amortization (DD&A) expenses for the Lower 48 segment increased substantially, rising from $4,854 million in 2022 to $5,729 million in 2023, reflecting the larger reserve base and ongoing development of proved undeveloped reserves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 164,
          "pages": [
            162,
            163,
            164,
            165,
            166
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83811,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21188,
        "completion_tokens": 210,
        "total_tokens": 21399
      }
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Emerson's ownership in AspenTech increased from 55% to approximately 57% after the November 2024 proposal to acquire the remaining shares, reflecting a continued strategic partnership. Financially, the acquisition contributed to gross margin expansion (50.8% in 2024 up from 49.0% in 2023) due to the Test & Measurement acquisition and higher pricing, while the amortization of acquisition‑related inventory step‑up of $231 modestly reduced margins by about 1.3 percentage points.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40791,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10427,
        "completion_tokens": 120,
        "total_tokens": 10547
      }
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the treatment and availability of shares under the 2015 Director Stock Plan evolved through increased recovery and re-authorization of shares. In 2022, 28,964,432 shares were recovered for issuance (2015–2020), with an additional 2,580,639 recovered in 2021, contributing to a total of 31,545,071 shares recovered since 2015. By 2024, this cumulative recovery reached 37,608,213 shares, with 42,343,146 shares covered by new awards and reinvested dividends on Deferred Shares since 2015. Despite these recoveries, the net shares remaining available for future issuance under the 2015 Stock Plan and 2015 Director Stock Plan decreased slightly from 34,073,114 (as of 2021) to 30,660,961 (as of 2024), reflecting the impact of new award grants and adjustments. Share recovery mechanisms, including forfeitures, cash settlements, and tax withholding, continued to replenish the pool of available shares, while issuance mechanics remained tied to treasury shares or new issuances, maintaining consistency with prior practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 335,
          "pages": [
            333,
            334,
            335,
            336,
            337
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41101,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10506,
        "completion_tokens": 261,
        "total_tokens": 10767
      }
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "From fiscal 2022 to 2023, Starbucks' strategic emphasis on the Global Coffee Alliance shifted toward greater revenue contribution through channel development, as evidenced by a $250 million (16%) increase in Channel Development revenue driven by higher product sales and royalty income from the Alliance, while operating margin declined due to inflationary pressures and supply‑chain constraints affecting the joint‑venture income. This indicates a stronger reliance on the Alliance for growth, offset by margin compression.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 36767,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9417,
        "completion_tokens": 131,
        "total_tokens": 9548
      }
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "Between 2022 and 2023, NextEra Energy's (NEE) direct financial stake in the Mountain Valley Pipeline (MVP) was fully written off through impairment charges recorded in 2022 and 2023, effectively ending its investment in the project. This is evidenced by the 2023 financial statements showing a $1.2 billion impairment charge related to MVP within its equity method investments (Note 8), which reduced NEE's carrying amount in the investment to zero. This outcome indicates NEE's strategic shift away from long-term infrastructure projects like MVP, prioritizing instead growth in renewable energy assets and regulated utility expansion, as reflected in its increased investments in wind, solar, and grid infrastructure through subsidiaries like NEER and NEP.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62304,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15801,
        "completion_tokens": 189,
        "total_tokens": 15991
      }
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic expanded its InterStim neurostimulation portfolio with newer, smaller, and more capable devices—including the InterStim Micro rechargeable and InterStim X platforms—and broadened their therapeutic indications to cover overactive bladder, urinary retention, fecal incontinence, and chronic pain (e.g., SCS therapies such as Intellis, Vanta, and the closed‑loop Percept PC). These advances were highlighted across its Neuroscience and Specialty Therapies segments, reflecting both product innovation and expanded clinical uses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40890,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10443,
        "completion_tokens": 139,
        "total_tokens": 10582
      }
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "From 2022 to 2024, Simon Property Group’s financial stake and strategic relationship with Authentic Brands Group (ABG) evolved through a series of transactions that increased its ownership and strategic alignment. In 2021, Simon acquired additional interests in ABG, including a 50% stake in Forever 21 and Brooks Brothers licensing ventures, and later sold portions of its ABG interest for significant gains (e.g., $18.8 million gain in December 2021). By 2022, Simon held approximately a 10.4% noncontrolling interest in ABG, which was further diluted to ~9.6% after ABG’s capital transactions in 2023. In 2024, Simon sold its remaining ABG stake for $1.2 billion, realizing a $414.8 million pre-tax gain, and subsequently acquired additional interests in ABG for $100 million, reflecting a cyclical pattern of investment and divestment that underscored ABG’s role as a key strategic partner in Simon’s licensing and brand portfolio strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50070,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12734,
        "completion_tokens": 236,
        "total_tokens": 12970
      }
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "Based on the provided SEC 10-K filing data, ConocoPhillips' investment activity in the Lower 48 region evolved significantly from 2021 to 2023, with depreciation, depletion, and amortization (DD&A) expenses reflecting this growth. In 2021, DD&A for the Lower 48 segment was $4,067 million; it increased to $4,854 million in 2022 and further rose to $5,729 million in 2023, indicating accelerated capital investment and reserve development in this key U.S. onshore basin. This upward trend in DD&A aligns with the company's strategic focus on expanding its Lower 48 operations, particularly through acquisitions like the Shell Permian purchase in 2021 and ongoing development of unconventional plays, which drove substantial increases in proved reserves (e.g., Lower 48 NGL reserves grew from 546 million barrels in 2021 to 2,100 million barrels in 2020 and 4,658 million barrels in 2021, though the 2021 figure appears to be a data inconsistency in the provided tables). The rising DD&A expenses thus mirror the company's intensified investment in reserve growth and production infrastructure within this region over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 158,
          "pages": [
            156,
            157,
            158,
            159,
            160
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 73077,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18498,
        "completion_tokens": 282,
        "total_tokens": 18780
      }
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon's treatment and valuation approach for international bonds remained consistent between 2023 and 2024, continuing to use a weighted-average discount rate of 5.0% in 2023 (as stated in the 2023 10-K) and applying the same methodology in 2024, which involved selecting high-quality bonds with maturities aligned to benefit payment periods, non-callable features, and sufficient marketability (minimum $300 million par outstanding). The 2024 disclosures confirm this approach was maintained, with no indication of a change in the methodology for valuing international bonds in the pension and postretirement benefit plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51514,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13096,
        "completion_tokens": 156,
        "total_tokens": 13253
      }
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Between 2022 and 2024, Emerson's relationship with AspenTech evolved from a partial ownership stake (55% as of 2022) to a full acquisition bid in November 2024, proposing to buy the remaining ~43% of AspenTech for $240 per share, implying a $15.3 billion fully diluted market cap. Financially, Emerson's stake in AspenTech grew significantly, with goodwill increasing from $77 million in 2021 to $8,326 million by 2022, reflecting the acquisition of Heritage AspenTech in 2022. Operationally, AspenTech became fully integrated into Emerson's portfolio, contributing to key segments like Software and Control, where its acquisition drove a 48% sales increase in 2024. The 2024 financial statements confirm AspenTech's substantial role, including its $1,000 debt issuance in 2028 and integration into Emerson's restructuring and financial reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38809,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9922,
        "completion_tokens": 211,
        "total_tokens": 10134
      }
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' interest rate swap position underwent a significant shift in classification and liability structure. In 2022, the company had designated interest rate swaps as fair value hedges with a cumulative fair value hedging adjustment of $(52.3) million included in the carrying amount of long-term debt ($21.7 million gain in 2021), but by 2023, these swaps were reclassified as non-designated derivatives, resulting in a $34.0 million liability reported in other long-term liabilities (up from $0 in 2022). This transition meant the swaps were no longer accounted for as hedging instruments with gains/losses in AOCI, but instead marked-to-market with changes recorded directly in earnings through interest expense. The shift reflected a strategic move away from formal hedge accounting for interest rate risk management, increasing the volatility of earnings but simplifying the accounting treatment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 71130,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18005,
        "completion_tokens": 232,
        "total_tokens": 18237
      }
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "From 2022 to 2023, NextEra Energy Resources’ financial commitment and involvement with the Mountain Valley Pipeline shifted dramatically. In 2020, NEER held a $1.9 billion equity investment that was written down to $400 million after regulatory and legal hurdles caused an other‑than‑temporary impairment, resulting in a $1.5 billion pre‑tax charge. By early 2022, further setbacks—including a Fourth Circuit vacatur of key permits—prompted NEER to reassess the project, concluding that completion was highly unlikely. Consequently, in the first quarter of 2022 NEER recorded an additional $800 million impairment, fully writing off its remaining equity stake and recognizing a $200 million liability for its share of future ARO costs. Thus, NEER’s financial exposure moved from a large, active investment to a fully impaired, essentially terminated involvement with the pipeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69516,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17596,
        "completion_tokens": 220,
        "total_tokens": 17816
      }
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The Company's investment in equity and debt securities related to its captive insurance company's reinsurance of group annuity contracts remained substantial and stable between 2023 and 2024, with solvency capital funds held in such securities totaling $1,378 million as of December 31, 2023 and increasing to $1,643 million as of December 31, 2024. This growth reflects the Company's continued investment of a majority of its captive insurance subsidiaries' solvency capital in marketable equity and debt securities to meet regulatory requirements, though the specific evolution of these investments within the captive structure is not detailed beyond the reported totals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55998,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14230,
        "completion_tokens": 168,
        "total_tokens": 14398
      }
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node has evolved from a delayed 2022 launch to full production by 2024, with Intel 4 now in high-volume manufacturing at its Ireland facility and serving as the foundation for the Intel Core Ultra Series 1 (the first AI PC chips). Strategically, Intel 4 is positioned as a critical enabler for its new hybrid architecture and AI-focused product roadmap, directly supporting the company's IDM 2.0 strategy to regain process leadership and drive competitive differentiation through features like the integrated neural processing unit (NPU) in its client CPUs. This node is central to Intel's 2024 product strategy, with the company emphasizing its role in delivering \"the first AI PCs\" and expanding its portfolio across client, data center, and edge segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43456,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11093,
        "completion_tokens": 199,
        "total_tokens": 11292
      }
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved from a partial ownership stake to full acquisition. In November 2024, Emerson proposed to acquire the remaining ~43% of AspenTech's shares for $240 per share, implying a $15.3 billion fully diluted market cap, building on its existing ~57% ownership. This followed the 2022 transaction where Emerson contributed its industrial software businesses to Heritage AspenTech, creating \"New AspenTech\" and increasing its stake to 55%. The 2024 proposal marks Emerson's intent to fully consolidate AspenTech, integrating it into its portfolio as a wholly owned subsidiary, while simultaneously exploring a sale of its Safety & Productivity segment. This acquisition would complete Emerson's strategic integration of AspenTech's asset optimization software into its broader automation ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43079,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10991,
        "completion_tokens": 216,
        "total_tokens": 11208
      }
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "Intel's Intel 4 process node has evolved from a planned 2023 launch to high-volume manufacturing in Ireland by 2024, featuring significant performance-per-watt improvements (approximately 20% over Intel 7) and serving as the foundation for the first high-volume client products like the Intel Core Ultra series. The company has shifted focus from the canceled Intel 20A node to the more advanced Intel 18A (featuring gate-all-around transistors and backside power delivery) for 2025 production, while continuing to leverage Intel 7 for the majority of 2024 processor production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58346,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14812,
        "completion_tokens": 144,
        "total_tokens": 14956
      }
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "Between 2022 and 2024, InterStim Micro’s role within Medtronic’s Pelvic Health therapies evolved from a rechargeable neurostimulation platform for overactive bladder and fecal incontinence to a fully implantable, recharge-free system (InterStim Micro) integrated into the broader InterStim product line. It was positioned alongside InterStim X and InterStim II as a next-generation, minimally invasive solution, emphasizing enhanced patient convenience and expanded clinical adoption through its recharge-free design and integration with Medtronic’s AI-driven surgical planning (AiBLE) ecosystem. This evolution was underscored by its U.S. FDA approval in April 2024, reflecting its growing clinical acceptance and strategic focus within the Pelvic Health portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39159,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10003,
        "completion_tokens": 191,
        "total_tokens": 10194
      }
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The dilutive impact of LTIP Units is described as “potentially dilutive securities include units that are exchangeable for common stock and long‑term incentive performance units, or LTIP units, granted under our long‑term incentive performance programs that are convertible into units and exchangeable for common stock,” but the filings explicitly state that “No securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019” (2021 filing) and similarly for 2022‑2024. Consequently, while LTIP Units are disclosed as potentially dilutive, the company’s disclosures consistently indicate that they have not produced a material dilutive effect across all reporting periods examined.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50955,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12964,
        "completion_tokens": 178,
        "total_tokens": 13143
      }
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 to 2024, MetLife’s approach to managing cash buffer needs in relation to stock repurchases has shifted toward greater emphasis on maintaining sufficient liquidity to support regulatory and operational requirements, including potential future repurchases. In 2022, the company disclosed a $3.0 billion repurchase authorization with approximately $1.5 billion remaining as of December 31, 2021, indicating active use of the authorization. By 2024, while specific repurchase authorizations and remaining capacity were not detailed in the provided pages, the company continued to highlight cash buffer considerations as a key factor influencing its ability to repurchase shares, alongside regulatory restrictions, capital ratios, and liquidity needs. This reflects a strategic evolution where repurchase decisions are increasingly tied to real-time cash flow management and risk mitigation rather than solely long-term authorization levels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39298,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10060,
        "completion_tokens": 236,
        "total_tokens": 10296
      }
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal 2022 to 2023, Starbucks’ foreign‑currency derivative positions shifted from a net derivative asset of $130.5 million (recorded in prepaid expenses and other current assets) to a net liability of $5.8 million (recorded in accrued liabilities), reflecting a $136.3 million swing from asset to liability. This change is evident in the balance‑sheet classifications: the 2022 filing shows derivative assets of $130.5 million and derivative liabilities of $0 million, while the 2023 filing reports derivative assets of $39.9 million and derivative liabilities of $5.8 million for foreign‑currency contracts, indicating that the company’s foreign‑currency hedging position moved from a net asset to a net liability over the one‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66653,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16897,
        "completion_tokens": 186,
        "total_tokens": 17083
      }
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Procter & Gamble's global cash management strategy has evolved to support its restructuring activities and corporate-level financial performance between fiscal 2022 and 2024. The company increased its restructuring spending to $659 million in fiscal 2024 (including $216 million in non-cash foreign currency translation losses from market exits), while maintaining its historical $250–$500 million annual range. This aligns with its broader cash strategy of using operating cash flow to fund dividends, share repurchases, and strategic investments, while leveraging extended supplier payment terms and supply chain financing to optimize liquidity. The strategy emphasizes balancing productivity gains from restructuring with disciplined capital allocation, as evidenced by a 21% increase in adjusted free cash flow to $16.9 billion in fiscal 2024, driven by improved operating cash flow and productivity initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59393,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15079,
        "completion_tokens": 229,
        "total_tokens": 15308
      }
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA expanded Omniverse from a free individual-use platform to a subscription-based enterprise solution, embedding it deeply within its automotive and industrial simulation stack. It became central to DRIVE Sim for autonomous vehicle testing, integrated with DRIVE Software (including Omniverse Avatar for real-time conversational AI), and positioned as a core tool for creating digital twins and 3D simulation workflows across enterprise industries like manufacturing and robotics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 40752,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10416,
        "completion_tokens": 126,
        "total_tokens": 10543
      }
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "Based on the provided 2023 and 2024 SEC filings, AMT's financial commitments related to communications sites evolved with increased capital expenditures and debt management. For 2024, the company expects total capital expenditures of $1,545 million to $1,655 million (including $450 million for data center assets and construction of 2,500-3,500 global communications sites), while maintaining sufficient liquidity through $9.6 billion in total liquidity (as of Dec 2023) and $7.6 billion in available credit capacity. Debt repayments continued through 2023-2024, including $1.7 billion in senior note repayments in 2023 and $1.5 billion in 2024, with future obligations detailed in a $36.8 billion total debt maturity schedule spanning through 2053.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55250,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14037,
        "completion_tokens": 187,
        "total_tokens": 14224
      }
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "ExxonMobil's language around asset divestitures has shifted subtly but significantly between 2023 and 2024, reflecting a more strategic framing of proceeds. In the 2023 10-K (pages 37-41), divestitures were described as part of a \"long-standing and regular disciplined review process\" to ensure assets \"are contributing to the Corporation's strategic objectives,\" with proceeds characterized as a byproduct of this routine optimization. By contrast, the 2024 10-K (pages 34-38) explicitly ties divestment proceeds to \"structural cost savings\" and \"disciplined expense management,\" emphasizing that assets are divested when they \"are no longer meeting these objectives or are worth considerably more to others,\" with proceeds framed as a deliberate tool to \"optimize spending\" and support \"sustainable\" efficiency gains. The language now positions divestitures not merely as asset sales but as active portfolio management to \"drive integration\" and \"deliver higher than average returns,\" with proceeds implicitly linked to structural savings targets ($12.1 billion cumulative by 2024). This evolution underscores a shift from passive disposal to proactive value maximization aligned with capital allocation priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43656,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11152,
        "completion_tokens": 304,
        "total_tokens": 11457
      }
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort shifted significantly from 2022 to 2023, with consolidated assets decreasing from $9.7 billion to $7.8 billion and liabilities declining from $8.1 billion to $7.2 billion. This reduction reflects the resort's debt repayment progress and the consolidation of its financial statements following its 2021 opening, though the company maintains a 30% ownership stake with no additional liquidity commitments beyond its initial investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 53901,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13700,
        "completion_tokens": 122,
        "total_tokens": 13823
      }
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "The nature of Customer Demand Volatility as a risk factor has shifted from a general macro‑economic sensitivity in 2023 to a more pronounced, pandemic‑driven uncertainty in 2024, with heightened emphasis on how volatile demand can disrupt supply‑chain stability and impair financial performance. In the 2024 filing, Caterpillar explicitly links demand swings to pandemic‑related inflation, component shortages and labor constraints, noting that these forces can cause abrupt shifts in order volumes, excess inventory risk, and pressure on pricing and profitability, whereas the 2023 discussion focused mainly on cyclical economic conditions and commodity price volatility. Consequently, the 2024 risk description underscores a tighter coupling between demand volatility, supply‑chain resilience and earnings volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49279,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12554,
        "completion_tokens": 204,
        "total_tokens": 12759
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "From the 2022 10‑K (pages 218‑222) and the 2024 10‑K (pages 215‑219) we see that Capital One classifies most derivatives as Level 2 when they are valued using market‑observable inputs (e.g., yield curves, credit spreads, option volatility) and as Level 3 only when significant unobservable inputs are required (e.g., derivatives with terms that do not align with observable market curves).  \n\nThe Level 3 roll‑forward tables show that net derivative assets (liabilities) were $31 million at the start of 2021 and $31 million at the start of 2020, with movements driven by gains/losses, purchases, settlements and transfers. By December 31 2021 the balance had risen to $19 million, and the 2024 roll‑forward shows a balance of $69 million (with a net gain/loss of $‑15 million and transfers in/out of Level 3).  \n\nThus, the fair‑value hierarchy for net derivative assets (liabilities) shifted from predominantly Level 2 in 2022 toward a larger Level 3 component in 2024, reflecting the use of more unobservable inputs for certain interest‑rate derivatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 220,
          "pages": [
            218,
            219,
            220,
            221,
            222
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 217,
          "pages": [
            215,
            216,
            217,
            218,
            219
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 107226,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 27021,
        "completion_tokens": 264,
        "total_tokens": 27285
      }
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA evolved GeForce NOW from a cloud gaming service into a core component of its broader GPU and cloud platform ecosystem, emphasizing integration with its AI and Omniverse technologies. The service leverages NVIDIA's accelerated computing platform—including RTX GPUs, AI-driven features like DLSS, and cloud infrastructure such as DGX Cloud—to deliver high-performance, low-latency gaming experiences. This positioning underscores its role in extending NVIDIA's full-stack strategy across gaming, AI, and enterprise applications, while expanding its ecosystem through partnerships with cloud providers and developers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 40752,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10412,
        "completion_tokens": 160,
        "total_tokens": 10572
      }
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta’s revenue grew modestly from $1.003 billion in 2022 to $1.036 billion in 2023, a roughly 3% increase. This rise was driven by continued adoption of Inlyta in combination with immune‑checkpoint inhibitors for first‑line treatment of advanced renal cell carcinoma in the U.S., as well as growth in emerging markets, even though it was partially offset by lower volumes and price reductions in certain European markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 72684,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18383,
        "completion_tokens": 105,
        "total_tokens": 18488
      }
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, the treatment of network location intangibles remained consistent in that they continue to be amortized over the shorter of the underlying ground lease term (typically up to 20 years) or their useful life, with renewal options considered only if reasonably certain. However, the Company revised its useful life assumptions for tower assets and related intangibles in early 2024, extending the estimated useful life from 20 to 30 years, which indirectly affects the amortization period of network location intangibles tied to those towers. This change, accounted for as a prospective change under ASC 250, reduced depreciation and amortization expense but did not alter the fundamental amortization methodology for network location intangibles. Additionally, impairment reviews for these intangibles continue to be performed on a site-by-site basis, focusing on recoverability via undiscounted cash flows, with no material change in process noted between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50974,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12973,
        "completion_tokens": 246,
        "total_tokens": 13219
      }
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has intensified between 2023 and 2024, marked by significant production growth and infrastructure expansion. In 2023, the company achieved record output from Guyana's Stabroek Block, with combined gross production exceeding 390,000 barrels per day (bpd) and reaching nearly 440,000 bpd in Q4 2023, driven by the Prosperity FPSO vessel reaching nameplate capacity in January 2024. This growth is part of a pipeline of projects, including the Whiptail development, with plans for six FPSO vessels operational by 2027. Concurrently, ExxonMobil expanded its Permian Basin portfolio through the $59.5 billion acquisition of Pioneer Natural Resources, which accelerated its net-zero emissions target for the basin from 2050 to 2035 and strengthened its upstream growth strategy. While Guyana's production now contributes substantially to global output, the company's overall upstream strategy emphasizes low-cost supply development across Guyana, the Permian, and LNG projects, aligning with its broader focus on advantaged volume growth and emissions reduction. (2-3 sentences)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45778,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11668,
        "completion_tokens": 278,
        "total_tokens": 11947
      }
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "The X1 platform's integration with third-party streaming services expanded significantly between 2022 and 2023, with the 2023 filing noting that X1 now integrates streaming content from services like Peacock, Disney+, and Netflix directly into its interface, and that the Flex/Xumo Stream Box platform enables such integrations as part of its service offering. This evolution reflects Comcast's strategy to reduce cord-cutting by embedding popular DTC streaming services into its core video platform, thereby increasing customer retention and engagement, while also generating commission revenue from third-party streaming service sales—contributing to higher ARPU through enhanced service bundling and reduced subscriber attrition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44333,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11325,
        "completion_tokens": 183,
        "total_tokens": 11508
      }
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Based on the provided 10-K filings, Caterpillar's relationship with FG Wilson has remained consistent in its distribution network structure between 2023 and 2024, with no indication of changes to the number of distributors or geographic coverage for FG Wilson branded electric power generation systems. The 2023 filing (page 65) states FG Wilson systems are sold through \"its worldwide network of 110 distributors covering 109 countries,\" while the 2024 filing (page 66) confirms this network remains unchanged at \"108 distributors covering 158 countries\" – a minor reduction in distributor count but no fundamental shift in the distribution model. The core relationship and global reach of FG Wilson's electric power generation systems distribution network has therefore remained stable, with only a slight adjustment in the reported distributor count.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58417,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14829,
        "completion_tokens": 213,
        "total_tokens": 15042
      }
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Between 2022 and 2024, Capital One’s exposure to securitized debt obligations declined in terms of both carrying value and fair value.  The company’s consolidated VIE tables show that the carrying amount of securitization‑related assets fell from $24,121 million at the end of 2021 to $24,121 million in 2021 (i.e., essentially unchanged in the 2021‑2022 period) and then to $24,121 million in 2022, while the corresponding liabilities (securitized debt) dropped from $15,203 million to $15,256 million and then to $15,256 million, indicating a modest reduction in the amount of debt tied to securitizations.  Moreover, the fair‑value hierarchy tables for 2024 report that the estimated fair value of securitized debt obligations is $14,335 million (Level 2), which is lower than the $18,067 million fair value recorded at the end of 2023, reflecting a downward shift in market‑based valuations of those obligations over the two‑year span.  Consequently, both the carrying amount and the fair‑value estimates of Capital One’s securitized debt decreased modestly from 2022 through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 179,
          "pages": [
            177,
            178,
            179,
            180,
            181
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 220,
          "pages": [
            218,
            219,
            220,
            221,
            222
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50864,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12945,
        "completion_tokens": 271,
        "total_tokens": 13217
      }
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "McDonald's 2023 Form 10‑K shows a $362 million pre‑tax charge in 2023 related to the write‑off of impaired software and $290 million of charges tied to its “Accelerating the Arches” growth strategy, while 2022 included a $1.281 billion pre‑tax charge from the sale of its Russia business and a $271 million gain from the sale of Dynamic Yield. These items are reflected in the “Impairment and other charges (gains), net” line and are excluded when calculating non‑GAAP operating income, which rose 16 % (16 % in constant currencies) in 2023. Consequently, the company’s financing activities and cash‑flow management in 2023 were shaped by these non‑recurring charges, influencing the net cash provided by operations and the composition of its debt‑related financing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30632,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7878,
        "completion_tokens": 191,
        "total_tokens": 8070
      }
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "The Worldwide Business Conduct Manual has evolved from a foundational governance statement in 2022 to a central pillar of Procter & Gamble’s internal control framework by 2024, explicitly integrated into management’s assessment of internal control over financial reporting and reinforced through annual audits, control self-assessments, and linkage to executive compensation. This progression demonstrates P&G’s systematic approach to embedding ethical conduct and compliance into its core governance structure, using the Manual not merely as a policy document but as an operational control mechanism that supports reliable financial reporting and accountability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44870,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11450,
        "completion_tokens": 165,
        "total_tokens": 11616
      }
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "Based on the provided disclosures, ExxonMobil's strategic positioning in Guyana has evolved significantly between 2023 and 2024, particularly through the acquisition of Pioneer Natural Resources. The 2024 10-K explicitly identifies Guyana as a key component of its \"Advantaged Assets\" earnings driver, highlighting its role in the company's growth strategy. This is underscored by the addition of $9.689 billion in long-lived assets in Guyana (up from $6.766 billion in 2023) and the inclusion of Guyana in the \"Advantaged Volume Growth\" category, which encompasses Guyana and LNG as core growth engines. The acquisition of Pioneer, finalized in May 2024, further solidified this positioning, with the transaction contributing to $109.332 billion in total additions to property, plant and equipment for 2024. Consequently, Guyana's operations are now a strategic pillar for ExxonMobil's upstream growth, directly contributing to its advantaged asset base and earnings drivers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46767,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11917,
        "completion_tokens": 244,
        "total_tokens": 12161
      }
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One’s reliance on securitized debt as a funding source has declined modestly over the two‑year period.  In 2021 the company reported $6.25 billion of securitized‑debt issuances (Table 33), while by 2024 the disclosed shelf capacity for credit‑card and auto‑loan securitizations remained $25 billion and $20 billion respectively, but actual issuances fell to $6.25 billion in 2021 and were not repeated in the 2024 filing, indicating a reduced use of securitizations relative to other wholesale funding (e.g., senior notes, which rose to $4.5 billion in 2021 and $4.0 billion in 2020).  Consequently, the proportion of total funding derived from securitized obligations has contracted, reflecting a strategic shift toward broader capital‑market issuances and retained‑loan funding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52383,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13321,
        "completion_tokens": 197,
        "total_tokens": 13518
      }
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA’s Omniverse platform shifted from being positioned primarily as a free‑to‑use, real‑time 3D collaboration and simulation tool for individual creators to a subscription‑based enterprise offering that underpins its broader digital‑twin and industrial‑metaverse strategy.  The 2023 filing highlights Omniverse as a “software subscription for enterprise use” and emphasizes its role in powering digital‑twin simulations, autonomous‑vehicle development, and virtual‑world creation, while also noting growing adoption by industrial customers and integration with the DRIVE ecosystem.  This repositioning reflects a deliberate move to monetize Omniverse for large‑scale corporate use cases, driving enterprise‑level revenue streams alongside its continued free‑tier availability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 40752,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10403,
        "completion_tokens": 203,
        "total_tokens": 10607
      }
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Based on the provided document pages, Pfizer's financial relationship with Viatris evolved such that after the Upjohn separation and combination with Mylan to form Viatris in November 2020, Pfizer entered into various agreements (including MSAs, TSAs, and other post-separation arrangements) with Viatris. Net amounts due from Viatris under these agreements were $53 million as of December 31, 2021 and $401 million as of December 31, 2020, reflecting the transitional financial relationships following the spin-off. These amounts were included in operating cash flows (except for a $277 million payment to Viatris in 2021 reported in financing activities).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 71078,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17992,
        "completion_tokens": 164,
        "total_tokens": 18156
      }
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has intensified between 2023 and 2024, reflecting a shift from exploration to active development and production. In 2023, the company reported 12.6 net exploratory and development wells completed in Guyana, with the Payara development commencing operations using the Prosperity FPSO vessel and continued activity on the Yellowtail project. By 2024, the company had funded the Uaru project and expanded its offshore acreage to 4.6 million acres, while also increasing its stake in the region through acquisitions like Pioneer (closing May 3, 2024). This evolution is underscored by the transition from exploratory drilling (511 total productive development wells in 2023) to sustained development activity, with Guyana now positioned as a core growth area alongside Permian and LNG, explicitly categorized as an \"Advantaged Asset\" in the company's 2024 earnings drivers. The strategic focus has thus moved from establishing reserves to scaling production infrastructure and securing long-term delivery commitments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37104,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9502,
        "completion_tokens": 263,
        "total_tokens": 9765
      }
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "The weighted‑average interest rate on senior notes with maturities > 10 years fell from **4.03 % in 2022 to 3.8 % in 2023**, while the face‑value amount of those notes remained essentially unchanged at **$54.5 billion in 2022 and $53.4 billion in 2023**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 44867,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11437,
        "completion_tokens": 63,
        "total_tokens": 11500
      }
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Based on the 2024 disclosures, Alabama Power and Georgia Power shifted their nuclear decommissioning trust equity allocations toward **Level 2** inputs: Alabama Power’s domestic‑equity holdings rose from 443 M (2023) to 443 M + 208 M (Level 2) and foreign‑equity increased to 145 M (Level 2), while Georgia Power’s domestic‑equity moved to 321 M (Level 2) and foreign‑equity to 170 M (Level 2). Both utilities continued to value these equity positions using observable market inputs (Level 2) rather than Level 1 quoted prices or Level 3 unobservable inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 284,
          "pages": [
            282,
            283,
            284,
            285,
            286
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 91541,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23135,
        "completion_tokens": 139,
        "total_tokens": 23274
      }
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "From 2022 to 2023, NVIDIA's strategic positioning of CUDA evolved from being a foundational software layer for GPU-accelerated computing to a core component of its full-stack platform, deeply integrated across end markets like automotive, data center, and professional visualization. In 2023, CUDA's role expanded through tighter integration with AI-specific hardware (e.g., Hopper architecture, Orin SoC) and software stacks (e.g., DRIVE Software, Omniverse), enabling end-to-end solutions for autonomous driving (DRIVE Hyperion, Orin) and enterprise AI (NVIDIA AI Enterprise). This reinforced CUDA’s role as the unifying programming model for diverse markets, supporting scalable deployment from data centers to edge devices while maintaining ecosystem growth through developer engagement (e.g., Deep Learning Institute, CUDA ecosystem).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 36270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9298,
        "completion_tokens": 209,
        "total_tokens": 9508
      }
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "Based on the provided financial disclosures, Pfizer's contractual relationships with Viatris evolved significantly from 2022 to 2023 through transitional agreements. The company maintained Manufacturing and Supply Agreements (MSAs) and Transition Service Agreements (TSAs) with Viatris following the Upjohn spin-off, with net amounts due to Viatris totaling $33 million as of December 31, 2023 (down from $94 million as of December 31, 2022). These agreements covered manufacturing, labeling, packaging, and other transitional services, with the TSAs largely completed by December 31, 2023, while the MSAs continued for a three-year term post-sale with a two-year extension option. The financial impact of these arrangements was not material to Pfizer's operations in 2023, 2022, or 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83372,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21074,
        "completion_tokens": 197,
        "total_tokens": 21271
      }
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "The relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs has intensified from 2022 to 2023, as evidenced by the company's heightened focus on regulatory risks tied to carbon reduction goals and environmental compliance. Specifically, Duke Energy's 2023 filing emphasizes that evolving state and federal environmental regulations—particularly those targeting greenhouse gas emissions and coal ash management—require significant capital expenditures, while deregulation risks (e.g., customer migration to distributed generation) could erode revenue streams needed to offset these costs. This is reflected in the 2023 document's expanded discussion of \"Regulatory, Legislative and Legal Risks\" and \"Environmental Regulations,\" which detail increased compliance costs for CCR management and climate-related mandates, juxtaposed with deregulation-related threats to cost recovery in retail markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69756,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17660,
        "completion_tokens": 237,
        "total_tokens": 17898
      }
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products declined from 11.3 % in 2022 to 9.5 % in 2023, and further to 7.6 % in 2024, reflecting ongoing share losses.  While pricing actions in 2023 (including a $0.15‑$0.20 per‑pack increase for Marlboro, L&M and Basic and a $0.15 per‑five‑pack increase for Middleton cigars) were modest, the 2024 pricing strategy raised list prices by $0.15‑$0.22 per pack for Marlboro, L&M and Basic and by about $0.13 per five‑pack for Middleton cigars, underscoring a more aggressive price‑increase approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65967,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16717,
        "completion_tokens": 134,
        "total_tokens": 16851
      }
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's investment in \"Other short-term interest-bearing securities\" increased from $138 million (as of December 31 2023) to $135 million (as of December 31 2024) – a modest decline of about $3 million, or roughly 2 %. This slight reduction suggests the company is reallocating a small portion of its short‑term cash holdings, but the overall level remains minimal and is not a material component of its investment strategy. Consequently, the change indicates that Amgen is maintaining a relatively stable, low‑risk short‑term investment position rather than dramatically shifting its short‑term asset mix.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46497,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11857,
        "completion_tokens": 151,
        "total_tokens": 12009
      }
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "From 2022 to 2024, General Dynamics' involvement in Abrams Main Battle Tank upgrades shifted from a $360 million award in 2021 (part of its Combat Systems segment) to $350 million in 2024 for upgrades, engineering, and sustainment support, reflecting continued but stable engagement. The contract scope expanded to include system enhancements like SEPv3 configurations and international production (e.g., Romania), while the estimated potential contract value for Abrams upgrades rose from $360 million in 2021 to $350 million in 2024 (with higher-value options in related programs), indicating incremental growth in scope rather than a transformative shift. The 2024 award emphasized modernization and multi-year sustainment, aligning with broader defense spending trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 19324,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 5055,
        "completion_tokens": 193,
        "total_tokens": 5249
      }
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG’s borrowing arrangements with Corebridge evolved significantly. In 2023, AIG provided a guarantee and collateral support for Corebridge’s debt (including CRBGLH notes and junior subordinated debt), with terms requiring AIG to reimburse any payments made on its behalf and to post collateral if Corebridge’s credit rating fell below specified levels or if it defaulted on debt payments. By 2024, Corebridge had become an independent entity (deconsolidated in June 2024), and AIG’s exposure shifted to a retained equity investment (22.7% ownership as of December 31, 2024), with dividends and stock price changes recognized in net investment income rather than debt guarantees. The $1.24 billion debt issuance by Corebridge in 2023 (reflected in \"Corebridge debt\" under \"Total debt issued or guaranteed by AIG\") was no longer a direct liability of AIG post-deconsolidation, though AIG retained a financial interest in Corebridge’s performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 91458,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23088,
        "completion_tokens": 241,
        "total_tokens": 23329
      }
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Between 2022 and 2024, Tesla’s Solar Roof strategy shifted from early‑stage pilot production to a more mature, volume‑focused rollout, but it remained dependent on external partners for key components and on the company’s broader manufacturing and engineering capabilities.  In 2022 the filing highlighted “retrofit solar energy systems” and noted that Solar Roof was being sold directly and through channel partners while the company worked to improve installation efficiency and collaborate with developers; by 2024 the same sections emphasized that Solar Roof was being integrated with Powerwall, that design and engineering efforts continued to refine durability and aesthetics, and that the business still relied on purchased components and external suppliers for the majority of its solar‑energy hardware.  Consequently, production challenges persisted—particularly in scaling installation capacity and ensuring reliable supply of glass tiles and inverters—while the product’s future success remained tied to Tesla’s broader engineering expertise, its ability to streamline manufacturing processes, and its strategic partnerships for component supply and installation services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45491,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11595,
        "completion_tokens": 295,
        "total_tokens": 11890
      }
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "The retail share of Skoal in the U.S. oral tobacco market declined from 9.3% in 2023 to 7.6% in 2024, reflecting a loss of competitive positioning as the segment's overall retail share also fell from 42.5% to 37.5%. This share erosion, driven by volume declines and competitive pressures in the oral tobacco category, indicates that Skoal is losing ground in the market despite pricing and promotional efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46706,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11899,
        "completion_tokens": 102,
        "total_tokens": 12002
      }
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "Between 2023 and 2024, the risk tied to the concentration of premium‑tier device share among a few companies intensified.  The 2023 filing notes that “the mobile industry is experiencing and may continue to experience concentration of device share among a few companies, particularly at the premium tier,” and that such concentration “may result in lower prices for our products, which could have an adverse effect on our revenues and margins.”  By 2024, Qualcomm explicitly warned that this concentration “could have an adverse effect on our revenues and margins” and highlighted that “the timing and size of purchases by our significant customers may be impacted by the timing of such customers' new or next‑generation product introductions,” which can cause revenue fluctuations.  Consequently, the growing reliance on a handful of premium‑tier OEMs has heightened the potential for pricing pressure and reduced pricing power, threatening revenue stability for Qualcomm.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64257,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16304,
        "completion_tokens": 243,
        "total_tokens": 16547
      }
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Based on the provided document pages, Amgen's allocation to money market mutual funds increased significantly from $2,659 million (as of December 31, 2022) to $10,266 million (as of December 31, 2023), reflecting a substantial expansion in its short-term liquidity management strategy between 2023 and 2024. This growth aligns with the \"Available-for-sale investments\" disclosures in Note 10, where money market mutual funds comprised the entirety of its interest-bearing securities portfolio, rising from $2,659 million to $10,266 million over the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46497,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11845,
        "completion_tokens": 140,
        "total_tokens": 11986
      }
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "Based on the provided document pages, General Dynamics' participation in the Capital Construction Fund (CCF) shows that the amount of U.S. government accounts receivable pledged to the fund remained relatively stable between 2022 and 2024. Specifically, the CCF-related U.S. government accounts receivable pledged was $295 million on December 31, 2021 and 2020 (as noted in the 2021 document), and increased to $333 million on December 31, 2024 (as stated in the 2024 document). This indicates a modest increase in the pledged amount over the period, with the 2024 figure representing the most recent reported balance. The pledged amounts are tied to the CCF program, which allows tax deferral on earnings from eligible U.S. flag merchant marine vessel activities when proceeds are deposited in the fund.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8800,
        "completion_tokens": 201,
        "total_tokens": 9001
      }
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "AIG's financial relationship with Corebridge evolved significantly between 2023 and 2024, marked by the deconsolidation of Corebridge from AIG's U.S. federal income tax group following its IPO and subsequent share sales. This deconsolidation triggered a $4.8 billion loss in the second quarter of 2024, primarily due to recognizing an $8.5 billion retained investment in Corebridge (valued at $28.90 per share) and reclassifying $7.2 billion of accumulated other comprehensive loss, resulting in a net after-tax loss of $4.754 billion from discontinued operations. Post-deconsolidation, AIG retained a 22.7% stake in Corebridge, reflecting its equity method accounting for the investment, with dividends and stock price changes now recognized in net investment income rather than consolidated results. The tax implications included the release of deferred tax assets tied to Corebridge's carryforwards and the impact of the deconsolidation on AIG's tax filing structure, though no material change occurred to the overall deferred tax asset valuation allowance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 255,
          "pages": [
            253,
            254,
            255,
            256,
            257
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 104603,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 26387,
        "completion_tokens": 265,
        "total_tokens": 26652
      }
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla shifted from relying on external battery cell suppliers toward developing its own high-volume, lower-cost cells and structural battery packs to support both vehicle and energy storage production, while expanding localized manufacturing at Gigafactory Texas and Berlin to mitigate supply chain risks. However, this transition has been hampered by persistent global component shortages, semiconductor constraints, and the complexity of scaling new manufacturing processes—particularly for Solar Roof, which faces installation bottlenecks and requires specialized labor, leading to continued sensitivity to supply chain volatility and operational execution challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49017,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12481,
        "completion_tokens": 172,
        "total_tokens": 12654
      }
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "From 2022 to 2023, Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina decreased from approximately $9.5 billion–$10.5 billion to about $7 billion–$8 billion, reflecting a $1.5 billion reduction due to the 2019 settlement with NCDEQ that lowered the excavation cost estimate. This decline indicates that Duke Energy is making measurable progress toward compliance with the Coal Ash Act, as the company has already completed excavation at several sites and is actively implementing closure plans, though the remaining spend will be spread over the next 10–20 years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68400,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17341,
        "completion_tokens": 156,
        "total_tokens": 17497
      }
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The retail share of Altria’s oral tobacco products segment declined from 42.5% in 2023 to 37.5% in 2024, reflecting a loss of market share for its core MST brands (Copenhagen and Skoal) and a modest increase in the on! nicotine pouch share (from 6.8% to 8.3%). This share erosion, coupled with a 1% drop in reported shipment volume and a 2% volume decline when adjusted for calendar and trade effects, indicates that the oral tobacco segment’s growth is being outpaced by the broader industry shift toward oral nicotine pouches and competitive pricing pressures, suggesting Altria’s position within the segment is weakening relative to the overall category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46706,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11914,
        "completion_tokens": 164,
        "total_tokens": 12078
      }
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "From 2023 to 2024, Qualcomm’s reliance on Chinese OEMs for revenue remained a material risk, with the company repeatedly highlighting that a significant portion of its semiconductor and licensing revenues comes from a small number of Chinese original equipment manufacturers (OEMs). This concentration is exacerbated by U.S./China trade tensions, national security policies, and the Chinese government’s “Made in China 2025” semiconductor self-sufficiency goals, which incentivize OEMs to develop their own integrated circuit products or shift to competitors’ solutions. The risk is further amplified by potential government actions—such as export restrictions, tariffs, or licensing limitations—that could curtail Qualcomm’s ability to sell to Chinese customers or source critical components from China. Consequently, this dependence creates substantial vulnerability to revenue volatility and operational disruption, undermining long-term business stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64257,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16285,
        "completion_tokens": 240,
        "total_tokens": 16525
      }
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Based on the provided document pages, Amgen's composition of total available-for-sale investments evolved significantly between 2022 and 2023, with a notable shift toward money market mutual funds. In 2022, total available-for-sale investments were $4,335 million (comprising $1,676 million in U.S. Treasury bills, $2,659 million in money market funds, and $0 in other securities), while in 2023, the total increased to $10,404 million (comprising $0 in U.S. Treasury bills, $10,266 million in money market funds, and $138 million in other short-term securities). This represents a substantial rise in money market fund holdings (from $2,659 million to $10,266 million) and a complete elimination of U.S. Treasury bill holdings, indicating a strategic shift toward higher-liquidity, short-term cash equivalents. The fair value of these investments also grew from $4,335 million to $10,404 million, reflecting both the portfolio expansion and the reclassification of cash equivalents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46497,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11849,
        "completion_tokens": 245,
        "total_tokens": 12095
      }
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Between 2022 and 2023, Shake Shack's presence at SPG's premium outlet properties remained unchanged, with no new locations added or removed. The company continued to operate at select premium outlet properties, including locations at The Mills (e.g., Arizona Mills), but its footprint across SPG's premium outlet portfolio was consistent year-over-year, as evidenced by its recurring mention in tenant lists across multiple properties without any reported expansion or contraction in the provided documentation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69775,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17657,
        "completion_tokens": 127,
        "total_tokens": 17784
      }
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, the classification of retirement annuity contracts within the fair value hierarchy remained consistently categorized as Level 3 assets, as evidenced by their persistent inclusion in the \"Significant Unobservable Inputs (Level 3)\" column across all disclosed tables for both years. This classification persisted despite quantitative changes in their fair value measurements—decreasing from $38 (2022) to $22 (2023) to $22 (2024) for retirement annuity contracts—reflecting minor fluctuations in underlying valuation inputs rather than a shift in hierarchy level. The sustained Level 3 designation indicates that GD maintained its valuation methodology for these contracts, which rely on unobservable inputs such as internal discount rates and actuarial assumptions, consistent with its broader approach to Level 3 assets like insurance deposit contracts. This stability suggests that GD's valuation methodology for retirement annuities remained anchored in internally developed estimates and discounted cash flow models, with no material adjustment to the hierarchy classification despite evolving market conditions or asset allocation strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49310,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12560,
        "completion_tokens": 292,
        "total_tokens": 12853
      }
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG's relationship with Corebridge underwent a fundamental transformation that directly impacted both equity structure and income recognition. Following Corebridge's IPO in September 2022, AIG executed three secondary offerings and repurchased shares, maintaining 52.2% ownership as of December 31, 2023. However, on June 9, 2024, AIG waived board representation rights and relinquished control, triggering deconsolidation of Corebridge. This resulted in a $4.8 billion after-tax loss from discontinued operations, primarily driven by writing off $7.2 billion of accumulated other comprehensive loss and retaining a $8.5 billion investment in Corebridge equity. Post-deconsolidation, AIG retained a 22.7% equity stake and now accounts for its interest using the equity method, recognizing $601 million in income from dividends and stock price changes during 2024. The shift eliminated consolidated equity exposure but introduced significant volatility in net investment income tied to Corebridge's stock price movements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 242,
          "pages": [
            240,
            241,
            242,
            243,
            244
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 130044,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 32736,
        "completion_tokens": 260,
        "total_tokens": 32997
      }
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "From 2022 to 2024, Comcast’s financial exposure to Universal Beijing Resort evolved through its consolidation treatment and debt disclosures. In 2022, Universal Beijing Resort was consolidated as a variable interest entity (VIE), with Comcast reporting $3.6 billion of debt subject to VIE guarantees and $3.5 billion of term‑loan debt outstanding. By 2024, the VIE debt had increased to $3.4 billion outstanding (including $3.0 billion of term‑loan principal), and Comcast’s consolidated balance sheet reflected $7.3 billion in assets and $7.0 billion in liabilities attributable to Universal Beijing Resort, underscoring a growing financial exposure that is now fully consolidated and supported by the company’s own debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54034,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13731,
        "completion_tokens": 183,
        "total_tokens": 13914
      }
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "The structure of aircraft trade-in commitments remained consistent between 2022 and 2023, with options generally establishing fair market value 45 or fewer days before delivery or guaranteeing a pre-determined trade-in value. However, the risk profile increased for commitments structured to guarantee a pre-determined value due to potential adverse market changes. In both years, any excess of the pre-established trade-in price above fair market value at delivery was treated as a reduction of revenue in the new-aircraft sales transaction, and as of December 31, 2023, the estimated change in fair market values from commitment dates was not material. Customer eligibility for these trade-in options was not restricted by the commitments themselves, as they were tied to existing aircraft order backlog rather than specific customer qualifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38688,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9893,
        "completion_tokens": 212,
        "total_tokens": 10105
      }
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Tesla's approach to the Semi has evolved from pilot production (Nevada) in 2022 to active production ramp-up by 2024, with the vehicle now positioned as a strategic component of its commercial electric vehicle lineup alongside the Cybertruck and Cybercab. The Semi is being manufactured at scale to support Tesla's broader goal of expanding its commercial vehicle offerings while leveraging advancements in battery technology and autonomy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37899,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9702,
        "completion_tokens": 109,
        "total_tokens": 9812
      }
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "Based on the provided SEC 10-K pages, the valuation allowance related to Altria's investment in Cronos decreased significantly from $2,256 million at the end of 2023 to $668 million at the end of 2024. This reduction primarily reflects the release of valuation allowances tied to JUUL-related capital loss carryforwards and the impact of the IRS Agreement, indicating that Altria now expects sufficient future taxable income to realize a portion of these deferred tax assets. Consequently, the company reduced its uncertainty regarding the realizability of deferred tax assets associated with its Cronos investment and other tax loss carryforwards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49426,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12596,
        "completion_tokens": 162,
        "total_tokens": 12758
      }
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "The financial treatment and valuation of Amgen’s investment in BeiGene shifted from the equity method to fair‑value accounting in Q1 2023, causing other‑income volatility: 2023 showed gains from fair‑value adjustments, while 2024 reflected net unrealized losses on strategic equity holdings, altering the investment’s earnings impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52465,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13329,
        "completion_tokens": 83,
        "total_tokens": 13413
      }
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's positioning evolved from a standalone regional service to a unified global offering under the Disney+ brand. The company merged its prior Combo+ multi-product offerings (which included Star+ in Latin America) into a single Disney+ product in June 2024, consolidating its streaming strategy to reduce complexity and strengthen brand consistency. This shift reflects a broader regional branding strategy where Disney+ Hotstar in India now operates as part of the global Disney+ platform, while maintaining localized content and market-specific features. The service structure now emphasizes a unified Disney+ identity across all international markets (excluding India, which remains under the Disney+ Hotstar brand), with pricing and subscription models aligned to global standards but adapted for regional market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46657,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11888,
        "completion_tokens": 216,
        "total_tokens": 12104
      }
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "PayPal’s protection‑program costs are recorded as part of transaction expense and credit‑loss provisions, and the company continually refines its risk‑assessment tools and loss‑recovery estimates to manage exposure.  In 2023 the firm expanded its loss‑recovery methodology (e.g., updating forfeiture estimates and adding detailed disclosures about fraud‑related losses) while maintaining the same overall approach to recognizing protection‑program costs, resulting in only modest changes to risk exposure and loss‑recovery mechanisms between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55291,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14045,
        "completion_tokens": 139,
        "total_tokens": 14184
      }
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "From 2022 through 2024, NextEra Energy’s solar‑related assets have shifted from being held primarily through wholly‑owned subsidiaries to being transferred into joint ventures and sold to third‑party investors via Class B membership interests.  These transactions retained a controlling interest for NEE but introduced noncontrolling and redeemable noncontrolling interests, with economics allocated using the hypothetical‑liquidation‑of‑book‑value (HLBV) method and contingent on achieving targeted returns or specific milestones (e.g., a solar PTC by 2022).  Consequently, NEE’s direct ownership of solar facilities has declined, while its financial exposure now consists of equity stakes in VIEs and contingent liabilities tied to the performance of sold projects rather than full ownership of the assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64565,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16366,
        "completion_tokens": 202,
        "total_tokens": 16568
      }
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "Based on the provided document pages, ACN's investment in Mutual Fund Debt Securities within defined benefit pension plans evolved as follows:  \n- **Valuation methodology change**: The fair value hierarchy shifted from Level 3 (with $130,934 ending balance in 2021) to Level 2 dominance, where Level 3 assets (primarily insurance contracts) decreased to $97,881 by 2022 and remained at that level through 2023. This reflects a move toward observable market inputs (Level 2) for debt securities, reducing reliance on actuarial valuations (Level 3).  \n- **Specific change**: The Level 3 reconciliation shows a $33,053 decrease in fair value from fiscal 2022 to 2023 (ending at $97,881), with Level 2 assets now comprising the majority of debt securities (e.g., $379,989 in mutual fund debt securities at Level 2 for Non-U.S. Plans in 2022).  \n\n*(Answer derived from \"Fair Value Measurements\" and \"Level 3 Assets\" sections in ACN_10k_2023.pdf pages 81-85 and ACN_10k_2022.pdf pages 87-91.)*",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33202,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8529,
        "completion_tokens": 246,
        "total_tokens": 8776
      }
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron's financial stake in Tengizchevroil increased from $22,685 million at the end of 2022 to $26,954 million by the end of 2023, reflecting a rise of roughly $4.3 billion in the carrying value of its 50 % equity investment. This growth is also evident in the equity‑method earnings reported for Tengizchevroil, which rose from $1,238 million in 2020 to $3,375 million in 2023, underscoring the company's expanding involvement and financial exposure to the joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56436,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14317,
        "completion_tokens": 118,
        "total_tokens": 14436
      }
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Disney's relationship with ABC Network has deepened strategically within its broader entertainment ecosystem, particularly through the integration of ABC's linear networks and local stations into Disney's Direct-to-Consumer (DTC) and content licensing frameworks. The ABC Network, owned by Disney, serves as a key distribution channel for Disney's entertainment content, with its programming (including ESPN on ABC and ABC-owned stations) generating affiliate fees and advertising revenue that support Disney's overall segment performance. This relationship is reinforced by Disney's investment in ABC's infrastructure, such as its eight owned television stations reaching nearly 100% of U.S. households, and its use of ABC for distributing Disney-produced content across linear and streaming platforms. Additionally, Disney's 2024 strategic moves, including the planned joint venture for sports-focused streaming (Venu Sports) and the integration of ABC content into Disney+ and Hulu, underscore ABC's role in enhancing Disney's content portfolio and revenue streams within its Entertainment segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42542,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10862,
        "completion_tokens": 275,
        "total_tokens": 11137
      }
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics' ASCOD vehicle positioning within its Land Systems portfolio evolved from being highlighted as part of a broader tracked combat vehicle offering (including Piranha, Duro, Eagle, and AJAX) in 2022 disclosures to being explicitly cited as a key platform under European Land Systems (ELS) production—specifically, ELS was producing ASCOD variants (e.g., Spanish Pizarro and Austrian Ulan) alongside upgrades for Germany, Switzerland, and other allies. This shift reflects a strategic emphasis on expanding ASCOD production and international partnerships, particularly in Europe, while simultaneously increasing investment in next-generation platforms like the M1E3 Abrams and Stryker upgrades. The rising revenue share of the Combat Systems segment (from 19% in 2021 to 20% in 2023) and the explicit focus on ASCOD production volumes (e.g., \"360 new LAVs\" for Canada and AJAX for the UK) indicate a clear pivot toward prioritizing land vehicle modernization and export growth, likely driving greater allocation of resources toward tracked vehicle development and production capacity expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 24349,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6325,
        "completion_tokens": 282,
        "total_tokens": 6607
      }
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal’s use of European customer balances for credit activities shifted markedly between 2023 and 2024: the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) approved a reduction in the amount of European customer balances that can be designated for credit funding, from $3.0 billion (≈39 % of European balances) in 2023 to $2.0 billion (≈26 % of European balances) in 2024.  Consequently, the company’s ability to fund its European‑focused credit products through that pool of customer deposits has declined, prompting it to rely more on external financing arrangements such as the $5 billion revolving credit facility, the Paidy credit line, and the sale of consumer installment receivables to third‑party investors.  This reallocation signals a strategic pivot toward diversifying its credit‑funding sources and reducing dependence on internal customer‑balance funding in Europe.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50946,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12968,
        "completion_tokens": 224,
        "total_tokens": 13193
      }
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, NEE's Special Use Funds disclosures show a clear evolution in both valuation methodology and transparency. The 2022 filing (pages 88-92 of NEE_10k_2022.pdf) details fair value measurements using Level 1, Level 2, and Level 3 hierarchies for equity and debt securities, with special emphasis on commingled funds and nuclear decommissioning reserves. By 2024 (pages 87-91 of NEE_10k_2024.pdf), the disclosure expands significantly to include more granular breakdowns of Level 3 inputs, enhanced commentary on valuation techniques (e.g., probability-weighted EBITDA multiples for impaired investments), and explicit references to regulatory frameworks governing fund management. Crucially, the 2024 filing also introduces detailed quantitative disclosures about credit-risk-related contingent features in derivatives, including specific collateral requirements tied to credit rating downgrades—a level of operational transparency not fully articulated in 2022. This evolution indicates not only improved transparency in fair value reporting but also a strategic shift toward greater disclosure of risk exposures, particularly in complex derivative instruments and regulatory capital management. The inclusion of forward-looking impairment assessments (e.g., for Mountain Valley Pipeline) further underscores a move toward more dynamic and risk-aware financial reporting practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70696,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17909,
        "completion_tokens": 350,
        "total_tokens": 18259
      }
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, the scope of Accenture's share purchase program remained focused on its publicly announced open‑market repurchase initiative, but the scale of activity shifted. In fiscal 2022, the company purchased 1,964,612 shares under that program for $576 million, with an additional $97,251 shares bought outside the program for employee‑related tax withholding. By fiscal 2023, the total dollar authorization for share purchases and redemptions had been expanded to $6.1 billion, reflecting an increase in available capital for repurchases, yet the public program continued to be the primary vehicle for acquiring shares, while employee‑related transactions remained a separate, smaller‑scale activity that did not affect the public‑program authorization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 29763,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7684,
        "completion_tokens": 194,
        "total_tokens": 7878
      }
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Between 2022 and 2023, Chevron's consolidation status and investment accounting approach for Chevron Phillips Chemical Company LLC remained consistent: the company continued to use the equity method for its 50% investment in CPChem (as disclosed in Note 8), with no change in consolidation status. The 2023 Annual Report (Note 8) confirms CPChem's summarized financial data is presented under the equity method, and the company's investment in CPChem is explicitly detailed in Note 8 as part of its summarized financial data, maintaining the same accounting treatment as in prior years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50683,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12907,
        "completion_tokens": 146,
        "total_tokens": 13053
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "From 2022 to 2023, the role of Hydra-70 rockets in General Dynamics’ Combat Systems segment shifted from a modest production line to a clearly defined growth priority.  In 2022 the company recorded a $175 contract award for Hydra‑70 rockets, and by 2023 OTS announced a major capacity expansion – increasing metal‑parts output from 18,000 to 86,000 rounds per month by 2025 and expanding propellant capacity from 4 million to 16 million lb per year by 2028 – to meet rising demand for the rockets.  This investment underscores that Hydra‑70 production is now being scaled up as a key component of the segment’s munitions portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 25933,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6713,
        "completion_tokens": 157,
        "total_tokens": 6871
      }
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "Based on the provided SEC 10-K filings, PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice has evolved in documentation status and associated agreements as follows:\n\n1.  **2023 Filing (PYPL_10k_2023.pdf):** The relevant documentation is explicitly listed as **Exhibit 10.07+** (\"Form of Global Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan\"), which was incorporated by reference from the 2015 plan documents (filed as 10-12B/A on 5/14/2015). This indicates the notice and agreement were formally part of the company's historical equity incentive framework.\n\n2.  **2024 Filing (PYPL_10k_2024.pdf):** The documentation status changes significantly. The **2023 Exhibit 10.07+** entry is **no longer listed** in the 2024 Exhibit Index. Instead, the **2024 filing explicitly references a new, updated agreement** under **Exhibit 10.08+** (\"Form of Global Performance Based Restricted Stock Unit Award Grant Notice and Performance Based Restricted Stock Unit Award Agreement under the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, as amended and restated\"), filed as a 10-Q on 4/30/2024. This indicates the original Global RSU Grant Notice and Agreement was superseded by a revised version specifically for performance-based awards, reflecting an evolution in the program's structure and documentation.\n\n**In summary:** The Global Restricted Stock Unit Award Grant Notice was formally documented in the 2023 filing as part of the original 2015 plan (Exhibit 10.07+), but by the 2024 filing, it was replaced and superseded by a new, amended agreement for performance-based RSUs (Exhibit 10.08+), indicating an evolution in the program's documentation and terms. The original notice is no longer referenced in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68206,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17288,
        "completion_tokens": 463,
        "total_tokens": 17752
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "Based on the provided 10-K excerpts, Opdivo's role within Bristol-Myers Squibb's portfolio has evolved from being a significant but secondary revenue driver to a central pillar of growth. Its revenue increased steadily from $6,992 million in 2020 to $7,523 million in 2021, and the drug received multiple new regulatory approvals between 2022 and 2024 (including subcutaneous formulation, urothelial carcinoma combinations, and expanded indications), solidifying its position as a key growth engine. These approvals, coupled with its expanding use across oncology and other therapeutic areas, have transitioned Opdivo from a mature product to a strategically vital asset driving substantial future revenue and portfolio diversification.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 43563,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11115,
        "completion_tokens": 184,
        "total_tokens": 11299
      }
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Chevron’s financial involvement and strategic support for Chevron Phillips Chemical Company LLC (CPChem) intensified between 2022 and 2023, with the company’s equity stake in CPChem rising from $6.843 billion to $7.765 billion and its share of CPChem’s earnings increasing from $867 million to $608 million, reflecting a stronger capital commitment.  During this period CPChem advanced two major projects— a 266,000‑ton‑per‑year 1‑hexene unit at Old Ocean, Texas (final investment decision in May 2021) and a new C3 splitter at Cedar Bayou, Texas (final investment decision in December 2021) — both slated for start‑up in 2023, and Chevron also expanded its non‑equity investments, underscoring a continued strategic focus on growing its petrochemical and downstream integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51606,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13135,
        "completion_tokens": 194,
        "total_tokens": 13330
      }
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "PayPal’s protection‑program costs are recorded as part of transaction and credit losses, with an allowance for transaction losses of $86 million at the end of 2024 (up from $64 million in 2023) and an allowance for negative customer balances of $256 million (up from $218 million). These reserves reflect the company’s ongoing estimation of losses from fraud‑related and other protection‑program reimbursements, and the increase signals a higher financial commitment to covering such losses in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47591,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12121,
        "completion_tokens": 124,
        "total_tokens": 12246
      }
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's continued to position franchising as the core of its growth strategy, emphasizing that \"franchising is paramount to delivering great-tasting food, locally relevant customer experiences and driving profitability.\" The company highlighted its co-investment model with franchisees to fund restaurant improvements and technology, stating that these investments \"are designed to cater to consumer preferences, improve local business performance and increase the value of the McDonald's brand.\" This framing reinforced the view of franchising as a mutually beneficial partnership where franchisee co-investment supports both operational enhancements and brand value creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61950,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15722,
        "completion_tokens": 175,
        "total_tokens": 15898
      }
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "Between 2022 and 2023, the FDA’s regulatory trajectory for heated tobacco products shifted from stalled authorization to renewed engagement: while the IQOS system and Marlboro HeatSticks had received PMTA and MRTP authorizations by 2020–2021, the FDA did not finalize action on Marlboro HeatSticks’ inclusion in graphic warning rules or resolve ongoing ITC enforcement disputes until 2023, when it authorized three new Marlboro HeatStick flavors (March 2023) and signaled intent to finalize product standards for menthol and characterizing flavors in cigars by 2024. This indicates Altria has made measurable regulatory progress—securing product authorizations and navigating FDA review cycles—but remains dependent on evolving FDA decisions regarding flavor restrictions, post-market surveillance, and potential future product standard expansions that could impact commercial viability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58316,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14807,
        "completion_tokens": 221,
        "total_tokens": 15028
      }
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of mutual fund equity securities held by ACN increased substantially from $239,293 million as of August 31 2022 to $239,293 million as of August 31 2023 (the figures shown are identical in the provided tables, indicating no change reported between those years). This suggests that ACN’s investment positioning in mutual‑fund equity securities remained stable during the period, with no net gain or loss reflected in the disclosed fair‑value measurements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33202,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8532,
        "completion_tokens": 117,
        "total_tokens": 8649
      }
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "From 2022 to 2023, Chevron's focus in Angola shifted from upstream development toward the operational execution of the Angola LNG project. In 2022, the company made significant progress on the Angola LNG plant, including finalizing the Sanha Lean Gas Connection Project and advancing the non-associated gas development to supply the facility, while continuing to manage its deepwater Angola operations (e.g., Block 0, Block 14, and Angola LNG Limited). By 2023, the emphasis remained on completing key infrastructure for Angola LNG, such as the multiphase subsea pump project at Jack/St. Malo and the Mad Dog 2 Project, but the strategic priority increasingly centered on leveraging Angola's gas resources for LNG production rather than expanding oil-focused upstream investment. This evolution reflects a sustained, though not expanded, commitment to Angola's gas sector as part of Chevron's broader international upstream strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50970,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12964,
        "completion_tokens": 233,
        "total_tokens": 13197
      }
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "From 2022 to 2023, 3M's investment in Certificates of Deposit/Time Deposits declined from $31 million to $14 million, a reduction of $17 million (approximately a 55% decrease). This represents a net decrease of $17 million in the balance of these deposits over the one‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63708,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16145,
        "completion_tokens": 70,
        "total_tokens": 16216
      }
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Based on the provided 10-K filings, McDonald's relationship with franchisees has evolved such that the proportion of franchised restaurants increased significantly between 2021 and 2024. In 2021, 93% of the 40,031 restaurants were franchised, and by 2024, approximately 95% of the 43,477 restaurants were franchised. This indicates a continued and growing reliance on the franchised business model, with franchising remaining paramount to the Company's strategy for delivering food, customer experiences, and profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54556,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13854,
        "completion_tokens": 130,
        "total_tokens": 13985
      }
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective October 26 2022 (as disclosed in the 2022 filing) and subsequently referenced again in the 2023 filing, confirming its continued use with no further structural changes reported between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60353,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15307,
        "completion_tokens": 73,
        "total_tokens": 15381
      }
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Accenture's investment in Duck Creek Technologies was valued at $138,902 (carrying amount) on its balance sheet as of August 31 2022, with an estimated fair value of $223,166. The company recognized a $253 million investment gain in fiscal 2023 related to this equity method investment, which was excluded from its adjusted earnings per share calculations. Consequently, the financial impact of the Duck Creek investment was reflected as a one‑time gain that boosted adjusted earnings but did not materially affect overall revenue trends between fiscal 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43698,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11156,
        "completion_tokens": 141,
        "total_tokens": 11298
      }
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, Breyanzi’s therapeutic application expanded through multiple new regulatory approvals that broadened its target populations and indications. In 2024 specifically, the FDA granted accelerated approvals for Breyanzi to treat relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after prior B‑cell lymphoma 2 inhibitor therapy, and also for relapsed or refractory follicular lymphoma after at least two prior lines of systemic therapy. Additionally, Japan’s PMDA approved Breyanzi for relapsed or refractory follicular lymphoma and for high‑risk follicular lymphoma, while the EU extended its approval to include first‑line treatment of adult patients with microsatellite‑instable or mismatch‑repair‑deficient colorectal cancer in combination with Yervoy. These approvals added new oncology indications and geographies, significantly increasing Breyanzi’s addressable patient pool and market potential.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50786,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12922,
        "completion_tokens": 239,
        "total_tokens": 13162
      }
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023 by incorporating more detailed analysis of pending respirator‑mask/asbestos claims and their associated insurance recoveries. In 2023 the company increased its accrual for these liabilities by $57 million and recorded $88 million in legal‑defense costs and settlements, while also recognizing an immaterial insurance receivable for recoveries, reflecting a more explicit estimation of probable losses and related insurance receivables in its financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54094,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13760,
        "completion_tokens": 150,
        "total_tokens": 13910
      }
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "Between 2022 and 2023, PepsiCo’s relationship with Naked evolved from full ownership to a strategic partnership: in the first quarter of 2022, PepsiCo sold its Tropicana, Naked and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in the newly formed joint venture (TBG) that operates across North America and Europe. This arrangement gave PepsiCo an operational role in distributing Naked’s portfolio through its exclusive direct-store-delivery network for small-format and foodservice customers in the U.S., while maintaining a financial stake in the joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42566,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10859,
        "completion_tokens": 151,
        "total_tokens": 11010
      }
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "The ExtraBucks Rewards program was initially treated as a separate performance obligation at the time of the initial transaction, with revenue allocated to the rewards based on relative standalone selling prices and historical redemption patterns. Revenue allocated to ExtraBucks is recognized only when the rewards are redeemed, and unredeemed rewards remain as a contract liability on the balance sheet. This approach was consistent in both 2023 and 2024, with no material changes to the accounting treatment or disclosure of the program between those years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 125,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47059,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12005,
        "completion_tokens": 140,
        "total_tokens": 12145
      }
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Based on the cost of revenues data provided for 2023 and 2024, Netflix's reliance on integrated payment partners has evolved in the following ways:\n\n1.  The cost of revenues section explicitly states that \"Other operations costs include customer service and payment processing fees, including those we pay to our integrated payment partners\" within the description of cost of revenues components.\n2.  While the specific dollar amount allocated to integrated payment partners isn't broken out separately in the provided cost of revenues tables for either year, the overall cost of revenues increased from $19,715,368 million (2023) to $21,038,464 million (2024), representing a 7% increase.\n3.  This increase was driven by a $376 million increase in \"other cost of revenues\" (as noted in the 2023 cost of revenues explanation: \"a $376 million increase in other cost of revenues primarily due to an increase in expenses directly associated with the acquisition, licensing and production of content\") and a $171 million increase in content amortization. The explanation for the 2024 increase specifically cites \"a $1,104 million increase in content amortization\" and references the overall cost of revenues increase being due to these factors, but does not isolate the portion attributable *specifically* to integrated payment partner fees.\n4.  The description of \"Other operations costs\" confirms that payment processing fees paid to integrated payment partners are a component of cost of revenues, meaning Netflix's reliance on these partners for payment processing remains a consistent, though not separately quantified, element within the overall cost structure. The evolution shows the *total* cost of revenues increasing, but the specific contribution of integrated payment partners to that increase cannot be isolated from the provided data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 82874,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20946,
        "completion_tokens": 461,
        "total_tokens": 21407
      }
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M’s approach to managing PFAS contamination in Minnesota shifted from a largely settlement‑focused strategy to a more proactive, regulator‑driven remediation program.  The company continued to work under the 2007 Settlement Agreement and Consent Order with the Minnesota Pollution Control Agency, but in 2023 it responded to newly issued, more stringent health‑based values (HBVs) for PFOA and PFOS by evaluating their impact on its obligations and by advancing additional groundwater monitoring, treatment, and storm‑water controls at its Cottage Grove and other sites.  This regulatory‑driven expansion reflects a move toward broader, long‑term remediation and compliance actions rather than solely relying on earlier settlement agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60710,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15405,
        "completion_tokens": 190,
        "total_tokens": 15596
      }
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo's use of foreign currency derivatives increased substantially from $1.9 billion in notional value at the end of 2020 to $2.8 billion at the end of 2021, and further to $3.8 billion by the end of 2023. This expansion reflects a more proactive hedging program aimed at mitigating foreign‑exchange volatility across its global operations, while still relying on net‑investment hedges and forward contracts with maturities of two years or less. The upward trend indicates that PepsiCo is strengthening its foreign‑exchange risk management strategy to protect earnings and cash flows from adverse currency movements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41394,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10576,
        "completion_tokens": 154,
        "total_tokens": 10730
      }
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil's chemical production capacity additions shifted geographically toward China with the sanctioned Dayawan Petrochemical Industrial Park complex in Guangdong Province, designed to produce over 2.5 million metric tons annually of high-performance polyethylene and polypropylene for the growing Chinese market. This expansion complements existing U.S. Gulf Coast projects like the Corpus Christi ethane cracker (operational late 2021) and Baytown advanced recycling facility (starting 2022), while 2023 saw strategic capacity additions in the U.S. (Baytown performance polymers and linear alpha olefins units) to support specialty chemical demand, though overall chemical margins remained pressured by bottom-of-cycle conditions and supply exceeding demand growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 25136,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6516,
        "completion_tokens": 198,
        "total_tokens": 6714
      }
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "From 2022 to 2023, 3M’s investment in Certificates of Deposit/Time Deposits declined sharply, falling from $21 million (as reported in the 2022 balance sheet) to just $49 million by year‑end 2023, with the net marketable securities balance dropping from $261 million to $73 million. This reduction reflects a strategic shift toward prioritizing liquidity and short‑term cash management over holding longer‑term, low‑yielding time deposits, indicating that 3M is reallocating cash to more flexible or higher‑return investments and to fund ongoing operations and capital projects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47018,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11982,
        "completion_tokens": 144,
        "total_tokens": 12127
      }
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard’s 2023 10‑K shows a clear shift in how it frames proprietary insights and data responsibility.  In the 2022 filing the language focused on “proprietary insights, drawing on Mastercard’s principled use of consumer and merchant data,” while the 2023 filing expands this to emphasize “principled and responsible use of secure consumer and merchant data” and explicitly ties these insights to its broader “value‑added services” and “cyber and intelligence solutions.”  This evolution reflects a more mature, trust‑building narrative that links data stewardship directly to the company’s franchise model and stakeholder‑centric approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 61541,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15607,
        "completion_tokens": 160,
        "total_tokens": 15768
      }
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "The accounting estimates for pension and retiree medical plans were revised downward in 2023, reflecting a more challenging external environment marked by rising inflation, higher interest rates, and ongoing geopolitical uncertainties (e.g., the Ukraine conflict and Middle East tensions). These factors increased the volatility and complexity of projecting long-term liabilities, prompting more conservative assumptions in the valuation of pension and retiree medical obligations. Consequently, the company recorded impairment charges related to these estimates, underscoring how macroeconomic pressures are reshaping critical accounting judgments and potentially affecting future financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39965,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10229,
        "completion_tokens": 175,
        "total_tokens": 10404
      }
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region declined from 37,833 gross (18,985 net) thousand acres at year-end 2020 to 32,441 gross (15,838 net) thousand acres at year-end 2021, reflecting a reduction of approximately 5,392 gross (3,147 net) thousand acres over the period. This decrease indicates the company is actively managing its exploration portfolio, likely focusing on higher-potential areas while maintaining sufficient undeveloped acreage to support future development through extensions and workovers, as noted in the document's statement that scheduled lease expirations are not expected to have a material adverse impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39272,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10050,
        "completion_tokens": 163,
        "total_tokens": 10213
      }
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, the financial impact of non-functional currency items shifted markedly: the gross notional amount of foreign‑exchange forwards not designated as hedging instruments fell from $3.7 billion to $3.4 billion, and the related after‑tax unrealized loss in accumulated OCI dropped from $87 million to $26 million (with an expected $26 million gain to be reclassified into earnings over the next 12 months). Consequently, the pre‑tax gain/loss on these de‑designated contracts moved from a $159 million gain in 2022 to an $81 million gain in 2023, reflecting a reduced reliance on non‑hedge foreign‑currency contracts and a smaller cash‑flow hedging balance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58934,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14971,
        "completion_tokens": 167,
        "total_tokens": 15139
      }
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, Cyber and Intelligence Solutions evolved from a niche offering within Mastercard's broader \"value-added services\" category to a clearly defined revenue stream with dedicated fee income. While the 2022 10-K only mentioned cyber and intelligence solutions as part of \"other revenues\" without specific growth metrics, the 2023 filing explicitly highlights \"Cyber and intelligence solutions fees\" as a distinct revenue source contributing to the $6.2B \"Other revenues\" figure (up from $4.7B in 2022), reflecting its growing strategic importance within Mastercard's value proposition. This shift underscores a deliberate emphasis on security and intelligence as core differentiators alongside its payments network.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46727,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11898,
        "completion_tokens": 183,
        "total_tokens": 12081
      }
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "Based on the provided pages, the treatment of Income Tax Expense and Accruals remains consistent between 2022 and 2023. The 2023 document (page 58) continues to describe the same critical accounting policy for income tax expense and accruals, emphasizing the use of an estimated annual effective tax rate applied to quarterly results, the establishment of reserves for uncertain tax positions, and the significant judgment required in determining tax rates and evaluating tax positions. The methodology for calculating the tax rate, including transfer pricing and tax structure, is unchanged from prior years, with no indication of a material shift in disclosure or treatment. The 2022 document (page 58) similarly details the policy, confirming its continuity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41947,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10707,
        "completion_tokens": 190,
        "total_tokens": 10897
      }
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Intel’s Universal Chiplet Interconnect Express (UCIe) standard has moved from a 2023 silicon demonstration to a commercial offering in 2024, where it is now positioned as a foundational interconnect for its broader systems‑of‑chips strategy.  Alongside the rollout of the Intel 18A process and expanded IFS Accelerator ecosystem partnerships (e.g., with ARM and Synopsys), Intel is leveraging UCIe to enable chiplet‑based AI and high‑performance compute designs, reinforcing its shift toward an open, multi‑node foundry model that integrates advanced packaging, software and ecosystem services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30983,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7976,
        "completion_tokens": 148,
        "total_tokens": 8125
      }
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "The accounting treatment for CVS's Accelerated Share Repurchase (ASR) transactions remained consistent between the 2023 and 2024 10-K filings, with each ASR structured as an initial treasury stock transaction combined with a forward contract classified as an equity instrument recorded within capital surplus. The key evolution is in the completion timeline: the $3.0 billion ASR with Morgan Stanley, referenced in both filings, was paid on January 4, 2024, and concluded in March 2024 when the remaining 15% of shares were received, whereas the $2.0 billion ASR with Citibank and $1.5 billion ASR with Barclays were completed in early 2023 and 2022, respectively, with their final share deliveries finalized in February 2023 and 2022. The 2024 filing explicitly details the March 2024 conclusion of the Morgan Stanley ASR, confirming the full settlement of that transaction, while the 2023 filing only described the initial receipt of shares in January 2024 without noting the final conclusion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 30782,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7919,
        "completion_tokens": 248,
        "total_tokens": 8168
      }
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS’s pension reporting showed a significant shift in actuarial outcomes related to the Central States Pension Fund (CSPF). In 2022, the company recorded a $2.3 billion pre‑tax actuarial loss tied to coordinating benefits with the CSPF, whereas in 2023 it recognized a $5.1 billion pre‑tax gain from the same source, reflecting a reduction in the estimated additional coordinating benefits required. This change was driven by a higher discount rate (3.11% vs. 2.87%) and other assumption updates, resulting in a net gain rather than a loss. Sensitivity analysis indicates that a 25‑basis‑point shift in the discount rate would affect the projected benefit obligation by roughly ±$1.5 billion, underscoring the material impact of actuarial assumptions on UPS’s pension reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44870,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11451,
        "completion_tokens": 199,
        "total_tokens": 11650
      }
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Between 2022 and 2023, Mastercard’s positioning of its Cyber and Intelligence Solutions evolved from being highlighted as a key growth driver within broader value-added services (e.g., \"Other revenues increased 32%, or 31% on a currency-neutral basis, which includes 8 percentage points of growth due to acquisitions. The remaining growth was driven primarily by our Cyber & Intelligence and Data & Services solutions\") to a more explicit strategic emphasis in its 2023 disclosures, where it was directly tied to revenue growth and framed as part of its differentiated, secure payment ecosystem. The company reinforced its value proposition to stakeholders by linking these solutions to tangible business outcomes—such as enabling secure transactions and providing proprietary insights—while integrating them into its financial narrative, as evidenced by their role in driving 22% currency-neutral net revenue growth in 2021 and continued emphasis on cyber/security in 2023. This evolution underscores a strategic shift toward positioning cyber and intelligence capabilities not just as ancillary services, but as core differentiators that enhance Mastercard’s competitive advantage and stakeholder value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50733,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12915,
        "completion_tokens": 301,
        "total_tokens": 13216
      }
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was referenced in Item 7A under “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks” and listed as Exhibit 4.11 in the Table of Contents. In the 2023 filing, the same note appears in Item 8 under “Item 8. Financial Statements and Supplementary Data – See ‘Item 15. Exhibits and Financial Statement Schedules.’” and is explicitly cited as Exhibit 4.11 in the Exhibits index, with the exhibit’s filing date shown as February 15, 2023. Thus, the presentation shifted from a risk‑related narrative reference in 2022 to a formal exhibit citation in the financial statements section of the 2023 filing, accompanied by an updated exhibit filing date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 129,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 32736,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8418,
        "completion_tokens": 189,
        "total_tokens": 8608
      }
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Intel continued its pre‑existing communications with Positive Technologies under an OFAC license, but there was no change in the nature or scope of that engagement between 2023 and 2024; the company reported that all such dealings remain authorized by General License 1B, carry no gross revenue or net profit impact, and are expected to continue in compliance with the license. No new licensing, sanctions‑related activity, or substantive shift in the relationship was disclosed in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48771,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12422,
        "completion_tokens": 124,
        "total_tokens": 12546
      }
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The 4.78% Senior Notes due March 2038 remained unchanged in principal amount at $5 billion from 2023 to 2024, indicating that CVS has maintained this long‑dated debt issuance as part of its capital structure without any reduction or refinancing during the period. This continuity suggests the company is relying on a stable, long‑term funding source to support its ongoing obligations and growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 168,
          "pages": [
            166,
            167,
            168,
            169,
            170
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 161,
          "pages": [
            159,
            160,
            161,
            162,
            163
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32197,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8277,
        "completion_tokens": 102,
        "total_tokens": 8379
      }
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 were initially listed as a security in both the 2022 and 2024 Form 10-K filings under the \"Securities registered pursuant to Section 12(b) of the Act\" table. In the 2024 filing, the description was updated to reflect the new corporate structure following the May 2024 acquisition of Pioneer Natural Resources, but the security itself (0.835% Notes due 2032) remained identified as part of Exxon Mobil Corporation's registered securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12379,
        "completion_tokens": 115,
        "total_tokens": 12494
      }
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "Based on the provided SEC 10-K pages, American Express's investment strategy toward U.S. Government treasury obligations evolved significantly between 2022 and 2024, particularly in fair value allocation and maturity distribution. In 2022, the company held $20,655 million in U.S. Government treasury obligations (cost) with a fair value of $20,731 million, but by 2024, this position was drastically reduced to $289 million in cost with a fair value of $287 million, reflecting a strategic shift away from long-duration holdings. The maturity distribution also changed substantially: in 2022, maturities were concentrated in longer terms (e.g., $832 million due within 1 year, $862 million due after 1–5 years, and $10 million due after 5–10 years), whereas by 2024, the allocation shifted to shorter maturities, with $189 million due within 1 year, $98 million due after 1–5 years, and no holdings beyond 10 years, indicating a deliberate move toward shorter-duration, lower-risk assets to manage interest rate sensitivity. This evolution is detailed in Note 4 (Investment Securities) of the 2024 filing, which shows a clear reduction in U.S. Treasury exposure and a corresponding increase in other securities like state/municipal obligations and foreign government bonds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39440,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10095,
        "completion_tokens": 318,
        "total_tokens": 10413
      }
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced the 2.500% Note due 2050 in its June 3 2020 Current Report on Form 8‑K (Exhibit 4.5), and subsequently amended the related indenture on May 12 2021 (Exhibit 4.6) to include additional tranches of the same series. The note remains outstanding through the 2024 filing, with no indication of redemption or repurchase, and the company continues to reference it in its debt disclosures as part of the broader 2050 maturity series.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44928,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11444,
        "completion_tokens": 110,
        "total_tokens": 11555
      }
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "The Citibank, N.A. Co-Branded Credit Card Agreement saw its amendments increase from six in 2022 (Sixth Amendment filed in 2019) to nine by 2023, with the Ninth Amendment filed in November 2022 and the Tenth Amendment filed in December 2022, indicating a progression of amendments through 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54790,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13911,
        "completion_tokens": 73,
        "total_tokens": 13984
      }
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "NVIDIA's CUDA ecosystem has deepened its integration with newer architectures and software stacks between 2022 and 2024, particularly through the Blackwell platform (launched in 2025 but rooted in 2022–2024 development). The company expanded CUDA's role beyond GPUs to unify data center-scale computing with CPUs (Grace), DPUs (from Mellanox acquisition), and networking, enabling end-to-end AI and HPC workloads. This is evident in the 2024 10-K’s emphasis on \"full-stack innovation\" across architecture, software, and systems, with Blackwell GPUs featuring \"neural graphics\" and transformer-based DLSS for AI-driven rendering. Concurrently, CUDA’s software ecosystem—spanning AI Enterprise, Omniverse, and DRIVE platforms—has been tightly coupled with automotive (e.g., DRIVE Hyperion, Orin SoC) and enterprise AI workflows, reinforcing its position as the foundation for accelerated computing across industries. The 2024 document underscores that CUDA now underpins not just GPUs but the entire data center infrastructure, with over 5.9 million developers leveraging its libraries and tools for AI, simulation, and graphics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 41076,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10492,
        "completion_tokens": 281,
        "total_tokens": 10774
      }
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Pfizer's financial relationship with Paxlovid shifted significantly between 2023 and 2024, with revenue recognition evolving from substantial government contracts to commercial market sales. In 2023, Paxlovid generated $1,279 million in revenue (down 92% from 2022's $18,933 million), driven by a non-cash revenue reversal of $3.5 billion in Q4 2023 related to expected returns of EUA-labeled government inventory, partially offset by commercial sales. By 2024, Paxlovid revenue stabilized at $1,191 million globally (a 1% decline from 2023), with the company recognizing $442 million in revenue from a U.S. government stockpile supply in Q3 2024 and recording a $771 million favorable adjustment to the 2023 reversal in Q1 2024. Contractually, Pfizer maintains remaining performance obligations for Paxlovid supply through 2028, with approximately $1 billion in contracted revenue expected to be recognized from these long-term agreements as of December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 89141,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22509,
        "completion_tokens": 241,
        "total_tokens": 22750
      }
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "Between 2022 and 2024, the availability of shares under the 2003 Incentive Program declined from 66.1 million shares remaining available for future issuance to 47 million shares, reflecting ongoing awards and conversions related to the Pioneer acquisition. The program continues to permit grants of stock options, SARs, restricted stock, and other awards, with the maximum share limit remaining unchanged at 220 million shares, though utilization has increased over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45435,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11572,
        "completion_tokens": 117,
        "total_tokens": 11689
      }
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "AdSense's role has diminished within Google's broader advertising technology portfolio between 2022 and 2024, as evidenced by its inclusion under the broader \"Google Network\" category (which also includes AdMob and Ad Manager) in revenue reporting. While AdSense contributed to Google Network revenue growth (driven by AdMob and Ad Manager strength), its specific revenue contribution is not isolated in the financials, and its growth was overshadowed by the faster expansion of Google Search & other and YouTube advertising. The 2024 document emphasizes AI-driven advertising innovations (like Gemini for Google Ads and Demand Gen) as the primary growth engine, indicating AdSense's functionality is now integrated into Google's larger, AI-optimized advertising ecosystem rather than operating as a distinct revenue stream.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45087,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11501,
        "completion_tokens": 206,
        "total_tokens": 11707
      }
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "Between 2022 and 2023, the UPS Retirement Plan ceased accruals of additional benefits for future service and compensation for non-union participants effective January 1 2023, and the plan’s benefit structure was further modified to replace the prior 3%‑8% retirement contribution with a new 5%‑8% contribution to the UPS 401(k) Savings Plan for non‑union employees. Additionally, the plan’s accrual methodology was updated to reflect a higher discount rate and revised expected return assumptions, resulting in a $2.1 billion actuarial gain in 2021 that was recorded in AOCI, and subsequent changes in 2023 adjusted the projected benefit obligation by roughly $62 million per basis‑point change in the discount rate. These adjustments collectively altered the future benefit accrual methodology for non‑union participants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44135,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11262,
        "completion_tokens": 205,
        "total_tokens": 11468
      }
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Based on the provided 10-K filings, Amazon's short-term credit facilities evolved significantly between 2022 and 2024, particularly in terms of capacity and structure. The company expanded its commercial paper program from $10.0 billion (including up to €3.0 billion) to $20.0 billion (including up to €3.0 billion) by 2024, and established a new $15.0 billion unsecured revolving credit facility extending to November 2028, replacing the prior $7.0 billion facility that expired in June 2023. Additionally, Amazon entered into a $5.0 billion 364-day revolving credit facility in October 2024, maturing in October 2025, which replaced the prior 364-day facility from November 2023. While outstanding borrowings under these facilities remained minimal (e.g., $0 under the $15.0 billion facility and $0 under the $5.0 billion facility as of December 31, 2023 and 2024), the credit capacity and maturity terms were substantially extended compared to the 2022 structure, which included a $7.0 billion facility expiring in June 2023 and a $1.0 billion secured revolving facility with a $740 million limit (increased to $918 million by 2021). The weighted-average interest rates on borrowings under the Credit Facility decreased slightly from 3.0% (2020) to 2.7% (2021), but the primary evolution was in facility size, maturity, and diversification of funding sources rather than interest rate terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56025,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14240,
        "completion_tokens": 348,
        "total_tokens": 14589
      }
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Costco's 2023 10-K shows no mention of variable-priced energy contracts or commodity price risk management strategies in its disclosures, indicating the company does not use such mechanisms to hedge energy price fluctuations. The document only references fixed-price contracts for warehouses and variable-priced index-based contracts for some purchases, but provides no details on how these evolved between 2022 and 2023 or their impact on risk management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37458,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9594,
        "completion_tokens": 114,
        "total_tokens": 9708
      }
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's strategic positioning of NVIDIA AI Enterprise evolved from being a nascent enterprise AI software offering to a core, full-stack platform component deeply integrated into its data center portfolio. Initially launched to provide enterprise-grade AI software (including NIM, NeMo, and AI Blueprints) for simplified deployment of generative AI applications, it transitioned to become the central software layer enabling the full potential of NVIDIA's new data center architectures—most notably the Blackwell platform launched in 2025 (referenced in the 2024 10-K as the foundation for future AI infrastructure). This evolution solidified AI Enterprise as the essential operating system for enterprise AI, tightly coupled with NVIDIA's hardware (GPUs, CPUs, DPUs) and networking, transforming it from a supplementary software suite into the strategic differentiator for its data center offerings, driving adoption by cloud providers and enterprises for large-scale AI workloads.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49512,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12597,
        "completion_tokens": 251,
        "total_tokens": 12849
      }
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Pfizer's contractual obligations related to Paxlovid evolved significantly between 2023 and 2024, reflecting a strategic shift from pandemic-driven government procurement to commercial market transition. In 2023, the company recorded a $3.5 billion non-cash revenue reversal due to expected returns of EUA-labeled Paxlovid inventory, followed by a $771 million favorable adjustment in early 2024 for returned courses, and recognized $442 million in revenue from supplying 1 million treatment courses to the U.S. Strategic National Stockpile. By 2024, Paxlovid revenue declined to $5.716 billion (from $1.279 billion in 2023 and $18.933 billion in 2022), indicating reduced reliance on pandemic-era demand as the company transitioned to commercial sales with negotiated pricing and patient assistance programs. This shift signals Pfizer's expectation that future revenue from Paxlovid will be materially lower and more volatile, dependent on commercial adoption rather than government stockpiling, with the company actively managing the transition through contractual adjustments and revenue recognition changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 77965,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19722,
        "completion_tokens": 277,
        "total_tokens": 20000
      }
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google’s exposure to new regulatory costs in international markets expanded both in scope and complexity. In 2022, the company highlighted emerging regulatory risks tied to AI and machine learning, data privacy, and content moderation, particularly in the U.S. and EU, with concerns about antitrust scrutiny and data localization rules. By 2024, these challenges had broadened to include heightened scrutiny over data transfers (e.g., EU-U.S. privacy frameworks), new customer requirements, and increased regulatory costs across jurisdictions, especially in the context of foreign policy shifts and geopolitical tensions. The 2024 filing also emphasized evolving foreign regulatory landscapes, including anti-corruption laws and data sovereignty rules, which introduced more concrete and costly compliance obligations compared to the more generalized risk descriptions in 2022. This reflects a maturation of regulatory exposure from anticipated threats to active, measurable financial and operational pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59489,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15108,
        "completion_tokens": 258,
        "total_tokens": 15366
      }
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "UPS's funding approach for postretirement medical benefits remained consistent between 2022 and 2023, with expected benefit payments continuing to be paid from plan trusts and corporate assets. The key change was a reduction in the 2024 expected employer contribution to the U.S. postretirement medical benefit plan from $177 million (2022) to $74 million (2023), while the overall funding policy of using plan trusts and corporate assets for these payments remained unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43857,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11191,
        "completion_tokens": 119,
        "total_tokens": 11311
      }
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "From its launch in 2022, NVIDIA AI Enterprise was positioned as a specialized software suite for enterprise AI workloads within the broader NVIDIA AI platform. By 2024, its scope had expanded significantly to become a core component of the full-stack NVIDIA AI Enterprise offering, deeply integrated with new hardware like the Blackwell architecture and tightly coupled with AI infrastructure services such as DGX Cloud and NIM microservices. This evolution transformed it from a standalone enterprise software product into a comprehensive, end-to-end AI enterprise platform that spans hardware, software, and cloud services, enabling deployment across data centers, cloud, and edge environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 38953,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9954,
        "completion_tokens": 174,
        "total_tokens": 10128
      }
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "From 2022 to 2024 ExxonMobil’s proved reserves through equity companies declined modestly—from 1,481 million oil‑equivalent barrels in 2021 to 1,467 million barrels in 2022 and then to 1,447 million barrels in 2023—reflecting a net reduction of roughly 34 million barrels over the three‑year period. This contraction is largely concentrated in the Americas and Africa, where equity‑company reserves fell from 1,047 million barrels in 2021 to 1,013 million barrels in 2024, while reserves in Asia and Europe remained relatively stable. The decline signals a strategic shift toward consolidating its resource base in higher‑margin regions such as the U.S. Permian and the Gulf of Mexico, while scaling back exposure in less‑favorable overseas basins. Consequently, ExxonMobil is positioning itself to focus capital on developed assets and large‑scale projects (e.g., Guyana, Qatar, and the Tengiz expansion) that offer stronger cash flows and better alignment with its long‑term earnings and emissions‑reduction objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46846,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11937,
        "completion_tokens": 255,
        "total_tokens": 12192
      }
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "The financial relationship with Google Network Partners has shifted toward a larger share of revenue and cost structure over the 2022‑2024 period.  While the 10‑K tables do not break out Network Partner revenue separately, the “Cost of revenues” note explains that TAC (which includes payments to Google Network partners) is a major component of cost of revenues, and the segment‑profitability tables show Google Services operating income rising as revenue grew and as TAC‑related costs were managed.  Consequently, Network Partners now play a more significant role in generating gross advertising revenue, while the amounts paid to them are recorded as a growing cost‑of‑revenues line item that is increasingly offset by higher overall service revenues.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52520,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13358,
        "completion_tokens": 188,
        "total_tokens": 13546
      }
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "Between 2022 and 2023, UPS's foreign currency exchange risk management strategy remained focused on using forward contracts to hedge anticipated foreign currency cash flows, but the financial impact of undesignated forward contracts on earnings volatility shifted significantly. In 2023, gains and losses on these non-designated contracts were recorded directly in income (e.g., a $7 million loss in 2023 compared to a $69 million loss in 2022), indicating reduced volatility compared to prior periods. This contrasts with 2022, where such contracts contributed to larger earnings fluctuations, as evidenced by the $69 million loss reported in 2022 for non-designated foreign currency forward contracts. The company's designated hedging program (using Level 2 derivatives) continued to manage exposure through forward contracts, but the lower earnings impact in 2023 reflects improved hedging effectiveness or reduced market volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 159,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 38518,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9870,
        "completion_tokens": 234,
        "total_tokens": 10104
      }
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco’s membership format remained a core profitability driver, but its impact evolved in key ways: membership fee revenue grew 9% to $4,224 million, driven by new sign-ups, Executive upgrades, and improved renewal rates, directly boosting non-merchandise income. While comparable sales growth (14%) fueled overall net sales expansion, the membership model’s emphasis on reinforcing loyalty and sustaining high renewal rates became even more critical as the company navigated inflationary pressures and competitive dynamics, ensuring stable recurring revenue that supported profitability despite margin compression from cost increases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83325,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21060,
        "completion_tokens": 164,
        "total_tokens": 21225
      }
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "NVIDIA's CUDA ecosystem has deepened its integration into the data center platform through expanded software stacks and hardware partnerships, particularly with the 2024 launch of the Blackwell architecture—which includes new GPUs, CPUs, and DPUs optimized for generative AI workloads—and the broader rollout of AI Enterprise software (featuring tools like NIM and NeMo for model deployment and fine-tuning). This end-to-end approach, reinforced by over 5.9 million CUDA developers and strategic partnerships with cloud providers and automotive OEMs, solidifies CUDA as the foundational layer for NVIDIA's accelerated computing platform across data center, automotive, and enterprise AI use cases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 41076,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10494,
        "completion_tokens": 174,
        "total_tokens": 10668
      }
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "From 2023 to 2024, Pfizer's financial commitment and contractual obligations related to Paxlovid shifted significantly as the product transitioned from government distribution to commercial sales. While 2023 revenues from Paxlovid were $1,279 million (driven largely by U.S. government purchases), 2024 revenues rose to $5,716 million, reflecting commercial market uptake. The company recorded a non‑cash revenue reversal of $3.5 billion in Q4 2023 related to expected returns of EUA‑labeled inventory, followed by a $771 million favorable adjustment in Q1 2024 for returned courses, and recognized $442 million of revenue from a U.S. SNS supply in Q3 2024. Remaining performance obligations for Paxlovid deliveries are expected through 2028, with approximately $1 billion of contracted revenue yet to be recognized.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 97612,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24635,
        "completion_tokens": 204,
        "total_tokens": 24839
      }
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has evolved from a focus on securing initial development funding and proving reserve additions (highlighted in 2022 disclosures as requiring significant management funding commitments for projects like the Stabroek Block) to a more mature phase centered on advancing advantaged assets and projects. By 2024, Guyana's development is positioned as a key component of its \"Advantaged Volume Growth\" strategy, specifically under \"Advantaged Assets\" (including Guyana alongside Permian and LNG), reflecting its role in driving high-return production from newly developed fields. This shift underscores a transition from reserve estimation and development planning to operational execution and integration into the broader portfolio of high-value, low-cost projects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54558,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13864,
        "completion_tokens": 200,
        "total_tokens": 14065
      }
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "The planned utilization of the ATR 72‑600F aircraft shifted from a modest presence in 2022 (11 units scheduled for 2023 and 6 units for 2024) to a more pronounced commitment by 2024, with 7 aircraft slated for delivery in 2025 and 3 in 2026, reflecting a clear expansion of its role in the fleet. This evolution underscores FedEx’s strategy to modernize and diversify its cargo fleet, leveraging the fuel‑efficient ATR 72‑600F to support growing international package and freight volumes while replacing older, less efficient aircraft.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39428,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10083,
        "completion_tokens": 133,
        "total_tokens": 10217
      }
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "NVIDIA's approach to Omniverse has evolved from a primarily enterprise-focused 3D collaboration and simulation platform in 2022 to a more integrated, AI-driven ecosystem by 2024, with deeper connections to automotive and broader AI applications. In 2022, Omniverse was positioned as a real-time 3D design collaboration tool for industrial digitalization, leveraging NVIDIA's GPU and simulation capabilities for use cases like architectural walkthroughs and virtual prototyping. By 2024, Omniverse became central to NVIDIA's automotive strategy, particularly through its integration with the DRIVE platform—specifically, Omniverse Avatar software was incorporated to enable real-time conversational AI capabilities within vehicles (e.g., for in-car driver assistance and cockpit experiences), while Omniverse itself powered simulation for autonomous driving development via DRIVE Sim and synthetic data generation. Additionally, Omniverse expanded beyond industrial use cases to support generative AI applications, as highlighted by NVIDIA's 2024 announcements around Blackwell architecture and AI Enterprise software, which emphasized Omniverse as a foundation for building AI-powered digital twins and virtual worlds across industries. This integration reflects a strategic shift toward embedding Omniverse within NVIDIA's broader AI and automotive platforms, moving from a standalone simulation tool to a core component of its end-to-end autonomous driving and AI infrastructure stack.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 41076,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10491,
        "completion_tokens": 371,
        "total_tokens": 10863
      }
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's contribution to non-advertising revenue grew as part of Alphabet's broader shift toward non-advertising streams like Google Cloud, YouTube subscriptions, and hardware. This is evident from the document's emphasis on \"Google Subscriptions, Platforms, and Devices\" (including Google Play) as a key growth area, with non-advertising revenues increasing and \"may adversely affect margins\" due to lower margins compared to advertising. The 2023 financial results also highlight that non-advertising revenues (including Google Play) grew alongside Google Cloud, contributing to the 9% consolidated revenue increase.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36814,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9413,
        "completion_tokens": 161,
        "total_tokens": 9575
      }
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods for workers' compensation reserving remained consistent between 2022 and 2023, continuing to apply these methods primarily to the most recent accident years (especially the latest five years) for excess of deductible business, while giving significant weight to loss development methods for guaranteed cost business. The company maintained its practice of segmenting business by risk characteristics (including state, industry, and deductible structure) and using expected loss ratios adjusted for trends, but did not indicate any fundamental change in the core reserving methodology between the 2022 and 2023 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 260,
          "pages": [
            258,
            259,
            260,
            261,
            262
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 268521,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 67365,
        "completion_tokens": 164,
        "total_tokens": 67529
      }
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco's product category segmentation evolved from the fiscal 2022 categories (Secure, Agile Networks; Internet for the Future; Collaboration; End-to-End Security; Optimized Application Experiences; Other Products) to a new fiscal 2024 structure (Networking; Security; Collaboration; Observability), with the Collaboration category continuing to exist but now grouped under a broader strategic framework. The Collaboration category's revenue declined 5% in fiscal 2022 (to $4,472M) compared to fiscal 2021, and remained relatively stable in fiscal 2023 (decreased 9% to $4,052M vs. fiscal 2022), showing a consistent downward trend in this category over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40560,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10361,
        "completion_tokens": 166,
        "total_tokens": 10527
      }
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen’s 2025 Notes disclosures shifted from a straightforward presentation of the 3.125% coupon rate and maturity schedule in 2022 to a more detailed financial‑presentation in 2023 that includes the notes’ placement within the broader “Other current assets and accrued liabilities” table, the maturity‑schedule breakdown, and the addition of fair‑value adjustments and unamortized discounts/premiums. The 2023 filing also adds context on interest‑rate swaps, cross‑currency hedges, and the effective interest rates tied to SOFR, reflecting a more integrated view of the debt’s financing structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43787,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11173,
        "completion_tokens": 149,
        "total_tokens": 11322
      }
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region have remained relatively stable in magnitude but shifted significantly in composition and strategic focus. From 2022 to 2024, the region's proved natural gas reserves (including both developed and undeveloped) increased from 1,041 million barrels of natural gas liquids equivalent to 1,041 million barrels of natural gas liquids (as reported in the reserves tables) and from 5,736 billion cubic feet to 5,736 billion cubic feet in total consolidated operations, but the key strategic shift is the **divestment of non-core assets and reduced emphasis on the region**. Specifically, the company sold its Indonesia assets (disclosed as \"sales in our consolidated operations in Asia Pacific/Middle East\" in 2022) and reduced equity affiliate reserves in the region from 1,779 million barrels (2022) to 2,681 million barrels (2024), while the region's contribution to total company reserves declined. This indicates a **strategic pivot away from the Asia Pacific/Middle East region toward other areas like the Permian Basin (Lower 48) and Africa**, as evidenced by major investments in the Permian (e.g., Marathon Oil acquisition) and the noted reduction in equity affiliate reserves in the region. The company's focus has shifted to \"unconventional plays in the Permian Basin\" and Africa, with the Asia Pacific/Middle East now primarily serving as a source of equity affiliate reserves (e.g., Australia) rather than a core strategic area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 174,
          "pages": [
            172,
            173,
            174,
            175,
            176
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 77101,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19510,
        "completion_tokens": 375,
        "total_tokens": 19885
      }
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Between 2022 and 2023, Alphabet’s repurchase activity for Class C Capital Stock increased from $59.3 billion to $62.2 billion, reflecting a continued aggressive share‑buyback strategy. This escalation signals that the company is allocating a larger portion of its cash flow to equity retirements, likely to support its capital‑allocation priorities of returning capital to shareholders while maintaining flexibility for strategic investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56455,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14342,
        "completion_tokens": 110,
        "total_tokens": 14453
      }
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "Between 2022 and 2023, AIG applied frequency/severity methods primarily to its long‑tail lines—U.S. Property (commercial, industrial, energy), U.S. Special Risk (aerospace, environmental, trade credit, surety, marine, program business) and U.S. Excess Casualty—where loss emergence is slow and severity varies. For short‑tail lines (e.g., U.S. Personal Insurance) it relied on expected loss‑ratio and development methods rather than frequency/severity techniques. The company continued to use these methods to estimate ultimate losses, adjust for inflation and market trends, and incorporate insights from actuarial reviews and internal risk‑management assessments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 298130,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 74765,
        "completion_tokens": 166,
        "total_tokens": 74931
      }
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "From 2022 to 2023 the Amgen‑BeiGene relationship continued to involve shared R&D costs and profit‑loss splitting, but the financial flows shifted: net cost recoveries from BeiGene fell from $220 million in 2021 to $109 million in 2023, while product sales to BeiGene rose from $72 million in 2021 to $125 million in 2023. Profit‑and‑loss share expenses also declined from $64 million in 2021 to $40 million in 2023, and the amounts receivable from BeiGene for cost recoveries and profit‑loss sharing dropped from $61 million (2021) to $44 million (2023). These changes reflect a continued but evolving cost‑recovery and profit‑sharing arrangement between the two companies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47151,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12015,
        "completion_tokens": 168,
        "total_tokens": 12183
      }
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "From 2022 to 2024 the Asia Pacific/Middle East proved reserves rose modestly, growing from about 628 MMBOE at the end of 2021 to 1,112 MMBOE by the end of 2024.  The increase reflects upward revisions (≈ 127 MMBOE in 2024, 118 MMBOE in 2023, 123 MMBOE in 2022), purchases—most notably the Marathon Oil acquisition adding ≈ 210 MMBOE in 2024 and earlier Concho‑related purchases—plus extensions and discoveries that added roughly 15–20 MMBOE each year, while production and sales trimmed the reserve base slightly each year.  Overall, the region’s proved reserves expanded by roughly 484 MMBOE over the three‑year period, driven by upward revisions and acquisitions, with modest net gains after accounting for production and sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 166,
          "pages": [
            164,
            165,
            166,
            167,
            168
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 82910,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20965,
        "completion_tokens": 182,
        "total_tokens": 21147
      }
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "From 2022 to 2024 FedEx’s planned usage of the B767F aircraft shifted from a large fleet of 114 owned aircraft (as reported in the 2022 10‑K) to a much smaller commitment of 11 owned B767Fs with additional purchases scheduled for 2025‑2026 (11 in 2025 and 3 in 2026) as reflected in the 2024 10‑K’s purchase‑commitment tables. This reduction and the modest future deliveries indicate that FedEx is deliberately phasing out the B767F type and replacing it with newer, more fuel‑efficient models such as the B777F and A300‑600, reflecting a strategic fleet‑modernization plan focused on long‑term operating cost savings and capacity alignment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39914,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10199,
        "completion_tokens": 160,
        "total_tokens": 10359
      }
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "Between 2022 and 2023, AIG applied Expected Loss Ratio methods primarily to its aviation and program lines of business for the latest accident years, using ground‑up claim projections and premium‑based loss ratios to set reserves. For longer‑tail lines such as U.S. Workers’ Compensation and Excess Casualty, it combined loss development and expected loss ratio techniques, while continuing to use frequency/severity methods for short‑tail classes like U.S. Property. The shift reflects a move toward more premium‑driven, ground‑up projections for newer business and a continued reliance on development factors for older, more mature accident years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 298130,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 74761,
        "completion_tokens": 162,
        "total_tokens": 74923
      }
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Cisco’s Enterprise Data Center Transformation positioning has shifted from a product‑centric focus in 2022 to a broader, alliance‑driven strategy by 2024, emphasizing co‑development and joint go‑to‑market efforts with key partners such as Microsoft, AWS, Google, and Equinix. This evolution reflects a move toward integrated, end‑to‑end solutions that combine networking, security, and observability, while leveraging strategic alliances to counter intensified competition from hyperscalers and specialized data‑center vendors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47022,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11984,
        "completion_tokens": 131,
        "total_tokens": 12116
      }
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The effective interest rate on the 3.125% 2025 Notes remained unchanged at 5.2% (the coupon rate) between 2022 and 2023, as disclosed in the \"Interest rate swaps\" section which states that there are no material differences between effective interest rates and coupon rates for all borrowings except for specific notes (including the 3.125% 2025 Notes, which had an effective rate of 5.2%). The notional amount of the 3.125% 2025 Notes remained constant at $1,000 million (or $1 billion) in both 2022 and 2023, as shown in the debt schedule tables for both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44739,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11402,
        "completion_tokens": 140,
        "total_tokens": 11543
      }
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "From 2022 to 2024, Cisco’s strategic positioning of AppDynamics evolved from being framed as part of its broader “Observability” and “Application Experience” portfolio within the “Optimized Application Experiences” pillar, to a more prominent, standalone emphasis as a key growth driver in its product strategy. By 2024, AppDynamics—integrated through the Splunk acquisition—was explicitly highlighted as a core component of Cisco’s Observability suite, contributing $837 million in product revenue (up 27% YoY) and positioned alongside Networking, Security, and Collaboration as one of the company’s primary growth categories. This reflects a clear shift toward prioritizing full‑stack observability, with AppDynamics serving as a central element that extends Cisco’s end‑to‑end visibility from applications through infrastructure to security, reinforcing its strategic pillar of “Optimized Application Experiences” and underscoring its importance within Cisco’s broader observability offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44316,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11306,
        "completion_tokens": 249,
        "total_tokens": 11555
      }
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The 4.663% 2051 Notes had a carrying value of $3,541 million at both December 31 2022 and December 31 2023, indicating that their notional amount and effective interest rate remained unchanged over that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44739,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11401,
        "completion_tokens": 52,
        "total_tokens": 11454
      }
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG’s use of expected loss ratio methods remained focused on long-tail lines such as U.S. Excess Casualty, U.S. Financial Lines (D&O), and U.S. Other Casualty, where loss cost trends and development factors continue to drive reserve estimates. The 2023 disclosures show the same segmentation and criteria applied as in 2022—loss cost trends are tested for U.S. Excess Casualty and D&O, with sensitivity analyses quantifying the impact of trend shifts (e.g., ±4.5 % to ±5.5 % changes) on reserves. No substantive change in methodology or segmentation is indicated; the evolution is limited to refined trend assumptions and updated development‑factor sensitivities rather than a shift in the lines of business or segmentation approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 167516,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 42104,
        "completion_tokens": 189,
        "total_tokens": 42293
      }
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolved from its initial incorporation in 2013 through the Board of Directors' resolutions authorizing the terms of the 2.850% Senior Notes due 2026, which were formally adopted in February 2013 and later referenced in multiple debt issuance filings. In 2024, PepsiCo further solidified its broader debt issuance strategy by introducing new notes, including the 2.850% Senior Notes due 2026, as part of a series of strategic debt offerings that emphasized longer-term maturities and diversified funding sources, reflecting a continued focus on optimizing its capital structure and maintaining financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16648,
        "completion_tokens": 168,
        "total_tokens": 16817
      }
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco's exposure to channel partner financing guarantees increased slightly from $1.3 billion in fiscal 2021 to $1.4 billion in fiscal 2022, reflecting a modest rise in the volume of guaranteed financing arrangements. This evolution indicates that while the company continues to support channel partners through financing guarantees, the scale of these guarantees remains relatively small compared with its overall balance‑sheet size, suggesting a conservative approach to limiting direct financial risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52441,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13342,
        "completion_tokens": 126,
        "total_tokens": 13468
      }
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "Between 2022 and 2023, the interest rate structure of the 2.45% 2030 Notes evolved through the use of interest rate swaps. In 2021, the company entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, converting the fixed 2.45% coupon to a floating rate of SOFR + 1.0% (later adjusted to SOFR + 1.3% by 2023). This swap was part of broader hedging activity to manage interest rate exposure, and the effective interest rate on these notes became SOFR + 1.3% as of December 31, 2023. The swaps were designated as fair value hedges and were part of the company's strategy to achieve a desired mix of fixed-rate and floating-rate debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44987,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11459,
        "completion_tokens": 176,
        "total_tokens": 11635
      }
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "FedEx's relationship with Pass-Through Certificates remained unchanged between 2022 and 2023, continuing to utilize pass-through trusts to issue securities backed by aircraft. The $970 million of Pass-Through Certificates, Series 2020-1AA (1.875% due 2034), issued by FedEx Express, were fully guaranteed by FedEx and secured by 19 Boeing aircraft (net book value $1.8 billion as of May 31, 2022), with payment obligations unconditionally guaranteed by FedEx. The financial guarantees and obligations related to these certificates were consistent with prior years, as the structure and terms did not materially change during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45912,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11701,
        "completion_tokens": 159,
        "total_tokens": 11860
      }
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "Mastercard’s risk‑mitigation arrangements for gross settlement exposure increased from 2023 to 2024, with gross exposure rising to $78.4 billion and risk‑mitigation offsets growing to $13.5 billion, resulting in a net exposure of $64.9 billion (up from $62.9 billion in 2023). This reflects a more aggressive use of cash collateral and credit enhancements to manage settlement risk, indicating that the company is strengthening its risk‑management framework and proactively adjusting its mitigation strategies as exposure grows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67745,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17170,
        "completion_tokens": 132,
        "total_tokens": 17302
      }
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased significantly from $457 million as of May 31 2021 to $77 million as of May 31 2022, and further to $151 million as of May 31 2024. This reduction reflects a strategic shift toward using fewer designated cash‑flow hedges and a greater reliance on undesignated derivatives, indicating that the company is managing foreign‑exchange risk more through direct exposure and less through formal hedge accounting, while still maintaining a sizable notional amount of hedging activity ($16.2 billion in 2024). Consequently, the amount of deferred net gains in accumulated other comprehensive income that is expected to be reclassified to earnings over the next 12 months has also declined (approximately $231 million as of May 31 2024).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63468,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16103,
        "completion_tokens": 209,
        "total_tokens": 16312
      }
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "Based on the provided 10-K filings, the representation of Bounty within the Baby, Feminine & Family Care segment evolved as follows: In the 2022 filing (Page 18), Bounty was explicitly listed as a major brand under this segment alongside Always, Tampax, and Charmin, with North America market shares noted as \"over 40% for Bounty.\" However, in the 2023 filing (Page 17), Bounty was no longer included in the major brands list for the Baby, Feminine & Family Care segment, which now only references Always, Tampax, and Charmin. This omission, coupled with the segment's net sales remaining unchanged year-over-year (Page 19), suggests a strategic reduction in Bounty's brand visibility and presence within the segment, likely reflecting market share erosion or portfolio restructuring. The absence of Bounty from the 2023 branding and the unchanged net sales performance indicate diminished emphasis on the brand compared to its prior prominence.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12940,
        "completion_tokens": 236,
        "total_tokens": 13177
      }
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Oracle's approach to its hardware business, particularly Oracle Engineered Systems, shifted between fiscal 2022 and fiscal 2023 toward greater strategic emphasis on cloud and license revenue growth, with hardware revenue declining slightly from $3.359 billion in fiscal 2022 to $3.183 billion in fiscal 2023, and its margin also decreasing from $2.026 billion to $1.878 billion, reflecting a reduced focus on hardware as a core growth driver.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49897,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12707,
        "completion_tokens": 110,
        "total_tokens": 12818
      }
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "Between 2022 and 2023, ERLEADA sales grew from $1,291 million to $2,387 million—a 85% increase—driven by continued market share gains and expansion in Metastatic Castration-Resistant Prostate Cancer. This robust growth, alongside strong performance of DARZALEX and IMBRUVICA, contributed to the Oncology segment's 10.5% overall sales increase, indicating a clear upward market trajectory for ERLEADA despite broader competitive pressures affecting other oncology products like IMBRUVICA and ZYTIGA.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37762,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9659,
        "completion_tokens": 124,
        "total_tokens": 9783
      }
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "From 2023 to 2024, CMCSA’s relationship with local broadcast television stations has shifted toward greater competition and heightened dependency for content distribution. The company notes that its domestic broadcast networks must secure affiliations with independently owned local stations to reach a nationwide audience, and that these stations can demand “must‑carry” status or negotiate retransmission‑consent fees, creating a competitive bargaining environment. At the same time, the company’s linear television networks and streaming platforms (e.g., Peacock) increasingly rely on these local stations to distribute network programming, making the stations a critical source of audience reach and advertising revenue. Consequently, CMCSA’s competitive positioning now hinges on its ability to negotiate favorable carriage and retransmission terms while remaining dependent on local broadcast stations for effective content distribution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55861,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14200,
        "completion_tokens": 235,
        "total_tokens": 14436
      }
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "Based on the provided 2023 and 2024 10-K pages, the value of Held-to-Maturity (HTM) securities held by Mastercard decreased significantly from **$306 million in 2023 to $38 million in 2024**. This substantial reduction indicates a strategic shift away from short-term time deposit investments toward a more liquid portfolio focused on available-for-sale securities and other investments, likely reflecting a deliberate reallocation of capital to optimize liquidity and support growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56738,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14410,
        "completion_tokens": 124,
        "total_tokens": 14534
      }
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand remained within the Baby, Feminine & Family Care segment, which held a 25% share of net sales and 23% of net earnings. The segment's categorization included Feminine Care (Adult Incontinence, Menstrual Care) and Family Care (Paper Towels, Tissues, Toilet Paper), with Always and Tampax as key brands. The 2023 restructuring of operations in markets like Argentina and Nigeria—resulting in non-cash currency translation charges—impacted the segment's financial reporting but did not alter the brand's categorization or sub-category structure within the segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12948,
        "completion_tokens": 150,
        "total_tokens": 13098
      }
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Oracle's Engineered Systems revenue recognition remained consistent with its broader hardware segment, recognizing revenue at the point of delivery when ownership transfers to the customer, as described in the \"Revenue Recognition for Hardware Products\" section of the 2022 10-K. While the 2023 10-K does not explicitly detail Engineered Systems-specific revenue trends, it confirms that hardware revenue (which includes Engineered Systems) represented 6% of total revenue in both fiscal 2023 and 2022, with no significant shift in recognition policy. The strategic emphasis on Engineered Systems appears to have diminished as cloud services (now 37% of total revenue in 2024) gained prominence, though the document does not indicate a material change in Engineered Systems' financial contribution between 2022 and 2023. Revenue recognition for hardware products, including Engineered Systems, continued to be recognized upfront upon delivery, with no mention of new accounting changes affecting this line item.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48475,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12349,
        "completion_tokens": 252,
        "total_tokens": 12602
      }
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Comcast's advertising sales strategy has evolved to increasingly utilize representation firms as an extension of its internal sales force, particularly for selling advertising units allocated to the company. This shift allows Comcast to record advertising revenue net of agency commissions, as noted in the Media segment description where \"we work with representation firms as an extension of our sales force to sell a portion of the advertising units allocated to us and record the revenue net of agency commissions.\" The strategy is part of broader efforts to manage advertising sales across its linear television networks, Peacock, and digital platforms, with revenue recognized upon airing/delivery of advertisements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55230,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14024,
        "completion_tokens": 180,
        "total_tokens": 14204
      }
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle’s industry‑specific hardware offerings continued to be reported as a separate operating segment, but the company’s strategic emphasis shifted further toward cloud and license revenues.  In the FY 2023 10‑K the hardware segment’s revenue fell to $3.183 billion (down from $3.359 billion in FY 2022) and its margin declined slightly, while the cloud‑and‑license segment grew to $36.052 billion and now accounts for roughly 84 % of total revenue.  Revenue recognition for hardware remains point‑in‑time at delivery, whereas cloud services and support are recognized ratably over contract terms; this difference means that any growth in hardware sales is recorded immediately, but the company’s overall earnings guidance increasingly relies on the higher‑margin, time‑based cloud and license revenue stream.  Consequently, while hardware remains a distinct line of business, Oracle’s focus and the bulk of its growth strategy have moved toward expanding cloud‑based offerings and the associated recurring revenue model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49897,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12705,
        "completion_tokens": 255,
        "total_tokens": 12961
      }
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "IMBRUVICA sales declined 13.7% from $4,369 million in 2022 to $3,264 million in 2023, primarily due to global competitive pressures from novel oral agents and COVID-19-related market dynamics including delays in new patient starts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38724,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9897,
        "completion_tokens": 57,
        "total_tokens": 9955
      }
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "From 2023 to 2024, Comcast's involvement with Universal Beijing Resort shifted from a debt‑financed joint venture to a more equity‑focused structure. While the resort's total debt remained roughly $3.5 billion in both years, the proportion of that debt that is guaranteed by Comcast fell from about $3.5 billion (subject to cross‑guarantees) in 2023 to $3.5 billion still outstanding but with a lower weighted‑average interest rate and a higher share of fixed‑rate obligations, reducing financial risk. Additionally, the resort's debt is now primarily secured by its own assets and the equity interests of the investors, meaning Comcast's direct debt exposure and related covenant risk have diminished, even though its 30 % ownership stake and associated investment balance remain.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51731,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13157,
        "completion_tokens": 195,
        "total_tokens": 13353
      }
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "From 2022 to 2023, FedEx's future scheduled principal payments on long‑term debt rose sharply from $1,337 million in 2026 to $1,391 million in 2027, while the total lease‑related future payments for build‑to‑suit facilities and equipment were disclosed as approximately $3.4 billion in undiscounted amounts, indicating that the company is increasing its reliance on long‑term financing and lease commitments to fund new aircraft, facilities and equipment. This reflects a strategic shift toward greater use of leveraged lease structures and debt issuance to support growth while maintaining a relatively low debt‑to‑adjusted EBITDA ratio (1.82 × in 2022).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47778,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12177,
        "completion_tokens": 163,
        "total_tokens": 12341
      }
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard’s relationship with Dynamic Yield LTD has remained unchanged between 2023 and 2024, with no additional acquisitions or strategic shifts involving the company disclosed in the 2024 filings. The 2024 10-K shows continued focus on expanding its portfolio through other acquisitions (e.g., Recorded Future), but Dynamic Yield is not referenced as a current strategic priority, indicating the company has moved on from that 2022 acquisition to newer growth areas.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51823,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13182,
        "completion_tokens": 117,
        "total_tokens": 13299
      }
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Lowe's Severance Plan for Senior Officers was most recently amended and restated effective May 26 2022, as disclosed in Exhibit 10.28 of the Lowe's 2024 Form 10‑K (filed March 25 2024). This amendment supersedes the prior plan and represents the latest evolution of the severance provisions between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 36559,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9365,
        "completion_tokens": 79,
        "total_tokens": 9445
      }
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "Based on the debt tables in both 2021 and 2023 documents, the fair value of Netflix's 6.375% Senior Notes increased from $995 million (as of December 31, 2021) to $872 million (as of December 31, 2023), reflecting a decline in market value relative to par. This evolution indicates that market perceptions of the company's debt became less favorable over the period, as the fair value discount relative to par widened (from a 0.5% premium to a 14% discount), likely signaling increased perceived credit risk or interest rate environment changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44119,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11268,
        "completion_tokens": 136,
        "total_tokens": 11404
      }
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA sales declined 13.7% (from $4,369 million to $3,264 million), reflecting growing competitive pressures in the oncology market, particularly from novel oral agents and market dynamics affecting new patient starts. This decrease contributed to a modest 10.5% overall oncology segment growth, underscoring IMBRUVICA's weakening market position despite continued strength in other oncology products like DARZALEX and ERLEADA.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37762,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9662,
        "completion_tokens": 113,
        "total_tokens": 9775
      }
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "LOW's inventory reserves evolved as follows: The LCNRV reserve decreased by $23 million to $222 million in 2024, while the shrink reserve increased by $2 million to $427 million, resulting in a net $25 million rise in total inventory reserves. These reserve changes reduced net earnings by roughly $17 million (from a 10 % shift in LCNRV assumptions) and $32 million (from a 10 % shift in shrink assumptions) for fiscal 2024. Consequently, the adjustments modestly pressured profitability, though the impact was limited relative to overall earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 36934,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9451,
        "completion_tokens": 137,
        "total_tokens": 9588
      }
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "From 2022 to 2023, Qulipta transitioned from having no revenue in 2021 to generating $405 million in U.S. sales and $3 million internationally in 2023, reflecting its recent FDA approval (April 2023) and EU launch (January 2024) for preventive migraine treatment. This rapid uptake drove net revenue growth of over 100 % for Qulipta in 2023, contributing to the overall neuroscience portfolio increase of 10 % and supporting AbbVie’s broader commercial expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48350,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12310,
        "completion_tokens": 115,
        "total_tokens": 12426
      }
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Between 2022 and 2023, Honeywell's environmental liability exposure shifted from relying on Resideo to cover 90% of its net environmental spending (capped at $140 million annually) to a reduced reimbursement mechanism where Resideo still pays 90% of such costs but the cap remains in place, while Honeywell recorded a $187 million receivable from Resideo in 2023 (up from $157 million in 2022). This evolution indicates that Honeywell’s direct risk exposure to environmental remediation costs has increased, as it now bears a larger share of uncapped liabilities and depends less on external reimbursements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 84482,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21352,
        "completion_tokens": 151,
        "total_tokens": 21504
      }
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of \"original maturity\" for cash equivalents remained consistent between 2022 and 2024, both specifying that cash equivalents include \"highly liquid investments with an original maturity of three months or less from the time of purchase.\" This consistency indicates Target maintains a stable, short-term cash management approach, prioritizing liquidity and minimal risk exposure without altering its core threshold for classifying investments as cash equivalents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42942,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10970,
        "completion_tokens": 120,
        "total_tokens": 11090
      }
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "The valuation of NVIDIA's 3.50% Notes Due 2040 increased from $870 million (amortized cost) at the end of fiscal 2023 to $851 million (amortized cost) at the end of fiscal 2024, reflecting a modest decline in fair value despite the passage of time. This shift, together with the overall growth in long‑term debt (total long‑term notes rising from $9.7 billion to $8.463 billion in net carrying amount) and the company's active refinancing (e.g., repayment of the 0.584% Notes Due 2024), indicates that NVIDIA is managing its long‑term debt strategically—issuing new long‑dated securities while retiring shorter‑dated obligations to optimize the capital structure and preserve liquidity for continued investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41078,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10497,
        "completion_tokens": 177,
        "total_tokens": 10675
      }
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Based on the provided financial data, AbbVie's total global revenue (net revenues) declined 6.4% from $58,054 million in 2022 to $54,318 million in 2023, representing a negative growth rate of approximately 6.4% year‑over‑year. This decrease was driven primarily by falling Humira sales and other portfolio pressures, despite growth in newer products such as Skyrizi, Rinvoq, and Venclexta.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45016,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11474,
        "completion_tokens": 97,
        "total_tokens": 11572
      }
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Based on the provided SEC filing excerpts, Netflix amended its Executive Severance and Retention Incentive Plan in September 2021 (effective immediately upon adoption), with the amendment filed as Exhibit 10.7 to its 2021 10-K. The 2023 filing (NFLX_10k_2023.pdf) confirms the plan was subsequently restated and amended again on December 8, 2023 (effective January 1, 2024), as evidenced by Exhibit 10.16 in the 2023 filing, which references the \"Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024.\" This indicates a significant evolution from the original 2021 plan through a formal restatement in late 2023, with the new effective date set for January 1, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46327,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11813,
        "completion_tokens": 177,
        "total_tokens": 11991
      }
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "The Benefit Restoration Plan’s structure and documentation remained consistent between 2022 and 2024, continuing to supplement 401(k) benefits for employees affected by IRS contribution limits. The 2024 filing (Note 12) confirms the plan’s ongoing role in providing supplemental retirement benefits, reflecting Lowe’s stable approach to enhancing employee retirement security without major structural changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47145,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12017,
        "completion_tokens": 102,
        "total_tokens": 12120
      }
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "Based on the provided financial disclosures, NVIDIA's financial obligations related to the 0.584% Notes Due 2024 were eliminated during fiscal year 2025. Specifically, the company repaid the entire $1.25 billion principal amount of these notes (as indicated in Note 11's maturity schedule showing $0 remaining as of January 26, 2025), having previously carried a balance of $1,250 million (in millions) as of January 28, 2024. This repayment is explicitly noted in the debt maturity table under \"0.584% Notes Due 2024 (1)\" where it states \"In fiscal year 2025, we repaid the 0.584% Notes Due 2024.\" Consequently, there were no outstanding obligations related to these notes in the subsequent fiscal period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41078,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10483,
        "completion_tokens": 176,
        "total_tokens": 10659
      }
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Between 2022 and 2023, global revenue for Mavyret declined modestly, falling from $1,430 million to $1,430 million? Actually Mavyret total net revenue was $1,430 million in 2023 versus $1,541 million in 2022—a 7.2% decrease at actual currency and a 5.7% decline at constant currency. In the United States, Mavyret sales slipped 12.7% (from $659 million to $577 million), while international sales were nearly flat, decreasing only 1.9% (from $771 million to $756 million). Thus, the downturn was driven primarily by the U.S. market, whereas overseas performance remained relatively stable.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 45298,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11551,
        "completion_tokens": 147,
        "total_tokens": 11698
      }
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Netflix's compliance with covenant limitations related to its Senior Notes remained consistent between 2022 and 2024, with no material breaches reported. The company maintained compliance with all covenants, including restrictions on incurring additional indebtedness, granting liens, and engaging in sale-leaseback transactions, as explicitly stated in the 2024 filing: \"As of December 31, 2024 and December 31, 2023, the Company was in compliance with all related covenants.\" While the 2022 filing noted covenants limiting certain corporate actions (e.g., mergers or asset transfers), the 2024 filing confirms continued adherence without changes to the covenant framework, with no new restrictions or adjustments to repayment obligations disclosed. The scope of restrictions remained focused on standard debt covenants, with no expansion or relaxation noted between the periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44559,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11371,
        "completion_tokens": 220,
        "total_tokens": 11591
      }
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Based on the 2022 and 2023 10-K notes, Honeywell's Safety and Retail product line was restructured in July 2022 when the Safety and Retail business unit was combined with the Advanced Sensing Technologies unit to form the new \"Sensing and Safety Technologies\" business unit, with historical periods recast to reflect this change. The structural change introduced in 2023 was the acquisition of Carrier Global Corporation's Global Access Solutions business on December 8, 2023, which was integrated into the Honeywell Building Technologies reportable segment, reflecting the evolution of the Safety and Retail line into a broader building technologies offering.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52053,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13241,
        "completion_tokens": 165,
        "total_tokens": 13406
      }
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "Between 2023 and 2024, Class B-2 Common Stock transitioned from having no outstanding shares to 49 shares issued and outstanding, with its conversion right into Class A Common Stock becoming active under Visa’s U.S. retrospective responsibility plan. This conversion, alongside Class B-1, would dilute existing Class A shareholders and could pressure the market price of Class A shares if significant conversions or sales occur. The evolving structure of these preferred and convertible classes—particularly the staged conversion of Series B and C preferred shares through 2028—reflects a strategic effort to manage litigation-related liabilities while impacting corporate governance through altered voting rights and stakeholder dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57610,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14626,
        "completion_tokens": 184,
        "total_tokens": 14811
      }
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "The Home Depot has deepened its interconnected shopping experience by expanding digital capabilities—enhancing website and mobile navigation, search, product detail pages, and fulfillment options—to create a seamless journey from inspiration through purchase and post‑sale support. At the same time, it continues to invest in store improvements (e.g., wayfinding, self‑service lockers, curb‑side pickup, expanded self‑checkout, and associate productivity tools) and targeted service enhancements for Pros, such as the SRS acquisition, broader credit and loyalty programs, and upgraded order‑management systems, all aimed at making both digital and in‑store interactions faster, more personalized, and more convenient.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52325,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13305,
        "completion_tokens": 179,
        "total_tokens": 13484
      }
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "From 2022 to 2024, Target’s Long-Term Incentive Plan added several new equity award types while retaining its core structures. The 2020 Long-Term Incentive Plan (effective June 11 2020) introduced forms such as Performance‑Based Restricted Stock Unit, Performance Share Unit, and Cliff‑Vested RSU agreements, and the 2022 Plan Statement (effective May 1 2022) further refined these awards. Earlier plans—including the 2011 and 2017 restatements—provided the foundational equity components (stock options, RSUs, performance shares), but the 2020 and 2022 updates expanded the specific equity‑award categories used under the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45727,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11662,
        "completion_tokens": 157,
        "total_tokens": 11819
      }
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Based on AbbVie's 2022 and 2023 10-K filings, Qulipta's commercial performance evolved from its initial FDA approval in September 2021 through 2023 with significant growth driven by expanded indications and market adoption. Following its September 2021 approval for episodic migraine prevention, Qulipta received additional regulatory milestones including FDA approval in April 2023 for chronic migraine prevention and European Commission approval in August 2023 for migraine prevention in adults with four or more migraine days per month. This expansion coincided with net revenue growth exceeding 100% for Qulipta in 2023 (as reported in the financial tables), driven by strong market uptake, market share gains across indications, and favorable market growth, despite pricing pressures. The document specifically notes that Qulipta's net revenues increased \"greater than 100%\" in 2023, reflecting its accelerating commercial traction beyond the initial approval.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42883,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10938,
        "completion_tokens": 241,
        "total_tokens": 11179
      }
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Netflix's 2020 Stock Plan (referenced in the 2022 10-K as the \"2020 Stock Plan\" and detailed in the 2024 10-K under \"Stock Option Plan\" and \"Restricted Stock Unit Awards\") has evolved structurally to include both time-based and performance-based equity compensation, with expanded grant activity and vesting terms. The 2024 filing shows increased stock option grants (575,856 in 2024 vs. 1,729,218 in 2023) and RSU/PSU awards (159,978 granted in 2024), alongside a significant rise in stock-based compensation expense ($272.6M in 2024 vs. $339.4M in 2023), reflecting ongoing emphasis on equity-based compensation for executives and employees. The plan's scope remains centered on stock options, RSUs, and PSUs, with no structural changes noted in its fundamental design between 2022 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51274,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13055,
        "completion_tokens": 200,
        "total_tokens": 13256
      }
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "The company's aluminum purchase agreements were classified as derivative instruments not receiving hedge accounting treatment, as disclosed in Note 19. These agreements, used for long-term strategic sourcing and non-U.S. business requirements, were accounted for at fair value with changes in fair value recorded directly in earnings rather than through other comprehensive income. The company also noted that gains/losses related to these undesignated derivatives were insignificant in the periods presented.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42893,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10955,
        "completion_tokens": 127,
        "total_tokens": 11082
      }
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "The Directors' Code of Conduct remained accessible on BNY Mellon’s investor‑relations website in both 2023 and 2024, with the 2024 filing confirming that any amendments or waivers to the code (including those affecting executive officers) will continue to be disclosed there. No material change in scope or accessibility is indicated; the company simply reiterated its intention to post such updates on the same website.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34529,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8854,
        "completion_tokens": 105,
        "total_tokens": 8959
      }
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "The 4.95% Senior Notes issued in November 2023 (with a $750 million principal and a $1.6 million discount) and the additional $750 million tranche issued in June 2024 are still outstanding as of February 2025, carrying a net carrying amount of $747 million. Their inclusion in the long‑term debt schedule shows a continued reliance on long‑dated, fixed‑rate financing, reflecting HD’s strategy of extending maturities and locking in low‑cost capital to fund growth initiatives such as the SRS acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52213,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13277,
        "completion_tokens": 126,
        "total_tokens": 13403
      }
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Between 2021 and 2023, Intel recognized $471 million in observable price adjustments for its non‑marketable equity investment in Beijing Unisoc Technology Ltd., increasing the net book value of that investment to $1.1 billion by the end of 2023. The investment remains recorded as a non‑marketable equity security, with its net book value fully offset by valuation allowances and no subsequent market‑based price adjustments reported after 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42098,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10760,
        "completion_tokens": 111,
        "total_tokens": 10871
      }
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "AbbVie's engagement with Qulipta evolved from 2022 to 2023 through significant regulatory approvals and commercial expansion. In April 2023, the FDA approved Qulipta for the preventive treatment of chronic migraine in adults, followed by European Commission approval in August 2023 for migraine prevention in patients with four or more migraine days per month. This marked a transition from regulatory milestones to active commercialization, with Qulipta generating $405 million in U.S. sales and $3 million internationally in 2023 (up from $158 million U.S. and $0 international in 2022), reflecting its growing market presence post-approval.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42979,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10965,
        "completion_tokens": 160,
        "total_tokens": 11126
      }
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Based on the comparative language in the 2022 and 2023 10-K filings, Boeing's framing of \"upgrades and conversions\" within Global Services evolved from a general service offering to a more strategic, market-share-focused emphasis. In 2022, it was described as part of a \"full spectrum of products and services\" including \"upgrades and conversions\" alongside maintenance and training, while in 2023, the language shifted to explicitly link these activities to \"grow[ing] market share by leveraging a high level of customer satisfaction and productivity\" within the services segment. This reflects a deliberate strategic pivot to position upgrades and conversions as a key driver for expanding market presence in both defense and commercial services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39612,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10131,
        "completion_tokens": 187,
        "total_tokens": 10318
      }
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel's investment in Beijing Unisoc Technology Ltd. was initially recorded at $658 million in 2020, increased to $1.1 billion by the end of 2022, and remained at that $1.1 billion carrying amount as of December 30 2023. The investment is classified as a non‑marketable equity security, and its value is subject to significant volatility and impairment risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54001,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13729,
        "completion_tokens": 89,
        "total_tokens": 13819
      }
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, the Self-Service Lockers evolved from a convenience feature supporting online order pickup to a core component of Home Depot’s interconnected shopping experience. The company expanded their use across stores (including pilots in Mexico), integrated them with curb‑side and BOPIS services, and leveraged them to streamline order fulfillment—helping drive higher customer satisfaction and enabling faster, more reliable delivery for both DIY and Pro customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50358,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12803,
        "completion_tokens": 120,
        "total_tokens": 12923
      }
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "The level of detail and specificity in Costco’s disclosures regarding the estimation methods for Insurance/Self‑insurance Liabilities remained essentially unchanged between 2023 and 2024. In both years the filing explains that retained‑risk liabilities are estimated using historical claims experience, demographic and severity factors, and other actuarial assumptions, and it notes that adjustments from actual results have been immaterial. The 2024 text adds only minor clarifications (e.g., referencing the captive subsidiary and the reinsurance program) but does not introduce new or more granular estimation techniques.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36440,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9336,
        "completion_tokens": 156,
        "total_tokens": 9492
      }
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory-related costs shifted from a $59 million inventory charge in 2021 (reflected in cost of sales) to an $87 million excess‑inventory charge recorded in the second quarter of 2023, which also negatively affected cost of sales and gross profit margins. Consequently, inventory‑related expenses increased sharply in 2023 compared with 2022, while the 2021 charge was a one‑time impact that no longer recurs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51181,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13006,
        "completion_tokens": 115,
        "total_tokens": 13122
      }
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "The treatment of shop card liabilities remains consistent between 2023 and 2024, with the Company continuing to record outstanding shop card balances as a liability net of estimated breakage, recognized upon redemption. This approach reflects Costco's strategy of accounting for breakage based on historical redemption patterns, ensuring that unclaimed balances are systematically reduced as actual redemptions occur, reinforcing a disciplined approach to managing unclaimed financial obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42433,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10834,
        "completion_tokens": 124,
        "total_tokens": 10959
      }
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved from a nascent offering into a strategically prioritized business with expanded partnerships and deeper customer engagement. In 2022, IFS focused on establishing foundational agreements (e.g., with ARM and Synopsys via the IFS Accelerator Ecosystem Alliance) and securing initial design wins, while actively building its ecosystem. By 2023, IFS significantly scaled its strategic partnerships—doubling agreements to over 40 across EDA, silicon IP, and cloud domains—and achieved key milestones like four design wins on Intel 18A (including a major high-performance computing customer) and expanded RAMP-C collaborations with U.S. defense and commercial partners (e.g., Nvidia, IBM, Microsoft). This shift reflected a move from foundational strategy to active customer delivery, emphasizing open-system foundry services, advanced packaging, and global capacity expansion to meet growing demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34030,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8741,
        "completion_tokens": 237,
        "total_tokens": 8979
      }
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "The financial impact of DHR's relationship with Aldevron evolved significantly between 2022 and 2023, with goodwill related to the acquisition declining from $6.1 billion (recorded in 2021) to $3.9 billion (preliminary estimate for the 2023 Abcam acquisition, reflecting ongoing evaluation of prior acquisitions including Aldevron). Net cash consideration for the original Aldevron Acquisition was $9.6 billion in 2021, and subsequent adjustments—such as $30 million in non-recurring fair value adjustments to inventory affecting 2021 earnings—were offset by ongoing integration impacts, though specific 2023 net cash consideration figures for Aldevron are not detailed beyond its inclusion in broader 2023 acquisition activity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50530,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12855,
        "completion_tokens": 182,
        "total_tokens": 13037
      }
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of AT&T’s 1.800% Global Notes due September 5 2026 was listed in the 2022 filing as 2026 and remained unchanged in the 2024 filing, indicating that the company’s debt structure has not altered the scheduled repayment of this specific tranche. This consistency suggests AT&T is maintaining a stable long‑term funding profile, even as it issues newer, longer‑dated notes to extend overall maturity horizons.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42122,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10756,
        "completion_tokens": 105,
        "total_tokens": 10862
      }
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target's compliance with its debt leverage covenant remained strong and unchanged between 2023 and 2024, as evidenced by its continued adherence to covenants in credit facilities (including the $3.0 billion revolving credit facility expiring in 2028) and long-term debt obligations, with no material changes to its debt structure affecting compliance. The company's debt leverage covenant, which is part of its credit facility agreements, was fully satisfied throughout both years, and the refinancing of its revolving credit facility (replacing the prior facility with a new $1.0 billion 364-day facility expiring in 2025 and extending the $3.0 billion facility to 2028) did not impact covenant compliance, as stated in the \"Liquidity and Capital Resources\" section of the 2024 Form 10-K.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38127,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9759,
        "completion_tokens": 197,
        "total_tokens": 9956
      }
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "Intel’s digital‑readiness push has moved from a broad, one‑API‑centric push in 2022—highlighting oneAPI adoption, developer‑training programs, and the Intel DevCloud for oneAPI—to a more structured, RISE‑driven agenda in 2023 that explicitly ties digital‑readiness to its RISE strategy and to external collaborations.  The 2023 disclosures show that Intel is leveraging the RISE framework to expand inclusive digital‑skill programs (e.g., AI‑for‑Youth, AI‑for‑Workforce, partnerships with Historically Black Colleges and Universities) and to embed inclusive‑leadership metrics into its talent and supplier initiatives, while also scaling its foundry and manufacturing capacity to support a wider ecosystem of customers.  This evolution reflects a shift from simply growing oneAPI usage to using that foundation as part of a broader, partnership‑focused effort to accelerate digital readiness worldwide.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51328,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13064,
        "completion_tokens": 225,
        "total_tokens": 13289
      }
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson's relationship with Micromine deteriorated between 2023 and 2024, culminating in AspenTech terminating its $623 million agreement to acquire Micromine in August 2023 due to unresolved Russian regulatory hurdles, with no termination fee paid. This failed acquisition attempt contributed to Emerson's financial results, including $56 of foreign currency transaction losses in 2023 related to the Micromine deal and $48 in restructuring costs from divesting two small Final Control businesses in 2024. The termination directly impacted AspenTech's financials, as evidenced by the pro forma 2023 results showing $1,693 million in sales attributable to NI (which included Micromine's $135 million backlog) and $424 million in ongoing intangibles amortization, while the failed Micromine transaction itself generated no direct financial gain for Emerson.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39055,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9983,
        "completion_tokens": 214,
        "total_tokens": 10197
      }
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) had approximately 17 million shares available at January 30, 2022, with associates contributing $22 million to purchase shares at 85% of the stock's fair market value on June 30, 2022. During fiscal 2023, approximately one million shares were purchased under the ESPPs at an average price of $277.19, compared to 1 million shares purchased in fiscal 2022 at an average price of $305.14.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42905,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10956,
        "completion_tokens": 111,
        "total_tokens": 11067
      }
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "The pattern of impairment triggers and associated charges across DHR's business segments shifted significantly from 2022 to 2023, reflecting evolving risks in its intangible asset portfolio. In 2022, impairment triggers were identified in the Diagnostics and Environmental & Applied Solutions segments during the first and third quarters, resulting in $22 million of impairment charges in 2020 and $10 million in 2021. By 2023, impairment triggers expanded to the Biotechnology and Diagnostics segments (including a second-quarter 2023 trigger in Biotechnology and fourth-quarter triggers in both Biotechnology and Diagnostics), leading to $77 million in impairment charges for 2023. This escalation indicates growing vulnerability in intangible assets—particularly technology-based assets and trade names—driven by market dynamics, segment realignments (e.g., post-2022 reporting unit changes), and heightened sensitivity to economic shifts, suggesting that the Company is proactively managing emerging risks in its increasingly complex intangible asset portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54519,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13870,
        "completion_tokens": 266,
        "total_tokens": 14136
      }
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The outstanding letters of credit related to trade contracts decreased from $362 million at January 30 2022 to $598 million at January 28 2024, reflecting an increase in the company’s exposure to trade‑related commitments. This growth suggests that Home Depot is becoming more involved in business transactions tied to trade contracts, likely expanding its role as a distributor or service provider in those markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43237,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11047,
        "completion_tokens": 104,
        "total_tokens": 11151
      }
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 were added to IBM's list of outstanding debt securities in the 2024 filing (page 5 of IBM_10k_2024.pdf), specifically noted as \"The instruments defining the rights of the holders of the 0.300% Notes due 2028\" being incorporated by reference from a February 2020 Form 8-K filing. This reflects a continuation of the debt issuance program, but the filing does not indicate any change in status or redemption of these notes between the 2023 and 2024 filings. The 2024 filing merely re-lists the existing debt instruments without mentioning any amendment, maturity, or redemption of the 0.300% Notes due 2028, indicating their status remains unchanged in IBM's financial instrument disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56004,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14226,
        "completion_tokens": 179,
        "total_tokens": 14405
      }
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "IBM's treatment of the 1.750% Notes due 2031 has evolved in terms of disclosure and registration between 2023 and 2024. In the 2023 filing (IBM_10k_2023.pdf), the notes were referenced under \"The instruments defining the rights of the holders of the 1.750% Notes due 2031 are Exhibits 4.2, 4.3 and 4.4 to Form 8-K, filed January 30, 2019\" (page 21 of the Table of Contents section). However, in the 2024 filing (IBM_10k_2024.pdf), the notes are explicitly listed in the \"Title of each class\" table under \"1.750% Notes due 2031\" with the trading symbol \"IBM31\" and registered on the New York Stock Exchange (page 1 of the 2024 Form 10-K). Additionally, the 2024 filing includes a new \"First Supplemental Indenture\" referenced as Exhibit 4.1 to Form 8-K filed February 2, 2024, which pertains to the 1.750% Notes due 2031 (page 22 of the 2024 document). This indicates that the notes were formally registered and disclosed in a dedicated SEC filing (Form 8-K) in early 2024, enhancing their visibility and compliance with registration requirements compared to the prior year's indirect reference. The 2024 filing also directly lists the notes in the securities table, confirming their active registration on a stock exchange.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56004,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14222,
        "completion_tokens": 305,
        "total_tokens": 14528
      }
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Eli Lilly’s financial relationship with Zyprexa shifted markedly between 2023 and 2024. In 2023, Zyprexa revenue was driven largely by the sale of the olanzapine portfolio rights, generating $79.4 million in the U.S. and $1.62 billion outside the U.S., producing a total of $1.69 billion—an “NM” (not‑meaningful) change from prior periods. By 2024, Zyprexa‑related revenue disappeared from the consolidated results, reflecting the company’s exit from that portfolio and the resulting decline in both volume and realized pricing for the product. This evolution illustrates a move away from recognizing Zyprexa revenue toward a business model that now relies on newer incretin therapies (e.g., Mounjaro, Trulicity) and other high‑growth products for the bulk of its top‑line performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47957,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12213,
        "completion_tokens": 196,
        "total_tokens": 12409
      }
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "The Mobility Preferred Interests were fully repurchased in April 2023, eliminating any redemption obligations and related liability. Consequently, there was no impact on earnings per share calculations for 2024, and the only remaining effect was the removal of the 72 million dilutive potential shares that had been included in the 2023 diluted EPS denominator.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67171,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17027,
        "completion_tokens": 90,
        "total_tokens": 17117
      }
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "Based on the provided document pages, IBM's treatment and disclosure of the 0.875% Notes due 2030 shows a consistent pattern of registration and listing in its SEC filings. In the 2023 10-K (pages 18-22), the notes were referenced under \"Item 13\" and \"Exhibits\" as part of the company's debt disclosures, with the specific instrument defining the rights of holders listed as \"Exhibits 4.2, 4.3 and 4.4 to Form 8-K, filed January 30, 2019.\" The 2024 10-K (pages 1-5) similarly includes the 0.875% Notes due 2030 in the \"Securities registered pursuant to Section 12(b)\" table (listed as \"0.875% Notes due 2030 | IBM30A | New York Stock Exchange\") and confirms its registration status in the \"Exhibits\" section (referencing \"The instruments defining the rights of the holders of the 0.875% Notes due 2030... are Exhibits 4.1, 4.2, 4.3, 4.4 and 4.5 to Form 8-K, filed February 8, 2022\"). Thus, the notes have remained continuously registered and listed on the New York Stock Exchange without any change in status between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56004,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14223,
        "completion_tokens": 257,
        "total_tokens": 14481
      }
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "The structure of AT&T's preferred equity instruments shows a clear evolution from 2023 to 2024, particularly in the Telco LLC and Mobility II entities. In 2023, AT&T issued $5,250 of additional Telco Class A-2 and A-3 preferred interests (bringing total Telco preferred interests to $7,250) and later amended the 2019 Tower Holdings preferred interests in August 2024 to reset rates and restructure terms (e.g., introducing Fixed and Floating Rate Classes with new distribution rates of 5.90% and SOFR+250 bps, respectively). This restructuring, coupled with the October 2024 agreement to issue $2,250 of new Telco Class A-4 preferred interests (with a 5.94% initial distribution rate and reset on November 1, 2028), indicates a strategic shift toward longer-term, reset-based preferred equity to manage financing costs and liquidity. Concurrently, the repurchase of all remaining Mobility II preferred interests in April 2023 (for $5,414) and the issuance of new Series B redeemable noncontrolling interests in June 2023 (paying 6.8% distributions) reflect a deliberate transition away from legacy preferred structures toward more flexible, debt-like instruments with clearer redemption pathways. This evolution demonstrates AT&T's approach to financing through preferred equity as a targeted, iterative strategy: leveraging perpetual preferred shares for capital deployment (e.g., funding tower assets or telecom assets via subsidiaries), then refinancing or restructuring these instruments to optimize terms, reset rates, or align with debt maturity profiles, while maintaining flexibility for dividends and share repurchases. The consistent emphasis on \"no limitations on cash movements\" or dividend declarations underscores that preferred equity is treated as a stable, non-dilutive financing tool rather than a restrictive obligation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69359,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17573,
        "completion_tokens": 460,
        "total_tokens": 18033
      }
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One’s multifamily commercial‑real‑estate loan exposure is managed through loss‑sharing agreements with government‑sponsored enterprises (GSEs).  The 2022 10‑K notes that, beginning January 1 2020, the company elected the fair‑value option for new loss‑sharing arrangements, recording unrealized gains and losses in non‑interest income and maintaining a liability of $82 million (2022) and $137 million (2023) for these guarantees.  This structure shifts a portion of the credit risk to the GSEs while still requiring Capital One to monitor and reserve for expected losses, a practice that continued through 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 217,
          "pages": [
            215,
            216,
            217,
            218,
            219
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48613,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12392,
        "completion_tokens": 155,
        "total_tokens": 12547
      }
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "From 2022 to 2023, Amazon’s co-branded credit card programs transitioned from a strategic growth lever to a higher-risk, compliance-intensive component of its financial model, marked by heightened regulatory scrutiny and potential financial exposure. While the 2022 filing (AMZN_10k_2022.pdf, p. 12) references co-branded credit cards as part of its payment ecosystem without explicit risk emphasis, the 2023 filing (AMZN_10k_2023.pdf, p. 13) explicitly details that these programs \"could adversely affect our operating results if renewed on less favorable terms or terminated,\" alongside new compliance obligations under evolving payment regulations (e.g., data security rules, licensing requirements, and anti-fraud mandates). This shift introduced significant regulatory risks, including potential fines, loss of payment processing capabilities, and liability for third-party obligations, which could directly impact revenue streams and profitability if programs were altered or terminated under unfavorable terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54816,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13946,
        "completion_tokens": 254,
        "total_tokens": 14200
      }
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Based on the provided document pages, PM's financial relationship with RBH has evolved such that RBH was deconsolidated from PMI's consolidated financial statements as of March 22, 2019 (due to CCAA proceedings), and PMI now accounts for its remaining investment in RBH as an equity security without readily determinable fair value. The document indicates that PMI recorded a $2,316 million non-cash impairment charge for its RBH investment as of December 31, 2024, reflecting a significant decline in the estimated fair value of the investment ($714 million) due to developments in RBH's CCAA proceedings and potential settlement allocations. This impairment and the deconsolidation mark a substantial shift in PM's financial relationship with RBH, moving from consolidation to equity method accounting with significant impairment considerations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50320,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12814,
        "completion_tokens": 211,
        "total_tokens": 13026
      }
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Between 2023 and 2024, Baqsimi transitioned from a standalone product to a strategic asset within Lilly's portfolio, highlighted by its inclusion in the $1.60 billion cash proceeds from the 2023 sale of the olanzapine portfolio rights (including Zyprexa) and Baqsimi. This divestiture, coupled with the $3.94 billion paid for acquired IPR&D (which included Baqsimi-related assets), underscored its role in refining Lilly's pipeline and generating capital. While Baqsimi contributed $677.6 million in total revenue in 2023 (up from $139.3 million in 2022), its revenue share within Lilly's overall portfolio declined slightly in 2024 as the company shifted focus toward higher-growth assets like Mounjaro, Jardiance, and Zepbound, with Baqsimi's contribution now reflecting a smaller, yet strategically integrated, component of Lilly's diversified product mix.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46823,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11937,
        "completion_tokens": 214,
        "total_tokens": 12152
      }
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s Total Highway Revenue Equipment composition shifted toward greater ownership of containers and chassis. In 2022, containers were 48,962 owned vs. 1,856 leased (96.4% owned), and chassis were 29,875 owned vs. 14,148 leased (67.8% owned). By 2024, ownership increased to 46,375 owned vs. 288 leased for containers (99.4% owned), and chassis rose to 4,356 owned vs. 1,197 leased (78.4% owned), reflecting a significant reduction in leased equipment share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 31202,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8030,
        "completion_tokens": 121,
        "total_tokens": 8152
      }
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Capital One’s use of securitized debt obligations grew modestly from $12.4 billion at the end of 2020 to $15.0 billion by the end of 2021, reflecting net issuances within its securitization programs. This increase contributed to the broader funding mix, where securitized debt represented about 4 % of total funding sources in both years, while overall funding rose to $354.1 billion, driven primarily by deposit growth and the expansion of loan portfolios. Thus, securitized debt remained a stable, though relatively small, component of Capital One’s overall funding structure during the 2022‑2023 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47767,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12169,
        "completion_tokens": 151,
        "total_tokens": 12321
      }
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "Based on the provided document pages, LLY's revenue from Zyprexa (specifically from the sale of the olanzapine portfolio rights, as noted in Note 2) evolved significantly between 2023 and 2024. In 2023, Zyprexa revenue was $79.4 million in the U.S. and $1,615.4 million outside the U.S., totaling $1,694.8 million. By 2024, this revenue collapsed to $0 in the U.S. and $0 outside the U.S., as the portfolio rights were sold in December 2023 (as detailed in Note 3 regarding the POINT acquisition and the olanzapine portfolio sale). The revenue recognition for this item was tied to the transfer of control of the intellectual property rights, with the gain from the sale recorded in \"collaboration and other revenue\" when control transferred. Post-sale, no further revenue from Zyprexa is recognized, as the rights were divested. The nature of the revenue shifted from ongoing product sales (pre-2023) to a one-time gain from the rights sale, recognized upon transfer of control under the collaboration accounting policy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46276,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11791,
        "completion_tokens": 255,
        "total_tokens": 12046
      }
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology for Federal Government Securities remained classified as Level 2 throughout the period, but the plan’s target allocation shifted markedly: in 2022 the target range was 45‑55 % equity and 45‑55 % debt, whereas by 2024 the target had moved to 20‑30 % equity and 70‑80 % debt, reflecting a continued de‑risking strategy. Consequently, the proportion of plan assets held in Federal Government Securities fell from $742 million (Level 2) in 2022 to $150 million (Level 2) in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42283,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10787,
        "completion_tokens": 125,
        "total_tokens": 10913
      }
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Capital One's utilization of credit score data for product segmentation decisions shifted markedly between 2022 and 2023, with the proportion of auto loans originated to borrowers with FICO scores above 660 increasing from 53% to 53% (wait, no—let's check the data). Actually, looking at Table 21 in the 2023 filing, 53% of auto loans had FICO scores above 660 at origination, compared to 50% in 2022 (Table 21 in 2022 showed 50% above 660). More significantly, the share of borrowers with scores 620 or below decreased from 34% in 2022 to 27% in 2023, indicating a strategic shift toward higher-quality credit profiles. This evolution suggests Capital One is increasingly using credit scores to refine product segmentation, moving away from subprime exposure and toward more credit-efficient product offerings, which aligns with their stated use of credit scores for \"product segmentation decisions\" as mentioned in the Credit Risk Measurement section. (2 sentences)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46604,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11882,
        "completion_tokens": 241,
        "total_tokens": 12123
      }
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "From 2022 to 2023, Amazon's strategic positioning of AWS evolved from being primarily described as a key growth driver within its broader technology and content investments to a more explicitly defined, standalone strategic pillar. The 2023 filing emphasizes AWS as a core business segment (\"Amazon Web Services\") with dedicated leadership (CEO Adam Selipsky) and highlights its role in \"building and deploying innovative and efficient software and electronic devices,\" while the 2022 filing framed AWS as part of broader technology infrastructure investments (\"investing in AWS... to enhance the customer experience\"). Crucially, the 2023 document underscores AWS's significance through dedicated capital allocation (\"investments in technology infrastructure (the majority of which is to support AWS)\") and positions it as a critical growth engine separate from North America and International segments, reflecting a strategic shift to prioritize AWS as a distinct, high-growth business area within Amazon's overall capital planning and investment focus. This evolution reflects a deeper integration of AWS as a central, self-sustaining growth driver rather than just a supporting technology initiative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46245,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11786,
        "completion_tokens": 301,
        "total_tokens": 12087
      }
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "PMI's accounting treatment of its relationship with Rothmans, Benson & Hedges (RBH) has evolved markedly. In 2022 the company continued to hedge RBH‑related foreign‑currency and interest‑rate exposures through qualifying cash‑flow and net‑investment hedges, recording gains/losses in accumulated other comprehensive losses and reclassifying them to earnings when the hedged transactions occur; by 2024, after RBH’s deconsolidation in March 2019 and the subsequent CCAA proceedings, PMI no longer applies hedge accounting to RBH‑related contracts, and any remaining derivative gains are expected to be reclassified to earnings within the next 12 months, while the company now records a $2.3 billion impairment charge on its equity investment in RBH. Consequently, PMI’s financial exposure to RBH is now limited to the residual effects of previously recorded hedges and the impaired equity holding, rather than ongoing derivative hedge accounting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40083,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10259,
        "completion_tokens": 236,
        "total_tokens": 10496
      }
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy’s commercial significance for GILD declined materially. In 2022, it generated $8.6 billion in total HIV revenue (≈ 53 % of total HIV sales), but by 2024 its revenue had fallen to $7.26 billion (≈ 42 % of total HIV sales), reflecting both a reduction in its revenue contribution and heightened product‑risk exposure (e.g., competition, declining market share, and the need to maintain pricing amid reimbursement pressures). Consequently, Biktarvy’s share of GILD’s overall revenue and its risk profile have both diminished over this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 80323,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20304,
        "completion_tokens": 141,
        "total_tokens": 20445
      }
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific's financial stake and operational relationship with TTX have remained consistent from 2022 to 2024, with the company maintaining a 36.79% economic and voting interest in TTX (as noted in the 2021 filing) and recognizing $1.6 billion in TTX-related investments on its balance sheet as of December 31, 2021. TTX car hire expenses of $375 million in 2021 (included in equipment and other rents) reflect the ongoing operational relationship, though specific changes in investment value or car hire expenses from 2022–2024 are not detailed in the provided 10-K pages. The 2024 filing confirms the continued use of the equity method for TTX accounting and references updated environmental liability estimates, but does not provide comparative data on TTX-related investment value or car hire costs across 2022–2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39817,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10182,
        "completion_tokens": 205,
        "total_tokens": 10388
      }
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "From 2022 to 2023, Tesla shifted its Solar Roof strategy from broad installer training to a more targeted approach focused on onboarding new installers and partnering with real estate developers to streamline installation, while simultaneously strengthening supply chain resilience by diversifying battery cell sources and advancing its in-house cell production to mitigate component shortages. This transition aimed to scale production efficiently amid ongoing global supply constraints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 44633,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11385,
        "completion_tokens": 122,
        "total_tokens": 11507
      }
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company’s relationship with U.S. fountain retailers remained unchanged in structure but saw a strategic shift in syrup supply. While U.S. bottlers continue to be prohibited from manufacturing fountain syrups (as noted in the 2023 10-K, page 36), the Company maintained its practice of manufacturing and selling fountain syrups directly to authorized U.S. fountain wholesalers and retailers (page 38). This contrasts with operations outside the U.S., where bottling partners typically produce fountain syrups from Company concentrates for sale to retailers. The 2023 report confirms that U.S. fountain syrup sales are included in the North America operating segment, with no indication of a structural change in this dynamic between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48772,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12425,
        "completion_tokens": 195,
        "total_tokens": 12620
      }
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "From 2022 to 2024, IBM's treatment of the 0.950% Notes due 2025 evolved from being classified as a \"debenture\" in the 2022 10-K (Item 13, \"7.00% Debentures due 2025 and 7.00% Debentures due 2045\") to being explicitly listed as a \"2.875% Notes due 2025\" and \"0.950% Notes due 2025\" in the 2024 10-K's \"Securities registered pursuant to Section 12(b)\" table (page 13), with the 0.950% Notes now clearly identified as a distinct debt instrument under the \"2.875% Notes due 2025\" and \"0.950% Notes due 2025\" entries. The registration details shifted from referencing \"7.00% Debentures due 2025\" in the 2022 filing to specifying the 0.950% Notes as a separate registered security (e.g., \"0.950% Notes due 2025\" with ticker \"IBM25B\") in the 2024 filing, reflecting a formal reclassification of the instrument's terms and registration details.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35722,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9159,
        "completion_tokens": 209,
        "total_tokens": 9368
      }
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "From 2022 to 2024, GILD's strategic positioning of Biktarvy evolved from being a key growth driver in its HIV portfolio to facing heightened competitive pressure and financial risk exposure. While Biktarvy remained a cornerstone product with strong sales (contributing significantly to Gilead's $16.3B retained earnings in 2021 and consistent cash flow), the company's 2024 SEC filing highlights intensified market competition—particularly from generic alternatives and alternative HIV regimens—necessitating strategic pricing and market share defense. This competitive differentiation, coupled with the financial risks of declining revenue from mature products like Truvada (which faced generic erosion), forced Gilead to prioritize Biktarvy as a high-margin anchor while simultaneously investing in new pipeline assets (e.g., cancer therapies like Trodelvy) to offset HIV market volatility. The 2024 filing underscores that Gilead's financial risk exposure now hinges on maintaining Biktarvy's market leadership amid pricing pressures and the need to fund R&D for next-generation therapies, making its strategic positioning critical to sustaining overall portfolio resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58637,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14892,
        "completion_tokens": 294,
        "total_tokens": 15186
      }
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Lockheed Martin's approach to defined contribution retirement savings plans remained consistent between 2022 and 2023, with no structural changes to the plans themselves. However, the company significantly reduced its pension obligations through strategic transfers of defined benefit liabilities to insurance companies. In 2021, it transferred $4.9 billion of pension obligations via group annuity contracts, followed by $1.4 billion in 2020 and $4.3 billion in 2022, which eliminated future payment responsibilities and generated noncash settlement charges (e.g., $1.7 billion in 2021). These transfers, coupled with the full freeze of qualified defined benefit plans effective January 1, 2020, shifted retirees to enhanced defined contribution plans, reducing long-term financial volatility. The 2023 financial impact included a $414 million settlement charge from voluntary lump-sum payments to former employees, but no major new transfers occurred that year. Overall, the company’s strategy focused on mitigating pension volatility through these targeted liability reductions rather than altering defined contribution plan structures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58732,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14918,
        "completion_tokens": 284,
        "total_tokens": 15202
      }
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "Between 2022 and 2024, IBM's debt maturity schedule shows that the 2.875% Notes due 2025 (trading symbol IBM 25A) remained part of its long-term debt structure, but the company increasingly relied on newer tranches of 2025 maturities. Specifically, the 2024 filing lists three 2025-dated notes: 2.875% Notes due 2025 (IBM 25A), 0.950% Notes due 2025 (IBM 25B), and 0.300% Notes due 2026 (IBM 26B, with maturity extending beyond 2025). This indicates a strategic shift toward lower-coupon, shorter-term debt instruments, though the 2.875% Notes due 2025 itself was not retired or restructured during this period. The evolution reflects IBM's broader debt management strategy to optimize refinancing costs amid changing interest rate environments, while maintaining a diversified maturity profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 40102,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10243,
        "completion_tokens": 198,
        "total_tokens": 10442
      }
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "From 2022 to 2024, Biktarvy's strategic importance within Gilead's HIV portfolio has grown significantly, transitioning from a key growth driver amid declining Truvada/Atripla sales to the cornerstone of Gilead's HIV franchise. This evolution is underscored by its expanded pediatric labeling (2021), robust global demand, and favorable pricing dynamics, which helped offset revenue pressures from generic competition and pandemic-related disruptions. However, its risk profile has intensified due to heightened competitive pressures from emerging HIV therapies (e.g., lenacapavir's long-acting potential) and the need to maintain market share in a maturing market, necessitating continued innovation and strategic investment to sustain its leadership position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55792,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14183,
        "completion_tokens": 190,
        "total_tokens": 14373
      }
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The U.S. litigation escrow account balance increased from $1,764 million at the end of fiscal 2022 to $3,089 million at the end of fiscal 2023. During fiscal 2023, the Company deposited $1,500 million into the escrow account, and during fiscal 2022 it deposited $1,000 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46237,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11794,
        "completion_tokens": 69,
        "total_tokens": 11863
      }
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Based on the provided 10-K pages, the role of fountain syrups in Coca-Cola's North America operating segment has evolved such that fountain syrup sales are now explicitly included within the North America operating segment (as stated in the \"Our Business\" section describing fountain syrup sales to fountain retailers and authorized wholesalers/bottling partners). However, the documents do not provide specific comparative data or details about changes in responsibilities between 2022 and 2023 regarding manufacturing and distribution for fountain syrups. The text only confirms that fountain syrup sales are part of the North America segment's operations without detailing evolution or shifts in responsibilities over those years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41345,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10569,
        "completion_tokens": 183,
        "total_tokens": 10752
      }
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "The composition of IBM's debt maturing in 2025 has shifted toward lower‑coupon notes over the 2022‑2024 period. In the 2022 filing, the 0.950% Notes due 2025 (IBM 25B) were listed alongside the 2.875% Notes due 2025 (IBM 25A) and the 7.00% Debentures due 2025 (IBM 25). By the 2024 filing, the 0.950% Notes due 2025 remain outstanding but are now paired with newer, even lower‑rate issues such as the 0.300% Notes due 2026 (IBM 26B) and the 1.250% Notes due 2027 (IBM 27B), reflecting IBM's strategy of refinancing maturing obligations at cheaper rates. This evolution shows a clear move from higher‑yielding 2025 maturities to a broader mix that includes very low‑coupon notes and extended maturities beyond 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 40102,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10243,
        "completion_tokens": 178,
        "total_tokens": 10422
      }
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Based on the 2022 and 2024 10-K filings, Disney's strategic approach to cruise ships has evolved from a planned 2024 destination expansion (Lighthouse Point on Eleuthera) to an active investment in fleet growth. The 2024 filing explicitly states Disney is \"announced plans for additional expansion of our fleet of cruise ships\" and references \"investment in our Experiences segment,\" indicating a strategic shift toward scaling cruise operations beyond the initial 2024 destination launch. This reflects a move from planning to tangible execution of cruise fleet expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62613,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15868,
        "completion_tokens": 143,
        "total_tokens": 16011
      }
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "From 2022 to 2023 Lockheed Martin’s pension‑risk‑transfer strategy remained focused on reducing defined‑benefit obligations through bulk annuity purchases funded by the master retirement trust. The 2021 transaction that transferred $4.9 billion of pension liabilities using group‑annuity contracts was already reflected in the 2022 results, and the company continued to seek additional risk‑transfer opportunities in 2023, which could generate further non‑cash settlement charges. Financially, the transfers lowered the volatility of pension expense and freed up prepayment credits, but they also created a potential earnings impact if future transactions trigger material settlement charges. Strategically, the moves are intended to stabilize long‑term pension funding, improve cash‑flow predictability, and mitigate the long‑term risk exposure of the company’s defined‑benefit plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61408,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15576,
        "completion_tokens": 221,
        "total_tokens": 15797
      }
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Tesla’s financing‑partner relationship remained stable from 2022 to 2023, but the company’s accounting focus shifted toward tighter accounts‑receivable management and heightened awareness of leasing‑program risk.  In the 2023 filing the firm notes that receivables can fluctuate by up to two weeks as it waits for payments from financing partners and that the timing of regulatory‑credit sales and long‑term government rebates creates variability in the receivable balance.  At the same time, the discussion of operating‑lease vehicles emphasizes that residual‑value estimates—critical to the profitability of its direct leasing program—are subject to market‑driven price changes, and any mis‑estimation could materially affect earnings.  Consequently, while the partnership structure did not change dramatically, Tesla is placing greater emphasis on managing receivable collections and monitoring residual‑value risk in its leasing operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54648,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13889,
        "completion_tokens": 236,
        "total_tokens": 14125
      }
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola shifted its fountain syrup distribution strategy to reduce direct sales to fountain retailers and increase reliance on authorized fountain wholesalers. This change allowed bottlers to focus on concentrate and syrup sales while the Company retained control over fountain syrup manufacturing and distribution through its North America operating segment. The roles of bottlers evolved to become more centralized in concentrate and syrup procurement under incidence-based pricing models, while fountain wholesalers gained greater responsibility for distributing syrups to retailers, reducing bottlers' direct involvement in fountain syrup sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48772,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12421,
        "completion_tokens": 168,
        "total_tokens": 12589
      }
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved through increased transaction volume and structural changes. Receivables from the ATMP JV rose from $9 million (as of Dec 31, 2022) to $12 million (as of Dec 28, 2024), while payables increased from $363 million to $476 million over the same period. Additionally, AMD recorded $33 million in equity income from the ATMP JV in 2024 (up from $16 million in 2023), and contributed $17 million in new equity capital to the JV in October 2024, reflecting deeper operational integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46602,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11872,
        "completion_tokens": 139,
        "total_tokens": 12012
      }
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin accelerated its pension risk management by transferring $4.1 billion of defined‑benefit obligations to insurers in 2023 (including a $414 million lump‑sum settlement in Q4 2023) following a similar $4.3 billion transfer in late 2022. These settlements generated non‑cash pension settlement charges of $1.5 billion in 2022 and $1.7 billion in 2021, and the 2023 transaction resulted in a $6.2 billion reduction in the company’s pension liability, improving the funded status but also creating a significant non‑operating expense impact. Consequently, the company’s pension‑related deferred tax assets fell from $2.994 billion (2022) to $1.985 billion (2023), reflecting the lower projected benefit obligations after these settlements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58732,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14921,
        "completion_tokens": 193,
        "total_tokens": 15114
      }
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Based on the provided SEC 10-K filings, AMD's financial relationship with the ATMP JV evolved as follows between 2023 and 2024:  \n- **Equity investment**: The Company's carrying value of its 15% equity interest in the ATMP JV increased from **$83 million (Dec 31, 2022)** to **$99 million (Dec 30, 2023)**, and further to **$149 million (Dec 28, 2024)**, reflecting additional $17 million equity contributions in 2024.  \n- **Equity income**: Gains from the ATMP JV rose from **$6 million (2021)** to **$16 million (2022)** and **$33 million (2024)**, with the Company recognizing $16 million in 2023 and $33 million in 2024.  \n- **Financial flows**: Purchases from the ATMP JV remained stable at **$1.7 billion (2023 and 2024)**, while payables to the JV decreased from **$463 million (Dec 2022)** to **$363 million (Dec 2023)**, and receivables increased from **$2 million (Dec 2022)** to **$9 million (Dec 2023)**.  \n- **No impairment**: The investment is accounted for under the equity method, with no indication of impairment, and the Company continues to assist in managing the JV’s raw material inventory without impacting consolidated operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49667,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12636,
        "completion_tokens": 288,
        "total_tokens": 12924
      }
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Johnson & Johnson’s financial stake in Kenvue declined sharply between 2023 and 2024. After the May 2023 IPO, J&J owned ~89.6 % of Kenvue; by August 23 2023 it exchanged an additional 80.1 % of its shares, retaining only about 9.5 % of the outstanding Kenvue stock (recorded as a $4.3 billion fair‑value asset). The exchange generated a $21 billion non‑cash gain (including a $2.8 billion gain on the shares J&J kept) that was recognized in discontinued‑operations earnings. By May 2024 J&J completed a debt‑for‑equity swap that eliminated its remaining Kenvue holdings, leaving it with no equity stake in the company. Consequently, any retained equity was fully divested, and the earlier gain/loss on that equity was reflected only in the 2023 discontinued‑operations results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38177,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9775,
        "completion_tokens": 194,
        "total_tokens": 9970
      }
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "Based on the provided 10-K pages, AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. is disclosed in Note 23 (Contingent Liabilities) and Note 4 (Financial Guarantees) of the 2022 filing. The documents indicate AT&T has a contractual obligation to purchase goods/services from various parties, including a $28,860 purchase obligation in 2022, but there is no specific mention of Southwestern Bell Telephone Co. being included in guarantee agreements in 2023. The 2023 filing (T_10k_2023.pdf pages 101-105) does not show any evolution in this relationship or inclusion in guarantee agreements, as the provided pages focus on other matters like DIRECTV, FirstNet, and general contingent liabilities without referencing Southwestern Bell Telephone Co. in the context of financial guarantees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10490,
        "completion_tokens": 203,
        "total_tokens": 10693
      }
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "Lockheed Martin has deepened its strategic focus on hypersonics, transitioning from early development to early production phases through 2026, with multiple programs advancing under U.S. Air Force and Army initiatives. The company has expanded its program development responsibilities, integrating hypersonics into its broader portfolio of classified programs and multi-year growth areas while maintaining its role as a key prime contractor for U.S. government systems. This evolution reflects a strategic positioning of hypersonics as a core growth area within its advanced technology development, supported by sustained U.S. government investment and program maturation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 51413,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13080,
        "completion_tokens": 168,
        "total_tokens": 13248
      }
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The U.S. litigation escrow account balance increased from $1.4 billion at the end of fiscal 2022 to $3.1 billion at the end of fiscal 2023, reflecting deposits of $1.5 billion in fiscal 2023 (compared with $1.0 billion in fiscal 2022) and net payments of $175 million in fiscal 2023 (versus $685 million in fiscal 2022). Consequently, deposits into the escrow account were $1.5 billion for fiscal 2023 and $1.0 billion for fiscal 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51352,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13068,
        "completion_tokens": 108,
        "total_tokens": 13177
      }
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "Based on the provided document pages, Outdoor Garden is classified within the Hardlines merchandising department, which falls under the Primary segment (retail operations in the U.S., Canada, and Mexico). Its performance metrics show consistent growth in net sales, with Outdoor Garden generating $10,317 million in fiscal 2021 (6.8% of total net sales), $9,602 million in fiscal 2020 (7.3%), and $7,595 million in fiscal 2019 (6.9%). The document indicates that Hardlines, which includes Outdoor Garden, contributed $45,730 million to net sales in fiscal 2021, reflecting its ongoing significance within the company's product strategy. This classification and performance trajectory align with HD's focus on expanding outdoor living and garden categories as part of its core hardlines offering, though specific strategic shifts post-2022 are not detailed in the provided materials.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40512,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10351,
        "completion_tokens": 220,
        "total_tokens": 10571
      }
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD maintains its emphasis on an engaging and open environment as its global workforce expands by consistently highlighting its culture of innovation, diversity, and employee empowerment in its 2024 disclosures. The company notes that its 2023 and 2024 employee surveys showed culture scores ranking among the top 10% of technology industry peers, with employees describing the environment as \"inclusive, innovative, open, and respectful,\" and emphasizes that this culture is foundational to its talent strategy in a competitive semiconductor market. This suggests AMD's talent retention strategy relies on fostering an open, inclusive workplace that drives engagement and aligns with its mission to \"build great products that accelerate next-generation computing experiences,\" helping it attract and retain top talent amid industry competition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47036,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12002,
        "completion_tokens": 211,
        "total_tokens": 12213
      }
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "Based on the provided document pages, AT&T's relationship with The Ohio Bell Telephone Company (a Baby Bell operating company) evolved in 2023 by transitioning from a traditional operating company structure to a corporate-level entity following the 2022-2023 divestiture of its local exchange assets. This restructuring meant AT&T no longer operated as a local exchange carrier but instead functioned as a holding company, with The Ohio Bell and other Baby Bells now operating as independent subsidiaries under the AT&T umbrella. Consequently, AT&T's guarantee obligations related to these entities were formally removed from its consolidated financial statements, as evidenced by the removal of Ohio Bell's financials from AT&T's balance sheet and the shift to equity accounting for its investment in DIRECTV (which included Ohio Bell's former assets). The company explicitly stated it was \"not committed, implicitly or explicitly, to provide financial or other support\" beyond the carrying value of assets and liabilities recognized on its balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10482,
        "completion_tokens": 264,
        "total_tokens": 10746
      }
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "Based on the provided document pages, the financial impact of GE's relationship with AerCap evolved significantly between 2023 and 2024, particularly regarding gains on retained and sold ownership interests. In 2023, gains on retained and sold ownership interests totaled $5,778 million, primarily driven by the sale of portions of the Steam Power business and related to GE HealthCare and AerCap investments. By 2024, these gains decreased substantially to $5,200 million (as reflected in the \"Continuing earnings (loss) attributable to common shareholders\" and adjusted earnings discussion), representing a $5.2 billion reduction from 2023 levels, primarily due to the nonrecurrence of prior-year gains on AerCap and GE HealthCare investments and the impact of the GE Vernova and GE HealthCare spin-offs. This decline directly contributed to the $2.5 billion decrease in continuing earnings per share from 2023 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62044,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15734,
        "completion_tokens": 230,
        "total_tokens": 15964
      }
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Home Depot’s strategic use of HD Supply has shifted from a standalone wholesale channel to an integrated part of its “interconnected retail” strategy, leveraging the acquired MRO and specialty‑trade network to deepen service for professional customers and expand its MRO offering.  The 2024 10‑K notes that the acquisition of SRS (the successor to HD Supply’s core business) adds a nationwide branch and distribution footprint that supports Pros with differentiated fulfillment, trade‑credit programs and enhanced product assortments, while also feeding the broader supply‑chain investments that underpin faster, lower‑cost delivery for both Pros and DIY shoppers.  Consequently, HD Supply’s role now centers on providing targeted MRO and specialty‑trade solutions that reinforce Home Depot’s focus on professional customers and its omnichannel delivery ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53344,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13558,
        "completion_tokens": 216,
        "total_tokens": 13774
      }
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "AMD's reliance on cross‑licensing agreements has remained steady from 2023 to 2024, with the company continuing to maintain a broad portfolio of roughly 12,800 issued patents and 5,600 pending worldwide, supporting ongoing technology exchange. While the patent count grew modestly, the firm emphasizes that no single patent or expiration is material, underscoring that its cross‑licensing strategy continues to facilitate collaborative innovation and protect its expanding IP assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47036,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11987,
        "completion_tokens": 120,
        "total_tokens": 12107
      }
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "Johnson & Johnson completed the Kenvue separation in 2023, retaining a 9.5 % stake that it later reduced through a debt‑for‑equity exchange in May 2024, which eliminated its remaining Kenvue shares and generated a $21 billion non‑cash gain (including a $2.8 billion gain on the retained Kenvue stock). The exchange was part of the broader divestiture of the Consumer Health business, which was reflected as discontinued operations and resulted in significant restructuring and separation costs recorded in earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37140,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9517,
        "completion_tokens": 128,
        "total_tokens": 9645
      }
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "Based on the provided 10-K pages, AT&T's relationship with Indiana Bell Telephone Co. Inc. is referenced only in Note 22 under \"Contingent Liabilities,\" where it lists \"Indiana Bell Telephone Co. Inc.\" as one of the companies for which it provides a guarantee of obligations (alongside other Bell operating companies like Pacific Bell, Southwestern Bell, etc.). The document does not indicate any significant evolution in this relationship between 2022 and 2023 regarding guarantee disclosures. The guarantee obligation for Indiana Bell remains part of the broader \"Guarantee of certain obligations of...\" disclosure, with no specific changes noted in the 2022 or 2023 filings beyond the standard inclusion of this entity in the list of subsidiaries with guaranteed obligations. The note confirms that such guarantees are not explicitly detailed beyond the general statement of contractual obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10482,
        "completion_tokens": 225,
        "total_tokens": 10707
      }
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE's cash involvement with AerCap was limited to a $203 million net cash payment to AerCap for ongoing sales or leases and transition services, and the company recorded a $1,189 million loss from discontinued operations related to AerCap and other activities. Investment gains tied to AerCap are reflected in the $1,656 million gain from discontinued operations (net of tax) reported for 2023, while the 2024 results show a $409 million net earnings from discontinued operations, indicating a significant decline in gains from AerCap. Consequently, cash outflows to AerCap were modest, and the investment gains associated with AerCap have sharply decreased.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64201,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16267,
        "completion_tokens": 169,
        "total_tokens": 16436
      }
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "From 2022 to 2024, The Home Depot has evolved its store appearance and customer experience strategy to prioritize seamless digital integration and enhanced service offerings, particularly for professional customers (Pros). The company has invested heavily in omnichannel capabilities—such as curb-side pickup, mobile app navigation, and interconnected fulfillment networks (BOSS, BOPIS, BODFS, BORIS)—to create a frictionless shopping journey that blends in-store experiences with online research and purchasing. This shift, underscored by $3.5 billion in capital expenditures in 2024 and the acquisition of SRS to strengthen Pro-focused services, reflects a strategic emphasis on convenience, speed, and personalized engagement. By modernizing store layouts, expanding self-service tools, and leveraging technology like electronic shelf labels and AI-driven inventory management, Home Depot aims to meet rising customer expectations for efficiency while reinforcing its competitive edge in a fragmented market. The focus remains on deepening relationships with Pros through tailored digital platforms and supply chain innovations to support complex project needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48023,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12232,
        "completion_tokens": 291,
        "total_tokens": 12523
      }
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Based on the provided SEC 10-K filings, AMD's financial relationship with the ATMP JV evolved significantly between 2023 and 2024:  \n- In 2023, the Company recorded $1.7 billion in purchases from and $14 million in resales to the ATMP JV, with $363 million payable to the JV as of December 30, 2023.  \n- By 2024, purchases increased to $1.7 billion (matching 2023 levels), but payables rose to $476 million (from $363 million in 2023), and resales surged to $121 million (from $14 million in 2023), reflecting expanded inventory management collaboration.  \n- The Company also committed $100 million in debt financing to the ATMP JV in October 2024, further deepening the financial relationship beyond simple resales.  \n- The equity investment in the ATMP JV grew from $99 million (as of Dec 30, 2023) to $149 million (as of Dec 28, 2024), driven by an additional $17 million equity contribution in August 2024.  \n\nThis evolution demonstrates a strategic deepening of the partnership, shifting from transactional resales to integrated financial and operational collaboration, including debt financing and increased investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44230,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11278,
        "completion_tokens": 281,
        "total_tokens": 11560
      }
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Johnson & Johnson’s privacy compliance program has been expanded to address emerging global data‑protection rules and cross‑border data‑flow constraints.  The 2023 filing notes heightened scrutiny of privacy laws and the risk of unauthorized data access, while the 2024 filing emphasizes new privacy legislation, stricter enforcement, and the need for controls over international data transfers to mitigate reputational and financial exposure.  Consequently, the Company has strengthened its privacy governance, training, and technical safeguards to keep pace with evolving legal requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42372,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10823,
        "completion_tokens": 148,
        "total_tokens": 10971
      }
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE's estimated losses from borrower litigation at Bank BPH increased from $2.669 billion to $2.461 billion, and the related valuation allowance for those losses was fully realized—resulting in a zero carrying value of the financing receivables after the allowance was applied. Consequently, the valuation allowance that previously offset the receivables was eliminated, and no additional allowance was required in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64429,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16333,
        "completion_tokens": 110,
        "total_tokens": 16443
      }
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "From 2022 to 2024, HD’s Indoor Garden product line shifted from being grouped under the broader Hardlines merchandising department in 2022 to being reported as a distinct merchandising department within the Primary segment in 2024, reflecting a reclassification of merchandising department structure. This evolution coincides with its growing contribution to net sales, rising from $11.261 billion in fiscal 2021 (10.2% of net sales) to $10.519 billion in fiscal 2024 (6.6% of Primary segment net sales), while maintaining a consistent presence in the company’s strategic merchandising focus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40512,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10360,
        "completion_tokens": 148,
        "total_tokens": 10508
      }
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive’s sourcing strategy has evolved to actively manage commodity price volatility by combining cost‑containment measures with targeted hedging. The company continues to use sourcing strategies—such as diversified supplier relationships, productivity initiatives, and limited commodity‑hedging contracts—to offset raw‑material price swings, while also leveraging price adjustments and productivity programs to protect margins amid fluctuating commodity costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39457,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10089,
        "completion_tokens": 122,
        "total_tokens": 10211
      }
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA sales increased sharply from $3.1 billion in 2023 to $3.67 billion in 2024, a 16.6% rise (driven by market growth and share gains). This growth was partially offset by a negative currency impact and the broader Innovative Medicine segment’s 4% sales increase, which included a 5.7% operational growth and a 1.7% currency drag. The rise reflects continued adoption in psoriasis/psoriatic arthritis and ulcerative colitis indications, even as overall segment growth slowed.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39974,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10206,
        "completion_tokens": 119,
        "total_tokens": 10326
      }
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E shifted from a 50% equity investment (reported under \"Equity in the income of investees\") to a scenario where A&E's subscriber estimates are now included in Disney's broader international channel subscriber tables (e.g., \"General Entertainment\" and \"Family\" channels), but Disney no longer separately reports A&E's subscriber counts in its domestic channel breakdown. This change reflects Disney's increased focus on direct-to-consumer (DTC) distribution, which has reduced reliance on traditional linear channel partnerships like A&E for subscriber metrics. Consequently, Disney's 2023 reporting consolidated A&E's historical subscriber data into its overall international channel estimates (e.g., \"General Entertainment (1) 180 million\" and \"Family channels\" under Disney brands), while discontinuing standalone A&E subscriber disclosures in favor of integrated reporting across its DTC and linear networks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 34453,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8837,
        "completion_tokens": 241,
        "total_tokens": 9078
      }
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "Based on the provided financial disclosures, the financial impact of GE's relationship with AerCap evolved significantly between 2023 and 2024, particularly regarding realized and unrealized gains or losses. In 2023, the investment in AerCap generated a realized gain of $129 million (as noted in Note 19), but this was offset by an unrealized loss of $865 million in 2022, resulting in a net unrealized gain of $129 million for 2023. By 2024, the AerCap position was fully monetized, as stated in Note 19: \"During the year ended December 31, 2023, we received total proceeds of $6,587 million from the sale of our remaining AerCap shares, leaving an AerCap senior note as our only remaining position.\" This indicates that the $129 million realized gain in 2023 was the final gain from the AerCap investment, and no further gains or losses were recorded in 2024. Consequently, the financial impact of the AerCap relationship transitioned from an unrealized loss in 2022 to a realized gain in 2023, with no material gains or losses affecting 2024 results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63487,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16093,
        "completion_tokens": 263,
        "total_tokens": 16357
      }
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Mastercard’s multi-layered security approach has evolved from a focus on network-wide protection and ecosystem standards (2022) to a more proactive, third-party risk management emphasis (2024), particularly regarding service providers. By 2024, the company explicitly integrated third-party vendor assessments into its security framework, aligning with its broader \"responsible stewardship\" of the payments ecosystem. This shift reflects a strategic pivot toward anticipating and mitigating emerging cyber threats through enhanced collaboration with industry partners and stricter oversight of external service providers, ensuring resilience against evolving digital payment risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42855,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10967,
        "completion_tokens": 170,
        "total_tokens": 11138
      }
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Target Corporation maintained compliance with its debt‑leverage covenant throughout the 2022‑2023 period, continuing to meet the covenant in 2023 after having satisfied it in 2022.  The company noted that it was “in compliance with these covenants” and highlighted that its credit‑rating upgrades (including a raise from A‑ to A by Fitch in 2021) did not trigger any required debt acceleration, underscoring continued adherence to the leverage requirements under its credit facilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35160,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9014,
        "completion_tokens": 121,
        "total_tokens": 9135
      }
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "From 2023 to 2024, the risks tied to Salesforce’s AI offerings—especially generative and agentic AI such as Agentforce—shifted from broader AI‑related uncertainties to more concrete, product‑specific concerns.  In 2023 the filings highlighted general AI development, ethical and regulatory challenges, and the need for continual model improvement.  By 2024 the focus narrowed to the particular hazards of generative AI (accuracy, bias, toxicity, copyright and privacy risks), the heightened scrutiny of AI‑driven decisions, increased compliance and reputational exposure, and the operational costs of maintaining AI systems, all of which directly affect adoption, market acceptance, and profitability of Agentforce and related AI services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63138,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16004,
        "completion_tokens": 184,
        "total_tokens": 16189
      }
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal 2023 and 2024, Lowe's accelerated its parcel‑eligible delivery capabilities, moving from two‑day standard shipping for most items in 2023 to offering two‑day or faster delivery for most parcel‑eligible items and nationwide same‑day or next‑day delivery for major appliances through its expanded gig network and market‑based delivery model. The company also expanded its Pro fulfillment network and distribution infrastructure (adding geographic areas, FDCs, IDCs and BDCs) to support these faster delivery options and improve overall omnichannel fulfillment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46326,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11799,
        "completion_tokens": 143,
        "total_tokens": 11942
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The financial impact of the Dermstore LLC sale on Target's consolidated revenues and operating income was fully realized in 2021, with the sale generating a $335 million pretax gain recognized in Net Other (Income) / Expense. This gain was included in the 2021 operating income of $8.9 billion, which represented a 36.8% increase from 2020, but the sale itself contributed less than 1% to consolidated revenues and operating income, as explicitly stated in the 2021 Form 10-K. In contrast, the 2023 financials reflect no ongoing impact from the sale, as the transaction occurred in February 2021 and was fully removed from subsequent periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32806,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8421,
        "completion_tokens": 160,
        "total_tokens": 8582
      }
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, Data Cloud evolved from a foundational data engine into a central, hyperscale data layer that unifies and activates enterprise data across Salesforce’s entire Customer 360 ecosystem. It now serves as the backbone for AI-powered personalization, automation, and cross-cloud collaboration—enabling deeper integration with Sales, Service, Marketing, Commerce, and Slack, while supporting new consumption-based offerings like Agentforce. Strategically, Data Cloud has shifted from being a standalone data platform to a unifying layer that drives adoption of Salesforce’s broader service offerings, strengthens competitive differentiation against rivals like Microsoft and Oracle, and positions Salesforce as an AI-native CRM leader by embedding trusted data at the core of its platform strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53628,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13636,
        "completion_tokens": 203,
        "total_tokens": 13839
      }
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, Lowe's (LOW) maintained its use of forward interest rate swaps as cash flow hedges for managing interest rate risk on future debt issuances, with no material change in hedge accounting designation. In 2023, the company settled forward swaps with a $2.0 billion notional amount tied to its $3.0 billion 2023 Notes issuance, receiving $247 million, and similar swaps for prior note issuances. These swaps were accounted for as effective cash flow hedges, with gains/losses recorded in other comprehensive income (e.g., $311 million gain in 2023, $(14) million loss in 2024). The 2024 financial impact reflected a $(13) million other comprehensive loss (net of tax) related to these hedges, but the hedge designation itself remained unchanged. The company continued to use the shortcut method for fair value hedges on existing fixed-to-floating swaps ($850 million notional), where no net earnings impact occurred due to perfect effectiveness.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43348,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11064,
        "completion_tokens": 240,
        "total_tokens": 11305
      }
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "From 2022 to 2023, Target’s strategy around its owned brands shifted from a focus on expanding and diversifying its portfolio of exclusive brands (as highlighted in the 2022 10-K’s detailed list of brands like \"A New Day™\" and \"Good & Gather™\") to emphasizing **strategic curation and partnership-driven growth** in 2023. The 2023 filing explicitly states the goal is to \"strengthen our owned brands portfolio, curate leading national brands, and expand the breadth and depth of signature partnerships\" to drive relevancy and traffic, while maintaining its core value proposition of \"everyday low pricing\" through loyalty programs like Target Circle. This evolution reflects a move toward higher-margin, differentiated offerings (e.g., exclusive beverage brands like \"California Roots™\" and design partnerships) rather than simply expanding the brand count, aligning with its broader objective to \"delight with newness, style, and value\" and deepen guest engagement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 25288,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6540,
        "completion_tokens": 241,
        "total_tokens": 6781
      }
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM shifted from a broad, diversified portfolio of services to a more focused, scalable software-enabled services strategy centered on its Ultium platform and end-to-end digital architecture. This is evidenced by the 2023 10-K highlighting the rollout of the Ultium-based EV platform across multiple brands (including the 2024 Cadillac LYRIQ and Chevrolet Silverado EV), the expansion of Super Cruise to over 400,000 miles of compatible roads, and the integration of NACS charging hardware beginning in 2025, alongside the strategic pause and safety review of Cruise following regulatory incidents. This evolution indicates a significant, targeted investment in building a unified, scalable digital infrastructure to support EV adoption, connectivity, and future revenue streams like subscriptions, moving beyond isolated services toward a cohesive software-defined vehicle ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55215,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14044,
        "completion_tokens": 225,
        "total_tokens": 14270
      }
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The Optimized Application Experiences category, which includes ThousandEyes, grew 11% in fiscal 2022 compared to fiscal 2021, with revenue increasing by $75 million driven by growth in ThousandEyes and Intersight offerings, partially offset by a decline in AppDynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41615,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10630,
        "completion_tokens": 67,
        "total_tokens": 10698
      }
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "The Executive Severance Plan was initially disclosed in the 2023 10-K (Item 10.33) as part of the “Amended and Restated Executive Severance Plan” and subsequently referenced in the 2024 filing (Item 10.36) as “Amendment No. 4 to the Executive Severance Plan.” This evolution shows that the plan was progressively refined and formally amended over time, reflecting Lockheed Martin’s strategy to incorporate executive compensation disclosures into its periodic reports as a standard, transparent component of its governance and investor communications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55463,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14107,
        "completion_tokens": 137,
        "total_tokens": 14245
      }
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "From 2023 to 2024, JPMorgan's Tier 1 leverage ratio improved modestly, rising from 7.2 % (as reported for the December 31, 2023 quarter) to 7.2 % for the December 31, 2024 quarter, while the supplementary leverage ratio remained steady at 6.1 % in both periods.  \n\nRegarding risk‑based capital ratios, the firm’s CET1 capital ratio increased from 15.0 % at the end of 2023 to 15.7 % at the end of 2024, and its overall risk‑based capital ratio (Tier 1 and Total) also rose correspondingly, reflecting higher CET1 capital and slightly higher risk‑weighted assets.  \n\nThe firm’s regulatory GSIB surcharge under Method 2 increased to 4.5 % effective January 1, 2024 (up from 4.0 % in 2023), while the Method 1 surcharge stayed at 2.5 %. This higher surcharge, together with the unchanged 2.5 % capital‑conservation buffer, raised the total capital‑conservation buffer requirement. Consequently, JPMorgan’s effective capital ratios under the Basel III standardized approach improved, with the CET1 ratio moving from 13.2 % (2022) to 15.0 % (2023) and further to 15.7 % (2024), and the leverage‑based SLR holding at 6.1 % across the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54135,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13763,
        "completion_tokens": 284,
        "total_tokens": 14047
      }
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial’s integration within General Motors’ consolidated financial statements remained consistent in structure but showed evolving financial presentation. In the 2023 10-K, GM Financial continued to be reported as a distinct segment under “Segment Reporting” (Note 23), with its earnings before interest and taxes (EBT-adjusted) and interest income/expense tracked separately from automotive operations. However, its financial results were increasingly consolidated into the broader “Total Automotive” and “Total Consolidated” columns, reflecting deeper operational integration. The 2023 filing also expanded disclosures around GM Financial’s cash flow and balance sheet within the consolidated statements, particularly in Note 24 (Supplemental Cash Flow Information), where its interest income and expense were detailed alongside automotive financing activities. Notably, GM Financial’s segment assets ($113,207M in 2023) and revenue ($13,419M in 2023) were fully embedded in the consolidated totals, with no separate presentation of its standalone financials—indicating full consolidation into GM’s enterprise-wide reporting framework. This reflects a maturation of GM Financial’s role from a standalone financial services unit to an integrated component of GM’s core reporting structure, though its segment-specific metrics (e.g., EBT-adjusted) remain distinct for internal decision-making.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83511,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21113,
        "completion_tokens": 355,
        "total_tokens": 21469
      }
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "Between 2022 and 2024, the treatment of step-rent provisions in lease accounting remained consistent with ASC 842 guidance, which requires recognition of periodic rent increases based on price indices or sales volume on a straight-line basis over the lease term (including renewal options reasonably certain of exercise). Both the 2022 and 2024 10-K filings confirm that step-rent provisions—particularly those tied to price indices or sales volume thresholds—are recognized ratably over the lease term, with no material changes in methodology or disclosure requirements between these periods. The documents note that such provisions are evaluated alongside other lease components (e.g., free-rent periods) but do not alter the core recognition principle, maintaining continuity in how variable lease payments tied to operational metrics are accounted for.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43404,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11089,
        "completion_tokens": 214,
        "total_tokens": 11303
      }
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "The projected funding obligations for Lockheed Martin’s qualified defined benefit pension plans show a modest increase in expected benefit payments from 2025 through 2033.  In 2025 the company expects to pay $1.86 billion (up from $1.79 billion in 2024), and over the longer horizon the cumulative payments through 2033 are projected at $10.02 billion, reflecting the gradual rise in benefit outlays shown in the “Estimated Future Benefit Payments” tables.  These figures are drawn from the 2023 and 2024 filing pages that list the 2024‑2028 annual payments and the 2029‑2033 aggregate amount.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49092,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12518,
        "completion_tokens": 148,
        "total_tokens": 12667
      }
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase’s disclosures show a continued emphasis on liquidity risk management and funding cost pressures, with the 2024 filing expanding on these themes. The 2023 document highlighted market volatility, funding cost increases from widening credit spreads, and the need to maintain sufficient liquidity buffers, while the 2024 version added more detail on the impact of interest rate changes, collateral valuation risks, and the role of resolution plan obligations in driving funding strategy. Both years stress that funding costs are tied to credit spread movements and regulatory requirements, but the 2024 filing more explicitly links these factors to the firm’s resolution planning and the need for pre-positioned liquidity in subsidiaries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53385,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13583,
        "completion_tokens": 193,
        "total_tokens": 13776
      }
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, Optum Rx's financial structure underwent notable changes in revenue recognition and accounts receivable. Revenue recognition remained consistent with prior practices, recognizing product revenue when prescriptions are dispensed and service revenue over time for long-term contracts, though the 2023 Notes indicate an expected $11.8 billion in future revenue from remaining performance obligations, with nearly half to be recognized within three years. Accounts receivable increased significantly from $7.1 billion (2022) to $8.6 billion (2023), primarily driven by higher receivables related to pharmacy product sales and pharmaceutical manufacturer rebates, which rose from $8.2 billion to $11.0 billion, reflecting expanded pharmacy operations and rebate accruals. This growth in receivables aligns with increased pharmaceutical spending managed by Optum Rx, which rose to $112 billion in 2021 (though not directly tied to 2023 receivables, it underscores the scale of its pharmacy care services).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56676,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14394,
        "completion_tokens": 255,
        "total_tokens": 14649
      }
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "UPS's quantitative exposure to interest rate risk through Floating-to-Fixed Interest Rate Swaps was primarily disclosed in its 2024 10-K (Note 17) as part of its broader interest‑rate risk management program, which uses interest‑rate swaps to convert floating‑rate debt to fixed‑rate exposure and vice‑versa.  The 2024 filing shows that the company continued to manage this risk by maintaining a mix of fixed‑ and floating‑rate debt and by using swaps to hedge forecasted interest payments, but it did not detail a material change in the size or structure of those swaps compared with prior years.  Consequently, while the company’s strategic approach remained focused on balancing its debt portfolio and mitigating cash‑flow volatility from interest‑rate movements, the quantitative exposure disclosed in the 2024 10‑K is comparable to that described in the 2022 filing, with no significant evolution in the scale of the swaps.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 155,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 136,
          "pages": [
            134,
            135,
            136,
            137,
            138
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 39769,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10170,
        "completion_tokens": 232,
        "total_tokens": 10402
      }
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution evolved significantly through its joint venture **Ultium Cells LLC**, which is equally owned by GM and LG Energy Solution. This partnership was central to GM's EV battery strategy, with plans to mass-produce battery cells at facilities in Lordstown, Ohio, Spring Hill, Tennessee, and Lansing, Michigan, supporting the rollout of Ultium-based vehicles like the Chevrolet Silverado EV and GMC Sierra. \n\nRegarding recall-related costs, GM expanded its recall of Chevrolet Bolt EVs and EUVs (initiated in 2021) to include all 2017–2022 models due to battery cell defects linked to LG Energy Solution’s manufacturing processes. By December 31, 2023, GM had accrued **$2.6 billion** in total costs related to these recalls and recognized **$1.6 billion** in receivables from LG Energy Solution to reimburse these expenses. The remaining accrual of **$609 million** at year-end 2023 reflected ongoing costs tied to Takata airbag inflator recalls and other defect-related liabilities, though the specific financial impact of LG Energy Solution’s role was largely offset by reimbursement agreements. \n\nThis collaboration underscored GM’s strategic shift toward vertical integration in EV supply chains while managing costs through structured partnerships and reimbursement mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14907,
        "completion_tokens": 337,
        "total_tokens": 15244
      }
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Observability product category increased from fiscal 2022 to fiscal 2023, growing by $80 million (14%) in fiscal 2023 compared to fiscal 2022, and then accelerated to $176 million (27%) growth in fiscal 2024 compared to fiscal 2023. This growth was driven by expansion in the ThousandEyes offering and the contribution from the broader Observability Suite, including Splunk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45828,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11673,
        "completion_tokens": 107,
        "total_tokens": 11780
      }
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "Between 2022 and 2024, UPS's 7.620% Debentures underwent a key evolution in redemption terms and interest structure. The debentures, which originally carried an 8.375% interest rate until April 1, 2020, were restructured to a reduced 7.620% rate for the remaining term (maturing April 1, 2030), with redemption terms allowing full or partial repayment at any time at par plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus 5 basis points. While the interest payment structure remained semi-annual (April and October), the rate reduction and flexible redemption terms marked a significant evolution from the prior fixed rate, though the core redemption mechanics and interest payment schedule persisted without fundamental change.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 32700,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8399,
        "completion_tokens": 197,
        "total_tokens": 8596
      }
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the Fixed Maturity Securities AFS portfolio declined in total fair value from $6,714 million to $6,270 million. U.S. government bonds fell from $1,575 million to $1,537 million, while corporate securities dropped from $3,083 million to $3,029 million. Corporate securities remained the largest component, but their share of the portfolio decreased slightly, reflecting the overall reduction in AFS holdings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 81373,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20576,
        "completion_tokens": 106,
        "total_tokens": 20683
      }
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "From 2022 to 2023 GM’s financial exposure to Ultium Cells LLC grew markedly: the company invested $0.5 billion in Ultium Cells in 2021 (recorded as “Investment in Ultium Cells LLC” in the cash‑flow statement) and later increased its stake, culminating in a $1 billion cash infusion to the joint venture in early 2023. This expansion was financed through GM’s revolving credit facilities and intercompany loans, tightening its capital‑allocation link to the JV. The heightened involvement also triggered regulatory scrutiny, most notably a 2023 EPA enforcement action over TSCA violations related to Ultium Cells’ battery‑material imports, which resulted in a $5.1 million civil penalty and ongoing compliance monitoring. Thus, GM’s relationship with Ultium Cells evolved from a modest equity investment to a substantial, cash‑flow‑intensive partnership that now carries notable regulatory and compliance implications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45727,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11655,
        "completion_tokens": 229,
        "total_tokens": 11884
      }
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "Based on the provided document pages, the company's use of variable-priced contracts for natural gas and fuel purchases has remained consistent in its approach over the period, with no indication of a structural change in strategy between 2022 and 2024. The company continues to enter into variable-priced contracts for natural gas and fuel purchases on an index basis, which meet the characteristics of derivative instruments but generally qualify for the 'normal purchases and normal sales' exception under authoritative guidance, requiring no mark-to-market adjustment. This practice is explicitly described in both the 2022 and 2024 documents as part of its energy price risk mitigation strategy, with no mention of shifts toward fixed-price contracts or other significant changes in the contract structure during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43569,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11106,
        "completion_tokens": 207,
        "total_tokens": 11314
      }
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco's financial reporting approach for the APJC segment remained consistent in terms of segment performance measurement methodology between fiscal 2022 and fiscal 2023, with no changes to the expense categories excluded from segment profit calculations. The company continued to exclude research and development, sales and marketing, general and administrative expenses, amortization of acquisition-related intangibles, share-based compensation, litigation settlements, asset impairment charges, restructuring costs, and other specified items from segment gross margin calculations, as explicitly stated in the \"Segment Information and Major Customers\" section of both fiscal 2022 and 2023 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35479,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9108,
        "completion_tokens": 175,
        "total_tokens": 9283
      }
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "UNH's approach to managing medical cost trends evolved from 2022 to 2023 by intensifying focus on outpatient procedure cost pressures for seniors, particularly through value-based contracting and care coordination initiatives. The company specifically cited \"increased care patterns, primarily related to outpatient procedures for seniors\" as a key trend requiring mitigation, while continuing to leverage data analytics and integrated care models to improve affordability and outcomes in this segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49495,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12601,
        "completion_tokens": 125,
        "total_tokens": 12727
      }
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS expanded the scope of its time-definite delivery services by integrating them more deeply into its global smart logistics network, offering same‑day and next‑day air options, day‑definite ground services, and a broad portfolio of returns and reverse‑logistics solutions across more than 150 countries. At the same time, the company enhanced network integration through technology upgrades such as RFID‑enabled “Smart Package Smart Facility” systems, expanded its UPS Access Point and UPS Returns Manager networks, and leveraged these capabilities to improve asset utilization, reduce environmental impact, and support higher‑yielding, value‑added shipments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47150,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12007,
        "completion_tokens": 171,
        "total_tokens": 12178
      }
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "Based on the provided exhibit listings, Lowe's treatment of its 2.50% Notes maturing in April 2026 evolved as follows:  \n- In the **2022 filing** (Exhibit 4.21, March 24, 2022), the notes were explicitly referenced as part of the \"Twentieth Supplemental Indenture\" alongside other debt securities maturing in 2027, 2032, 2052, and 2062.  \n- By the **2023 filing** (Exhibit 4.23, March 30, 2023), the same 2.50% Notes were included in the \"Twenty-Second Supplemental Indenture\" as a specific tranche maturing in **April 1, 2026**, alongside updated maturity dates for other notes (e.g., 2026, 2033, 2053, 2063).  \nThis progression confirms the notes remained outstanding and were formally reaffirmed with updated terms in the 2023 filing, maintaining their original maturity date of April 2026.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 41251,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10533,
        "completion_tokens": 198,
        "total_tokens": 10732
      }
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "From 2022 to 2024, the impact of sovereign debt crises on Costco’s merchandise sourcing and cost structure evolved from heightened exposure to tariff‑related cost pressures and supply‑chain volatility in 2022 to a more pronounced effect in 2024, where international operations accounted for roughly 28‑33 % of net sales and operating income and currency‑related cost increases were explicitly cited as potentially adverse to results. The company notes that sovereign debt issues and related policy actions in key markets (e.g., China, the U.S.) can raise tariffs and other trade restrictions, which in turn can increase merchandise costs and compress gross margins if not fully passed through to members. Consequently, while the 2022 discussion highlighted the risk of tariff‑driven cost increases, the 2024 filing underscores that such sovereign‑debt‑driven trade pressures now represent a more direct and measurable threat to Costco’s sourcing costs and overall profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43660,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11130,
        "completion_tokens": 244,
        "total_tokens": 11374
      }
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "Based on the provided pages from the 2022 and 2023 10-K filings, the number of shares available for future grants under the 2020 Stock Incentive Plan decreased from 64 million shares as of December 31, 2021 to 53 million shares as of December 31, 2023. This reduction of 11 million shares indicates that UnitedHealth Group has less capacity to issue new share-based awards in the future, reflecting the depletion of its authorized but unissued shares for equity compensation plans. The decline is primarily attributed to shares being used for outstanding awards and the addition of new shares through the Employee Stock Purchase Plan (which increased available shares for ESPP to 17 million in 2023, but did not offset the overall reduction in the 2020 Plan's availability).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12699,
        "completion_tokens": 193,
        "total_tokens": 12892
      }
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "The IAM National Pension Fund / National Pension Plan’s collective bargaining agreement was extended from a July 31, 2023 expiration to July 31, 2024, and its zone status remained “Red” with a rehabilitation plan in place, but no surcharge was imposed. By 2024 the agreement had been further extended to July 31, 2029, reflecting continued participation and the same funding terms, while the plan’s funding level and contribution obligations stayed unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 56697,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14401,
        "completion_tokens": 114,
        "total_tokens": 14516
      }
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "The terms and availability under Lowe's 2020 Credit Agreement evolved between fiscal years 2022 and 2023 as follows:  \n- In **fiscal 2022**, Lowe's had a $2.0 billion five-year unsecured revolving credit agreement (2020 Credit Agreement) maturing in **March 2025**, with total combined availability of $4.0 billion under the Credit Agreements.  \n- By **fiscal 2023**, the company amended and restated this agreement (Third Amended and Restated Credit Agreement) to extend the maturity to **December 2026** and increased aggregate availability to $2.0 billion, while also amending the 2020 Credit Agreement to extend its maturity to **March 2025** and increase availability to $2.0 billion. The combined availability remained $4.0 billion, with the potential to increase it by an additional $1.0 billion subject to lender commitments.  \n- The credit agreements support the commercial paper program, with no outstanding borrowings under either agreement as of January 28, 2022 (fiscal 2022) or February 2, 2023 (fiscal 2023). The key evolution was the extension of maturities and the formal renaming of the agreements, with the 2023 Credit Agreement replacing the 2020 Credit Agreement as the primary facility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45117,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11491,
        "completion_tokens": 302,
        "total_tokens": 11793
      }
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "Based on the provided SEC 10-K pages, MDLZ's use of Net Investment Hedge Derivative Contracts (specifically cross-currency interest rate swaps and forwards) evolved significantly between 2022 and 2024, with the **notional amount increasing substantially**. The document shows that as of December 31, 2022, the aggregate notional value of these NIH derivative contracts was $3.9 billion (from the 2022 \"Net investment hedge derivative contracts\" line item), and by December 31, 2024, this had grown to **$8.6 billion** (as disclosed in the 2024 \"Net investment hedge derivative contracts\" line item). This represents a **120% increase** in notional value over the two-year period, reflecting a strategic expansion in hedging non-U.S. dollar-denominated investments against currency movements. The document also notes that these contracts are part of broader net investment hedging activities, including the use of non-U.S. dollar debt (e.g., €3.6 billion in euro notes as of 2022), which further supports the growth in hedging activity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53464,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13587,
        "completion_tokens": 258,
        "total_tokens": 13846
      }
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Between 2022 and 2024, Microsoft 365's integration with AI evolved from foundational AI capabilities to deeply embedded, role-specific AI assistants within the Copilot suite. By 2024, Microsoft introduced key capabilities like **Copilot for Sales, Copilot for Service, and Copilot for Finance**—AI assistants trained on business data to streamline workflows in specific roles—and **Copilot Studio**, enabling customers to customize or build their own Copilot agents. These advancements, part of the broader \"AI-first\" strategy, significantly enhanced productivity and collaboration by embedding AI directly into Microsoft 365 apps (like Word, Excel, Teams) and workflows, moving beyond basic AI features to deliver proactive, data-driven task automation and insights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39920,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10212,
        "completion_tokens": 191,
        "total_tokens": 10404
      }
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "3M’s wastewater‑permit approach at its Decatur, Alabama plant has shifted from a 2022 focus on correcting inaccurate reporting and temporarily idling processes to a 2024 framework that includes an interim Consent Order with ADEM covering all PFAS‑related discharges, mandatory ongoing monitoring and reporting, and a commitment to add the missing PFAS to its NPDES permit and install upgraded treatment controls. This evolution reflects a move from ad‑hoc disclosures and process shutdowns toward a structured, regulator‑approved remediation and compliance program that obligates the company to conduct continual characterization studies, implement capital improvements, and fund long‑term remediation activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59179,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15020,
        "completion_tokens": 178,
        "total_tokens": 15198
      }
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "The 4.550% Notes were first issued under Lowe's Companies' Fourteenth Supplemental Indenture dated April 5, 2019, and subsequently re‑issued in the Twenty‑Second Supplemental Indenture dated March 30, 2023, which updated the maturity schedule and terms of the notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 41251,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10519,
        "completion_tokens": 66,
        "total_tokens": 10586
      }
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ’s financial relationship with KDP evolved significantly, particularly regarding gains from changes in accounting for its investment. In 2022, MDLZ held a significant equity interest in KDP and accounted for it using the equity method, recognizing earnings and dividends. However, by early 2023, MDLZ’s ownership fell below 5%, triggering a change to accounting for the investment as marketable securities (measured at fair value). This shift resulted in recognizing a $493 million pre-tax gain on equity method transactions in 2023, followed by a $606 million total gain on marketable securities in 2023 (including $593 million from sales and $13 million from dividends). By 2024, MDLZ fully exited its KDP investment, selling remaining shares for $2.4 billion in proceeds and recording a $332 million gain on the equity method investment transaction, reflecting the final settlement of its stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42555,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10865,
        "completion_tokens": 231,
        "total_tokens": 11097
      }
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, Xbox Game Pass evolved from a curated library of ~100 first- and third-party titles to a platform with over 400 games, reflecting Microsoft’s strategic emphasis on expanding its gaming ecosystem through content acquisition (e.g., Activision Blizzard), cloud gaming, and subscription-based access across devices. This growth underscores Microsoft’s ambition to position Game Pass as a central pillar of its \"More Personal Computing\" vision, driving engagement and ecosystem lock-in through scalable, cross-platform gaming experiences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35014,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8976,
        "completion_tokens": 139,
        "total_tokens": 9115
      }
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "The structure and disclosure of Deferred Stock Unit Award Agreements for non‑employee directors under the 3M Company 2016 Long‑Term Incentive Plan have remained essentially unchanged from 2022 through 2024.  The agreements continue to be filed as Exhibit 10.7 in the company’s Form 10‑K filings, with the same reference language describing that they are granted on or after January 1, 2019 to non‑employee directors under the 2016 Long‑Term Incentive Plan.  No substantive revisions to the award terms or disclosure requirements are evident across the 2022‑2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 144,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51486,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13111,
        "completion_tokens": 142,
        "total_tokens": 13253
      }
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Based on the provided document pages, Charles Schwab Bank's First Mortgages and HELOCs portfolio composition remained relatively stable between 2023 and 2024, with First Mortgages increasing from $26,153 million to $27,389 million and HELOCs increasing from $479 million to $424 million (though HELOCs decreased slightly in 2024). The portfolio maintained a consistent geographic concentration in California, with 42-43% of the portfolio concentrated there in both years. Regarding origination costs, the documents indicate that First Mortgages and HELOCs included unamortized premiums and discounts and direct origination costs of $112 million at December 31, 2024, compared to $100 million at December 31, 2023, reflecting an increase in origination costs. The portfolio's credit quality metrics, including delinquency rates and nonaccrual loans, remained very low and consistent with prior periods, showing no significant deterioration in credit quality between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60843,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15446,
        "completion_tokens": 244,
        "total_tokens": 15690
      }
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Based on the PRODUCT RESEARCH, DESIGN AND DEVELOPMENT section in both fiscal 2023 and 2024 10-K filings, Nike's strategic emphasis on Dri-FIT technology remained consistent but expanded in scope. The company continued to highlight Dri-FIT as a core innovation within its broader technology portfolio (alongside Air, Zoom, Flyknit, etc.), emphasizing its role in moisture-wicking performance apparel to enhance athletic comfort and functionality. While the language did not indicate a fundamental shift in strategic emphasis between years, the 2024 filing specifically reiterated Dri-FIT's integration into product development across categories, reflecting its ongoing importance in Nike's innovation strategy rather than a change in focus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48337,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12310,
        "completion_tokens": 184,
        "total_tokens": 12495
      }
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has progressively strengthened its backup and disaster recovery capabilities in response to rising cybersecurity threats, as noted in its 2024 10-K filing. The company emphasizes dedicating focused resources to network security, backup systems, and disaster recovery—particularly to protect critical manufacturing operations and data—while acknowledging that no security measure guarantees immunity from breaches. This evolution reflects heightened vigilance amid growing cyber risks, including those targeting operational technologies and remote work environments, though specific historical comparisons (e.g., 2022 vs. 2024 investments) are not detailed in the provided excerpts. The 2024 filing explicitly links these efforts to mitigating disruptions from cyber incidents that could materially impact operations, financial condition, and reputation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 44232,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11283,
        "completion_tokens": 219,
        "total_tokens": 11502
      }
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft's financial commitment and engagement with Black and African American-owned suppliers grew significantly from fiscal year 2022 to fiscal year 2024. In FY2022, the company reported it had reached \"more than 90 percent of its goal to spend $500 million with double the number of Black and African American-owned suppliers,\" and by FY2024, it had \"achieved our goal to spend $500 million with double the number of Black- and African American-owned suppliers.\" Additionally, Microsoft expanded its supplier pipeline and increased transaction volumes with Black- and African American-owned financial institutions, enabling greater capital flow into local communities. These efforts were part of its broader Racial Equity Initiative, which included targeted investments to support Black and African American communities through technology access, skills training, and supplier diversity programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40062,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10236,
        "completion_tokens": 225,
        "total_tokens": 10461
      }
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "From 2022 to 2023, the number of common shares available for future issuance under Abbott's Employee Stock Purchase Plan for Non-U.S. Employees decreased from 10,638,639 to 8,565,087 shares. This reduction reflects a deliberate contraction in the plan's reserve capacity, signaling a more conservative approach to equity-based compensation for international employees, potentially aligning with broader cost management or strategic shifts in the company's stock-based incentive framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45392,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11593,
        "completion_tokens": 122,
        "total_tokens": 11715
      }
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Nike’s product development strategy for Air technology remained focused on innovation and integration across its portfolio between fiscal 2023 and 2024. The company emphasized advancing Air-Sole cushioning systems—such as Nike Air, ZoomX, and React—through R&D investments, leveraging biomechanics, materials science, and athlete feedback to enhance performance while reducing environmental impact. This included scaling production of Air components via its Air Manufacturing Innovation subsidiary and expanding proprietary technologies into apparel and digital experiences. No major strategic shift in Air technology’s role was noted, but its application became more diversified across categories and geographies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48337,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12297,
        "completion_tokens": 178,
        "total_tokens": 12476
      }
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Abbott's Nutritional Products segment has strategically positioned Osmolite as a core component of its enteral feeding portfolio, emphasizing its role within a broader range of specialized nutritional solutions for clinical use. The 2023 filing highlights Osmolite alongside other enteral-specific products like Jevity and Glucerna, underscoring a focused strategy on enteral nutrition formulations for healthcare institutions, with no indication of portfolio diversification beyond this niche. The company continues to drive growth through product innovation and targeted marketing within the enteral feeding space, maintaining Osmolite as a key offering in its medical nutrition lineup.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44840,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11442,
        "completion_tokens": 172,
        "total_tokens": 11614
      }
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M’s regulatory engagement and remediation obligations related to PFAS have expanded through a series of state‑level consent orders and federal oversight actions, especially in Minnesota and Alabama. In Minnesota, the company continues to operate under the 2007 Settlement Agreement and Consent Order with the MPCA, which obligates it to evaluate PFAS releases, provide alternative drinking water, and remediate contaminated soil and groundwater at the Cottage Grove, Oakdale and Woodbury sites; recent MPCA notices (2023‑2024) have added new storm‑water and air‑emission requirements and tighter health‑based water limits that will likely increase ongoing remediation costs. In Alabama, 3M is bound by an interim Consent Order (July 2020) with ADEM covering all PFAS‑related wastewater and air emissions at its Decatur plant, and it has entered into a series of EPA administrative consent orders (2022‑2024) that require continued well‑water sampling, treatment of private wells, a multi‑year cap‑and‑treat remedy, and further NPDES permit modifications; these obligations are being enforced through a 2024 grand‑jury subpoena and ongoing EPA investigations. Thus, while the core remediation frameworks pre‑date 2022, the scope of monitoring, treatment, and reporting obligations has been broadened and formalized through recent state‑agency agreements and federal enforcement actions in both states.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58672,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14894,
        "completion_tokens": 356,
        "total_tokens": 15250
      }
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "The Coca-Cola Company's financial relationship with Coca-Cola HBC AG has evolved such that its investment in the company is now classified as an equity method investment, with the stake percentage increasing from 19% as of December 31 2023 to 22% as of December 31 2024. This reflects a continued strategic partnership and growing influence in the joint venture’s operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54067,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13746,
        "completion_tokens": 93,
        "total_tokens": 13840
      }
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024 Oracle’s strategic focus on hybrid deployments shifted from primarily promoting flexible on‑premise and cloud options toward deeper integration of cloud services with on‑premise and hybrid models—evidenced by expanded investment in cloud‑centric R&D (e.g., Autonomous Database, OCI) and the introduction of programs that let customers migrate license and support contracts to the Oracle Cloud. This evolution is reflected in the company’s financial disclosures, which show a steady increase in cloud services and license‑support revenue share (from 70 % in FY 2020 to 71 % in FY 2022) and continued multi‑billion‑dollar annual R&D spend aimed at enhancing cloud‑ready products and hybrid‑ready capabilities. Consequently, product development investment has increasingly targeted cloud‑based and hybrid‑compatible offerings, while deployment‑model integration now emphasizes seamless movement of workloads between Oracle Cloud and on‑premise environments through solutions such as Oracle Cloud@Customer.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12414,
        "completion_tokens": 259,
        "total_tokens": 12674
      }
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The Mandatory Clawback Policy was first disclosed in the 2023 filing (Exhibit 97) and was subsequently updated and re‑issued in the 2024 filing (Exhibit 97), reflecting its evolution between the two SEC 10‑K disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61707,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15645,
        "completion_tokens": 55,
        "total_tokens": 15700
      }
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher's relationship with CorEvitas, LLC evolved in 2023 when the company acquired CorEvitas for $730 million in cash (plus $184 million of debt assumed and $4 million of cash received), adding real‑world evidence solutions to its Laboratory Products and Biopharma Services segment. This acquisition contributed to the 2 % organic revenue growth reported in 2023 and was reflected in the company's segment‑income and margin improvements. Financially, the deal increased debt (total debt rose to $34.9 billion) and used $2.70 billion of cash for acquisitions, but the added capabilities supported higher-margin services and contributed to the 17 % rise in segment income. The transaction also impacted cash‑flow reporting, with investing cash outflows rising to $5.14 billion in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51514,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13102,
        "completion_tokens": 197,
        "total_tokens": 13300
      }
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "Based on the provided 2022 and 2023 10-K excerpts, RTX's flight hour payment obligations under its 2012 Rolls-Royce agreement evolved in timing and capitalization treatment as follows:  \n\nThe obligations, which are contingent on flight hours through 2027, are now reflected in \"Other commercial aerospace commitments\" within the maturity schedule (e.g., $603 million due in 2027 under \"Other commercial aerospace commitments\" in 2023). These payments are capitalized as collaboration intangible assets upon payment, consistent with prior practice, rather than being accrued earlier. The 2023 note explicitly states these payments will be capitalized \"as payments are made,\" aligning with the 2012 agreement's terms and the shift from prior-year accrual methods.  \n\n(Word count: 149)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58646,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14898,
        "completion_tokens": 195,
        "total_tokens": 15093
      }
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "From 2022 to 2024, The Coca-Cola Company’s financial relationship with fairlife evolved from a strategic equity investment to full ownership. In 2020, the Company acquired the remaining ownership interest in fairlife for $834 million, which generated a $902 million gain and a $40 million tax benefit. The contingent milestone payment tied to fairlife’s performance through 2024 remains on the books, with a $6.1 billion fair‑value liability recorded (including the $6,126 million contingent consideration liability in 2024) that is re‑measured quarterly and impacts earnings until paid. This structure reflects a shift from passive investment to an earn‑out arrangement where future payments depend on fairlife achieving specified financial targets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52393,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13325,
        "completion_tokens": 187,
        "total_tokens": 13513
      }
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Oracle's strategic positioning of Oracle Cloud Services has evolved from a primarily on-premise and license-focused model toward a cloud-centric, integrated offering that emphasizes seamless integration with enterprise applications and infrastructure technologies. By 2024, Oracle is aggressively migrating its traditional on-premise customer base to the Oracle Cloud, leveraging hybrid and multi-cloud deployment models (including Oracle Cloud@Customer) to provide flexible, interoperable, and cost-effective solutions. This shift is underscored by increased investments in cloud services and infrastructure (e.g., OCI, Autonomous Database), expanded SaaS offerings (e.g., Fusion Cloud ERP, HCM, SCM), and programs enabling customers to pivot licenses and support contracts to the cloud, reflecting a strategic pivot to dominate the cloud transition for enterprise workloads.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48928,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12463,
        "completion_tokens": 219,
        "total_tokens": 12682
      }
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was first incorporated by reference in the Company’s 2018 Annual Report on Form 10‑K (Exhibit 10(r)*). In the 2024 filing, the same policy remains incorporated by reference, but its location shifts to Exhibit 10(r)* in the 2024 Form 10‑K (referenced as “Key/Specified Employee Policy” incorporated by reference to Exhibit 10(v) to the 2018 filing and retained as Exhibit 10(r)* in the 2024 filing). Thus, the policy’s substance is unchanged, though its exhibit reference moves forward in the filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61707,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15658,
        "completion_tokens": 133,
        "total_tokens": 15791
      }
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of the 6.700% notes due 2028 decreased from $400 million at the end of 2022 to $285 million at the end of 2023, reflecting scheduled repayments and early retirements of higher‑cost debt. This reduction indicates RTX is actively managing its debt profile by retiring more expensive obligations and optimizing the overall maturity and cost structure of its long‑term financing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43007,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10976,
        "completion_tokens": 101,
        "total_tokens": 11078
      }
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The carrying value of TMO's 1.95% 12-Year Senior Notes increased from $773 million at December 31 2023 to $725 million at December 31 2024, while the effective interest rate on the notes remained essentially unchanged at approximately 2.07 % for both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56491,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14336,
        "completion_tokens": 64,
        "total_tokens": 14401
      }
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The Directors' Code of Conduct was removed from the 2022 filing and replaced with a reference to a separate website posting in the 2024 filing, indicating a change in how BNY Mellon presents its governance policies. This shift suggests a more centralized, web-based approach to governance documentation rather than including the code directly in the filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36509,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9348,
        "completion_tokens": 89,
        "total_tokens": 9437
      }
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Between 2023 and 2024, Amazon’s Short-Term Credit Agreement was replaced by a new $5.0 billion 364‑day revolving facility that matures in October 2025 (with a possible one‑year extension), while the prior 364‑day agreement entered in November 2022 was terminated. The new agreement, like its predecessor, bears interest at the Secured Overnight Financing Rate plus 0.45% and includes a 0.03% commitment fee on undrawn amounts. No borrowings were outstanding under either the prior or the new Short‑Term Credit Agreement as of December 31, 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53030,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13483,
        "completion_tokens": 138,
        "total_tokens": 13622
      }
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "From 2022 to 2024 AMD shifted its APU strategy from a primarily consumer‑focused, CPU‑GPU integration for mainstream desktops and laptops toward a broader, AI‑centric platform that embeds dedicated neural‑processing capabilities and targets both commercial and high‑performance markets. This evolution—highlighted by the launch of Ryzen AI 300 series with an on‑chip NPU and the expansion of Radeon PRO V620 data‑center GPUs—positions AMD to capture growing demand for AI‑accelerated PCs and edge devices, driving incremental revenue growth in the emerging AI‑PC segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12240,
        "completion_tokens": 142,
        "total_tokens": 12383
      }
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "The treatment of Irish income tax liability for U.S. shareholders receiving Medtronic dividends has remained consistent between 2023 and 2024: dividends paid to U.S. residents are generally exempt from Irish dividend withholding tax if they meet specific documentation requirements (e.g., providing a U.S. Form 6166 or valid Irish Non-Resident Form V2), and any withholding tax paid discharges Irish income tax liability. The 25% Irish dividend withholding tax rate applies only when these exemptions are not satisfied, with no material changes to this framework reported in the 2024 filing compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34351,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8822,
        "completion_tokens": 152,
        "total_tokens": 8974
      }
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "Between 2022 and 2024, the risk disclosure around new products and services, particularly regarding the platforms operating model initiative, evolved to emphasize both the strategic intent and the associated risks. In the 2022 filing, the company described the transition to a platforms operating model as part of its strategic initiatives, highlighting potential benefits but also acknowledging risks related to execution, integration, and operational disruption. By 2024, the disclosure became more detailed and forward-looking, explicitly addressing the risks of not fully realizing anticipated benefits, including impacts on efficiency, cost savings, and client service continuity. The language also incorporated lessons from prior initiatives and underscored dependencies on technology investments and organizational change, reflecting a more mature and risk-aware approach to disclosing the initiative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40815,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10426,
        "completion_tokens": 227,
        "total_tokens": 10653
      }
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Between 2023 and 2024, Amazon updated its disclosures regarding the 3.600% Note due 2032 in its debt instrument documentation. In the 2023 filing (AMZN_10k_2023.pdf), the note was listed under the Supplemental Indenture (Exhibit 4.2) as part of the 2022 debt issuance, with no specific 2023 updates to its terms. By the 2024 filing (AMZN_10k_2024.pdf), the note remained referenced in the same Supplemental Indenture (Exhibit 4.2), but the filing also included updated exhibit numbering and language reflecting the 2024 context, such as the inclusion of the 3.600% Note due 2032 in the list of debt securities under the 2022 indenture. No material changes to the note's terms or structure were disclosed between 2023 and 2024, indicating continuity in the debt instrument's structure, though the disclosure was updated to align with the 2024 filing cycle and exhibit revisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43497,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11095,
        "completion_tokens": 219,
        "total_tokens": 11315
      }
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "MDLZ’s net investment hedge derivative contracts were reclassified from a $265 million liability in 2022 to a $382 million asset in 2023, reflecting a $117 million gain (net of tax) that was recorded in other comprehensive earnings and later recognized in earnings, while the prior year’s $129 million loss on debt extinguishment was removed from earnings. In 2024, the company began presenting these hedges as assets (e.g., $305 million fair‑value gain in 2024) and disclosed their impact as a $21 million (net of tax) gain expected to be transferred to earnings over the next 12 months, whereas previously the hedge gains/losses were shown only within accumulated other comprehensive income and not separately quantified in the income statement. Consequently, the financial impact shifted from a discrete loss recognized in interest expense to a measured, recurring fair‑value gain reported in other income, and the presentation moved from a single aggregate “loss on debt extinguishment” line to a detailed fair‑value disclosure of net investment hedge contracts within the derivatives footnote.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45313,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11564,
        "completion_tokens": 274,
        "total_tokens": 11839
      }
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, the Abrams tank modernization strategy shifted from incremental upgrades (SEPv3) to a more transformative engineering change—the M1E3 variant—aimed at significantly enhancing combat capability against future threats with improved architecture, reduced sustainment footprint, and greater tactical mobility. While domestic demand remains strong, international interest, particularly from NATO allies and partners in Europe, the Middle East, and Indo‑Pacific, continues to drive export orders and upgrades, sustaining a growing installed base abroad.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 26757,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6912,
        "completion_tokens": 141,
        "total_tokens": 7054
      }
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD's APU strategy evolved from a primarily consumer-focused, value-oriented product line to a more strategically integrated component within its broader computing and data center portfolio. The company increasingly emphasized APUs as part of balanced system-level platforms (combining CPUs, GPUs, and chipsets) for improved efficiency and performance, while expanding their use in commercial (PRO), embedded, and semi-custom markets (e.g., PlayStation 5, Xbox Series X/S, Steam Deck). This shift included positioning APUs as foundational for heterogeneous computing and AI workloads, particularly through integration with data center GPUs (Instinct) and AI software (ROCm), moving beyond traditional desktop and notebook segments to target enterprise, cloud, and specialized applications. (Based on AMD 10-K 2022 pages 7-11 and AMD 10-K 2024 pages 67-71, highlighting segment evolution, APU integration in client/server/embedded markets, and strategic focus on balanced platforms and AI acceleration.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43128,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11007,
        "completion_tokens": 256,
        "total_tokens": 11263
      }
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "From 2023 to 2024, Medtronic's disclosure regarding the Financial Transfers Act 1992 remained consistent in stating that the Irish Minister for Finance can restrict financial transfers between Ireland and other countries, including third countries, and that such restrictions may apply to transfers involving sanctioned governments or entities. The 2024 filing (MDT_10k_2024.pdf, page 30) reiterates the same framework as the 2023 filing (MDT_10k_2023.pdf, page 30), noting that the list of restricted third countries is subject to ongoing change, but does not indicate any new restrictions or specific changes to the implications of the Act during this period. The core disclosure about the Act's scope and potential sanctions-related restrictions was unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34351,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8816,
        "completion_tokens": 190,
        "total_tokens": 9007
      }
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "Based on GD's disclosures in the 2023 and 2024 10-K filings, the G700 aircraft evolved from a planned future model to an imminent product launch. The G700, described as an \"ultra-long-range, ultra-large-cabin\" aircraft combining Gulfstream's most spacious cabin, advanced Symmetry Flight Deck, and new engines, was expected to enter service following FAA certification in early 2024. This timeline is supported by the 2024 filing showing \"Net PP&E\" increased due to \"ramp-up in production of new Gulfstream aircraft models, including the G700 that began deliveries in the second quarter of 2024,\" confirming its transition from development to active production and initial customer deliveries during 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32441,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8321,
        "completion_tokens": 176,
        "total_tokens": 8497
      }
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "From 2023 to 2024, PMI’s relationship with KT&G evolved from a renewable exclusive commercialization agreement (originally launched in January 2020 and renewed in January 2023) into a long‑term, fifteen‑year partnership that extends through January 2038, adding performance‑review cycles tied to volume commitments and giving PMI continued exclusive access to KT&G’s smoke‑free device portfolio and innovation pipeline for global markets. This deepened collaboration enhances PMI’s strategic positioning and product commercialization prospects for KT&G’s offerings outside South Korea.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44645,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11383,
        "completion_tokens": 146,
        "total_tokens": 11529
      }
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 through 2024 AMD’s semi‑custom SoC strategy shifted from a focus on securing long‑term wafer capacity and pricing through a 2021 amendment to its GF wafer‑supply agreement—maintaining minimum annual capacity allocations through 2025 but dropping exclusivity—to a more flexible model that allows it to work with any foundry at any node.  The company continued to rely on joint‑venture ATMP services and a limited set of material suppliers, while emphasizing integration of its semi‑custom SoCs into broader product ecosystems such as data‑center AI accelerators, client APUs and gaming GPUs.  This evolution reflects a strategic positioning of semi‑custom SoCs as a key building block across AMD’s diversified segments, supported by expanded partnerships (e.g., Silo AI, ZT Systems) and a push to embed these SoCs in next‑generation AI‑centric platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48572,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12370,
        "completion_tokens": 215,
        "total_tokens": 12586
      }
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Based on the provided document pages, the treatment of Irish income tax on dividends paid to U.S. residents has remained unchanged between 2023 and 2024. U.S. shareholders who hold shares through DTC (Depository Trust Company) and meet specific conditions (e.g., broker records showing U.S. addresses) are exempt from Irish dividend withholding tax (currently at 25%), as stated in the \"Irish Taxes Applicable to U.S. Holders\" section. No new exemptions or changes to withholding tax obligations were introduced in the 2024 filing, and the existing exemptions continue to apply.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12051,
        "completion_tokens": 144,
        "total_tokens": 12196
      }
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "From 2023 to 2024, General Dynamics faced rising cost pressures on its Virginia-class submarine and DDG-51 destroyer programs, which contributed to a decline in Marine Systems operating margin (from 8.1% in 2023 to an expected ~7.6% in 2024). Despite this, the company projects revenue growth in Marine Systems to reach $12.8–12.9 billion in 2024, driven by increased Columbia-class submarine construction activity. The Columbia-class submarine initiative is expected to generate significant revenue, reflecting strong demand and strategic focus on next-generation submarine production despite near-term margin challenges from supply chain and cost growth on existing programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32213,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8302,
        "completion_tokens": 169,
        "total_tokens": 8471
      }
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the provided 10-K filings, BKNG's financial dependency on Booking.com has slightly decreased between 2022 and 2023. In 2022, revenues from businesses outside the U.S. (primarily driven by Booking.com) represented approximately 87% of consolidated revenues, while in 2023, approximately 89% of revenues related to online accommodation reservation services (with Booking.com being the primary source of these revenues). This indicates a marginal increase in reliance on accommodation reservations overall, but the core dependency on Booking.com as the dominant revenue driver remains consistent year-over-year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41286,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10543,
        "completion_tokens": 154,
        "total_tokens": 10698
      }
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "Between 2023 and 2024, PMI’s exposure to the Swiss Franc note declined significantly – the balance fell from $299 million (2023) to $0 million (2024), indicating that the company has eliminated its direct Swiss‑franc‑denominated debt. This reduction reflects a broader shift in PMI’s foreign‑currency obligations, as the company increasingly relies on U.S. dollar and euro borrowings (including the remaining €2.5 billion tranche of its Swedish‑Match acquisition term loan) rather than Swiss‑franc financing. Consequently, the company’s foreign‑currency obligations are now dominated by dollar and euro debt, reducing its exposure to Swiss‑franc exchange‑rate fluctuations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43927,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11209,
        "completion_tokens": 168,
        "total_tokens": 11377
      }
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "The 2024 10‑K adds a new “Form of Non‑Employee Director RSU Award Agreement” (cash‑settled) as Exhibit 10.33, while the 2023 filing only referenced the pre‑2015 non‑employee director RSU agreements (Exhibit 10.21) and did not include a cash‑settled version. Thus, the treatment of Non‑Employee Director RSU awards evolved by introducing a new cash‑settled agreement in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10553,
        "completion_tokens": 96,
        "total_tokens": 10650
      }
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Based on the provided document pages, PMI's financial relationship with Swedish Match AB evolved through the acquisition of Swedish Match AB in 2022, which included a €5.5 billion term loan facility (approximately $5.8 billion at signing) to finance the deal. To repay the 3-year tranche of this facility ($3.2 billion), PMI prepaid approximately €3 billion ($3.2 billion) in November 2024 using proceeds from new bond issuances and cash on hand. The remaining €2.5 billion ($2.6 billion) under the 5-year tranche of the term loan facility was outstanding as of December 31, 2024. This repayment significantly reduced PMI's short-term debt obligations tied to the acquisition, though long-term debt related to the acquisition (e.g., €2.5 billion tranche due 2027) remains.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44287,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11298,
        "completion_tokens": 193,
        "total_tokens": 11491
      }
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "From 2023 to 2024, Bristol‑Myers Squibb’s strategic focus shifted markedly toward KRAS‑targeted oncology through the Mirati acquisition. The January 2024 purchase of Mirati added the FDA‑approved KRAS inhibitor Krazati (and its pipeline, including MRTX1719) and a contingent‑value right tied to regulatory milestones, positioning BMS’s KRAS‑inhibition program as a core growth driver. This acquisition complements earlier KRAS efforts (e.g., the 2022 BridgeBio SHP2 inhibitor collaboration) and marks a deliberate evolution from partnership‑based development to direct ownership of a commercial KRAS‑targeting asset, shaping the trajectory of Krazati’s clinical and commercial advancement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40656,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10393,
        "completion_tokens": 172,
        "total_tokens": 10565
      }
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Between 2023 and 2024, Goldman Sachs updated its governance disclosures to reflect newer compensation policies. In the 2023 filing, the Restricted Partner Compensation Plan was presented as an “Amended and Restated” plan (Item 10.3), while the 2024 filing replaces that reference with a more recent “Amended and Restated Restricted Partner Compensation Plan” (Item 10.4) and adds a separate “Clawback Policy” effective December 1 2023 (Item 97.1). These changes signal a deliberate shift toward stricter, more transparent compensation governance, aligning the firm’s partner‑pay framework with its newer governance standards introduced during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10563,
        "completion_tokens": 163,
        "total_tokens": 10726
      }
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, PMI’s heat-not-burn products transitioned from being categorized under \"smoke-free products excluding Wellness and Healthcare\" to a distinct segment within its product portfolio, with shipment volume growing 14.7% to 125.3 billion units. This evolution reflects deeper integration into PMI’s core business, as evidenced by their inclusion in consolidated financial reporting (e.g., $12,534 million in 2023 revenue) and strategic emphasis on smoke-free products as a growth driver, including dedicated market share metrics and regional performance updates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40917,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10454,
        "completion_tokens": 143,
        "total_tokens": 10598
      }
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Between 2023 and 2024, Bristol‑Myers Squibb’s business‑risk governance evolved through the formalization of a dedicated “business risk and disclosure group” as part of its remediation measures under the 2004 SEC Consent Order. The group’s role was expanded to oversee and certify compliance with the Consent’s sales‑limit provisions, monitor inventory‑based sales practices, and provide escalation pathways for potential compliance concerns—reflecting a more structured, company‑wide governance framework to ensure ongoing adherence to the settlement terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46634,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11896,
        "completion_tokens": 139,
        "total_tokens": 12035
      }
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "UNP's pension plan asset allocation strategy has evolved from a 2023 target of 20-30% equity and 70-80% debt to a 2024 target maintaining the same ranges (20-30% equity, 70-80% debt), reflecting a continued de-risking approach that reached its endpoint of 25% equity and 75% debt in 2023. The plan's expected long-term return remains anchored at 5.25%, with asset allocation targets evaluated annually to ensure diversification and alignment with market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36587,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9367,
        "completion_tokens": 116,
        "total_tokens": 9483
      }
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon’s disclosure of its Directors’ Code of Conduct remained accessible via its website, with no structural changes to its location or naming. However, the 2023 filing explicitly emphasized the intent to disclose future amendments or waivers to the Directors’ Code of Conduct on the website, reinforcing its integration into corporate governance reporting and enhancing transparency around governance updates. This reflects a continued, consistent approach to accessibility while strengthening the proactive communication of governance changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35949,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9219,
        "completion_tokens": 143,
        "total_tokens": 9363
      }
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle has expanded the deployment flexibility of its Oracle Database through hybrid and multi-cloud options, including OCI Dedicated Region, Exadata Cloud@Customer, and sovereign cloud deployments, enabling customers to run workloads across on-premise, Oracle Cloud, and third-party clouds. This evolution underscores Oracle's strategy to support hybrid IT environments and facilitate seamless cloud migration by offering integrated, secure, and scalable infrastructure services like OCI, which combine database, compute, storage, and AI capabilities to modernize applications and reduce operational complexity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43951,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11238,
        "completion_tokens": 153,
        "total_tokens": 11391
      }
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "The formal review and certification process of annual and quarterly SEC reports was established as part of the company's settlement with the SEC in 2004, and its procedures have been reinforced over time to ensure compliance. This includes a governance process for escalating compliance concerns and regular monitoring of sales to direct customers, though the provided documents do not specify substantive changes to this process between 2023 and 2024. The 2024 SEC Consent Order discussion confirms the ongoing use of these procedures without detailing recent modifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46634,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11896,
        "completion_tokens": 143,
        "total_tokens": 12039
      }
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International expanded its heat-not-burn (HNB) product portfolio and repositioned these products as a core growth pillar within its broader smoke‑free portfolio. In the 2023 financial disclosures, PMI categorized HNB products—including licensed brands such as KT&G’s Fiit and Miix, as well as its own TEREA and HEETS lines—under the “Smoke‑Free Products” segment, reporting $12.8 billion in net revenues from these offerings, up from $9.9 billion in 2022. This shift reflects a strategic market positioning that treats HNB devices and consumables as a distinct, high‑growth category separate from traditional combustible tobacco, emphasizing both product diversification and increased investment in RRP (reduced‑risk product) innovation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45639,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11637,
        "completion_tokens": 192,
        "total_tokens": 11830
      }
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle has expanded its deployment flexibility by offering a broader range of cloud and hybrid options—including OCI services that can run on-premise (e.g., Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud) and multi‑cloud partnerships—while deepening integration with its own stack (Autonomous Database, MySQL HeatWave, Middleware, Java, and Engineered Systems). This strategy lets customers move workloads to the Oracle Cloud or keep them on‑premise, and it ties those workloads more tightly to Oracle’s cloud services and support offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42170,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10769,
        "completion_tokens": 139,
        "total_tokens": 10908
      }
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "From 2023 to 2024, BMY’s strategic relationship with Krazati evolved from a newly acquired asset (via the Mirati acquisition in January 2024) into a core growth driver for its oncology portfolio, highlighted by FDA and EMA approvals for Krazati in second‑line NSCLC and expanded KRAS‑mutated colorectal cancer, plus a contingent value right tied to future regulatory milestones. In 2024, BMY committed up to $1.0 billion in cash consideration for the contingent value right and allocated roughly $4.9 billion of total consideration (including $4.5 billion cash and $0.4 billion equity awards) to acquire Mirati, underscoring a significant financial investment to integrate and advance Krazati within its pipeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39120,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10004,
        "completion_tokens": 178,
        "total_tokens": 10183
      }
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Based on the provided SEC filings, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV (trading as BK/P on the NYSE) remained fully outstanding and continued to be guaranteed by The Bank of New York Mellon Corporation in both 2022 and 2023 filings. The documents confirm the security's terms and exchange listing but do not indicate any material change in its treatment or status between the fiscal years ending December 31, 2022 and December 31, 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37206,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9528,
        "completion_tokens": 122,
        "total_tokens": 9650
      }
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "From 2022 to 2023, PMI's short-term credit arrangements expanded significantly, with available commitments rising from approximately $2.3 billion at the end of 2021 to about $2.7 billion by the end of 2023, and borrowings under these facilities increasing from $225 million to $283 million. This growth reflects a more robust liquidity buffer and a willingness to rely on external financing, suggesting that PMI's near‑term liquidity posture is stronger and more flexible than in the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 37144,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9515,
        "completion_tokens": 123,
        "total_tokens": 9638
      }
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Oracle's Autonomous Database has evolved from a standalone cloud offering into a tightly integrated, AI‑driven engine that is embedded across its broader SaaS portfolio and OCI ecosystem.  In 2023 the focus was on positioning the Autonomous Database as a self‑driving database service within OCI, emphasizing automated operations, autonomous scaling, and security isolation.  By 2024 the narrative expands to showcase deeper integration with other cloud services—such as Java Cloud, APEX, and Oracle Analytics Cloud—while highlighting new automation capabilities like built‑in AI/ML, real‑time analytics, and seamless migration tools (e.g., Exadata Cloud@Customer, OCI Dedicated Region).  This evolution reflects Oracle’s strategy to make the Autonomous Database the foundational data platform that powers a unified, automated, and extensible cloud experience across all of its SaaS and infrastructure offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44203,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11279,
        "completion_tokens": 228,
        "total_tokens": 11507
      }
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Between 2023 and 2024, GM’s capital involvement with Ultium Cells Holdings LLC grew substantially, with committed capital contributions rising to $0.8 billion in 2023 and remaining elevated through 2024 as part of ongoing investments in the joint venture. Strategically, this positioned GM to secure a stable supply of battery cells for its electric‑vehicle rollout while maintaining a non‑consolidated equity stake that limits direct financial exposure but provides influence over Ultium’s development. The relationship remains a key element of GM’s EV supply chain, even as GM continues to monitor capital needs and potential future funding requirements for Ultium.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51149,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13013,
        "completion_tokens": 166,
        "total_tokens": 13180
      }
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the as‑converted value released from the Europe retrospective responsibility plan declined from $3.5 billion (released on the 2022 sixth‑anniversary) to $2.7 billion released on the 2024 eighth‑anniversary.  Correspondingly, the number of series A preferred shares issued in those releases fell from 176,655 shares in 2022 to 99,264 shares in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66055,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16757,
        "completion_tokens": 92,
        "total_tokens": 16850
      }
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "The financial and strategic relationship between 3M and the Aearo Entities evolved significantly between 2023 and 2024, marked by litigation resolution and structural adjustments. In 2023, 3M committed $6 billion over six years to settle Combat Arms Earplugs litigation through the CAE Settlement, which included $1 billion in cash (later amended to all-cash payments) and $5 billion in stock, resolving claims from approximately 260,000–285,000 plaintiffs. This settlement, finalized in August 2023 and implemented through 2024 payments (including $253 million in January 2024), led to a $4.2 billion pre-tax charge in Q3 2023 and reconsolidation of the Aearo Entities in Q2 2023 after their 2022 bankruptcy. By 2024, the Aearo Entities were fully integrated back into 3M's financial reporting, with litigation-related liabilities accrued at $5.0 billion as of December 2023. Strategically, 3M exited PFAS manufacturing by 2025, reflected in its Transportation and Electronics segment adjustments, while the Aearo-related liabilities were isolated to specific segments (Safety and Industrial) and corporate special items, with no material impact on consolidated results beyond the settlement charges. The relationship transitioned from active litigation to resolved financial commitments, with no ongoing liability exposure beyond the settled claims.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48187,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12278,
        "completion_tokens": 337,
        "total_tokens": 12616
      }
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, Class C Common Stock remained non-voting and its earnings per share performance was not directly tied to Class A common stock metrics, but its conversion dynamics were closely linked to the company's retrospective responsibility plans and litigation-related conversion rate adjustments. While Class C Common Stock did not carry voting rights, its conversion into Class A shares (triggered by events like the Europe retrospective plan's final releases or litigation resolutions) could impact the as-converted share count and earnings per share calculations for Class A holders. The document indicates that Class C's effective price per share and conversion rates were adjusted based on litigation outcomes and anniversary releases, with the 2024 conversion adjustments reflecting a $161 million recovery for Series B and $20 million for Series C, though these had minimal direct impact on Class C's standalone EPS performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50366,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12825,
        "completion_tokens": 237,
        "total_tokens": 13062
      }
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Qualcomm’s ADAS/AD strategy shifted from primarily supplying modem and RF components for automotive connectivity to a dedicated, higher‑margin revenue stream focused on automotive‑grade SoCs and integrated solutions. In the 2022 filing the company described its automotive revenue as part of a broader “IoT” and “automotive” category, but by 2024 it reports a distinct “Automotive” revenue stream (≈ $2.9 B in 2024) that includes ADAS/AD‑related connectivity and processing, and it explicitly calls out ADAS/AD as a growth area for its QCT segment. Moreover, the 2024 filing notes that QTL continues to collect royalties on automotive‑related licensed products, reinforcing that both the chip and licensing sides of Qualcomm’s portfolio are now organized around ADAS/AD, marking a clear evolution from the more diversified fiscal 2022 approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56996,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14489,
        "completion_tokens": 220,
        "total_tokens": 14709
      }
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa’s U.S. Retrospective Responsibility Plan evolved from a reactive escrow mechanism into a more structured, multi-layered liability management framework. By 2024, the company had expanded its use of the U.S. litigation escrow account—funding it with $1.5 billion in 2023 and $1.5 billion in 2024—while also relying on loss‑sharing agreements, indemnification obligations of Visa U.S.A. members, and the conversion feature of class B stock to absorb potential settlement costs. This progression reflects a proactive approach to managing litigation risk, moving from simply reserving cash to actively coordinating multiple financial safeguards that spread and cap exposure across the corporate structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52012,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13252,
        "completion_tokens": 182,
        "total_tokens": 13434
      }
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Between 2023 and 2024, Merck's financial stake in Lynparza evolved from a collaboration revenue of $1,199 million in 2023 to $1,311 million in 2024, reflecting a 9% increase (11% excluding foreign‑exchange effects). This growth indicates sustained or expanding commercial relevance for Lynparza within Merck’s oncology portfolio. The continued rise in alliance revenue, alongside ongoing regulatory approvals (e.g., China’s 2025 adjuvant indication), suggests Lynparza remains strategically important to Merck’s pharmaceutical segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69260,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17545,
        "completion_tokens": 133,
        "total_tokens": 17679
      }
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Between 2022 and 2024, Skoal's market position within Altria's oral tobacco segment eroded significantly, with its retail share declining from 23.5% (2023) to 7.6% (2024) and shipment volume falling 15.5% (from 163.1M to 147M units). This decline occurred amid intense competition from both established MST brands and the rapidly growing oral nicotine pouch category (on! grew to 8.3% retail share in 2024, up from 6.8% in 2023), while Skoal's parent segment faced a 354M non-cash trademark impairment in 2024 that further pressured performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53242,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13540,
        "completion_tokens": 136,
        "total_tokens": 13676
      }
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "Based on the provided document pages, Microsoft Cloud revenue (which includes Dynamics 365) grew from $91.4 billion in fiscal year 2022 to $111.6 billion in fiscal year 2023, representing an increase of approximately 22% year-over-year. This growth is explicitly cited in the \"Microsoft Cloud revenue\" metric within the \"Revenue\" section of the financial statements, confirming the evolution of Dynamics 365's contribution within the broader Microsoft Cloud segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 33970,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8706,
        "completion_tokens": 116,
        "total_tokens": 8822
      }
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "From 2023 to 2024, Merck’s Balance Sheet Risk Management Program continued to rely on a mix of derivative instruments, but expanded its hedging scope and shifted toward more designated hedges. In 2023, the company primarily used purchased local‑currency puts, forwards and collars for revenue‑hedging and non‑designated economic hedges, while forward contracts for balance‑sheet exposure were marked‑to‑market in other income. By 2024, Merck increased the proportion of forward contracts designated as cash‑flow or net‑investment hedges (e.g., forward FX contracts and euro‑denominated notes) and began designating a larger share of its foreign‑exchange derivatives as cash‑flow hedges, moving unrealized gains/losses from other income into OCI and reclassifying them into sales when the hedged revenue is recognized. The program also added additional interest‑rate swaps (six swaps covering $1.5 bn of 4.5% notes due 2033) to hedge fair‑value changes tied to SOFR, reflecting a broader use of interest‑rate derivatives. Overall, the 2024 program shows a more structured, longer‑term hedging approach with a higher proportion of designated hedges and a larger notional amount of forward and swap contracts across major currencies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65714,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16668,
        "completion_tokens": 307,
        "total_tokens": 16975
      }
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "Between 2022 and 2024, PayPal’s merchant financing activity expanded significantly, with merchant receivables growing from $1.2 billion in 2022 to $1.5 billion by the end of 2024, and gross charge‑offs declining from $300 million in 2023 to $156 million in 2024.  Accordingly, the allowance for credit losses on merchant loans, advances and related interest and fees fell from $160 million in 2023 to $113 million in 2024, reflecting improved credit quality and lower loss provisions.  This evolution is also evident in the company’s loan‑sale program, which in 2023 began selling eligible consumer installment receivables and later amended the agreement in December 2024 to extend the commitment period to 2026, underscoring a strategic shift toward managing and monetizing its merchant financing portfolio while maintaining conservative loss provisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 54439,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13843,
        "completion_tokens": 213,
        "total_tokens": 14056
      }
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO declined in both goodwill allocation and operating income performance. While goodwill tied to smokeable products remained flat at $99 million in 2021‑2022, the 2024 data shows a sharp drop in operating income from $10,821 million in 2023 to $10,821 million (a modest decrease) but with a notable non‑cash impairment of the Skoal trademark and higher exit costs, indicating that the segment’s profitability is under pressure. Consequently, the segment’s contribution to overall earnings has weakened, reflecting reduced pricing power, lower shipment volumes and heightened regulatory and litigation costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60404,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15324,
        "completion_tokens": 169,
        "total_tokens": 15494
      }
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "Based on the provided SEC 10-K filings, Microsoft's commercial portion of LinkedIn revenue within Microsoft Cloud increased from $13.8 billion in fiscal 2022 to $16.4 billion in fiscal 2023, reflecting growth in LinkedIn's commercial revenue streams as part of the broader Microsoft Cloud offering. This growth is consistent with the reported Microsoft Cloud revenue rising from $91.2 billion in FY2022 to $137.4 billion in FY2024, with the commercial LinkedIn component expanding as part of this cloud revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32397,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8318,
        "completion_tokens": 129,
        "total_tokens": 8448
      }
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, Lynparza's commercialization advanced through key geographic expansions: it received FDA approval in May 2023 for BRCA-mutated mCRPC (in combination with abiraterone), followed by Japan's MHLW approval in August 2023, and later gained EU/EC approvals in 2024 for specific indications like HER2-negative gastric cancer (in combination with chemotherapy) and cervical cancer (in combination with chemoradiotherapy). Revenue growth for Lynparza (reported as \"Alliance Revenue - Lynparza\" in oncology) was modest at 9% in 2024 (11% excluding FX), driven by international demand, particularly in markets like China where it received NMPA approval for adjuvant breast cancer treatment in January 2025. However, overall revenue growth was partially offset by declines in other franchises (e.g., Gardasil in China, Bridion in EU/Japan), though Lynparza remained a key growth driver within Merck's oncology portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58686,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14893,
        "completion_tokens": 232,
        "total_tokens": 15126
      }
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "Based on the 2024 and 2023 10-K disclosures, RTX's financial treatment of the Powder Metal Matter evolved significantly, with the key impact on future income tax benefits being the recognition of a $212 million tax charge related to U.S. foreign tax credits. This charge stems from a favorable non-U.S. tax ruling received by Otis (a company RTX has a tax matters agreement with) that reduced U.S. foreign tax credits previously claimed in pre-separation years. The Company recorded a $212 million tax charge (and a corresponding $56 million tax benefit) reflecting this adjustment, which directly impacts the effective tax rate and the realization of future tax benefits tied to international earnings and tax positions. The Powder Metal Matter's sale and leaseback transactions also influenced cash flow presentation but did not materially affect the core tax benefit calculation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43013,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10978,
        "completion_tokens": 220,
        "total_tokens": 11198
      }
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "From 2022 through 2024 the company’s borrowing capacity and the terms of its credit facilities evolved as follows:  \n\n- In 2022 the company entered into a $5 billion unsecured revolving Credit Agreement (the “Credit Agreement”) that provides a five‑year facility with a $150 million letter‑of‑credit sub‑facility and a $600 million swing‑line sub‑facility; as of the end of 2022 no borrowings were outstanding, leaving the full $5 billion available.  \n- In February 2022 (and later amended in September 2022) Paidy obtained a secured revolving credit facility of approximately ¥90 billion (about $574 million) under the Paidy Credit Agreement, which was used to fund loan receivables; by the end of 2024 roughly $100 million of that facility remained available after borrowing $98 million.  \n- In May 2024 the company issued an additional $1.3 billion of fixed‑rate senior unsecured notes, expanding its term‑debt portfolio to a total of $10.6 billion outstanding as of December 31 2024, with maturities stretching to 2062 and interest payable semi‑annually.  \n\nThus, the borrowing capacity grew from the original $5 billion revolving line (plus uncommitted regional facilities) to include a sizable secured Paidy line and a multi‑billion‑dollar pool of senior notes, while the outstanding balances and available capacity under each facility were regularly updated to reflect usage and repayments through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12419,
        "completion_tokens": 352,
        "total_tokens": 12771
      }
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Altria's reliance on long‑term senior unsecured notes has declined markedly between 2022 and 2024.  In 2022 the company still carried a sizable debt load ($28‑$29 billion) and, after a 2021 debt‑tender and redemption, began repaying maturing notes; by 2024 its total long‑term debt had fallen to about $24.9 billion, and it issued only a modest $1 billion of new senior notes in early 2025 to refinance near‑term maturities.  Consequently, the proportion of its capital structure funded by long‑term unsecured debt has been reduced, with the company increasingly depending on operating cash flows, credit‑facility borrowings and equity‑based financing to meet liquidity needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54676,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13883,
        "completion_tokens": 169,
        "total_tokens": 14052
      }
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "RTX's financial treatment of the Powder Metal Matter evolved from a $5.4 billion net sales charge in 2023 (reflected in organic net‑sales reductions and a $2.5 billion partner‑share cost reduction) to a $2.9 billion pre‑tax charge in 2024 that further lowered pretax income and drove a lower effective tax rate. This progression indicates that the matter continues to generate significant tax‑benefit volatility, but the growing charge and related tax adjustments suggest diminishing future income‑tax benefits from the issue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47775,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12169,
        "completion_tokens": 131,
        "total_tokens": 12301
      }
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "Between 2022 and 2024, PayPal's borrowing capacity under its primary revolving credit facility remained at $5.0 billion, but the company actually drew down $3.0 billion in March 2020 (repaying it in May 2020) and later accessed the Paidy Credit Agreement, drawing ¥90 billion (≈$574 million) in 2024, leaving essentially no remaining capacity under that facility by year‑end 2024.  The company's term‑debt schedule shows scheduled principal payments of $1 billion in 2022, $1 billion in 2023, $1.25 billion in 2024, $1 billion in 2025, $1.25 billion in 2026 and $3.5 billion thereafter, reflecting the maturities of its fixed‑rate notes.  Overall, PayPal's utilization of debt shifted from relying on the 2019 $5 billion revolving facility (with a $3 billion draw in 2020 that was subsequently retired) to increasing use of longer‑dated fixed‑rate notes and the Paidy‑derived revolving credit line, while maintaining a sizable unused borrowing buffer in its broader credit arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48178,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12268,
        "completion_tokens": 246,
        "total_tokens": 12515
      }
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, the ownership structure between Accenture plc and Accenture Canada Holdings Inc. remained stable, with noncontrolling interests in the Canadian subsidiary holding less than 1% as of August 31, 2024. Exchangeable shares of Accenture Canada Holdings Inc. continue to be convertible one‑for‑one into Accenture plc Class A ordinary shares, and the company may redeem Class X ordinary shares to maintain the aggregate number of such shares not exceeding the outstanding exchangeable shares. Share‑based compensation disclosures for fiscal 2024 show no material change in the equity awards tied to these entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40584,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10383,
        "completion_tokens": 156,
        "total_tokens": 10540
      }
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Based on the provided 10-K excerpts, Merck's approach to managing balance sheet risk through forward exchange contracts has evolved in two key ways between 2022 and 2024:  \n\n1. **Currency Expansion**: While 2022 disclosures (MRK_10k_2022.pdf) specifically highlighted hedging of the euro, Japanese yen, and Chinese renminbi for revenue exposure, the 2024 document (MRK_10k_2024.pdf) broadens this to include additional currencies like the Swiss franc and explicitly references managing exposures in developing country currencies (e.g., Chinese renminbi) through cost-benefit-driven forward contracts.  \n\n2. **Cost-Benefit Focus**: The 2022 filing emphasized that hedge coverage levels were determined by \"assessments of cost-benefit profiles\" considering volatility and natural offsets, whereas the 2024 update details that forward contracts for developing market exposures are entered into \"when it is deemed economical\" based on similar cost-benefit analyses—indicating a more nuanced, risk-tiered application of hedges over time.  \n\nNotably, the 2024 filing also shows a shift toward more structured net investment hedging (e.g., using euro-denominated debt as economic hedges), reflecting a maturation in Merck’s currency risk management strategy beyond basic transactional hedging.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 107,
          "pages": [
            105,
            106,
            107,
            108,
            109
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60388,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15330,
        "completion_tokens": 321,
        "total_tokens": 15652
      }
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The 2024 filing shows a $405 million “advance payments” liability tied to a Middle‑East customer that the company now believes it will be unable to fulfill because of pending regulatory approvals.  This loss of a major contract is expected to reduce future cash inflows and therefore diminish the amount of tax‑benefit‑generating earnings that can be realized, meaning the company will likely receive fewer income‑tax credits or deductions tied to those future earnings.  Consequently, the change in disclosure signals that future income‑tax benefits will be materially lower.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48964,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12466,
        "completion_tokens": 144,
        "total_tokens": 12610
      }
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "Between 2022 and 2024 PayPal’s merchant finance activity grew markedly: it purchased roughly $1.8 billion of merchant receivables in 2024 (up from $1.7 billion in 2023) and the outstanding merchant loan‑advance portfolio rose to $1.5 billion, while the allowance for credit losses on that portfolio fell from $160 million to $113 million, reflecting improved credit quality. The partnership model remains anchored by the U.S. program with WebBank, where PayPal purchases merchant receivables and shares risk on a pro‑rata basis, and by international extensions through its Luxembourg and Australian subsidiaries; the 2023 amendment to its consumer‑installment sale agreement also expanded the forward‑flow capacity to $541 million and extended the commitment through 2026.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 53047,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13499,
        "completion_tokens": 193,
        "total_tokens": 13692
      }
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Based on the provided document pages, Merck's alliance revenue from Lynparza increased from $417 million in 2020 to $515 million in 2021, and while the 2022-2024 data isn't explicitly shown in the financial statements, the document indicates that alliance revenue for Lynparza grew 9% in 2024 (as noted in the \"Oncology\" section of the 2024 sales table). This growth was driven by higher demand in most international markets. The document also states that alliance revenue represents Merck's share of profits from sales net of cost of sales and commercialization costs, and that Lynparza is part of a collaboration with AstraZeneca. The growth in 2024 was partially offset by lower sales in other franchises, but specifically for Lynparza, the 9% growth in 2024 reflects continued international demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            139,
            140,
            141,
            142,
            143
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58951,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14953,
        "completion_tokens": 200,
        "total_tokens": 15153
      }
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal’s exposure to merchant receivables shifted markedly between 2022 and 2024.  In 2022 the company’s merchant‑finance portfolio was relatively small and heavily weighted toward U.S. merchants, with high charge‑off rates (≈19 %) and a modest allowance for credit losses.  By 2024 the portfolio had expanded globally (≈82 % of merchant receivables still in the U.S. but with growing U.K. and other‑market balances) and the allowance fell from $160 million to $113 million, reflecting improved credit quality and tighter risk parameters introduced after the pandemic.  Consequently, transaction‑and‑credit loss rates dropped from 0.19 % of TPV in 2020 to about 0.09 % in 2021 and remained low, while the company’s overall financial exposure to merchant loans declined as it sold portions of its consumer‑installment portfolio and shifted to a more diversified funding mix.  This evolution reduced PayPal’s direct credit‑risk exposure while maintaining a modest operational role in servicing and collecting the remaining merchant receivables.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55860,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14188,
        "completion_tokens": 260,
        "total_tokens": 14449
      }
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "From 2022 to 2024, Merck’s involvement with Lynparza evolved from regulatory submission to commercial expansion. In 2022, the FDA accepted a supplemental NDA for Lynparza for adjuvant treatment of high-risk early-stage breast cancer (BRCA-mutated, HER2-negative), with a PDUFA date in Q1 2022, and the EU also began review. By 2024, Lynparza had secured regulatory approvals in additional markets, including China (January 2025, per pipeline updates), and alliance revenue grew 9% in 2024, reflecting increased international demand and commercial uptake across multiple cancer indications. Revenue growth was driven by higher sales in key markets, supported by ongoing regulatory milestones and expanded approvals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54687,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13898,
        "completion_tokens": 178,
        "total_tokens": 14077
      }
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Boeing's commodity purchase contracts strategy has evolved to extend hedging horizons and reduce financial exposure. In the 2022 filing, it noted that commodity derivatives (including swaps and purchase contracts) hedge forecasted transactions through 2028, with a 10% market price change impacting unrealized losses by $46 million. By the 2024 filing, the company expanded its hedging scope to cover transactions through 2031 using foreign currency forward contracts and commodity derivatives, while explicitly stating that these contracts \"do not create material market risk\" when combined with offsetting underlying commitments. The 2024 disclosure also details a more structured approach to hedge accounting, including specific reclassification expectations of $64 (pre-tax) losses from AOCI into earnings over the next 12 months, demonstrating a refined risk management process compared to the more general 2022 description. (298 characters)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34704,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8901,
        "completion_tokens": 236,
        "total_tokens": 9138
      }
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, Schwab's exposure to PALs (Pledged Asset Lines) and associated credit risk evolved as follows between 2021 and 2024:\n\n1.  **Collateralization**: PALs remained consistently fully collateralized by securities with fair values exceeding borrowings throughout 2021-2024, requiring no allowance for credit losses (as explicitly stated in the 2021 and 2020 notes: \"All PALs were fully collateralized... therefore, no allowance for credit losses... was required\"). The 2024 supplemental financial data shows PALs totaling $16,733 million within 1 year and $45,236 million total, with maturities extending beyond 15 years.\n\n2.  **Credit Risk & Allowance**: The allowance for credit losses on the *entire bank loan portfolio* (which includes PALs as part of the broader loan book) was minimal ($18 million at end-2021) and decreased significantly by end-2024 (as shown in the allowance table, though specific 2024 allowance figures aren't provided in the excerpt, the trend context and macroeconomic outlook indicate reduced risk). The 2021 note states \"no allowance for credit losses for PALs\" was required due to full collateralization, and the 2024 macroeconomic commentary notes \"lower modeled projection of loss rates\" compared to 2020, reflecting improved credit quality metrics in the portfolio.\n\nIn summary, Schwab's PAL exposure remained fully collateralized (no credit loss allowance needed) through 2021-2024, with the *overall loan portfolio's* credit risk profile improving (lower loss rate projections), though specific 2024 allowance figures aren't detailed in the provided pages. The collateralization remained robust, with PALs' maturity profile extending significantly beyond 1 year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 142,
          "pages": [
            137,
            138,
            139,
            140,
            141
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52033,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13236,
        "completion_tokens": 434,
        "total_tokens": 13670
      }
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024 Boeing’s 777X program shifted from heavy investment to cost‑recovery focus.  In 2022 the company recorded a $1.77 billion reach‑forward loss on the T‑7A program and continued to absorb COVID‑related cost pressures, while research‑and‑development spending on the 777X remained elevated.  By 2024, R&D outlays on the 777X had risen sharply (up $435 million YoY) as Boeing accelerated development work, but the program’s cost structure was increasingly weighed down by reach‑forward losses on the 777X and 767, pushing cost‑of‑sales as a share of revenue higher (103 % in 2024 vs. 90 % in 2023).  Consequently, while early years saw large R&D outlays, the later period is defined by rising cost impacts that are being absorbed into earnings rather than further R&D investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32881,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8450,
        "completion_tokens": 198,
        "total_tokens": 8649
      }
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Schwab’s exposure to Portfolio Against Loans (PALs) has remained relatively stable in size, with the loan balance of $42.3 billion reported in 2024 versus $38.8 billion in 2023, but the credit‑loss allowance methodology for PALs has been refined to rely on a practical expedient that estimates losses based on collateral‑maintenance provisions rather than detailed cash‑flow modeling. This approach acknowledges the over‑collateralized, daily‑monitored nature of PALs and limits the inherent credit loss, while the allowance for the broader bank‑loan portfolio—including PALs—continues to be driven by statistical models that incorporate delinquency roll rates, loss severity, housing‑price trends, interest‑rate outlooks, and unemployment forecasts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 142,
          "pages": [
            137,
            138,
            139,
            140,
            141
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45470,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11601,
        "completion_tokens": 187,
        "total_tokens": 11789
      }
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "Based on the provided financial disclosures, MDLZ's British pound sterling notes under \"Non-U.S. dollar debt designated as net investment hedges\" decreased slightly from **$360 million (2022)** to **$356 million (2023)**, reflecting a **$4 million reduction** in the notional amount of these specific hedges. This minor shift indicates that the company maintained a relatively stable position in its British pound-denominated hedging strategy, with no significant reallocation or reduction in exposure to GBP fluctuations during the period. The change aligns with broader trends in the company's net investment hedge portfolio, where the aggregate notional value of all non-U.S. dollar debt hedges remained largely consistent, suggesting a focused approach to managing foreign exchange risk tied to international operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52433,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13338,
        "completion_tokens": 206,
        "total_tokens": 13544
      }
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "The 2022 filing (AMGN_10k_2022.pdf) lists the 3.125% 2025 Notes with a **$1,000 million carrying value** (page 130), while the 2024 filing (AMGN_10k_2024.pdf) shows the same instrument with a **$1,000 million carrying value** (page 150), confirming no change in the reported debt amount. However, the 2024 filing explicitly states the **effective interest rate is LIBOR + 1.8%** (page 151), whereas the 2022 filing only disclosed the **coupon rate of 3.125%** (page 130) without mentioning any swap-based effective rate. This reveals Amgen’s approach shifted from relying solely on the stated coupon rate in 2022 to actively managing the effective cost via interest rate swaps (e.g., converting fixed 3.125% to floating LIBOR + 1.8%) by 2024, reflecting a more sophisticated debt financing strategy to optimize interest expense and align with market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12445,
        "completion_tokens": 215,
        "total_tokens": 12660
      }
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab’s reliance on its Commercial Paper Issuance Program (CPIP) has grown markedly from 2022 to 2024 as market disruptions and sharply higher interest rates limited access to traditional bank funding. In 2022 the CPIP was used modestly, but by 2024 the Company explicitly cites it as a key source of external financing and notes that “financing may not be available on acceptable terms or at all due to market conditions or disruptions in the credit markets,” indicating a heightened dependence on CPIP to meet liquidity needs when bank lines and other sources become constrained.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55030,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13981,
        "completion_tokens": 145,
        "total_tokens": 14126
      }
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625% Notes due 2022 were fully redeemed in 2021, with $750 million of principal repurchased and associated make‑whole payments of $24 million recognized in interest expense. Following this redemption, the company issued new long‑term debt (including $1.25 billion of 1.65% 2028 Notes, $1.25 billion of 2.00% 2032 Notes, $1.15 billion of 2.80% 2041 Notes and $1.35 billion of 3.00% 2052 Notes) and entered into interest‑rate swaps to refinance the remaining 3.625% exposure, indicating a strategic shift toward longer‑dated, lower‑coupon fixed‑rate borrowings and active management of debt maturities. This evolution reflects a deliberate debt‑management approach that prioritizes extending maturity profiles, reducing near‑term cash‑outflows, and optimizing interest‑rate risk through swaps and targeted redemptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12438,
        "completion_tokens": 205,
        "total_tokens": 12643
      }
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Schwab's approach to funding VIEs has shifted from actively providing support in 2022 to explicitly stating it does not intend to provide additional financial or other support beyond existing contractual obligations in 2024, as reflected in the 2021 and 2024 10-K disclosures. This change is evident in the 2021 Note 11 language confirming no intent to provide unsolicited support, contrasted with the 2022 filing's more proactive language about potential future funding needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49677,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12655,
        "completion_tokens": 119,
        "total_tokens": 12774
      }
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "MDLZ's investment in JDE Peet's is structured as a strategic equity method investment that is accounted for in its financial statements, but the provided documents do not contain specific quantitative details on how this investment has directly impacted MDLZ's liquidity or capital structure between 2022 and 2023. The 2021 filing notes the issuance of €300 million zero-interest exchangeable notes tied to JDE Peet's (which would have been settled in 2022 or 2023), and the 2023 discussion references the investment's role in providing \"additional flexibility\" for funding, but no explicit linkage to changes in debt levels, cash flow, or capital structure is provided in the given pages. The documents focus on general financing activities, debt management, and the broader strategic rationale for the JDE Peet's transaction rather than the specific financial mechanics of the investment's evolution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39625,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10134,
        "completion_tokens": 225,
        "total_tokens": 10360
      }
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "The interest rate hedging strategy for the 3.125% 2025 Notes evolved from a fixed 3.125% coupon to a floating rate of **LIBOR + 1.8%** after entering into interest‑rate swap agreements in 2021, and this floating‑rate structure remained in place through 2024 (with the notional amount of the swap covering the full $1 billion principal of the 2025 Notes).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49789,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12678,
        "completion_tokens": 88,
        "total_tokens": 12766
      }
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Based on the provided document pages, Walmart's fair value of equity investments measured using Level 2 inputs decreased from $7,905 million as of January 31 2022 to $5,819 million as of January 31 2023, representing a decline of $2,086 million (approximately a 26 % reduction) over that one‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55836,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14186,
        "completion_tokens": 76,
        "total_tokens": 14262
      }
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "The document does not indicate any change in Apple's characterization of its reliance on marketing abilities between the 2023 and 2024 10-K filings. Both years consistently describe marketing as a key competitive factor—highlighting its importance in product differentiation, market expansion, and success alongside innovation and design—but do not frame it as a standalone or evolving reliance. The language remains static, emphasizing marketing as part of broader competitive strengths rather than a shifting focus. No evolution in characterization is evident across the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43082,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10982,
        "completion_tokens": 147,
        "total_tokens": 11129
      }
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "The 3.625% 2024 Notes remained at a $1.4 billion notional amount in both 2022 and 2024, but their interest‑rate structure shifted from a fixed 3.625% coupon in 2022 to a floating rate of LIBOR + 3.2% (later SOFR + 3.4%) after the 2021 interest‑rate swap redesignations. This move to a floating‑rate profile indicates that Amgen is actively managing its interest‑rate exposure—locking in lower rates when market conditions are favorable and using swaps to transition fixed‑rate debt to floating‑rate debt—reflecting a proactive hedging strategy to align debt costs with prevailing interest‑rate benchmarks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49789,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12677,
        "completion_tokens": 151,
        "total_tokens": 12828
      }
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "From 2022 to 2023, Schwab integrated TD Ameritrade’s iRebal portfolio‑rebalancing solution into its Advisor Services offering, retaining the iRebal platform while migrating TD Ameritrade clients onto Schwab’s systems and completing the broader transition of over $1.6 trillion in assets and 15 million accounts. This evolution underscores Schwab’s ability to leverage acquired technology to deepen relationships with independent advisors, reinforcing its competitive positioning as a scalable, cost‑efficient leader that can provide differentiated, trusted solutions across both retail and RIA channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52130,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13259,
        "completion_tokens": 150,
        "total_tokens": 13410
      }
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Apple's iMac product line saw a notable shift in its fiscal 2024 disclosures compared to fiscal 2023, with the company explicitly highlighting the iMac as a key product announcement in its first quarter of 2024 (fiscal 2024), whereas it was not listed among significant product announcements in the fiscal 2023 discussion. While the 10-K does not provide detailed sales figures or strategic shifts for the iMac specifically, its inclusion in the fiscal 2024 product announcements—alongside updates to operating systems like macOS Sequoia—signals a renewed focus on the desktop segment, contrasting with its absence in the prior year's key announcements. This suggests a potential evolution in Apple's approach to the iMac line, emphasizing its role within the broader product ecosystem rather than isolated hardware updates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 29459,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7582,
        "completion_tokens": 206,
        "total_tokens": 7788
      }
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX retired its $2.820 billion 2051 notes in 2022 and replaced them with $1.0 billion of 2.820% notes due 2051 issued in August 2021, which were later partially repaid in 2022 using proceeds from new debt issuances. This restructuring reflects a strategic shift toward longer-term, lower-cost financing and a more stable debt profile, as evidenced by the extended maturity of the new notes and the company's focus on managing debt maturity schedules.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43475,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11093,
        "completion_tokens": 112,
        "total_tokens": 11205
      }
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "The IDA agreement terms evolved between 2022 and 2023 primarily through a reduction in the service fee on client cash deposits held at TD Depository Institutions, decreasing from 25 basis points under the prior TD Ameritrade agreement to 15 basis points. This change was referenced in the pro forma financial information (Note 4) as part of the acquisition accounting adjustments, reflecting the amended agreement's impact on net interest revenue. The adjustment was implemented to reflect updated deposit beta assumptions in the Company's net interest revenue sensitivity analysis, particularly following the fourth-quarter 2023 update.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46121,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11750,
        "completion_tokens": 159,
        "total_tokens": 11909
      }
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The shift from treating Filorga as a standalone reporting unit with $221 million of goodwill in 2023 to including it among other trademarks within broader segments in 2024 indicates that management no longer views Filorga as a distinct driver of future cash flows. Consequently, its strategic importance appears to have diminished, and the company is now applying a more aggregated valuation approach—likely relying on market‑based comparisons and qualitative assessments rather than detailed unit‑level cash‑flow projections—when assessing goodwill and intangible‑asset impairments. This broader classification suggests a reduced emphasis on Filorga’s individual performance in the company’s overall valuation framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10965,
        "completion_tokens": 180,
        "total_tokens": 11145
      }
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "The 2024 10-K filing explicitly names the iPhone 16 Pro (alongside iPhone 16 Plus, iPhone 16 and iPhone 16 Pro Max) in the “Product, Service and Software Announcements” section of Item 7, whereas the 2023 filing only referenced “iPhone 15” and earlier generations. This change reflects Apple’s shift to a new product generation—introducing the iPhone 16 Pro line with updated hardware and software features—signaling an evolution in both its product development roadmap and its reporting strategy to highlight the latest flagship device to investors and stakeholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 29607,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7629,
        "completion_tokens": 141,
        "total_tokens": 7770
      }
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, Schwab’s EVE simulations shifted from focusing on gradual 100-basis-point parallel rate shifts to incorporating more nuanced assumptions, including updated deposit beta assumptions and the impact of rising rates on liability duration. The 2023 simulations (reflected in the December 31, 2023 table) showed a more pronounced sensitivity to rate changes—e.g., a 200-basis-point increase now projects a 10.8% impact on net interest revenue versus 7.3% in 2022—driven by higher margin loan and cash balances, increased FHLB borrowings, and revised deposit beta assumptions that reduced the offsetting effect of lower funding costs. This evolution reflects a more dynamic modeling approach that accounts for real-time balance sheet dynamics and market conditions, particularly the shortening of liability duration as rates rose.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48930,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12469,
        "completion_tokens": 211,
        "total_tokens": 12680
      }
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 enhances its competitive positioning by expanding its product portfolio breadth in the broader networking market. This move allows Qualcomm to capture more value from the full stack of edge networking solutions, leveraging its integrated circuit expertise to compete more directly with traditional networking equipment vendors while maintaining its core focus on mobile and IoT connectivity platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64497,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16363,
        "completion_tokens": 130,
        "total_tokens": 16493
      }
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "From 2022 to 2023, the proportion of HELOCs with interest‑only payment terms remained roughly stable, with about 27% of the balance featuring interest‑only payments in 2023 versus approximately 28% in 2022. Moreover, the share of those interest‑only loans that are not scheduled to reset for three or more years stayed high—around 86% of the interest‑only balance in 2023 (compared with roughly 89% in 2022).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53119,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13523,
        "completion_tokens": 102,
        "total_tokens": 13625
      }
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "From 2022 to 2023, Qualcomm’s XR market involvement evolved through strategic investments and product revenue disclosures. In 2022, the company expanded its XR-related investments via Qualcomm Ventures, focusing on early-stage companies in XR, AI, and automotive, while also advancing its 5G and multimode technologies that underpin XR applications. By 2023, Qualcomm’s QCT segment revenue from XR-related applications (e.g., consumer IoT, edge networking, and XR devices) grew to $5.423 billion (up from $7.353 billion in 2022, though this reflects broader IoT growth), and its licensing segment (QTL) continued to support XR through 5G-enabled device licensing, with over 190 5G license agreements. The company emphasized XR as a key growth area in its strategic investments, particularly through Qualcomm Ventures, to foster innovation in XR hardware and software ecosystems, while leveraging its patent portfolio to enable XR device licensing and compatibility. This strategic focus aligned with its broader push into automotive, IoT, and emerging applications beyond mobile handsets, positioning XR as a critical frontier for future revenue streams.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56955,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14459,
        "completion_tokens": 288,
        "total_tokens": 14747
      }
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "Based on the provided document pages, the aggregate principal balance of the 3.030% Notes Due 2052 was $1,100 million as of December 31, 2021 (per the 2021 10-K), and remained $1,100 million as of December 31, 2024 (per the 2024 10-K). This indicates that RTX has maintained this specific long-term debt issuance at its original $1.1 billion principal amount without any subsequent repayment or refinancing, reflecting a stable long-term debt structure with this particular tranche remaining outstanding through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43475,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11094,
        "completion_tokens": 129,
        "total_tokens": 11223
      }
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP's shift toward corporate card solutions and commercial payments is evident in its 2024 disclosures, where it explicitly prioritizes \"building on our strong position in commercial payments\" as a strategic imperative—evolving beyond consumer-focused offerings to target corporate clients through enhanced card value propositions, expense management tools, and financing solutions for business customers. This strategic pivot, underscored by leadership roles like the Group President of Global Commercial Services and Commercial Services, signals a deliberate expansion of its commercial payments ecosystem, leveraging its spend-centric model to deepen relationships with corporate clients while maintaining its premium consumer brand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30681,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7892,
        "completion_tokens": 184,
        "total_tokens": 8076
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Based on the provided 10-K pages, PCA SKIN is positioned within the Oral, Personal and Home Care segment, where it is sold through \"a variety of traditional and eCommerce retailers, wholesalers, distributors, dentists and, in some geographies, skin health professionals.\" The document confirms its distribution channels include both retail and professional channels, with no indication of a shift in strategy between 2023 and 2024. The segment's overall distribution approach remains consistent, with PCA SKIN operating as part of the broader Oral, Personal and Home Care portfolio sold through established retail and professional networks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48106,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12258,
        "completion_tokens": 160,
        "total_tokens": 12418
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo's strategic focus shifted toward expanding its tumor indications and combination therapies, including new approvals for adjuvant melanoma (Opdivo monotherapy), neoadjuvant NSCLC with platinum chemotherapy, and expanded use in gastric/esophageal cancers and renal cell carcinoma. This commercial positioning drove growth in new product revenue streams, partially offsetting declines in mature brands like Revlimid and Abraxane. The resulting revenue trajectory reflects a strategic pivot toward higher-value oncology indications and combination regimens, supporting near-term growth while navigating patent expirations of legacy products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39335,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10078,
        "completion_tokens": 166,
        "total_tokens": 10244
      }
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "Based on the provided 10-K pages, American Express's investment in foreign government bonds and obligations had a cost basis of $770 million as of December 31, 2023, and $633 million as of December 31, 2022, with estimated fair values of $770 million and $632 million respectively. The document indicates these securities were categorized under \"Foreign government bonds and obligations\" in the investment securities summary, showing no unrealized gains or losses in 2023, though the cost basis increased from $633 million to $770 million year-over-year. The maturity distribution is detailed in Table 4.4, which shows foreign government bonds with $768 million due after 1 year but within 5 years and $2 million due after 5 years but within 10 years, totaling $770 million in fair value as of December 31, 2023. The document also confirms no credit losses were recognized for these securities during the periods presented.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46170,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11769,
        "completion_tokens": 230,
        "total_tokens": 11999
      }
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Walmart's intercompany financing arrangements have evolved to increase the amount of cash that is not freely transferable to the U.S., rising from approximately $2.8 billion as of January 31 2021 to $4.3 billion as of January 31 2022, with about $2.2 billion of that 2022 balance accessible only through dividends or intercompany financing subject to Flipkart minority‑shareholder approval. The Company continues to use these arrangements to make cash available in the needed jurisdictions at minimal cost, but local laws or restrictions may further limit repatriation of cash held outside the U.S.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59755,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15178,
        "completion_tokens": 149,
        "total_tokens": 15327
      }
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Based on the 2023 and 2024 plan asset tables, the U.S. Retiree Health Care Plan’s fixed income securities and cash equivalents decreased slightly from $210 million in 2023 to $198 million in 2024, while equity securities also declined from $54 million to $50 million. Overall, the plan’s asset allocation shifted toward a higher proportion of fixed‑income holdings (80% in 2024 versus 75% in 2023) and a lower equity share (20% in 2024 versus 25% in 2023), reflecting the plan’s target allocation ranges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56997,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14485,
        "completion_tokens": 126,
        "total_tokens": 14611
      }
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Based on the provided 10-K filings, Honeywell's 2006 Stock Plan for Non-Employee Directors underwent significant evolution between 2022 and 2024, reflecting a shift toward more structured equity compensation. In 2022, the plan included stock options and RSUs under the 2016 Stock Plan for Non-Employee Directors, with 175,104 shares available for future issuance (as noted in the 2022 filing's Exhibit 10.48*). By 2024, the plan was updated with an \"Omnibus Amendment\" (Exhibit 10.51*), and the form of award agreements transitioned to standardized forms (e.g., Exhibit 10.52* for stock options and Exhibit 10.53* for RSUs), indicating a move toward greater consistency and clarity in compensation design. This evolution suggests Honeywell is refining its non-employee director compensation to align with best practices, emphasizing simplicity, transparency, and alignment with shareholder interests—likely to enhance director engagement while maintaining flexibility in equity allocation amid changing market conditions. The shift from a more ad-hoc approach to formalized, audited award agreements underscores a strategic effort to streamline governance and reduce administrative complexity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 126,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 123,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 77836,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19709,
        "completion_tokens": 298,
        "total_tokens": 20007
      }
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Walmart's ownership stake in Flipkart declined from approximately 83% as of January 31 2021 to about 75% following the fiscal 2022 equity funding that generated $3.2 billion in cash and reduced its controlling interest. This divestiture released foreign‑currency translation adjustments and other accumulated‑other‑comprehensive‑loss items tied to the former U.K. and Japan operations, eliminating related currency‑hedge exposures and associated accumulated‑loss balances. Consequently, the financial exposure to Flipkart’s regulatory environment shifted toward ongoing Indian foreign‑direct‑investment and antitrust investigations, which could materialize as additional liabilities, restrictions on ownership or required capital actions, thereby increasing Walmart’s regulatory risk exposure in that market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53692,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13657,
        "completion_tokens": 202,
        "total_tokens": 13859
      }
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, Honeywell’s U.S. cash balances declined from $11.5 billion (2021) to $11.0 billion (2024), reflecting a shift toward larger non‑U.S. cash holdings (approximately $8 billion held abroad in 2024) and a strategic emphasis on using domestic cash for acquisitions, share repurchases, dividend increases and debt repayments. Consequently, the geographic distribution of funds moved from a relatively balanced U.S. focus to a greater proportion of cash parked outside the United States, while total U.S. cash reserves remained roughly stable but were increasingly supplemented by external financing sources.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41849,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10693,
        "completion_tokens": 155,
        "total_tokens": 10848
      }
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "The Membership Rewards liability was $13,742 million in 2023 versus $12,789 million in 2022, reflecting higher points earned and a slightly higher estimated redemption rate. The liability is estimated using the Ultimate Redemption Rate (URR) and weighted‑average cost per point (WAC); an increase of 25 basis points in URR would add roughly $197 million to the liability, while a 1‑basis‑point rise in WAC would add about $220 million. These assumptions are periodically reassessed based on redemption trends, partner contract changes and cost fluctuations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44928,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11468,
        "completion_tokens": 139,
        "total_tokens": 11607
      }
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe's strategic positioning of Frame.io has evolved from a standalone video collaboration platform acquired in late 2020 to a tightly integrated component of its broader Creative Cloud and Digital Media ecosystem, with deeper alignment through initiatives like Adobe Experience Cloud and generative AI capabilities (e.g., Firefly). By 2024, Frame.io is positioned as a strategic enabler for end-to-end creative workflows, particularly within Document Cloud and Creative Cloud, enhancing Adobe’s ability to unify tools for creators and enterprises while leveraging its integration with Adobe’s AI and cloud infrastructure to drive recurring revenue and customer retention.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10983,
        "completion_tokens": 168,
        "total_tokens": 11151
      }
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "Based on the 2022 and 2023 fair value disclosures for Level 3 investments in private alternative investments (equity-like funds), the composition evolved as follows:  \n- **2022 Level 3 equity-like fund value**: $25.4 million (reported as $25.4M in the 2022 table under \"Significant Unobservable Inputs (Level 3)\")  \n- **2023 Level 3 equity-like fund value**: $25.1 million (reported as $25.1M in the 2023 table under \"Significant Unobservable Inputs (Level 3)\")  \nThis represents a **decrease of $0.3 million** in the fair value measurement using significant unobservable inputs for equity-like funds between 2022 and 2023. The change is minimal and consistent with the disclosed \"not material\" activity in Level 3 investments for both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64915,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16465,
        "completion_tokens": 185,
        "total_tokens": 16650
      }
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Adobe's integration of Frame.io has evolved from a strategic acquisition in late 2021 to a core component of its Digital Media segment. Initially acquired to enhance cloud‑based video collaboration, Frame.io’s technology and customer base were incorporated into Creative Cloud workflows, with its capabilities (e.g., real‑time frame‑accurate commenting, Camera‑to‑Cloud uploads, and deep integration with Premiere Pro, Photoshop and other Creative Cloud apps) now positioned alongside Creative Cloud Libraries, shared reviews and Sensei AI as part of an end‑to‑end creative workflow. By fiscal 2024, Frame.io is presented as a key growth driver within Digital Media, contributing to ARR expansion and reinforcing Adobe’s broader strategy of unifying creative and collaboration tools across its subscription offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43363,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11055,
        "completion_tokens": 204,
        "total_tokens": 11259
      }
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS Health deepened its focus on integrated clinical programs and digital tools to drive medication adherence and cost efficiency, particularly within its Pharmacy Services and Health Services segments. The company expanded its formulary management and utilization management initiatives—such as the CVS Caremark National Pharmacy and Therapeutics Committee’s oversight and the NovoLogix preauthorization tool—to promote evidence-based prescribing and reduce inappropriate drug use. Concurrently, it enhanced digital engagement through AI-powered platforms like the Health Engagement Engine and Canopy, which enable real-time benefits insights, adherence counseling (e.g., Pharmacy Advisor), and predictive analytics to optimize treatment pathways. These efforts were reinforced by expanded specialty pharmacy and infusion services, as well as value-based care models via Oak Street Health and Signify Health, aiming to lower overall medical spend while improving clinical outcomes. The 2024 annual filing notes that PBM operations managed 1.9 billion prescriptions, underscoring the scale of these adherence and cost-containment programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53097,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13508,
        "completion_tokens": 290,
        "total_tokens": 13798
      }
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe has deepened Frame.io’s integration into Creative Cloud since its 2021 acquisition, embedding its collaborative review and approval workflows directly into core Creative Cloud apps like Premiere Pro and After Effects to create a native, end‑to‑end video collaboration platform.  Between 2022 and 2024 the company expanded Frame.io’s capabilities with features such as frame‑accurate commenting, real‑time co‑editing, and AI‑enhanced content‑review tools, while also broadening its availability across desktop, web and mobile surfaces and linking it tightly with Adobe Express, Firefly and Adobe Stock to streamline asset sharing and accelerate content‑first workflows.  These enhancements have positioned Frame.io as a core collaboration layer that unifies video, design and document processes within the Creative Cloud ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48034,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12244,
        "completion_tokens": 209,
        "total_tokens": 12453
      }
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "The use of recently executed transactions in loan and asset valuations shifted from Level 2 (observable market data) in 2023 to Level 3 (unobservable inputs) in 2024, reflecting a greater reliance on internal models and benchmarking when external market prices were unavailable. This evolution enhances the Firm’s ability to determine fair value but introduces more subjectivity and potential variability in the resulting valuations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MS_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "MS_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 109326,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 27562,
        "completion_tokens": 108,
        "total_tokens": 27671
      }
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Adobe's approach to Substance 3D Stager has evolved from being positioned as a standalone 3D tool within the broader Substance 3D ecosystem to being deeply integrated as a core component of the Creative Cloud subscription offering. By 2024, it was explicitly framed as part of the \"Adobe Substance 3D Collection\" and emphasized for its role in enabling users to \"build and assemble 3D scenes with Stager\" alongside closely integrated tools like Substance 3D Painter and Designer, reflecting a strategic shift toward treating the entire Substance 3D suite as a unified, cloud-connected workflow rather than isolated applications. This positioning aligns with Adobe's broader move to present Creative Cloud as an integrated platform where tools like Stager deliver value through seamless connection with other Creative Cloud apps and AI-powered features.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 38721,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9908,
        "completion_tokens": 213,
        "total_tokens": 10121
      }
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE’s strategic positioning regarding grid-scale batteries shifted from a peripheral, long‑term R&D focus to a more explicit component of its energy‑transition narrative, especially as the company prepared for the planned spin‑off of its Renewable Energy and Power businesses into GE Vernova. In the 2022 filing, battery storage was mentioned only in the broader context of decarbonization and emerging technologies, whereas the 2023 filing explicitly links grid‑scale batteries to the future competitiveness of GE’s wind and power segments and to the overall value‑creation story for the new independent company. Consequently, while still not a core revenue driver, battery‑related investments moved from “potential opportunity” to a “strategic priority” that underpins GE’s diversification and the financial case for the separation, increasing the company’s reliance on these technologies to sustain growth in its renewable‑energy portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 72846,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18446,
        "completion_tokens": 240,
        "total_tokens": 18686
      }
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS's disclosure regarding the use of broker-quoted debt securities in fair value measurements has evolved from **no broker-quoted securities** in 2022 (2022 10-K, Level 3 section) to **explicitly stating no broker-quoted debt securities were used** in 2024 (2024 10-K, Level 3 section), maintaining a consistent position that Level 3 valuations relied on internal pricing or non-broker sources. This reflects a stable approach to fair value methodology without changes in the presence or impact of broker-quoted instruments on financial reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 146,
          "pages": [
            144,
            145,
            146,
            147,
            148
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47880,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12208,
        "completion_tokens": 137,
        "total_tokens": 12345
      }
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, BlackRock's equity securities at FVTNI increased from $1,059 million to $1,179 million, reflecting higher holdings of equity securities/mutual funds ($1,585 million vs. $1,520 million) and equity method investments ($2,305 million vs. $2,510 million). Concurrently, equity method investments rose from $2,510 million (2023) to $2,305 million (2024) in fair‑value terms, while the overall exposure to VIEs/VREs grew, with BlackRock's net interest in these entities increasing from $1,479 million to $1,460 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 97403,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24580,
        "completion_tokens": 134,
        "total_tokens": 24714
      }
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group’s evaluation of credit-related impairments for available-for-sale debt securities remained focused on assessing whether the fair value of securities was below amortized cost due to credit deterioration. The Company determined that unrealized losses were primarily driven by interest rate increases—not credit quality—and concluded that no significant credit-related impairment existed. As a result, the allowance for credit losses on both available-for-sale and held-to-maturity securities remained not material throughout this period, with no material changes in the evaluation or treatment of such impairments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53856,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13705,
        "completion_tokens": 162,
        "total_tokens": 13867
      }
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Between 2022 and 2023, AMD's investment in the ATMP joint venture increased from a carrying value of $69 million to $69 million (the document shows $69 million as of Dec 25 2021 and $69 million as of Dec 26 2020, with later pages indicating $99 million as of Dec 30 2023 and $83 million as of Dec 31 2022). The equity‑method investment generated modest gains of $6 million in 2021 and $5 million in 2020, but no specific equity‑income figure is disclosed for 2023. The Company’s financial statements note that the ATMP JV purchases and sales are recorded within the consolidated statements and do not affect the Company’s consolidated results, and there is no separate line‑item for “equity income” in the 2023 filing. Consequently, while the investment’s carrying value grew modestly, the equity‑income recognized remained limited to the $6 million gain recorded in 2021, with no material change reported for 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45166,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11511,
        "completion_tokens": 228,
        "total_tokens": 11740
      }
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth Group’s exposure to tort claims has remained significant from 2022 to 2024, with claims primarily centered on medical malpractice related to the delivery of health care services by its affiliated physicians and facilities. The nature of these claims includes allegations of negligence in clinical care, failure to adhere to quality and patient safety standards, and disputes over provider compensation, particularly in risk-based arrangements and out-of-network disputes. While the company continues to self-insure these liabilities and records estimates for probable losses, the potential financial impact remains material due to the high cost of litigation, possible regulatory penalties, and reputational harm—especially as physician-related lawsuits and medical malpractice claims have increased in frequency and complexity, including novel legal theories that may bypass damage caps. This exposure is further amplified by the company’s extensive network of contracted and employed health care providers, where disputes over payment or performance can trigger liability even after services are rendered.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 56640,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14386,
        "completion_tokens": 280,
        "total_tokens": 14666
      }
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "The 2024 SEC filing shows Boeing replaced its legacy three-year revolving credit facility (which had $3.0 billion of commitments and expired in August 2025) with a new $3.0 billion three‑year revolving agreement that now expires in August 2028, while the prior five‑year facility (expiring October 2024) was terminated. This restructuring extends the primary borrowing horizon by three years and adds $3 billion of additional capacity, underscoring a strategy to preserve liquidity and maintain a sizable undrawn credit buffer amid ongoing cash‑flow volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36540,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9364,
        "completion_tokens": 140,
        "total_tokens": 9504
      }
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "The 2017 Performance‑Based Options had $56 million of fair value recognized as vested during 2023 and generated $44 million of intrinsic value when exercised in 2023; there was no comparable vesting or intrinsic value reported for 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 89623,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22642,
        "completion_tokens": 59,
        "total_tokens": 22701
      }
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Based on the provided document pages, AMD's approach to estimating adjustments for product return rights remained consistent in methodology between 2022 and 2023, but the specific inputs and data sources used evolved with their business growth and supply chain dynamics. In 2022, the company relied on \"trended actual historical product return rate information\" adjusted for known events to estimate return reserves, particularly for distributor and OEM customers. By 2023, this evolved to incorporate more granular analysis of \"trended actual historical product return rate information gathered, adjusted for actual known information or events,\" reflecting deeper integration of historical data with real-time supply chain insights (e.g., post-pandemic inventory corrections and strategic wafer pre-payments under the GLOBALFOUNDRIES agreement). The core estimation framework—using historical activity, economic conditions, and market data to adjust contract price for returns—was unchanged, but the 2023 analysis explicitly tied adjustments to newer operational realities like the Xilinx acquisition integration and shifts in client segment demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48915,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12459,
        "completion_tokens": 287,
        "total_tokens": 12746
      }
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The number of shares underlying the 2017 Performance-based Options declined from 1,549,080 at December 31 2023 to 625,825 at December 31 2024, reflecting the exercise of 905,219 options and the forfeiture of 18,036 options during 2024. This reduction, together with the $160 million of remaining unrecognized compensation expense for these options (to be recognized over a 3.4‑year weighted average), indicates that a substantial portion of the original awards has been exercised or will be forfeited before full vesting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 85814,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21688,
        "completion_tokens": 130,
        "total_tokens": 21818
      }
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx expanded its service scope and strategic positioning within UnitedHealth Group’s ecosystem by significantly scaling its pharmacy care offerings and deepening integration across the health system. In 2022, Optum Rx managed $112 billion in pharmaceutical spending, including $45 billion in specialty drugs, and served health plans, employers, and government entities through retail, specialty, and home-delivery pharmacies, while also offering clinical programs for medication adherence and utilization management. By 2024, it had grown to manage $178 billion in pharmaceutical spending—over $74 billion in specialty drugs—leveraging a network of over 65,000 retail pharmacies and expanding into rare disease and gene therapy support services, while embedding pharmacists into broader care teams to integrate medical, pharmacy, and behavioral health care. This evolution reflects Optum Rx’s shift from a standalone pharmacy benefits manager to a core component of Optum’s value-based, data-driven health care delivery model, reinforcing UnitedHealth Group’s strategy to provide end-to-end, coordinated care through its Optum and UnitedHealthcare platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50332,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12821,
        "completion_tokens": 296,
        "total_tokens": 13117
      }
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "Between 2023 and 2024, BlackRock’s equity securities at FVTNI (Fair Value Through Net Income) increased from $1,585 million to $1,950 million, reflecting higher valuations of its equity holdings. Notably, $241 million of these investments were held specifically to economically hedge market valuation changes in certain deferred cash compensation plans, underscoring their role in managing liabilities tied to employee deferred compensation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 87091,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22004,
        "completion_tokens": 110,
        "total_tokens": 22114
      }
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "The aggregate available authorization for Accenture's open-market share purchase program increased from $3,129,296 as of August 31 2022 to $6,129,296 after the Board approved an additional $3 million authority in September 2022, indicating a deliberate expansion of its capital‑allocation strategy to return more cash to shareholders through share repurchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40585,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10382,
        "completion_tokens": 90,
        "total_tokens": 10472
      }
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, Accenture’s treatment and disclosure of Accenture Canada Holdings Inc. Exchangeable Shares shifted from limited discussion in 2022 to detailed, structured disclosure in 2024, particularly regarding shareholder rights and repurchase activity. In 2022, exchangeable shares were mentioned only in passing under “Equity of Subsidiaries” and “Share Purchases and Redemptions,” with no quantitative detail on redemptions or repurchase impact. By 2024, the filing explicitly details the mechanics of exchange rights, redemption pricing, and the open-market purchase program that includes Accenture Canada Holdings Inc. exchangeable shares, including specific share volumes (47,752 shares repurchased/redemed for $15,254) and integration into the broader $6.69 billion share repurchase authorization. Shareholder rights, including redemption mechanisms and voting distinctions (e.g., Class X shares having no dividend rights), were clarified in 2024’s “Class X Ordinary Shares” and “Accenture Canada Holdings Inc. Exchangeable Shares” sections, which were absent or underdeveloped in 2022. Most notably, 2024 provides quantitative data on repurchase activity under the open-market program and clarifies that exchangeable shares are subject to the same repurchase framework as Class A ordinary shares, including Rule 10b5-1 plans and board discretion—details only implicitly referenced in 2022. This evolution reflects a move from descriptive, qualitative references to full quantitative and procedural transparency around exchangeable share treatment and shareholder rights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39273,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10053,
        "completion_tokens": 397,
        "total_tokens": 10450
      }
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The global revenue from Electrophysiology Devices increased from $2,195 million in 2023 to $2,467 million in 2024, reflecting a 12.3 % rise (or 14.4 % when adjusted for foreign‑exchange effects). This growth represents the percentage change in Electrophysiology revenue, excluding the impact of foreign exchange fluctuations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47176,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12026,
        "completion_tokens": 81,
        "total_tokens": 12107
      }
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Accenture's investment valuation in Duck Creek Technologies shifted from $138,902 (carrying amount) and $223,166 (estimated fair value) as of August 31 2022 to a $253 million investment gain recognized in fiscal 2023, which was excluded from adjusted earnings; this gain reflects an increase in the fair‑value of its ~16 % equity stake, and the subsequent fiscal 2024 results show no further equity‑method adjustments, indicating the investment's valuation impact has stabilized and is now reflected only in the carrying amount of $138,902.  \n\nThe financial performance impact of this investment is modest relative to Accenture’s overall results: while the 2023 gain contributed to a $11.44 diluted EPS (a 6 % increase), the adjusted EPS of $11.95 excludes the gain, showing that the investment’s net effect on profitability is limited, and the company continues to recognize revenue from its consulting and managed‑services contracts without material volatility from the Duck Creek stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45230,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11542,
        "completion_tokens": 247,
        "total_tokens": 11789
      }
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, Union Pacific’s executive compensation strategy shifted toward a greater emphasis on performance‑linked equity awards and reduced reliance on traditional stock options. The company granted 387,000 stock options in 2021 (down from 753,000 exercised in 2020) and increased retention‑share grants to 297,000, while performance‑based stock units rose to 227,000 shares with a higher weighted‑average fair‑value ($204.45 vs. $141.93 in 2020). Concurrently, unrecognized compensation expense for non‑vested options fell to $15 million and for retention awards to $87 million, indicating a move to longer‑term, performance‑driven incentives that align executive pay with sustained ROIC and operating‑income growth targets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51029,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12990,
        "completion_tokens": 184,
        "total_tokens": 13174
      }
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "Between 2023 and 2024, MetLife’s application of GAAP guidance for adjusted earnings evolved through the adoption of LDTI (effective January 1 2024), which simplified the measurement model for DAC and VOBA and reclassified most embedded derivatives as MRBs. This change updated the calculation of adjusted earnings to exclude certain DAC/VOBA amortization, fair‑value remeasurement of MRBs, changes in discount rates on annuitization guarantees, inception‑of‑year losses on single‑premium annuities, and asymmetrical accounting for in‑force reinsurance. Consequently, the exclusions related to market volatility (e.g., net investment gains/losses, derivative gains/losses, MRB remeasurements) and asymmetrical accounting adjustments were formally codified and applied consistently across all segments in the 2024 reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 170,
          "pages": [
            168,
            169,
            170,
            171,
            172
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60750,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15426,
        "completion_tokens": 205,
        "total_tokens": 15631
      }
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture’s approach to compressed transformations evolved from a focus on foundational digital core-building, operational optimization, and revenue acceleration—leveraging technologies like cloud, AI, and data analytics—to a more advanced, AI-centric model emphasizing generative AI, ecosystem partnerships, and industry-specific reinvention (e.g., Industry X and Song). By 2024, the scope expanded to integrate AI as a core driver across all transformation areas, with heightened emphasis on sustainability, talent, and the metaverse continuum, supported by strategic investments in R&D ($1.2B in 2024), acquisitions (46 deals), and platforms like SynOps and AI Navigator.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33088,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8503,
        "completion_tokens": 173,
        "total_tokens": 8676
      }
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Abbott's interest rate hedge contracts decreased in notional value from approximately $2.9 billion in 2022 to $2.2 billion at December 31 2023, reflecting the maturity of $700 million of hedges in 2023, and the company continues to use these fair‑value hedges to offset changes in the fair value of its fixed‑rate debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44548,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11359,
        "completion_tokens": 79,
        "total_tokens": 11438
      }
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "Between 2023 and 2024, MetLife updated its definition of Adjusted Earnings to reflect the adoption of the LDTI framework, which simplified the measurement model for DAC and VOBA and reclassified most embedded derivatives as MRBs. This change removed certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and required exclusions of changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, inception-period losses on single-premium business, and asymmetrical accounting for in-force reinsurance. Adjusted Earnings is now defined as adjusted revenues less adjusted expenses (net of income tax), and it serves as the GAAP measure of segment performance used by management and the CODM to evaluate performance and allocate resources. The updated definition ensures consistency with LDTI requirements and enhances comparability across periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55551,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14117,
        "completion_tokens": 227,
        "total_tokens": 14344
      }
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Accenture’s share‑purchase authorization has expanded: the company reported $3.1 billion of available authorization as of August 31 2022, then added $3 billion in September 2022 and later $4 billion in September 2024, bringing total outstanding authority to roughly $6.1 billion (2022) and $6.7 billion (2024). The company funds these purchases through its open‑market share‑purchase program and other employee‑share programs, acquiring shares both on the open market and via employee‑share‑withholding, and it funds the purchases with cash on hand and operating cash flow. Thus, the program’s authorization has grown substantially, while the methods of acquiring shares have remained centered on open‑market purchases and employee‑share‑withholding, supported by the company’s cash resources.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9647,
        "completion_tokens": 207,
        "total_tokens": 9854
      }
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "MetLife’s valuation methodology for Unit-linked and FVO securities remained consistent between 2023 and 2024, with cost basis defined as original cost reduced by repayments and amortization of premiums/discounts (or original cost for equity securities). Fair value sensitivity analysis shows that significant increases in inputs—such as default rates, market pricing, or equity volatilities—result in higher estimated fair values, while decreases have the opposite effect, particularly for Level 3 assets like fixed maturity securities and MRBs. The company’s disclosures confirm that these inputs are applied consistently across reporting periods, with no material change in methodology noted from 2023 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 320,
          "pages": [
            318,
            319,
            320,
            321,
            322
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 77410,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19581,
        "completion_tokens": 178,
        "total_tokens": 19759
      }
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "The market-based RSU structure remained unchanged between fiscal years 2022 and 2023, with vesting still subject to both service and market conditions (e.g., total stockholder return compared to an index group). However, the vesting timeline for new market-based RSU grants shifted from a four-year schedule in 2022 to a five-year schedule in 2023, as noted in the 2023 equity award disclosures. The core structure of performance and market-based conditions persisted, but the extended vesting period in 2023 introduced a longer potential vesting horizon for new grants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41424,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10568,
        "completion_tokens": 142,
        "total_tokens": 10711
      }
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase-in treatment of CECL's ongoing impact evolved from a 50% phase-in completion as of December 31 2023 to a 75% phase-in completion by January 1 2024, with the remaining $600 million to be phased in over 2025. During the phase-in period, the applicable regulatory capital treatment allowed the Company to add back the after‑tax “day 1” CECL adoption impact and to phase in the cumulative “day 2” ongoing impact at 25 % per year, resulting in a CET1 capital ratio of 12.9 % (reflecting CECL) versus 12.6 % on a fully phased‑in basis as of December 31 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50954,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12974,
        "completion_tokens": 146,
        "total_tokens": 13120
      }
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom issued new senior notes under multiple indentures with Wilmington Trust, National Association, expanding its debt profile. In 2022, it issued $1.25 billion of 4.00% Senior Notes due 2029 (Exhibit 4.42) and $1.0 billion of 4.926% Senior Notes due 2037 (Exhibit 4.46), while in 2023 it issued $1.0 billion of 5.050% Senior Notes due 2027 (Exhibit 4.51) and $1.0 billion of 5.050% Senior Notes due 2029 (Exhibit 4.51), all under the same trustee arrangement. The terms of these notes are defined by the respective indentures, which include standard covenants and maturity dates ranging from 2027 to 2037.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 134,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56335,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14316,
        "completion_tokens": 158,
        "total_tokens": 14474
      }
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "From 2023 to 2024, Capital One’s regulatory capital add‑back under the CECL Transition Rule increased from 75 % to 100 % of the phased‑in amount, reflecting the final stage of the five‑year phase‑in schedule. Accordingly, the company added back $600 million on January 1 2025, and as of December 31 2024 the CECL transition had been fully phased in, raising the CET1 capital ratio to 13.5 % (versus 13.3 % on a fully‑phased‑in basis).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51314,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13056,
        "completion_tokens": 108,
        "total_tokens": 13165
      }
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Based on the provided SEC 10-K filings, the treatment of VMware stock options for non-employee directors evolved as follows:  \n\nIn the 2022 filing (AVGO_10k_2022.pdf, page 97), it was disclosed that \"all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors will be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts.\" This acceleration was part of the merger agreement terms prior to the VMware acquisition closing.  \n\nBy the 2023 filing (AVGO_10k_2023.pdf, page 66), after the VMware Merger was completed on November 22, 2023, the language shifted to describe the outcome: \"each share of VMware common stock issued and outstanding immediately prior to the effective time of the VMware Merger will be indirectly converted into the right to receive... [cash or Broadcom stock],\" and specifically noted that \"all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors were accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts\" as part of the merger execution.  \n\nThus, the evolution was from a *pre-merger commitment* (2022) to accelerate and convert these awards into cash/stock upon merger completion, to the *actual post-merger implementation* (2023) where the accelerated VMware equity awards were settled in cash and Broadcom shares for non-employee directors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44073,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11237,
        "completion_tokens": 363,
        "total_tokens": 11600
      }
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures in the 2022 and 2024 10-K filings, the therapeutic positioning of Vraylar has expanded significantly from 2022 to 2024. In 2022, Vraylar was approved as an adjunctive treatment for major depressive disorder (MDD) following positive Phase 3 data in two trials (Study 3111-301-001 and 3111-302-001), though only one trial met its primary endpoint. By 2024, Vraylar's approved indications had broadened to include acute and maintenance treatment of schizophrenia, acute treatment of manic/mixed episodes in bipolar disorder, and as an adjunctive therapy for major depressive disorder—reflecting its established role across multiple psychiatric conditions. This evolution underscores a strategic expansion from a niche adjunctive MDD application to a broader portfolio spanning schizophrenia, bipolar disorder, and MDD, solidifying its position as a key neuroscience asset.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42049,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10721,
        "completion_tokens": 224,
        "total_tokens": 10946
      }
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "From 2022 to 2024, GE’s accounting policy for long‑term services agreements remained consistent: revenue is recognized over time using the percentage‑of‑completion method, based on costs incurred to date relative to the estimate of total expected costs. The key evolution is in how contract‑billing estimates are applied—GE now explicitly accounts for potential losses on these agreements when it is probable that a loss will be incurred, and it adjusts estimates of future billings, utilization and costs on a cumulative‑catch‑up basis, reflecting changes in customer utilization trends, market conditions and proven cost‑improvement initiatives. This refined estimation process better aligns revenue recognition with the timing of cash flows and the underlying economics of the long‑term service contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 51763,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13168,
        "completion_tokens": 202,
        "total_tokens": 13370
      }
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "Based on the provided document pages, IBM's disclosure of the 1.250% Notes due 2027 has remained consistent between the 2022 and 2023 10-K filings. The notes are listed in the \"Securities registered pursuant to Section 12(b) of the Act\" table in both filings (IBM_10k_2022.pdf pages 28-32 and IBM_10k_2023.pdf pages 1-5), where they are identified as \"1.250% Notes due 2027\" with the same ticker symbol \"IBM 27B\" and exchange listing on the New York Stock Exchange. The description and terms of the notes have not changed between the two filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35923,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9188,
        "completion_tokens": 136,
        "total_tokens": 9325
      }
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "AbbVie's performance-vested RSUs have evolved with a more complex performance framework over time, particularly shifting toward tying vesting to specific financial metrics like ROIC relative to a peer group and EPS achievement, as detailed in the 2024 Form 10-K (page 89). The 2024 Form 10-K specifies that performance-vested RSUs for senior executives now require vesting based on three-year performance periods tied to AbbVie's ROIC performance relative to a defined peer group and its total stockholder return (TSR) relative to the same peer group, replacing earlier simpler metrics. While the 2022 and 2023 filings (e.g., 2022 Form 10-K page 113) referenced performance metrics like \"return on invested capital\" and \"EPS achievement,\" the 2024 structure explicitly incorporates both ROIC and TSR as dual performance conditions, with vesting occurring in one-third increments over the three-year period only if both metrics are met. This represents a significant evolution from earlier years, which primarily focused on financial performance thresholds without the TSR market condition. The vesting increments remain tied to three-year performance periods, but the criteria have become more rigorous and multi-faceted, requiring simultaneous achievement of both ROIC and TSR targets for full vesting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 123,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 52206,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13282,
        "completion_tokens": 325,
        "total_tokens": 13608
      }
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "From 2022 to 2024, GE’s investment in AerCap shifted from a $865 million unrealized loss in 2022 to a $129 million unrealized gain in 2023 and a $38 million realized/unrealized gain in 2024, reflecting a significant improvement in the financial relationship and resulting in net realized/unrealized gains of $38 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 54170,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13764,
        "completion_tokens": 82,
        "total_tokens": 13846
      }
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "Based on the provided SEC filing excerpts, IBM's treatment of the 0.300% Notes due 2026 (listed as \"0.300% Notes due 2026\" in the 2023 debt table) shows no meaningful change in disclosure status between 2022 and 2023. The notes remain consistently identified as a registered debt instrument in the \"Securities registered pursuant to Section 12(b)\" table of both filings (IBM_10k_2022.pdf: page 28; IBM_10k_2023.pdf: page 1), with identical naming and exchange listing details. However, the 2023 filing (page 1) explicitly includes the notes in the debt table while the 2022 filing (page 29) references them only within the broader context of debt disclosures without a dedicated line item, indicating slightly reduced visibility in the 2023 summary financial presentation despite unchanged legal status.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35923,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9210,
        "completion_tokens": 200,
        "total_tokens": 9411
      }
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "Between 2022 and 2024, GE Aerospace’s RISE program evolved from a strategic technology initiative into a central pillar of its growth and sustainability agenda.  In the 2022 filing, RISE was highlighted as a collaborative effort with Safran focused on Open‑Fan, compact‑core and hybrid‑electric technologies aimed at achieving >20 % lower fuel burn and CO₂ emissions.  By 2024, the program had expanded its scope and investment, with total R&D spending rising to $2.7 billion (up from $2.1 billion in 2022) and a dedicated $1.3 billion of GE Aerospace‑funded R&D, reflecting a stronger internal commitment.  The emphasis shifted toward scaling these advanced propulsion technologies—particularly Open‑Fan and hybrid‑electric systems—while integrating them across both commercial and defense platforms to meet emerging regulatory and decarbonization goals.  Consequently, RISE moved from a pilot‑scale research effort to a core, company‑wide strategic priority that drives both product development and long‑term profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 52360,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13307,
        "completion_tokens": 256,
        "total_tokens": 13564
      }
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, American Express's funding strategy shifted toward greater reliance on asset securitizations of Card Member loans and receivables, as evidenced by the detailed disclosure of securitization activities, debt issuances, and the use of special-purpose entities in the 2023 10-K (pages 66-70). The company explicitly highlighted securitization as a key funding source, with $13.5 billion in asset-backed securities issued through its trusts in 2023, and emphasized its role in achieving cost-effective funding and diversification. This contrasts with the 2022 filing (pages 86-90), which focused more broadly on funding sources like deposits and unsecured debt without the same level of granular detail on securitization transactions, indicating an increased strategic emphasis on securitization to support liquidity and capital efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42041,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10741,
        "completion_tokens": 213,
        "total_tokens": 10955
      }
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "From 2022 to 2023, Emerson's financial relationship with AspenTech shifted from a minority ownership stake to full operational integration following its $15.3 billion acquisition of the remaining shares in May 2022. This integration generated $656 million in segment sales and $12 million in earnings (loss) for the AspenTech segment in 2023, up from $319 million in sales and a $7 million loss in 2022, reflecting the combined impact of the Heritage AspenTech acquisition and subsequent operational synergies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44738,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11410,
        "completion_tokens": 127,
        "total_tokens": 11538
      }
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved through the acquisition of Heritage AspenTech, which created a new consolidated entity where Emerson held a 55% stake and recorded a $5.9 billion noncontrolling interest for the remaining 45% ownership. The acquisition required accounting for the noncontrolling interest at fair value, resulting in a $550 reduction to additional paid-in-capital, and impacted equity by allocating goodwill and intangible assets from the purchase price. This transaction also generated acquisition-related impacts on expenses, including amortization of intangibles and inventory step‑up, which affected earnings and required adjustments in the consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41600,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10634,
        "completion_tokens": 185,
        "total_tokens": 10819
      }
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "The 6.22% Debentures due 2027 were disclosed in both the 2022 and 2023 SEC filings as part of the \"Securities registered pursuant to Section 12(b) of the Act\" table, where they were listed under the same description and exchange (New York Stock Exchange) in both years. No significant change in the terms or disclosure of these debentures is evident from the provided pages of the 2022 and 2023 10-K filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35923,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9193,
        "completion_tokens": 102,
        "total_tokens": 9295
      }
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "UnitedHealth Group’s exposure to financial risk through risk‑based arrangements with healthcare providers has increased markedly from 2023 to 2024, as reflected by a rise in premium revenues tied to value‑based contracts and higher medical‑costs payable estimates that now total $5.056 billion (up from $5.056 billion in 2023 and $5.615 billion in 2022). This heightened risk requires the company to more precisely estimate and accrue medical‑costs payable, which directly influences its cost‑estimation methodology and expands its service‑delivery responsibilities, as it must manage both the funding of care and the integration of value‑based payment models across its Optum and UnitedHealthcare segments. Consequently, the company’s financial statements now show larger adjustments to earnings from changes in these estimates and greater reliance on actuarial projections to set premiums and control costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67670,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17161,
        "completion_tokens": 227,
        "total_tokens": 17388
      }
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's investment in AspenTech evolved from a 57% ownership stake to a proposal to acquire the remaining shares at $240 per share, implying a $15.3 billion fully diluted market capitalization. This strategic move followed Emerson's earlier acquisition of Heritage AspenTech in 2022 and its subsequent divestiture of a majority stake in Climate Technologies (including Copeland) to Blackstone in 2023, while retaining a 45% non-controlling equity interest in the new joint venture. The proposed acquisition reflects Emerson's intent to deepen its strategic involvement with AspenTech's asset optimization software, moving from passive investment to full ownership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41780,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10668,
        "completion_tokens": 172,
        "total_tokens": 10840
      }
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Adobe Target’s role within the customer journey solutions evolved from being part of the broader Adobe Experience Cloud portfolio (highlighted in the 2022 10-K as a key component for personalization and journey orchestration) to being more tightly integrated with Adobe Experience Platform and Journey Optimizer, emphasizing AI-driven personalization at scale. This shift reflects Adobe’s strategic direction to embed AI and machine learning deeper into its Experience Cloud stack, positioning Target as a core engine for real-time, AI-powered personalization across customer journeys rather than a standalone tool. Consequently, Adobe is prioritizing AI-driven personalization as a central growth pillar, integrating it natively into its platform to deliver unified, intelligent customer experiences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46818,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11942,
        "completion_tokens": 208,
        "total_tokens": 12150
      }
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "From 2022 to 2023, Emerson's relationship with AspenTech evolved significantly: Emerson acquired AspenTech in the third quarter of 2022, resulting in AspenTech becoming a separate publicly traded company within Emerson's Software and Control business group. Following the acquisition, AspenTech's financials were integrated into Emerson's reporting, with goodwill and intangible assets increasing substantially—goodwill for AspenTech rose from $77 million in 2021 to $8,326 million in 2022, and intangible assets for AspenTech grew from $4,121 million in 2021 to $10,141 million in 2022. Post-acquisition, AspenTech continued to operate under its own stock-based compensation plans, including performance shares and restricted stock units, with integration-related compensation expenses recognized, including $58 million of integration-related stock compensation expense reported as part of restructuring costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40329,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10306,
        "completion_tokens": 227,
        "total_tokens": 10534
      }
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform's role within Adobe's customer journey solutions evolved significantly through deeper AI integration and enhanced cross-channel orchestration. The 2023 document highlights that Adobe Experience Platform now powers AI-driven personalization via Adobe Sensei GenAI, enabling real-time customer journey orchestration across B2B and B2C use cases through solutions like Journey Optimizer. This integration allows for hyper-personalized experiences at scale, building on the platform's foundational role in unifying customer data and activating AI insights across Adobe Experience Cloud applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47931,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12219,
        "completion_tokens": 160,
        "total_tokens": 12379
      }
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "UnitedHealth Group has responded to Medicare Advantage funding pressures by accelerating its shift toward value-based care delivery models, expanding integrated in-clinic, in-home, behavioral, and virtual care services, and leveraging data analytics to coordinate care around primary physicians. This strategic evolution aims to improve care quality while controlling costs amid persistent downward pressure on Medicare Advantage rates and risk adjustment model revisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54450,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13831,
        "completion_tokens": 118,
        "total_tokens": 13949
      }
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "Based on the 2022 and 2023 Form 10-K filings, the composition of TMO's debt instruments remained largely consistent, with the 1.950% Notes due 2029 still listed among the registered debt securities. However, the 2023 filing (page 5 of the provided excerpt) includes additional note maturities not present in the 2022 listing, such as 3.200% Notes due 2026 (TMO 26B) and 3.650% Notes due 2034 (TMO 34), while retaining the 1.950% Notes due 2029 (TMO 29) as a key long-term instrument. The 2022 filing (page 5) only listed notes up to 2032, indicating a strategic expansion of debt maturities into newer years in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47798,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12163,
        "completion_tokens": 154,
        "total_tokens": 12317
      }
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, Thermo Fisher Scientific updated its debt disclosures in the 10-K filings to reflect the 0.500% Notes due 2028 (identified as TMO 28A in both years) and introduced new note categories, including 3.200% Notes due 2026 (TMO 26B) and 3.650% Notes due 2034 (TMO 34), while maintaining the existing 0.500% Notes due 2028 alongside other long-term debt instruments such as the 1.375% Notes due 2028 (TMO 28). The 2023 filing expanded the list of registered debt securities to include these newer tranches, indicating a diversification of debt maturity profiles and interest rate exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47798,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12174,
        "completion_tokens": 151,
        "total_tokens": 12325
      }
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The Company's 2023 annual goodwill impairment analysis showed that the excess fair value over carrying value for each reporting unit ranged from approximately 140% to 495%, and when a hypothetical 10% decrease was applied to those fair values, the excess ranged from approximately 115% to 435%. In contrast, the 2024 analysis indicated an excess ranging from approximately 70% to 450%, with the hypothetical 10% decrease resulting in an excess ranging from approximately 55% to 395%. Thus, the range of excess fair value over carrying value contracted across both the base and sensitivity scenarios from 2023 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51008,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12974,
        "completion_tokens": 154,
        "total_tokens": 13129
      }
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "The 2022 Employee Stock Plan (2022 Plan) was designed to replace the terminated 2014 Plan, authorizing up to approximately 1.3 billion shares for issuance and allowing RSUs to be canceled or withheld to increase the available share pool by a factor of two × the number of such cancellations or withholdings. Consequently, the available share pool under the 2022 Plan grew as RSUs were canceled or shares were withheld, offsetting the dilution from new RSU grants. By contrast, the 2023 filings show that the available pool was further expanded by the same cancellation/withholding mechanism, but the net effect was a continued increase in the pool size due to the higher volume of RSU cancellations and tax‑withheld shares in 2023 compared with 2022. Thus, the treatment of canceled RSUs and tax‑withheld shares under the 2022 Plan evolved from modestly expanding the pool in 2022 to a more pronounced expansion in 2023, maintaining a larger pool of shares available for future grants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10988,
        "completion_tokens": 246,
        "total_tokens": 11234
      }
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Danaher's strategic relationship with Aldevron, acquired in August 2021 for approximately $9.6 billion, has deepened its presence in the Life Sciences segment. The acquisition, which added significant plasmid‑DNA, mRNA and protein capabilities, generated about $300 million in 2020 revenue and contributed roughly $6.1 billion of goodwill. Subsequent integration continues to expand Danaher’s product line and market reach, supporting its broader growth strategy within the segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48853,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12441,
        "completion_tokens": 120,
        "total_tokens": 12561
      }
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Microsoft's strategic positioning of Microsoft 365 has evolved significantly between 2023 and 2024 by embedding AI more deeply into its core commercial offerings and expanding its role in driving revenue growth. The company now markets Microsoft 365 as an \"AI-first platform\" that integrates Copilot across Office applications, leveraging Microsoft Graph to deliver role-specific workflow enhancements (e.g., Copilot for Sales, Service, and Finance) and tools like Copilot Studio for customization. This integration directly fuels growth in Microsoft Cloud revenue (up 23% to $137.4B in FY2024), Office 365 Commercial growth (16%), and Dynamics 365 (24% growth), while also contributing to broader commercial metrics like Microsoft Cloud gross margin and Microsoft 365 Consumer subscriber expansion to 82.5 million. The shift reflects Microsoft's broader ambition to make AI a central driver of productivity, cloud adoption, and commercial revenue across its business segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40605,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10387,
        "completion_tokens": 244,
        "total_tokens": 10631
      }
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Microsoft's positioning of Copilot Pro evolved from a consumer‑focused AI subscription that offered faster, more powerful assistance within Microsoft 365 apps and on the web (highlighted in 2023 as a way to boost productivity across Office, Windows and Edge) to a more integrated, role‑specific offering within the broader Copilot stack by 2024. In the 2024 filing, Copilot Pro is presented as part of the AI‑first Microsoft 365 platform, emphasizing its role in delivering AI‑enhanced workflows across Teams, Viva, Dynamics 365 and other services, and it is tied to Azure AI capabilities such as Copilot Studio and role‑based extensions (e.g., Copilot for Sales, Service, Finance). This shift underscores a transition from a standalone consumer subscription to a core component of Microsoft’s AI‑driven productivity suite, providing deeper, enterprise‑grade assistance directly inside the company’s cloud‑based applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42866,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10943,
        "completion_tokens": 231,
        "total_tokens": 11174
      }
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "Based on the provided document pages, the 2007 Omnibus Incentive Plan had approximately 50 million shares remaining available for issuance as of December 31, 2023, and approximately 47 million shares remaining available as of December 31, 2024. This represents a decrease in available shares from 2023 to 2024 due to ongoing equity awards and repurchases, but the plan remains active with shares still available for future issuance under the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58719,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14907,
        "completion_tokens": 111,
        "total_tokens": 15019
      }
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Microsoft increased the estimated useful lives of its server and network equipment from four to six years, effective in fiscal year 2023, due to software investments that improved operational efficiency and advances in technology. This change reduced depreciation expenses in subsequent periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 30427,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7838,
        "completion_tokens": 73,
        "total_tokens": 7912
      }
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "Based on the provided financial statements, MDT's exposure to auction rate securities (ARS) remained classified as Level 3 fair value measurements throughout the transition from 2022 to 2023. The fair value of ARS was consistently reported at $33 million in both the April 29, 2022 balance sheet (as \"Other Assets\") and the April 30, 2021 balance sheet, with no change in classification or significant valuation adjustments during this period. The Company explicitly stated there were no transfers into or out of Level 3 during these fiscal years, and the ARS fair value was derived using significant unobservable inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51315,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13048,
        "completion_tokens": 155,
        "total_tokens": 13203
      }
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "The net gains or losses from Cisco's available-for-sale debt investments decreased significantly from $15,592 million at July 29 2023 to $9,865 million at July 27 2024, reflecting a $5,727 million decline in fair value. This reduction indicates that the company's investment performance in this category weakened over the fiscal year, likely due to rising interest rates and market adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50254,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12801,
        "completion_tokens": 98,
        "total_tokens": 12899
      }
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Between 2023 and 2024, Cisco’s operational structure in the APJC region remained anchored to its three geographic segments (Americas, EMEA, APJC), but its financial commitment to the region intensified. The 2024 10-K reveals a significant increase in capital deployment—highlighted by a $25.994 billion acquisition spend (largely tied to the Splunk purchase) and higher capital expenditures ($670 million in 2024 versus $849 million in 2023)—while operating cash flow from the segment declined from $19.886 billion to $10.880 billion, reflecting a shift from pure cash generation to strategic investment. This heavier investment, combined with a more than $5 billion increase in share repurchases and dividend outlays, signals a revenue model that increasingly relies on subscription‑based and services‑driven growth (e.g., AI‑enhanced security, Splunk integration) rather than solely on traditional product sales, positioning the APJC market for higher‑margin, recurring‑revenue streams.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14894,
        "completion_tokens": 247,
        "total_tokens": 15141
      }
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple’s App Store commission structure and regulatory compliance evolved in direct response to mounting legal and market pressures. While the company maintained its standard 15‑30 % commission on app and in‑app purchases, it began to adjust practices to address antitrust scrutiny and legislative mandates—most notably the EU’s Digital Markets Act, which forced Apple to permit alternative app‑store distributions and third‑party payment options, and ongoing U.S. investigations that led to settlements and proposed rule changes. These shifts included modifying the App Store’s “no‑alternative‑payment” rules, introducing new API and fee frameworks for EU developers, and revising its App Store Review Guidelines to accommodate regulatory requirements, all while continuing to defend its commission model in court and through policy revisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58881,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14945,
        "completion_tokens": 216,
        "total_tokens": 15161
      }
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "Between 2022 and 2024, Texas Instruments' U.S. Retiree Health Care Plan allocation strategy shifted significantly toward fixed income securities. In 2022, the plan's assets were allocated approximately 65-80% to fixed income and 20-35% to equities (as shown in the 2022 document's target allocation ranges and actual 2021 asset breakdown showing 70% fixed income/30% equity for U.S. defined benefit plans). By 2024, the target allocation for U.S. defined benefit plans had shifted to 60-75% fixed income and 25-40% equity, with actual 2024 allocations showing 61% fixed income and 39% equity. This represents a clear increase in the fixed income portion of the portfolio over the period, while the equity allocation remained relatively stable but slightly decreased in proportion. The plan's investment policy consistently emphasizes matching asset duration to liability sensitivity, with fixed income securities comprising the majority of assets to align with discount rate volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55488,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14097,
        "completion_tokens": 246,
        "total_tokens": 14343
      }
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "Texas Instruments' strategic emphasis on Embedded Processing Products has evolved from 2022 to 2024 by solidifying its role within the broader Analog and Embedded Processing segments, with increasing focus on high-growth industrial and automotive markets. While Embedded Processing revenue declined slightly from $3.261B in 2022 to $2.533B in 2024 (down 22%), its operating profit margin improved significantly from 38.3% to 13.9% due to higher gross margins and operational efficiencies, reinforcing its contribution to TI's sustainable competitive advantages in manufacturing control and product diversity. This strategic focus remains integral to TI's capital allocation and free cash flow growth strategy, as highlighted in the 2024 MD&A and segment reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45326,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11570,
        "completion_tokens": 191,
        "total_tokens": 11761
      }
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "Based on the provided document pages, TMO's 2.00% 10-Year Senior Notes due 2025 (euro-denominated) were issued in 2021 with an effective interest rate of 2.10% and a carrying value of $728 million as of December 31, 2021. By 2024, the same notes were still outstanding with an effective interest rate of 2.07% and a carrying value of $663 million, reflecting the ongoing amortization of discount and debt issuance costs over the 10-year term. The notes were part of a broader refinancing strategy, as evidenced by the company's redemption of other senior notes in 2022 and 2021, though no specific valuation changes to the 2025 notes are detailed beyond routine accounting adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48246,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12270,
        "completion_tokens": 171,
        "total_tokens": 12441
      }
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "Between 2022 and 2024, REMICADE’s sales declined sharply from $1,839 million (2023) to $1,605 million (2024), reflecting a 12.8% drop driven by biosimilar competition and share loss, particularly in Europe. This decline is part of a broader trend of pressure on immunology products, with STELARA also experiencing significant sales erosion due to biosimilars. Despite these challenges, REMICADE remains a key contributor to Johnson & Johnson’s Pharmaceutical segment, which grew 4.0% in 2024 to $56.9 billion, driven by strong performance in oncology, pulmonary hypertension, and newer immunology agents like TREMFYA. However, the declining trajectory of REMICADE highlights its diminishing role in the segment’s growth, as newer products and therapeutic areas increasingly drive revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43845,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11185,
        "completion_tokens": 197,
        "total_tokens": 11382
      }
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "From 2022 to 2024, REMICADE sales declined sharply—down 14.9% in 2021, 12.8% in 2023, and 12.8% in 2024—driven by biosimilar competition and loss of market exclusivity. This downward trend indicates that REMICADE’s market position within JNJ’s Immunology portfolio is weakening, even as other Immunology products like STELARA and TREMFYA continue to grow.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40175,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10266,
        "completion_tokens": 88,
        "total_tokens": 10355
      }
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "Between 2021 and 2024, REMICADE sales declined significantly from $3,747 million in 2021 to $1,605 million in 2024 (a 57% reduction), primarily due to biosimilar competition entering the market after patent expirations. The document explicitly states that \"Biosimilar versions of REMICADE have been introduced in the United States and certain markets outside the United States and additional competitors continue to enter the market. Continued infliximab biosimilar competition will result in a further reduction in sales of REMICADE.\" This competitive pressure, combined with the expiration of U.S. patents for REMICADE, drove the consistent downward trend in sales across all years shown in the data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41137,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10497,
        "completion_tokens": 175,
        "total_tokens": 10673
      }
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Between 2022 and 2024, STELARA's sales declined due to biosimilar competition. In 2021, its U.S. sales were approximately $5.9 billion, but by 2024, sales had dropped 4.6% year-over-year to $10.361 billion globally, with U.S. sales falling to around $6.7 billion. This decline was driven by biosimilars entering the market, particularly in Europe and the U.S., with further biosimilar launches expected in 2025 that will continue to pressure STELARA's performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39052,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9972,
        "completion_tokens": 116,
        "total_tokens": 10088
      }
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased by 38.5% in 2023 and by 55.2% in 2024. The percentage decrease was 38.5% for 2023 and 55.2% for 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16288,
        "completion_tokens": 42,
        "total_tokens": 16330
      }
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "Master Lease Agreements have become increasingly strategic for AMT between 2022 and 2023, serving as foundational tools to secure long-term, consistent revenue streams that underpin its international expansion and tenant relationship management. These agreements, particularly comprehensive master lease structures, reduce non-contractual churn by enabling rapid colocation cycles and locking in multi-year terms with key carriers, thereby supporting sustained growth in international markets where network development is accelerating. This strategic use of MLAs directly contributes to predictable organic revenue growth from site leasing, which constitutes the vast majority of AMT's property segment revenue, as evidenced by its focus on leveraging these agreements across emerging and mature markets to drive sustainable, long-term international revenue opportunities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52625,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13381,
        "completion_tokens": 218,
        "total_tokens": 13599
      }
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "The role of Google Marketing Platform in advertising revenue generation has shifted from being a distinct revenue stream to being integrated within the broader Google Network and advertising ecosystem, where it is primarily used to facilitate ad placements across Google's owned and operated properties and partner networks. Advertising revenues, including those generated through Google Marketing Platform, are recognized on a gross basis when control of ad inventory is transferred to customers, with amounts paid to Google Network partners recorded as cost of revenues, and this structure has remained consistent between 2023 and 2024 as reflected in the revenue recognition policies and financial statement disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51576,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13138,
        "completion_tokens": 180,
        "total_tokens": 13319
      }
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "Based on the provided SEC 10-K filings, Federal Funds Purchased & Securities Loaned decreased from $301,015 million (2023) to $214,369 million (2024), representing a $86,646 million decline. This reduction reflects a strategic shift toward relying more on alternative short-term funding sources like short-term borrowings ($152,548 million in 2023 vs. $137,277 million in 2024) and commercial paper, indicating Bank of America is actively managing its liquidity profile by reducing reliance on the Federal Funds market. The decline in both volume and fair value suggests a deliberate contraction in this specific funding channel, likely driven by changing market conditions or internal liquidity management priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 155,
          "pages": [
            153,
            154,
            155,
            156,
            157
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 114924,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 28959,
        "completion_tokens": 179,
        "total_tokens": 29139
      }
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's disclosures on pension and retiree medical plan liabilities shifted from describing market sensitivity in general terms (e.g., referencing \"exposure of our pension and retiree medical plan assets and liabilities to risks related to market fluctuations\" in 2022) to providing specific quantitative details in 2024. In the 2024 filing, the company explicitly states that a 1-percentage-point increase in interest rates would decrease net interest expense by $32 million due to higher cash balances and variable rate debt, and discusses how market fluctuations impact pension liabilities through mechanisms like settlement charges and annuity purchases. This evolution reflects a move from broad risk acknowledgment to concrete, forward-looking disclosures about interest rate sensitivity and specific financial impacts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 31664,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8139,
        "completion_tokens": 212,
        "total_tokens": 8351
      }
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Adobe Scan remains positioned as a free, mobile‑first scanning tool that converts paper documents into searchable PDFs via Adobe Document Cloud, but its strategic emphasis has shifted toward deeper integration with Adobe’s broader PDF and e‑signature ecosystem (Acrobat Sign, Document Cloud) and AI‑enhanced features such as the “Liquid Mode” reflow and AI‑assisted summarization. In 2024 the service is promoted alongside Adobe Acrobat’s generative AI capabilities (Acrobat AI Assistant) and is highlighted as part of the unified Document Cloud platform that ties scanning, signing, and collaborative workflows together across desktop, web and mobile surfaces.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44356,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11314,
        "completion_tokens": 165,
        "total_tokens": 11479
      }
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "From its 2023 launch, Gemini was introduced as Google’s first natively multimodal model, capable of understanding and generating text, code, audio, images and video. By 2024, Google rolled out Gemini 2.0, a more capable version that powers AI features across all seven of its billion‑user products (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube) and is integrated into Google Cloud’s Vertex AI platform for developers. This evolution reflects Gemini’s shift from a single‑model launch to a broadly embedded, multimodal foundation across Google’s services and cloud offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45044,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11489,
        "completion_tokens": 146,
        "total_tokens": 11636
      }
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Linde's helium-related sales and operating profit trends are not explicitly detailed in the provided 2022–2024 financial document excerpts. However, helium is referenced in the \"Other\" segment (which includes global helium wholesale), where operating profit increased 44% in 2024 due to \"insurance recovery for LAMT partially offset by higher costs due to helium.\" This suggests helium-related costs impacted profitability, but no direct correlation to sales or operating profit changes between 2022 and 2024 is provided in the document. The text focuses on broader segment performance, currency effects, and pension/insurance matters rather than helium-specific financial impacts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34725,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8899,
        "completion_tokens": 170,
        "total_tokens": 9070
      }
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights decreased from $789 million at the end of 2021 to $598 million at the end of 2024, a reduction of $191 million over the three‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44129,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11246,
        "completion_tokens": 45,
        "total_tokens": 11291
      }
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron’s natural‑gas delivery commitments and Tengizchevroil production volumes both declined in 2024.  The 2024 filing shows the company is contractually obligated to deliver roughly 2.9 trillion cubic feet of natural gas from Australia and Israel through 2026, down from the 3.2 trillion cubic feet referenced in the 2023 filing, and its net daily gas production from Tengizchevroil fell from ≈ 1.3 billion cubic feet (2023) to ≈ 1.1 billion cubic feet (2024).  Consequently, both the volume of gas it must deliver and the amount of gas produced at Tengizchevroil have decreased year‑over‑year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 71195,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18012,
        "completion_tokens": 149,
        "total_tokens": 18161
      }
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "The role of Google Network partners in Google's advertising revenue model has shifted from being treated primarily as a cost of revenue (where payments to partners were recorded as \"cost of revenues\") to a more integrated component of the revenue structure, as evidenced by the 2023 filing showing that payments to these partners are now explicitly accounted for within the broader \"cost of revenues\" line item that includes TAC (Traffic Acquisition Costs) and other partner payments. This evolution reflects a more formalized and scaled partnership model where Network partners are no longer just a cost but a structured channel for monetization, with the company now reporting the financial impact of these payments as part of its operating expense framework, including the $3.9 billion in charges related to workforce reductions and office space optimization that indirectly affect partnership-related cost management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48299,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12305,
        "completion_tokens": 230,
        "total_tokens": 12535
      }
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, the impact of public policies on Bank of America’s climate‑related regulatory requirements intensified, marked by greater jurisdictional divergence.  The 2023 filing highlighted emerging climate‑related legal and compliance risks and the difficulty of meeting GHG‑emissions targets amid evolving regulations.  By 2024, the language explicitly warned that divergent state, federal and non‑U.S. climate rules were expected to increase legal, compliance and public‑disclosure costs, and that any misstep could trigger reputational harm, litigation and enforcement actions.  Consequently, compliance risks grew as the company faced a more fragmented regulatory landscape and heightened stakeholder scrutiny of its climate strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64503,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16359,
        "completion_tokens": 187,
        "total_tokens": 16546
      }
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "From 2022 to 2024 GM’s strategic emphasis on full‑size pickup trucks shifted from a focus on overall volume growth to a more targeted push that leveraged higher‑margin trucks to improve profitability.  In 2024 the company reported a 10.1% increase in GMNA wholesale vehicle sales, with full‑size pickups accounting for 23.7% of total units and generating a variable profit of roughly 160% of the GMNA portfolio, underscoring their outsized contribution to earnings.  Quantitative indicators of this shift include the rise in full‑size truck residual values—from $6,793 million in 2023 to $7,458 million in 2024 (a 9.9% increase) and the corresponding rise in their share of total residual value from 21.9% to 23.7%—signaling stronger market positioning and higher expected returns for this product line.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59553,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15128,
        "completion_tokens": 200,
        "total_tokens": 15329
      }
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "The allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts declined from $314 million in 2021 (Level 2) to $21 million in 2024 (Level 3), reflecting a strategic shift toward higher‑yielding, longer‑duration assets such as private‑equity and other non‑government investments. This reduction indicates the company is moving away from the low‑risk, liquid government securities toward assets that may better match the long‑term funding needs of the decommissioning liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 88228,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22296,
        "completion_tokens": 130,
        "total_tokens": 22427
      }
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo’s relationship with independent bottlers shifted from direct financial incentives (e.g., bottler funding for advertising, shelf space, and new product support) to a more strategic, licensing‑focused model that reduces dependency on bottler‑specific funding. While the company continues to provide incentives tied to annual targets, the 2024 restructuring of its bottling operations and the move toward trademark licensing indicate a tighter, more centralized control, limiting the financial leverage previously enjoyed by independent bottlers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 37365,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9559,
        "completion_tokens": 142,
        "total_tokens": 9702
      }
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly’s role has shifted from a nascent, experimental AI capability in 2023 to a core, strategically‑integrated component of Adobe’s product‑innovation agenda by 2024.  In the 2023 filing the company merely listed Firefly among “new product introductions” and highlighted AI‑related risk factors, whereas the 2024 filing positions Firefly prominently in the trademark portfolio, ties its development to the company’s broader AI‑governance and regulatory compliance initiatives, and explicitly links its monetization and integration across Creative Cloud, Document Cloud and Experience Cloud to Adobe’s growth strategy.  Consequently, Firefly moved from a peripheral, risk‑focused mention to a central driver of Adobe’s innovation roadmap and revenue model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52019,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13234,
        "completion_tokens": 191,
        "total_tokens": 13425
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "The role of contractual rent escalations in driving tenant billing growth declined modestly from 2022 to 2023, as churn from lease cancellations and non‑renewals increased—particularly in the U.S. & Canada segment due to T‑Mobile and legacy Sprint terminations—reducing the net contribution of escalations despite continued growth in new tenant and colocation revenue. Consequently, escalations now contribute a smaller share of overall billing growth than in the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56164,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14272,
        "completion_tokens": 118,
        "total_tokens": 14391
      }
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's capital expenditure commitments and production involvement in Tengizchevroil have remained stable between 2023 and 2024. The company projects approximately $3 billion in affiliate capital expenditures for 2024, with nearly half allocated to the Tengizchevroil FGP/WPMP Project in Kazakhstan, consistent with its 2023 spending pattern. Production involvement continues through ongoing upstream activities in Kazakhstan, though specific capital allocation details for Tengizchevroil are not explicitly detailed beyond its inclusion in the broader affiliate capex estimate. (Based on Affiliate Capex data showing $3 billion 2024 estimate with \"nearly half... for Tengizchevroil's FGP/WPMP Project\" and the context of ongoing upstream development in Kazakhstan.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60247,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15284,
        "completion_tokens": 192,
        "total_tokens": 15476
      }
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "The specificity of UPS’s bond‑matching approach for determining the discount rate for its U.S. pension and postretirement benefit plans remained the same between 2023 and 2024 – it continued to select individual bonds that match the plans’ projected benefit payments to derive the discount rate. However, the discount rates themselves shifted upward in 2024 (e.g., the U.S. pension discount rate increased from 5.79 % in 2023 to 5.88 % in 2024), reflecting the updated bond‑matching calculations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58508,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14853,
        "completion_tokens": 124,
        "total_tokens": 14977
      }
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "Linde's helium-related sales and operating profit declined from 2022 to 2024, with helium volumes falling 5% year-over-year in 2024 and pricing remaining flat. This reduction directly impacted the \"Other\" segment, where operating profit increased only 44% due to insurance recoveries partially offset by higher helium costs, while sales decreased 2% driven by lower helium volumes. The company's overall operating profit growth in 2024 was primarily driven by pricing and productivity initiatives in other segments, not helium.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32263,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8294,
        "completion_tokens": 131,
        "total_tokens": 8426
      }
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Based on the provided 2023 and 2024 10-K pages, Bank of America's unfunded capital commitments for renewable energy investments **decreased** from $6.2 billion (as of December 31, 2023) to $4.6 billion (as of December 31, 2024), reflecting a $1.6 billion reduction in unfunded commitments. Correspondingly, the recognized tax credits related to renewable energy investments **increased** from $4.0 billion (2023) to $3.9 billion (2024) in 2024, though the document indicates the 2024 tax credit recognition was $3.9 billion (with pretax losses of $3.0 billion), while 2023 recognition was $4.0 billion (pretax losses of $3.1 billion). The reduction in unfunded commitments aligns with the Corporation's contingent funding requirements for renewable energy projects, which are tied to project qualification for tax credits prior to investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 97055,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24503,
        "completion_tokens": 210,
        "total_tokens": 24714
      }
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "From 2022 to 2024, GM's fleet sales strategy shifted toward higher-value commercial customers while reducing volume and improving profitability. In 2022, GM reported fleet sales as 11.3% of total vehicle sales (710,000 vehicles), declining to 8.7% in 2023 (6,826 vehicles) and further to 7.6% in 2024 (6,291 vehicles), reflecting a strategic move away from low-margin daily rental and small fleet transactions toward more profitable commercial fleet customers like FedEx and Verizon for BrightDrop EVs. This evolution is underscored by GM's emphasis on \"commercially developed solutions\" for government/military customers through GM Defense and its focus on EV-specific fleet offerings (e.g., BrightDrop EV600/EV410) that command premium pricing and better margins compared to traditional fleet channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62704,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15906,
        "completion_tokens": 201,
        "total_tokens": 16107
      }
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "PepsiCo's relationship with Sabra evolved significantly between 2022 and 2024, marked by the sale of its Tropicana, Naked, and select juice brands to PAI Partners in early 2022 while retaining a 39% noncontrolling interest in a newly formed joint venture operating across North America and Europe. This strategic shift, detailed in Note 13 of the 2022 10-K, positioned Sabra as a key partner for PepsiCo's distribution network, with PepsiCo acting as the exclusive distributor for the joint venture's portfolio in the U.S. for small-format and foodservice customers via direct-store-delivery. Financially, the transaction generated a $3,029 million gain in PepsiCo's PBNA division (2022) and contributed to the $122 million pre-tax gain recognized in FLNA (2022) from remeasurement of its prior 50% stake, though subsequent impairment charges related to Sabra's operations (e.g., $187 million in 2024 for the Quaker Recall and associated costs) impacted earnings. The change underscored a strategic pivot toward leveraging joint ventures for growth while managing portfolio complexity, with financial impacts reflected in division operating profits and restructuring charges across multiple regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51783,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13163,
        "completion_tokens": 299,
        "total_tokens": 13462
      }
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Adobe has increasingly integrated Adobe Scan into its broader Document Cloud ecosystem, positioning it as a core component of its AI‑enhanced PDF and e‑signature services. In the 2023 filing, Scan is highlighted alongside Acrobat AI Assistant and other Document Cloud tools as part of Adobe’s strategy to deliver unified, cloud‑based document workflows that leverage generative AI, reinforcing its role within the overall product portfolio rather than as a standalone offering.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41443,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10581,
        "completion_tokens": 119,
        "total_tokens": 10700
      }
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "From 2022 through 2024 GM’s exposure to historical obligations tied to the 2017 sale of Opel/Vauxhall to Stellantis remained limited to indemnification and guarantee obligations for certain pre‑sale emissions, product‑liability and recall matters; these liabilities were considered remote or immaterial, with no material loss estimated beyond accrued amounts.  At the same time, GM’s exposure to Stellantis‑related indemnities and guarantees has not increased materially, and the company continues to be unable to quantify any additional potential loss from those obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13733,
        "completion_tokens": 144,
        "total_tokens": 13877
      }
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "Based on the provided 2022 and 2024 SEC 10-K excerpts, PepsiCo's relationship with co-packers has evolved from operational reliance to strategic partnership. While the 2022 document (pages 25-29) details co-packers as part of their distributed network of plants and distribution centers owned or leased by contract manufacturers, co-packers, and strategic alliances, the 2024 update (pages 28-32) specifically references \"contract manufacturers, co-packers, strategic alliances or joint ventures\" in the context of property utilization, indicating deeper integration. However, neither document explicitly details a significant shift in *strategic involvement* beyond this operational expansion; the evolution is characterized by continued reliance on co-packers for manufacturing and distribution, with no mention of increased strategic decision-making authority or reduced operational dependency. The core relationship remains one of outsourced production within a broader network, not a fundamental change in partnership depth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 36428,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9329,
        "completion_tokens": 257,
        "total_tokens": 9586
      }
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "Between 2023 and 2024, SPG's financial relationship with ABG evolved significantly through multiple capital transactions that resulted in dilution of its ownership stake and multiple deemed disposals. In 2023, SPG recognized non-cash pre-tax gains totaling $145.8 million from SPARC Group's equity issuance diluting its ownership to 33.3%, plus $59.1 million in gains from ABG's capital transactions that diluted its ownership, and $157.1 million from the partial sale of its ABG interest. These transactions marked a strategic reduction in SPG's ownership from 12.3% to 9.6% by year-end 2023, while generating substantial non-cash gains that impacted its income statement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50025,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12726,
        "completion_tokens": 168,
        "total_tokens": 12894
      }
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "From 2022 to 2024, Lockheed Martin’s involvement in Sikorsky helicopter programs shifted from production-focused growth to broader program scope and strategic evolution. In 2022, the company highlighted increased production volume on Sikorsky programs—including the CH-53K heavy-lift helicopter and training systems—driven by higher delivery rates and international partnerships, as noted in the 2022 10-K (pages 41–45). By 2024, the focus expanded to include modernization efforts and new initiatives, such as the CH-53K’s final delivery in 2024 and advancements in autonomous capabilities (e.g., the X-62A and optionally piloted Black Hawk), reflecting a shift toward next-generation platforms and multi-domain solutions. While production volume remained significant, the program scope broadened to include sustainment, training, and cutting-edge technology integration, aligning with Lockheed Martin’s 21st Century Security strategy. This evolution underscores a transition from pure production scaling to a holistic approach encompassing innovation, international collaboration, and future-ready capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45177,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11516,
        "completion_tokens": 278,
        "total_tokens": 11794
      }
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "Based on the provided SEC 10-K filings, Walmart's ownership stake and financial investment in Alert Innovation evolved as follows:\n\n1.  In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100% of the company (as stated in the \"Purchases and Sales of Subsidiary Stock\" section of Note 3).\n2.  In fiscal 2024, Walmart paid $3.5 billion to acquire shares from certain Flipkart noncontrolling interest holders and settle liabilities related to PhonePe, but this transaction was specifically related to Flipkart and PhonePe, **not** Alert Innovation. The document confirms Alert Innovation was fully owned by Walmart as of the end of fiscal 2023 and was subsequently sold and deconsolidated in fiscal 2025 (as noted in the same \"Purchases and Sales of Subsidiary Stock\" section for fiscal 2024).\n\nTherefore, Walmart's ownership in Alert Innovation was 100% at the end of fiscal 2023 and remained 100% throughout fiscal 2024, with no additional investment or change in ownership stake reported for fiscal 2024. The $3.5 billion payment in fiscal 2024 was unrelated to Alert Innovation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59173,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15007,
        "completion_tokens": 287,
        "total_tokens": 15295
      }
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG’s Supplemental Facility borrowing activity shifted from being a primary source of liquidity to being actively used for targeted repayments and refinancing. In 2023, the Operating Partnership issued €750 million of senior unsecured bonds (equivalent to $808 million) specifically to repay the full €750 million outstanding under the Supplemental Facility on November 17, 2023. Subsequent financing actions—including the $1.0 billion 2.00% senior notes redeemed in September 2024 and the $1.0 billion 4.75% notes issued in September 2024—were similarly funded using proceeds from debt issuances rather than new draws on the Supplemental Facility. Consequently, the Facility’s role transitioned to a residual, short‑term liquidity buffer, with repayment strategy focused on retiring its balances through strategic bond issuances and cash flows from operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45163,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11516,
        "completion_tokens": 221,
        "total_tokens": 11737
      }
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Linde continues to position helium as a key process gas within its industrial gases portfolio, maintaining its focus on merchant and packaged gas distribution while leveraging long-term supply agreements. The company's helium supply strategy emphasizes global sourcing and distribution through its established merchant and packaged gas channels, supporting industrial applications in sectors like electronics and healthcare, with no fundamental shift in its core positioning between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43076,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11002,
        "completion_tokens": 124,
        "total_tokens": 11126
      }
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retiree Health Care Plan maintained its funding structure where employees hired after January 1, 2001 bear the full cost of medical benefits, while the company continues to contribute toward retiree medical costs for eligible employees based on hire date, retirement date, years of service, and Medicare eligibility. The plan's asset allocation remained focused on fixed income securities (65%-80% target) and equity securities (20%-35% target), with no direct investment in TI common stock. The document does not indicate any material change in the allocation strategy between 2022 and 2023, though the 2023 data shows slightly higher fixed income allocations (65% vs. 64% in 2022 for U.S. defined benefit plans) and lower equity allocations (35% vs. 36% in 2022). The plan's funding requirements continue to be met through employer contributions, with expected 2023 contributions of about $10 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59824,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15182,
        "completion_tokens": 233,
        "total_tokens": 15416
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's revenue grew significantly from $680 million to $1,063 million, representing a 56% increase, driven by higher demand across new and existing geographies. This growth occurred alongside broader company‑wide revenue pressures, as total revenues declined 1% to $27.1 billion in 2023, primarily due to lower Veklury sales, while net income and diluted EPS rose sharply (23% and 24% respectively) from improved HIV and oncology performance and lower IPR&D impairments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 81735,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20661,
        "completion_tokens": 124,
        "total_tokens": 20785
      }
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron’s downstream‑related earnings and investment relationship with GS Caltex evolved markedly from 2022 to 2024.  In the 2022 filing (pages 83‑87 of CVX_10k_2024.pdf) the company reports that its 50 % equity stake in GS Caltex contributed $1.003 billion of earnings from equity affiliates in 2021 and $874 million in 2022, while the joint‑venture’s downstream earnings rose to $525 million in 2021 before slipping to $618 million in 2020, reflecting higher refined‑product margins and the 2020 acquisition of Puma Energy.  By 2024 the same 10‑K shows GS Caltex’s earnings now flow through the “Downstream” segment, with the company noting “higher downstream‑related earnings from CPChem and GS Caltex in Korea” as a driver of improved equity‑affiliate income (page 41 of CVX_10k_2022.pdf).  This progression indicates that the Chevron‑GS Caltex joint venture has become a strategically important source of downstream earnings and a key conduit for Chevron’s market entry and profitability in the Asian refined‑products and petrochemical space.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58046,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14744,
        "completion_tokens": 261,
        "total_tokens": 15006
      }
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 through 2024 the CH‑53K program moved from early production to a higher‑volume, risk‑retirement‑driven phase.  In 2022 the program posted modest net‑sales growth and operating‑profit gains, but 2023 saw a sharp profit‑booking‑rate decline as $1.4 billion of losses were recorded on a classified CH‑53K contract and other risk retirements fell.  By 2024 the backlog had risen (to $38.8 bn in MFC and $38.1 bn in RMS, reflecting CH‑53K orders) while operating profit remained pressured by continued large risk‑retirement adjustments, though the segment’s overall profit margin showed modest improvement.  Overall, the CH‑53K’s production volume expanded, but profitability was shaped by evolving risk retirements and the timing of loss recognitions across the years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49558,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12615,
        "completion_tokens": 193,
        "total_tokens": 12809
      }
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "PayPal's seller protection programs have shifted from a focus on minimizing transaction losses to a more strategic emphasis on risk management and customer protection. The company now explicitly ties its protection programs to broader risk exposure considerations, particularly in credit products and merchant financing, while maintaining a consistent transaction loss rate range of 0.09%-0.15% of TPV. This evolution reflects a strategic move to balance risk mitigation with growth in credit offerings like \"Buy Now, Pay Later\" solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48779,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12415,
        "completion_tokens": 134,
        "total_tokens": 12550
      }
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Starbucks’ ready‑to‑drink (RTD) beverage revenue is reported in “Other revenues” under the Channel Development segment and is recognized when the product is shipped to customers, typically upon transfer of control. In fiscal 2024 the company recorded $187.6 million of breakage revenue from stored‑value cards that ultimately went unredeemed, which is recognized as company‑operated store revenue, and $20.0 million of breakage revenue from licensed stores. The RTD line therefore appears as part of other revenues rather than as a separate beverage category, and its recognition is tied to shipment/control rather than point‑of‑sale.  \n\nRegarding supplier dependency, the 10‑K notes that Starbucks purchases green coffee under fixed‑price and price‑to‑be‑fixed contracts, uses forward contracts, futures and collars to hedge “C” price exposure, and relies on multiple suppliers for coffee, dairy, plant‑based alternatives, and packaging. While the company states the risk of non‑delivery from these suppliers is remote, it also acknowledges that price volatility and supply constraints can affect the business, indicating a continued but diversified dependency on external coffee and commodity suppliers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45396,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11573,
        "completion_tokens": 301,
        "total_tokens": 11874
      }
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy’s geographic reach expanded markedly: it received European Commission marketing authorization for metastatic triple‑negative breast cancer in November 2021 and was later approved in Canada (joining the Orbis program) and additional markets, while its U.S. approval was broadened to include HR⁺/HER2‑ breast cancer and other indications.  Regulatory approvals also grew – the FDA granted full approval for adult patients with unresectable locally advanced or metastatic TNBC in April 2021 and later extended the label in January 2022 to include HR⁺/HER2‑ breast cancer, and the company continued to leverage accelerated pathways (e.g., Orbis) to gain access in multiple countries.  Consequently, Trodelvy moved from a limited 2020 launch to a globally approved oncology asset with sales spanning the United States, Europe, Canada, Australia, Switzerland and other regions by the end of 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51572,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13101,
        "completion_tokens": 230,
        "total_tokens": 13331
      }
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Simon Property Group's ownership stake in ABG declined from approximately 12.3% to 9.6% through a series of capital transactions in 2023, triggering multiple deemed disposals that generated non-cash pre-tax gains totaling $157.1 million (from a portion sale in Q4 2023), $10.3 million (from subsequent dilution), and $12.4 million (from Q3 2023 dilution). These transactions resulted in deferred tax expenses of $39.3 million, $2.6 million, and $3.1 million respectively, while the carrying value of its ABG investment was $733.2 million as of December 31, 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49066,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12483,
        "completion_tokens": 140,
        "total_tokens": 12624
      }
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "The 2012 Equity Incentive Plan was amended in the 2023 filing (10‑K Item 10.2(B) – “Third Amendment to the 2012 Equity Incentive Plan”) and further amended in the 2024 filing (10‑Q Item 10.2(C) – “Fourth Amendment to the 2012 Equity Incentive Plan”), with the 2024 amendment introducing additional forms of award agreements that expand the types of equity awards and related settlement provisions. The 2023 filing also disclosed the existing forms of award agreements (10‑K Item 10.2(C) – “2012 Equity Incentive Plan forms of award agreements”), while the 2024 filing adds new supplemental forms (10‑Q Item 10.2(K) – “2012 Equity Incentive Plan forms of award agreements (Additional Forms)”) that detail updated settlement and withholding provisions for equity awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 127,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43325,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11057,
        "completion_tokens": 192,
        "total_tokens": 11249
      }
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "Based on the provided 10-K excerpts, the company's treatment of capitalized software licenses remained consistent in both 2022 and 2023, with such licenses amortized on a straight-line basis over their contractual terms. The 2023 financial statements (page 38) show capitalized software licenses of $223 million, up from $152 million in 2022 (page 37), indicating increased investment in software licensing. This growth in capitalized software assets, coupled with the consistent amortization policy, demonstrates the company's strategic, ongoing investment in software licensing infrastructure, though the amortization expense itself ($63 million in 2023) remains a relatively small component of total operating costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47850,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12191,
        "completion_tokens": 179,
        "total_tokens": 12371
      }
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities grew from $2.7 billion approved for credit use as of December 31 2021 (≈27 % of European balances) to $3.0 billion approved as of December 31 2023 (≈39 % of European balances), reflecting a deliberate expansion of its European funding pool to support credit products. This strategy signals PayPal’s intent to broaden its credit offerings and reduce reliance on external capital by leveraging customer deposits as a source of funding for its loan and “Buy Now, Pay Later” programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49449,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12595,
        "completion_tokens": 138,
        "total_tokens": 12733
      }
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Based on the provided 10-K pages, Starbucks' investment in Valor Siren Ventures I L.P. (and related private equity funds) is disclosed as part of \"Other investments\" within equity investments. The total carrying value of these private equity investments was $211.9 million as of September 29, 2024, compared to $19.1 million in accounts receivable from equity investees. However, the specific carrying value of the investment in Valor Siren Ventures I L.P. alone is not disclosed separately in the financial statements. The document states that the total carrying value of \"these private equity interests\" (including Valor Siren) was $211.9 million, but does not break out the individual carrying value for Valor Siren Ventures I L.P. The financial impact on consolidated statements is noted as \"not material\" during the periods presented.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45230,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11553,
        "completion_tokens": 209,
        "total_tokens": 11763
      }
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, Analog Products' strategic positioning shifted toward leveraging TI's four sustainable competitive advantages—particularly manufacturing scale and portfolio breadth—to offset revenue declines in a challenging macro environment. While Analog revenue fell 15% and operating profit dropped 30% (from $8.359B to $5.821B), its gross margin remained relatively stable at 44.6% of revenue, reflecting continued efficiency in 300mm production and supply chain control. This period saw Analog's cash flow contribution decline (free cash flow fell to $1.35B, or 7.7% of revenue), but the segment maintained its strategic emphasis on industrial and automotive markets as long-term growth drivers, aligning with TI's capital allocation discipline to reinvest in capacity expansion (e.g., Lehi facility) while returning capital via dividends and repurchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36242,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9282,
        "completion_tokens": 217,
        "total_tokens": 9499
      }
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron's capital allocation strategy in the Lower 48 region shifted significantly from 2022 to 2023, marked by a substantial increase in capital expenditures and investments ($6.487 billion in 2023 vs. $5.630 billion in 2022) and a notable rise in depreciation, depletion, and amortization expenses ($5.729 billion in 2023 vs. $4.854 billion in 2022), reflecting intensified investment in upstream activities and asset base expansion. This strategic pivot was accompanied by a marked reduction in share repurchases ($3.623 billion in 2023 vs. $892 million in 2022) and a significant increase in debt issuance ($300 million in 2023 vs. $0 in 2022), indicating a deliberate reallocation of capital toward growth initiatives rather than shareholder returns or debt reduction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57009,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14481,
        "completion_tokens": 193,
        "total_tokens": 14674
      }
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Verizon has elevated Fixed Wireless Access (FWA) broadband as a strategic growth pillar within its Consumer segment, explicitly positioning it alongside 5G as a core connectivity offering for both residential and business customers. In 2024, FWA connections reached approximately 3.1 million (up from 3 million in 2023), with the company emphasizing its integration into the \"Intelligent Edge Network\" architecture to drive cost-efficient expansion, particularly through its expanding C-Band spectrum footprint. While FWA remains a smaller component of the Business segment (contributing to Enterprise/Business Markets and Other revenues), its primary strategic focus and growth trajectory are clearly defined within the Consumer segment, targeting both new customer acquisition and competitive differentiation in the broadband market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49921,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12710,
        "completion_tokens": 208,
        "total_tokens": 12919
      }
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "From 2022 to 2024, Emerson’s relationship with AspenTech evolved from a 55 % equity stake created by contributing its industrial‑software businesses in May 2022 to a full acquisition proposal announced on Nov 5 2024, under which Emerson would buy the remaining shares for $240 per share (≈ $15.3 bn market cap). This progression gave Emerson majority control and set the stage for a potential full consolidation. The integration contributed to a 1.8‑percentage‑point rise in gross margin (to 50.8 % in 2024) and added roughly $869 million to cost of sales, while also boosting SG&A; however, the equity investment is now being divested (sale of the 40 % stake and note receivable in mid‑2024 for $3.4 bn), which will reduce Emerson’s equity exposure and alter its capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39765,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10166,
        "completion_tokens": 195,
        "total_tokens": 10362
      }
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "The financial relationship between NEE and FPL Group Capital Inc. remained fundamentally unchanged from 2022 to 2023, continuing to be governed by the same longstanding trust and guarantee arrangements established in 1998. Specifically, FPL Group Capital Inc. continues to provide a guarantee for certain debt obligations of FPL Group, Inc., while NEE maintains its role as the parent entity ensuring these commitments are honored, with no material evolution in the nature or structure of these obligations during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 94735,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23917,
        "completion_tokens": 131,
        "total_tokens": 24049
      }
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "Between 2022 and 2024, InterStim II’s market positioning evolved from a newer, lower‑profile offering to a more widely adopted component of Medtronic’s Pelvic Health portfolio, gaining traction alongside the established InterStim and InterStim Micro platforms. The 2024 disclosures highlight continued acceptance and growth of InterStim II (and related X/Micro variants) within the broader InterStim family, noting its role in treating overactive bladder, urinary retention, and fecal incontinence, and its integration into the company’s “Pelvic Health” growth strategy. This expansion is reinforced by competitive gains in specialty‑therapy sales (e.g., ENT and Pelvic Health) and by the broader rollout of robotics and navigation technologies that support minimally invasive implantation, helping InterStim II capture additional market share against other neuromodulation devices and within the overall pelvic‑health therapy landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40890,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10454,
        "completion_tokens": 234,
        "total_tokens": 10688
      }
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group’s Supplemental Facility borrowing capacity expanded from an initial $3.5 billion to a $4.5 billion ceiling, with the facility maturing in January 2026 and extendable to 2027. The company consistently leveraged the Supplemental Facility alongside its broader Credit Facilities, issuing commercial paper and unsecured notes to fund repayments, acquisitions and debt maturities. It has employed a mix of fixed‑rate and floating‑rate borrowings, using interest‑rate swaps to lock in rates (e.g., a €750 million swap at 3.81 % in early 2023) and issuing new senior unsecured bonds at fixed rates ranging from 3.5 % to 6.65 % to replace maturing debt. Repayment actions included the optional redemption of floating‑rate notes and large tranche repayments of $600 million, $900 million and $1 billion senior notes in 2023‑2024, while maintaining overall debt levels and preserving investment‑grade credit ratings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51155,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13024,
        "completion_tokens": 237,
        "total_tokens": 13261
      }
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "Verizon's approach to device payment plans remained largely consistent from 2023 to 2024, continuing to offer non-interest-bearing installment plans (typically over 36 months) for wireless devices, with no return to fixed-term subsidized plans for consumers. However, the 2024 10-K highlights enhanced promotional incentives, including trade-in programs that allow customers to upgrade devices after paying a specified portion of their payment plan and trading in their device, which introduced a new guarantee liability accounting requirement. This reflects a strategic evolution to drive device adoption and customer retention through flexible financing and upgrade incentives, while maintaining the core structure of installment-based payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52161,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13262,
        "completion_tokens": 186,
        "total_tokens": 13449
      }
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company maintained its position that it has no liability for Aqua-Chem’s asbestos-related claims, relying on the contractual and insurance settlement history that established the Company’s obligations were limited to insurance coverage and not direct liability for Aqua-Chem’s claims. The company continued to enforce its legal stance through ongoing litigation and appeals related to insurance coverage for Aqua-Chem’s asbestos claims, most recently with the Wisconsin Supreme Court denying review in 2014 and the Georgia case remaining stayed. No new legal admissions or settlements regarding liability for Aqua-Chem’s asbestos claims were disclosed in the 2023 or 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 75563,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19120,
        "completion_tokens": 179,
        "total_tokens": 19300
      }
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-U.S. tax credits and lower foreign tax rates significantly reduced its effective tax rate from 16.7% in 2020 to 8.5% in 2021, driven by restructuring non-U.S. subsidiaries and releasing valuation allowances on foreign deferred tax assets. This reflects a strategic shift toward concentrating operations in lower-tax jurisdictions like Ireland, Israel, and Malaysia, where statutory rates range from 12.5% to 24.0% and conditional reduced rates apply. The company actively manages its international tax structure to maximize benefits from these jurisdictions, as evidenced by the $67 million tax benefit from tax holidays in 2024 and the continued use of R&D tax credits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39964,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10224,
        "completion_tokens": 174,
        "total_tokens": 10398
      }
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, pension risk transfers have become more sensitive to interest rate movements, with rising rates increasing reinvestment yields and lowering liability values, while falling rates pressure margins through lower asset returns. Regulatory influence remains significant, as changes in reserving standards and capital requirements continue to shape how these transfers are structured and accounted for.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51263,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13043,
        "completion_tokens": 104,
        "total_tokens": 13147
      }
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic’s InterStim Micro neurostimulator transitioned from a newly launched product in 2022 to a core growth driver within its Pelvic Health portfolio, supported by expanded indications and integration into broader neuromodulation offerings. The 2024 documents highlight its continued acceptance and growth, driven by products like InterStim Micro and InterStim X, which are specifically noted for treating overactive bladder, urinary retention, and fecal incontinence, underscoring its strategic role in Medtronic’s less-invasive therapy expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40890,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10438,
        "completion_tokens": 143,
        "total_tokens": 10581
      }
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group’s Supplemental Facility was actively utilized and strategically managed to address debt maturities and optimize financing costs. The facility’s outstanding balance was reduced through targeted repayments, including a $1.05 billion draw in December 2021 that funded the early redemption of $1.16 billion of mortgages, followed by a $1.05 billion repayment on January 12 2022 funded by new note issuances. Subsequent activity included the repayment of $600 million of 2.75% notes in June 2023 and the redemption of $900 million of 3.38% notes on October 1 2024, alongside new issuances of $1.0 billion of 4.75% notes in September 2024. These actions reflect a pattern of using the Supplemental Facility to refinance higher‑cost debt, reduce leverage, and manage the company’s overall debt profile, with outstanding borrowings declining from $2.1 billion (peak in 2021) to negligible levels by 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49846,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12688,
        "completion_tokens": 235,
        "total_tokens": 12923
      }
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "From 2022 to 2023, COP's investment activity in the Lower 48 region shifted significantly toward increased development spending and reduced focus on unproved property acquisitions. While unproved property acquisitions in the Lower 48 decreased from $11,261 million (2022) to $16,101 million (2023) in absolute terms, this reflects a strategic pivot toward development expenditures, which rose from $2,461 million (2022) to $6,487 million (2023). This reallocation of capital toward development activities in the Lower 48, coupled with the substantial decline in unproved property acquisition spending, indicates a strategic evolution in investment priorities toward more productive, development-focused projects in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 172,
          "pages": [
            170,
            171,
            172,
            173,
            174
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56603,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14380,
        "completion_tokens": 181,
        "total_tokens": 14561
      }
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "Verizon's corporate networking solutions have evolved from 2023 to 2024 with a strategic shift toward emphasizing enterprise-grade connectivity and managed services within its Business segment. In 2023, the Business segment's corporate networking solutions were described as part of a broader portfolio including \"corporate networking solutions, security and managed network services\" under Enterprise and Public Sector, generating $15.1 billion in revenue (50% of Business segment revenue). By 2024, this emphasis intensified through the introduction of the \"Intelligent Edge Network\" architecture, which explicitly positions corporate networking as a core component of its next-generation platform to enable IoT services and enterprise connectivity. The 2024 segment data shows Business segment revenues of $29.5 billion, with \"Enterprise and Public Sector\" revenue declining slightly to $14.2 billion (48% of segment revenue), while \"Business Markets and Other\" (which includes tailored networking solutions for small/medium businesses) grew to $13.1 billion (44% of segment revenue), reflecting a strategic pivot toward broader business market penetration with managed networking services. This evolution is underscored by the 2024 financials showing $2.1 billion in Wholesale revenue (primarily network access services) and the explicit inclusion of \"network connectivity products\" like private networking and SD-WAN in the Business segment's service offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49921,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12704,
        "completion_tokens": 366,
        "total_tokens": 13070
      }
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife’s sensitivity analysis shows that a 10% U.S. dollar appreciation would have reduced the estimated fair value of interest‑sensitive assets by about $11.8 billion and increased the fair‑value loss on liabilities by roughly $3.7 billion, while equity‑market risk sensitivities remained relatively modest (≈$123 million). The company notes that these sensitivities exclude $217.5 billion of insurance‑contract liabilities, which would largely offset the fair‑value changes from interest‑rate and foreign‑currency movements. Consequently, while the dollar’s appreciation would materially affect reported fair‑value estimates, the actual impact on earnings is mitigated by these offsetting liabilities and by the company’s use of models as supplementary tools rather than predictive measures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 84140,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21267,
        "completion_tokens": 203,
        "total_tokens": 21470
      }
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "Between 2022 and 2023, NextEra Energy’s power marketing activities expanded significantly, particularly through NEER’s energy trading operations that generated $2.5 billion in gains from non‑qualifying commodity hedges and contributed to a $3.3 billion increase in operating revenue, while the associated financial performance reflected higher gains on disposal of businesses and assets and increased interest expense due to higher rates and debt balances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 57701,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14656,
        "completion_tokens": 114,
        "total_tokens": 14770
      }
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "Based on the provided SEC 10-K filings, The Coca-Cola Company's financial relationship with Coca-Cola FEMSA has evolved such that its stake ownership in Coca-Cola FEMSA remains unchanged (28% as of 2024), but the company's equity income from this investment is now explicitly linked to potential tax litigation outcomes. Specifically, the Company's $16 billion estimated potential tax liability from its IRS litigation (which could be partially offset by appeal success) directly impacts its equity income, as noted in Note 12 where it states \"the Company currently estimates that the potential aggregate incremental tax and interest liability could be approximately $16 billion as of December 31, 2023\" and that \"some or all of this amount... would be refunded if the Company were to prevail on appeal.\" This tax litigation risk is now a key factor affecting the company's equity income from its stake in Coca-Cola FEMSA, as reflected in the equity method investment disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51932,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13213,
        "completion_tokens": 245,
        "total_tokens": 13458
      }
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Based on the provided financial data, the Lower 48 region's operational focus shifted significantly between 2022 and 2023, with production volumes increasing substantially while depreciation expenses also rose. Specifically, Lower 48 production volumes (as reflected in the \"Net Production\" table) jumped from 213,000 barrels daily in 2022 to 447,000 barrels daily in 2023 for crude oil, and from 74 to 110 million cubic feet daily for natural gas, indicating expanded operational activity. This surge in production is directly linked to a dramatic increase in depreciation expenses for the region, which climbed from $2,544 million in 2022 to $5,729 million in 2023 (as shown in the \"Depreciation, Depletion, Amortization and Impairments\" table), reflecting the capital-intensive nature of scaling up operations in the Lower 48. Consequently, while production volumes grew exponentially, the associated depreciation costs also escalated sharply, underscoring the region's heightened operational focus and investment during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 169,
          "pages": [
            167,
            168,
            169,
            170,
            171
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61653,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15640,
        "completion_tokens": 259,
        "total_tokens": 15899
      }
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Verizon's strategic relationship with its 4G LTE network has evolved from being a foundational network for consumer and business services to a more integrated component of its broader network infrastructure and growth initiatives. While the 2023 10-K (pages 95-99) details operational metrics and financials, the 2024 10-K (pages 21-25) emphasizes that Verizon is prioritizing 5G expansion and fiber investments (e.g., acquiring Frontier) while still leveraging its 4G LTE network for Fixed Wireless Access (FWA) broadband and network densification. The document notes that 4G LTE remains critical for supporting FWA and enhancing network capacity, but the strategic focus has shifted toward 5G as the primary growth driver, with 4G LTE serving as a complementary layer within the evolving infrastructure. (2 sentences)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44134,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11262,
        "completion_tokens": 204,
        "total_tokens": 11467
      }
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "From 2022 to 2024, Emerson’s financial and strategic relationship with AspenTech evolved significantly: Emerson initially acquired a 55% stake in AspenTech in 2022 (via the Heritage AspenTech transaction), which it later increased to approximately 57% ownership. In November 2024, Emerson proposed to acquire the remaining ~43% of AspenTech shares at $240 per share, implying a total market capitalization of $15.3 billion. This move solidified Emerson’s majority ownership and strategic control. Financially, AspenTech contributed to backlog growth (increasing from $328 million in 2021 to $1,042 million in 2022) and bolstered gross margin through the Test & Measurement acquisition, though inventory step-up amortization slightly pressured margins. The AspenTech segment’s backlog and revenue growth were pivotal to Emerson’s overall financial performance, particularly in driving software and control sales growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 38271,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9807,
        "completion_tokens": 229,
        "total_tokens": 10036
      }
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "Based on the provided 10-K filings, NEE's financial commitment to the Mountain Valley Pipeline (MVP) evolved significantly between 2022 and 2023, reflecting a strategic shift in its investment approach. In 2022, NEE recorded a $110 million commitment related to MVP under \"Other clean energy (g)\" in its capital expenditure estimates, with $1,060 million allocated to \"Other\" in 2024 (including MVP-related investments). By 2023, this commitment was substantially reduced and reclassified, with only $5 million allocated to MVP in 2024 under \"Other (i)\" – a minimal amount compared to the $1,060 million total for \"Other\" that year. This reduction, coupled with the note that \"In the first quarter of 2022, NextEra Energy Resources recorded an additional impairment charge to completely write off its investment in Mountain Valley Pipeline,\" indicates NEE exited its equity investment in MVP entirely by 2023. Consequently, the $110 million 2022 commitment was effectively eliminated, signaling a strategic retreat from MVP as a core investment. This abandonment of MVP aligns with NEE's broader shift toward prioritizing regulated utility infrastructure (e.g., FPL's $9.4 billion capital expenditures in 2023) and scalable clean energy projects (e.g., $18.3 billion total capital expenditures at NEER), rather than high-risk, non-core pipeline ventures. The near-total divestment underscores a deliberate focus on higher-return, rate-regulated assets and internal growth opportunities, abandoning the MVP project after significant impairments and regulatory delays.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69969,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17716,
        "completion_tokens": 391,
        "total_tokens": 18108
      }
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "From 2023 to 2024, Coca-Cola's relationship with Costa Limited evolved from being a standalone business within the Global Ventures segment to becoming a more integrated component of that segment's strategic growth framework. The 2024 10-K explicitly positions Costa Limited as part of the Global Ventures operating segment, highlighting its role in expanding the company's portfolio of non-sparkling beverages and its contribution to the \"For a Better Shared Future\" vision through sustainable growth and community investment. This reflects a strategic shift toward deeper operational integration, as Costa's beverage offerings (including its coffee and tea brands) are now explicitly tied to Global Ventures' objectives for portfolio diversification and consumer engagement, moving beyond its prior status as a separate entity within the broader segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13144,
        "completion_tokens": 213,
        "total_tokens": 13357
      }
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Based on the provided financial statements, Intel's investment in economically hedged marketable debt instruments has decreased significantly. The fair value of these hedged investments was $13.5 billion as of December 28, 2024, compared to $17.1 billion as of December 30, 2023, representing a $3.6 billion decline. This reduction reflects the company's shift in strategy or market conditions affecting its hedged debt portfolio over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54315,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13809,
        "completion_tokens": 113,
        "total_tokens": 13923
      }
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "From 2023 to 2024, AMT's financial focus evolved to emphasize recurring revenue generation from its communications site leases, which constitute the vast majority of its revenue and are characterized by long-term, noncancellable terms with periodic escalations (e.g., ~3% annual increases in the U.S.). This recurring revenue model, underpinning over $60 billion in non-cancellable future lease revenue, ensures stable cash flows. Simultaneously, the company addressed asset retirement obligations, recognizing a $4.5 billion estimated undiscounted future cash outlay for site remediation as of December 2024, reflecting ongoing commitments to compliance and infrastructure maintenance. The strategic shift also included significant actions like the Pending ATC TIPL Transaction to restructure its India operations and optimize long-term value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47964,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12218,
        "completion_tokens": 211,
        "total_tokens": 12429
      }
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "ExxonMobil's strategic positioning in Guyana has evolved significantly between 2023 and 2024, marked by a formalized legal operating framework under the **Petroleum Activities Act 2023**, which established a 20-year production period for oil fields with up to 10-year renewal options. This regulatory shift underscores Guyana's growing importance to ExxonMobil's growth strategy, particularly as a high-potential, advantaged asset. The company emphasized **volume growth in Guyana** as a key driver of its \"Advantaged Volume Growth\" strategy, leveraging the Stabroek Block's prolific discoveries to expand production capacity. This focus aligns with ExxonMobil's broader capital allocation priorities, where Guyana—alongside the Permian Basin and LNG—represents a cornerstone of its advantaged growth projects, directly contributing to earnings through high-value, low-cost upstream development. The legal framework now provides greater certainty for long-term investment, reinforcing ExxonMobil's commitment to Guyana as a strategic growth engine.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45424,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11580,
        "completion_tokens": 262,
        "total_tokens": 11842
      }
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar’s diesel‑electric locomotive business remains part of the Energy & Transportation segment, with segment profit rising 16% to $5.736 billion in 2024 driven by favorable price realization. The segment continues to report revenue from diesel‑electric locomotives and related services (including remanufacturing and leasing) and maintains its strategic focus on rail‑related products within the broader Machinery, Energy & Transportation portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39570,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10126,
        "completion_tokens": 114,
        "total_tokens": 10240
      }
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "From 2022 to 2024, Capital One’s reliance on securitized debt obligations grew modestly but remained a small share of total funding—securitized debt increased from $12.4 billion in 2020 to $15.0 billion in 2021 and stayed at that level through 2024, while total funding sources rose to $354.1 billion and deposits grew to $311 billion. This indicates the company continues to use securitizations as a supplemental funding channel, but its primary strategy remains heavily dependent on deposit growth rather than securitized financing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51840,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13186,
        "completion_tokens": 133,
        "total_tokens": 13320
      }
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees evolved in two key ways: First, financial reporting for these relationships was formally integrated into the \"International Developmental Licensed Markets & Corporate\" segment, where revenue from royalties and initial fees is now disclosed separately and presented as a distinct line item within total franchise revenue (e.g., $120.8 million in 2023 versus $308.6 million in 2022 for that segment). Second, relationship management was reinforced through updated accounting for lease and franchise arrangements, including the addition of renewal‑option assumptions in lease‑right‑of‑use calculations and the allocation of consideration between lease and non‑lease components, reflecting a more structured approach to managing developmental licensees’ financial obligations and performance metrics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52890,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13446,
        "completion_tokens": 216,
        "total_tokens": 13663
      }
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Southern Company's Equity and Incentive Compensation Plan had 26.9 million shares available for awards at December 31 2023, up from 23.2 million shares reserved at the end of 2023 (as disclosed in the 2023 filing). The 2024 filing shows no change in the share‑reservation methodology, indicating that the plan’s share availability remained essentially unchanged between 2023 and 2024. Executive award disclosures continue to reference the same plan, with no new equity‑compensation plan introduced, and the number of shares reserved for future awards is still reported as 26.9 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 232,
          "pages": [
            230,
            231,
            232,
            233,
            234
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 316,
          "pages": [
            314,
            315,
            316,
            317,
            318
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 80922,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20463,
        "completion_tokens": 146,
        "total_tokens": 20610
      }
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Inlyta revenue grew 26% in the U.S. and 5% internationally in 2023, driven by adoption of combinations of certain immune checkpoint inhibitors and Inlyta for first-line treatment of advanced RCC, partially offset by lower volumes and net price declines in certain European markets. This growth contributed to the overall revenue decline from 2022 to 2023, which was primarily driven by reductions in Comirnaty and Paxlovid sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 98760,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24909,
        "completion_tokens": 107,
        "total_tokens": 25016
      }
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's financial structure with franchisees remained fundamentally unchanged, continuing to rely on a heavily franchised model where franchisees pay rent, royalties (typically a percentage of sales with minimum rent requirements), and initial fees. The Company's revenue recognition for franchise fees and royalties is based on sales occurring in the underlying restaurants, with initial fees recognized over the 20-year franchise term. While the Company does not share costs for technology platforms in a way that generates margins, it does recover a portion of technology costs from franchisees through fees, which are recognized as revenue when the related services are provided. The Company's relationship remains characterized by stable, predictable revenue streams derived primarily from franchisee sales, with no significant shift in financial dependency or structure noted between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62385,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15832,
        "completion_tokens": 231,
        "total_tokens": 16063
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "The fair value of Southern Company's energy-related derivatives held by its subsidiaries increased from $210 million at the end of 2022 to $358 million at the end of 2023, indicating that the company's exposure to energy market fluctuations grew during this period. This rise reflects higher valuations of natural‑gas and power derivatives across the subsidiaries, suggesting greater sensitivity to changes in energy prices and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 285,
          "pages": [
            283,
            284,
            285,
            286,
            287
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 84049,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21249,
        "completion_tokens": 111,
        "total_tokens": 21361
      }
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The Procter & Gamble 2019 Stock and Incentive Compensation Plan (the \"2019 Plan\") has evolved from 2022 to 2024 primarily through changes in its share reserve and reporting details. In the 2022 filing (PG_10k_2022.pdf), the plan allowed up to 187 million shares for future grants, with 119 million shares available for issuance, and outstanding options/RSUs totaled 133.2 million shares with a weighted average exercise price of $99.52. By the 2024 filing (PG_10k_2024.pdf), the maximum shares authorized remained 187 million, but future issuance under the plan decreased to 77 million shares, with outstanding options/RSUs reduced to 114.1 million shares and a higher weighted average exercise price of $111.57. This reflects a contraction in available shares for future grants despite the unchanged maximum reserve, likely due to increased usage of shares for prior awards (including full-value awards counted as five shares each). The plan’s structure and share counting methodology (e.g., full-value awards counting as five shares) remained consistent, but the reduced availability in 2024 indicates near-term exhaustion of the reserve for new grants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68537,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17364,
        "completion_tokens": 288,
        "total_tokens": 17652
      }
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company's approach to managing the risk of large losses in its pension plan assets has remained focused on diversification and prudent investment practices, with no fundamental change in strategy between 2023 and 2024. The 2024 disclosures show continued emphasis on broad asset class diversification across major categories (equity, fixed income, real estate, private equity, infrastructure, etc.) and reliance on external managers subject to written guidelines, but with a notable shift in allocation emphasis. Specifically, the target allocation for real estate increased from 12% to 13% and private equity from 9% to 12%, while the actual allocation to private equity rose significantly from 12% to 12% (with a substantial increase in fair value to $1,797 million), and infrastructure allocations remained minimal (2% target, 0% actual in 2023 vs. 2% target, 0% actual in 2024). The most significant change is the increased weight given to private equity and real estate within the portfolio, reflecting a strategic shift toward alternative investments to enhance returns while maintaining diversification, though the core risk management framework of diversification and external manager oversight remains unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 263,
          "pages": [
            261,
            262,
            263,
            264,
            265
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 255,
          "pages": [
            253,
            254,
            255,
            256,
            257
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62309,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15812,
        "completion_tokens": 307,
        "total_tokens": 16120
      }
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's role in the CUDA platform evolved from being primarily a software ecosystem enabling GPU acceleration to a more integrated, full-stack foundation for AI and data center computing. This shift is underscored by the company's strategic investments in AI-specific software like NVIDIA AI Enterprise, DGX Cloud, and NeMo, as well as the expansion of CUDA-X libraries and partnerships with cloud providers to offer AI-as-a-service. The emphasis on CUDA's role in powering AI workloads, combined with the acquisition of Mellanox and development of DPUs, indicates a strategic pivot toward dominating the end-to-end data center infrastructure stack—where software, hardware, and networking converge to accelerate AI adoption. This reflects NVIDIA's focus on transforming from a GPU vendor into a platform company driving the AI computing ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 86,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49188,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12523,
        "completion_tokens": 218,
        "total_tokens": 12741
      }
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Based on the provided document pages, Pfizer's financial relationship with Viatris evolved significantly between 2022 and 2023, particularly regarding supply agreements and outstanding balances. The 2023 Form 10-K (page 71) states that Pfizer recorded a $33 million balance due from Viatris as of December 31, 2023, reflecting amounts owed under transitional agreements, including billings, collections, and remittance of rebates performed on Viatris's behalf. This follows the 2020 separation of Upjohn (which formed Viatris) where Pfizer and Viatris entered into long-term manufacturing and supply agreements. The document notes that services under these interim agreements (including TSAs and MSAs) were largely completed by December 31, 2023, and the $33 million balance represents outstanding amounts due to Viatris under these arrangements. The 2022 Form 10-K (page 42) references the \"Analysis of the Consolidated Statements of Income--Revenue Deductions\" section for further details on revenue deductions related to these agreements, but the key financial relationship detail is the $33 million receivable from Viatris as of 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 89897,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22696,
        "completion_tokens": 284,
        "total_tokens": 22980
      }
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "The treatment and disclosure of communications sites in relation to debt obligations have evolved significantly between 2023 and 2024. In 2023, the Company completed a securitization transaction (the '2023 Securitization') that introduced new collateralized debt obligations backed by communications sites, with specific terms governing cash flow distribution, reserve accounts, and amortization triggers based on debt service coverage ratios (DSCR). By 2024, these mechanisms were further detailed and operationalized, including the use of restricted cash accounts, mandatory amortization periods upon DSCR breaches, and explicit disclosures about the rights of trustees to enforce claims on secured sites upon default. Additionally, the Company expanded its disclosure of securitization structures, including the 2023 Securitization’s risk retention requirements and the impact of covenants on excess cash flow distribution, reflecting a more structured and transparent approach to leveraging communications site assets as collateral while emphasizing compliance with financial tests and potential consequences of default.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61681,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15636,
        "completion_tokens": 281,
        "total_tokens": 15917
      }
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Between 2022 and 2023, Comcast's approach to retransmission consent agreements remained consistent in structure but evolved in operational and financial execution. The company continues to recognize revenue from retransmission consent fees as part of its Cable Communications segment, with fees generally passed through to customers and recognized on a monthly basis. However, in 2023, Comcast reported an increase in programming and content expenses, including $13,550 million in video distribution programming costs (up from $12,684 million in 2022), reflecting higher retransmission consent-related payments. Revenue recognition for these arrangements remains tied to the delivery of programming under multiyear agreements, with revenue recognized monthly as services are provided, consistent with prior years. The company also noted that future revenue from fixed pricing under existing retransmission agreements equals approximately half a year to one year of annual content licensing revenue, with the majority recognized within two years. (Based on CMCSA_10k_2022.pdf pages 92–96 and CMCSA_10k_2023.pdf pages 8–12.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41997,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10724,
        "completion_tokens": 280,
        "total_tokens": 11005
      }
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "Caterpillar’s involvement in diesel‑electric locomotives remained focused on its Energy & Transportation segment, where it continues to manufacture and support diesel‑electric locomotives and related rail products; there was no indication of a new strategic shift or expansion of this activity between 2023 and 2024. The company’s reporting shows ongoing product support and remanufacturing of engines and components, but the filings do not describe any material change in the scope or strategic positioning of its diesel‑electric locomotive business over that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39332,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10050,
        "completion_tokens": 142,
        "total_tokens": 10192
      }
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Based on the provided 10-K disclosures, McDonald's relationship with its franchisees regarding revenue recognition and cost-sharing has evolved in two key ways between 2023 and 2024:\n\n1.  **Revenue Recognition from Franchise Fees:** The Company recognizes initial franchise fees and ongoing royalties (based on a percentage of sales) as the performance obligations are satisfied over the typical 20-year franchise term. This includes revenue from conventional franchised restaurants (minimum rent + royalties) and developmental licensees (royalties + initial fees). The Company also recognizes revenue from technology platform fees paid by franchisees on a gross basis as services are delivered, and brand licensing revenues based on a percentage of sales.\n\n2.  **Cost-Sharing for Restaurant Improvements:** The Company shares costs of certain restaurant improvements with franchisees. During project execution, the Company estimates and allocates costs between its own property and equipment and accounts receivable (from franchisees), and finalizes this allocation upon project completion. This cost-sharing arrangement is a key part of the franchise relationship, where the Company often provides upfront funding and manages the project, but the franchisee ultimately bears responsibility for their portion of the costs. The Company's 2023 and 2024 disclosures confirm this ongoing practice, though specific cost-sharing amounts are not detailed in the provided financial statement pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16725,
        "completion_tokens": 372,
        "total_tokens": 17098
      }
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Southern Company's executive equity compensation approach evolved between 2023 and 2024 primarily through updated plan documentation and award terms. The 2023 Equity and Incentive Compensation Plan (effective May 26, 2021) remained in effect, but 2024 saw specific amendments to executive severance and change-in-control benefits (effective August 15, 2022, with updates referenced in 2022 and 2023 filings). Executive awards continued to use performance share units (PSUs) and restricted stock units (RSUs) with immediate vesting upon retirement eligibility, though the 2023 PSU vesting conversion used a $66.95 weighted average price, reflecting market conditions. Unrecognized compensation cost for PSUs ($32 million) and RSUs was expected to be recognized over ~19 and ~17 months, respectively, with no material changes to the core compensation structure between years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 276,
          "pages": [
            274,
            275,
            276,
            277,
            278
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 316,
          "pages": [
            314,
            315,
            316,
            317,
            318
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 87160,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22015,
        "completion_tokens": 218,
        "total_tokens": 22233
      }
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "From 2022 to 2024, Procter & Gamble’s strategic reliance on membership club stores has shifted from being a key channel (noted as a top customer representing ~15% of sales in 2022) to being explicitly referenced in sustainability and channel diversification efforts in 2024, particularly through initiatives like \"irresistibly superior products and packages that are sustainable\" and expanded direct-to-consumer focus. This evolution indicates a broader retail channel strategy that prioritizes sustainable growth, diversified distribution (including e-commerce and specialty channels), and reduced dependence on traditional mass merchandisers, while still leveraging high-value partnerships like Walmart but emphasizing resilience and environmental impact over pure sales concentration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 59647,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15139,
        "completion_tokens": 196,
        "total_tokens": 15335
      }
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "Based on the provided 10-K pages, AMT's involvement with Nigeria Letters of Credit remained unchanged between 2023 and 2024, with no new disclosures indicating a material evolution. The 2024 filing confirms the continued existence of these instruments as part of subsidiary debt, noting they were drawn during 2023 and 2024 with interest at S OFR plus a spread, maturing 270 days after draw. The document explicitly states that the carrying value of Nigeria Letters of Credit was $3.4 million as of December 31, 2023, and the 2024 filing shows no increase or change in this obligation, indicating no significant financial obligation evolution occurred during this period. This consistency suggests AMT's exposure to Nigeria Letters of Credit remained stable, with no new commitments or adjustments reported in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49605,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12630,
        "completion_tokens": 203,
        "total_tokens": 12833
      }
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the composition of GD's Retirement Annuity Contracts shifted from being classified as Level 3 (with a fair value of $38 in 2022) to Level 2 (with a fair value of $22 in 2024), indicating a reduction in valuation complexity and unobservable inputs used in their reporting. This change reflects a more transparent and observable valuation approach, as the contracts moved from relying on significant unobservable inputs to being primarily valued using Level 2 inputs like observable market data. Consequently, the company's reporting of these assets became less subjective and more aligned with standard fair value hierarchy practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44367,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11325,
        "completion_tokens": 164,
        "total_tokens": 11489
      }
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "Between 2022 and 2024, restricted cash for securitization investors declined from $441 million (as reported in the 2022 consolidated balance sheet) to $441 million in 2024 – essentially unchanged in absolute terms – but its fair‑value hierarchy classification shifted from Level 2 (where it was disclosed as “$ 441 million” with a Level 2 hierarchy reference) in the 2022 filing to Level 1 in the 2024 filing, where it is presented as “$ 441 million” with a Level 1 hierarchy reference and no separate Level 2 or Level 3 designation. Consequently, while the carrying amount remained roughly stable, the valuation level moved up one tier, indicating a higher degree of observable market inputs used for its fair‑value measurement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 179,
          "pages": [
            177,
            178,
            179,
            180,
            181
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55177,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14025,
        "completion_tokens": 182,
        "total_tokens": 14207
      }
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees regarding financial recognition and asset management remained consistent with prior practices, as no material changes were identified in the accounting policies governing franchisee-related revenues or asset allocations. The company continues to recognize royalty and rent revenues from franchised restaurants based on sales percentages and minimum payments, while property and equipment costs related to restaurant improvements are allocated between the company and franchisees during projects, with final adjustments made post-completion. Goodwill acquired from franchisee purchases (e.g., $240 million in 2024) is subject to impairment testing, though no significant impairments were noted, and the company maintains its historical approach to variable interest entity assessments, concluding consolidation is unnecessary for franchisee relationships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68921,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17448,
        "completion_tokens": 230,
        "total_tokens": 17679
      }
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "Between 2022 and 2024, the treatment of the 2019 Stock and Incentive Compensation Plan (2019 Plan) evolved from being referenced as a plan that \"allows for future grants of securities\" with a maximum of 187 million shares authorized and 119 million shares available for future issuance (as disclosed in the 2022 filing for grants under the plan), to maintaining a similar structure but with updated disclosures in 2024 showing that only the 2019 Plan permits future grants, with a maximum of 187 million shares authorized and approximately 77 million shares remaining available for future issuance as of June 30, 2024. The plan continues to be the sole equity compensation plan permitting future issuances, with shares subject to a five-to-one ratio for full-value awards like RSUs and PSUs, and it remains distinct from other plans such as the 2001, 2009, and 2014 Plans, which were all closed to new grants by 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68537,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17378,
        "completion_tokens": 229,
        "total_tokens": 17607
      }
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Based on the provided property tables, Salvatore Ferragamo's presence in Simon Property Group's international outlet locations remained consistent between 2022 and 2023. The brand was listed as a tenant in multiple international Premium Outlet properties across Japan, Mexico, South Korea, Malaysia, Thailand, and Canada, including specific locations such as Gotemba Premium Outlets (Japan), Punta Norte Premium Outlets (Mexico), and Yeoju Premium Outlets (South Korea), with no indication of new openings or closures during this period. The company maintained its footprint through existing lease agreements within these joint venture-operated outlets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49976,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12709,
        "completion_tokens": 163,
        "total_tokens": 12872
      }
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "From 2023 to 2024 ConocoPhillips shifted its focus in the Asia Pacific/Middle East region from a largely exploratory stance to a more development‑driven strategy.  In 2023 the company reported only a handful of exploratory wells in that region (e.g., 3 exploratory wells for equity affiliates and none for consolidated operations), whereas by 2024 it was actively drilling and completing development wells there—recording 20 development wells for consolidated operations and 45 development wells through equity affiliates, with a corresponding increase in productive wells and acreage.  This evolution indicates that the firm is concentrating on expanding and optimizing existing assets (particularly in the Middle East) rather than pursuing new exploratory discoveries in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 155,
          "pages": [
            153,
            154,
            155,
            156,
            157
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74127,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18761,
        "completion_tokens": 196,
        "total_tokens": 18957
      }
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "From 2022 to 2024, Comcast’s wireless gateway strategy shifted from a focus on expanding broadband and video service penetration (as detailed in the 2021 10-K’s “Broadband” and “Wireless” sections) to a more integrated, technology‑driven approach emphasizing next‑generation network capabilities and customer‑experience enhancements.  The 2024 filing highlights continued investment in DOCSIS 4.0 upgrades, multigigabit symmetrical speeds, and the deployment of advanced wireless gateways (e.g., xFi Pods and in‑and‑out‑of‑home Wi‑Fi) as part of the “Connectivity & Platforms” capital‑expenditure focus, while also leveraging these gateways to bundle wireless services and drive additional revenue streams.  This represents a strategic emphasis on using wireless gateways to strengthen the company’s connectivity platform, support higher‑speed broadband offerings, and create new monetization opportunities across both residential and business segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46637,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11876,
        "completion_tokens": 238,
        "total_tokens": 12114
      }
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, Gulfstream's market presence and production evolution are evident in its cumulative deliveries and product lineup advancements. By the end of 2024, cumulative deliveries of the G500 and G600 aircraft exceeded 300, up from nearly 150 by the end of 2021, reflecting strong market reception to these newer models that replaced the G450 and G550. The G600 entered service in 2019, and the G500 in 2018, forming a modernized core of Gulfstream's fleet. Concurrently, the G700, certified by the FAA in March 2024, entered service as the latest ultra-long-range, ultra-large-cabin model, expanding the lineup further. The G800 and G400 are also in development, with the G800 targeting 2023 service and the G400 slated for 2025, completing a nearly two-decade effort to refresh its entire aircraft family. This progression underscores Gulfstream's strategy of replacing older models with technologically advanced, more efficient aircraft while maintaining its leadership in business aviation through innovation and global support networks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31311,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8055,
        "completion_tokens": 263,
        "total_tokens": 8318
      }
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent a significant structural shift, primarily involving equity ownership and income recognition. In 2023, AIG held 52.2% of Corebridge common stock and continued selling down its stake, with plans to reduce ownership over time. By December 31, 2024, AIG's ownership had declined to 22.7% following a series of secondary offerings and a strategic sale of 120 million shares to Nippon Life for $3.8 billion. This deconsolidation, completed on June 9, 2024, resulted in AIG recognizing a $4.8 billion loss (primarily due to an $8.5 billion retained investment valuation and reclassification adjustments), with Corebridge's results now reported as discontinued operations. Post-deconsolidation, AIG accounts for its remaining 22.7% stake as an equity method investment, recognizing income from dividends and stock price changes in Net investment income, rather than consolidation. This shift eliminated AIG's direct control and consolidated financial exposure to Corebridge, replacing it with equity method accounting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 96687,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24394,
        "completion_tokens": 272,
        "total_tokens": 24666
      }
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla's Solar Roof production strategy shifted from a high‑complexity, in‑house manufacturing model toward a more localized, streamlined approach. The company expanded dedicated Gigafactory New York facilities for Solar Roof and related components, emphasizing localized procurement and assembly to reduce supply‑chain risk and lower costs. Operational challenges persisted—including scaling production capacity, managing raw‑material price volatility, and meeting aggressive installation targets—requiring iterative design refinements and tighter integration with energy‑storage and charging infrastructure to achieve manufacturability and cost‑effectiveness.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49971,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12717,
        "completion_tokens": 170,
        "total_tokens": 12888
      }
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm’s strategic focus on on‑device AI shifted from a broad, diversified investment across emerging markets and new product areas to a more concentrated, partnership‑driven approach targeting premium mobile and automotive applications. The company continued to allocate significant R&D resources to AI‑enabled chipsets and software, while also expanding collaborations with OEMs and automotive suppliers to embed AI capabilities directly in devices, reflecting a tighter integration of AI into its core semiconductor and licensing businesses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65349,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16566,
        "completion_tokens": 141,
        "total_tokens": 16708
      }
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "Between 2022 and 2023, Dolce & Gabbana’s presence in SPG-operated properties remained consistent, with the brand featured in multiple international Premium Outlet locations across Japan, Mexico, South Korea, Malaysia, Thailand, and Canada. The 2023 data shows continued inclusion of Dolce & Gabbana among the selected tenants at key global outlets, such as Gotemba Premium Outlets (Japan), Yeoju Premium Outlets (South Korea), and Punta Norte Premium Outlets (Mexico), indicating that SPG maintains strategic brand partnerships with luxury designers to reinforce its premium outlet positioning. This sustained presence underscores SPG’s focus on curating high-end, globally recognized brands to enhance the desirability and competitive differentiation of its Premium Outlet destinations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49976,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12727,
        "completion_tokens": 196,
        "total_tokens": 12924
      }
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "Between 2023 and 2024 ConocoPhillips increased its investment in exploration and development in the Asia Pacific/Middle East region – the consolidated development wells there rose from 20 in 2023 to 20 in 2024 (a flat level), while equity‑affiliated development wells grew from 45 to 45 (also flat), but the company’s overall spending on development in that region jumped markedly (e.g., $416 million of development spending in 2023 versus $462 million in 2024, and $46 million of exploration outlays in 2023 versus $462 million in 2024). This surge in capital allocation signals a strategic shift toward concentrating more resources on the Asia Pacific/Middle East, where the firm sees higher growth and reserve‑addition potential, even as activity in other regions remained comparatively stable.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 156,
          "pages": [
            154,
            155,
            156,
            157,
            158
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 76997,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19485,
        "completion_tokens": 199,
        "total_tokens": 19684
      }
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "From 2022 to 2024, Comcast's financial stake and debt involvement in Universal Beijing Resort evolved as follows: Comcast increased its ownership stake to 30% and consolidated the resort (reporting it in the Theme Parks segment), while Universal Beijing Resort accumulated significant debt—$3.4 billion outstanding as of December 2024 (down slightly from $3.5 billion in 2023), primarily consisting of a $3.0 billion term loan used to fund the resort's construction. This debt burden and the resort's operating performance (including pre‑opening costs in 2021 and subsequent performance) directly affect Comcast's consolidated balance sheet and cash flows, though Comcast's direct financial exposure remains limited to its 30% equity interest and the associated risk of loss.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43060,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10977,
        "completion_tokens": 193,
        "total_tokens": 11171
      }
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "From 2022 to 2023 Duke Energy’s net derivatives balance shifted from a $(77) million liability to a $(121) million liability, reflecting an increase in net derivative obligations. The accompanying quantitative tables show that Level 3 derivatives—primarily electricity contracts and FTRs—were valued using unobservable inputs such as forward electricity price curves (ranging from $19 to $139 per MWh) and RTO auction prices for FTRs (ranging from $0.36 to $2.11 per MWh). This evolution indicates the company is managing modest but growing exposure to market‑price volatility, with the liability expanding as positions became larger and more sensitive to observable market movements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 199,
          "pages": [
            197,
            198,
            199,
            200,
            201
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 192,
          "pages": [
            190,
            191,
            192,
            193,
            194
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63136,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16021,
        "completion_tokens": 171,
        "total_tokens": 16192
      }
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG’s treatment of LTIP Units remained consistent in disclosure but evolved in valuation modeling. While prior years (2021–2022) noted no material dilutive effect from LTIP Units and described their grant date fair values using Monte Carlo models for market-based awards, the 2023 filing continues to reference LTIP units under the 2023 LTI Program with performance conditions tied to FFO and TSR modifiers, though no specific fair value or dilutive impact was quantified in the provided text. The company maintains that no securities had a material dilutive effect in 2021–2023, and LTIP units are accounted for as participating securities under the two-class method, with expense recognition over performance periods. Valuation now emphasizes detailed performance metrics (e.g., FFO and objective criteria) and adjusted amortization of grant date fair values, particularly for 2021–2023 grants, but still does not adjust net income attributable to common stockholders or weighted average shares for dilution, as such adjustments would have no dilutive impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51522,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13104,
        "completion_tokens": 270,
        "total_tokens": 13374
      }
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Between 2022 and 2024, Comcast’s financial commitment to Atairos evolved from a $5 billion aggregate funding limit (with annual capital calls up to $400 million) to a reduced $4.5 billion limit, while its annual management‑fee commitment was set at $40 million (subject to adjustments). The company continues to fund Atairos through cash capital contributions (e.g., $73 million in 2024) and retains an unfunded capital commitment of roughly $1.4 billion, absorbing about 99 % of any losses and receiving approximately 86 % of residual returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43908,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11208,
        "completion_tokens": 136,
        "total_tokens": 11344
      }
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP's proved natural gas reserves in the Asia Pacific/Middle East region rose modestly from **124 billion cubic feet at the end of 2023 to 124 billion cubic feet at the end of 2024** (the tables show essentially no change, with only minor revisions and additions offsetting each other). This stability—driven by modest upward revisions and purchases that were largely offset by production and sales—indicates that the company is **maintaining its focus on the region but not aggressively expanding reserves there**, keeping its operational emphasis more balanced across other geographies such as the U.S. and Canada.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 137,
          "pages": [
            135,
            136,
            137,
            138,
            139
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17443,
        "completion_tokens": 154,
        "total_tokens": 17597
      }
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "Comcast’s 2022 wireless gateway procurement strategy centered on acquiring customer‑premise equipment—including wireless gateways and set‑top boxes—from a limited pool of suppliers to support its expanding broadband and bundled services. By contrast, its 2024 network deployment focus has shifted toward heavy investment in scalable infrastructure and line extensions to upgrade the cable network (e.g., DOCSIS 4.0 upgrades, multigigabit symmetrical speeds, and expanded Wi‑Fi coverage), with capital spending directed at building out capacity rather than expanding device‑level procurement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47596,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12112,
        "completion_tokens": 147,
        "total_tokens": 12260
      }
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Tesla's Solar Roof has transitioned from a niche offering to a strategically important but production-constrained product. In 2022, it was positioned within the Energy Generation and Storage segment, contributing to a 40% year-over-year revenue increase driven by Solar Roof deployments, though it operated at a negative gross margin (-4.6% in 2021). By 2024, the product remained part of Tesla's energy expansion strategy, with the company emphasizing its integration into broader energy offerings and scaling efforts, but faced ongoing challenges including manufacturing underutilization, lower margins due to temporary production ramp inefficiencies, and the need to balance Solar Roof with higher-margin products like Megapack and Powerwall. Production challenges persist due to complex manufacturing requirements and scaling difficulties, though Tesla continues to invest in its development as part of its long-term energy strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57214,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14527,
        "completion_tokens": 234,
        "total_tokens": 14761
      }
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "From 2022 to 2023 Duke Energy’s “Net pending transactions and other investments” increased from **$53 million** (2022) to **$54 million** (2023), a modest rise of about **$1 million** (≈2%). This slight uptick suggests the company is maintaining or marginally expanding its short‑term, non‑core investment position within the Duke Energy Master Retirement Trust, reflecting a cautious but stable approach to managing its other post‑retirement assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 226,
          "pages": [
            224,
            225,
            226,
            227,
            228
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61552,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15623,
        "completion_tokens": 112,
        "total_tokens": 15736
      }
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "The company’s liability-driven investment framework remained focused on aligning plan assets with liabilities, maintaining a 20% equity/80% fixed‑income target for pension assets and a 55% equity/45% fixed‑income target for post‑retirement assets. Disclosure of plan asset composition shows the 2023 pension portfolio was 18% equity, 57% corporate bonds and 25% government/Treasury securities, while the 2024 pension portfolio shifted to 21% equity, 63% corporate bonds and 16% government/Treasury securities (plus other investments). Post‑retirement assets were disclosed as 53% equity, 31% corporate bonds and 16% government/Treasury securities in 2023 and 57% equity, 30% corporate bonds and 13% government/Treasury securities in 2024. Thus, between 2023 and 2024 the equity allocation increased modestly and the fixed‑income allocation correspondingly decreased, reflecting a continued emphasis on liability hedging while maintaining growth assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51201,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13038,
        "completion_tokens": 238,
        "total_tokens": 13276
      }
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Qualcomm’s strategic focus on On‑Device AI remained centered on leveraging its Snapdragon platforms to embed high‑performance, low‑power AI capabilities across handsets, automotive and IoT, but the company emphasized accelerating investments in AI‑centric chip architectures and software ecosystems to sustain growth beyond 5G.  In its fiscal‑2024 disclosures, Qualcomm highlighted expanded licensing agreements and new collaborations that integrate on‑device AI functions—particularly in automotive cockpit and connectivity products—while also noting increased R&D spending and capital allocation to support AI‑driven product development and to offset the impact of capitalizing R&D expenses for tax purposes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55812,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14186,
        "completion_tokens": 177,
        "total_tokens": 14364
      }
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The Voting Trust Agreement (referenced as Exhibit 9.1 in both the 2022 and 2023 10‑K filings) remains disclosed in the same form and location within the Exhibit Index, indicating no structural or substantive change to its classification or presentation. This consistent disclosure suggests that the governance framework surrounding the Melvin Simon & Associates voting trust has maintained stability across the two reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 140,
          "pages": [
            138,
            139,
            140,
            141,
            142
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51297,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13076,
        "completion_tokens": 108,
        "total_tokens": 13184
      }
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "Between 2023 and 2024, ConocoPhillips' natural gas reserves in the Asia Pacific/Middle East region increased from 48 billion cubic feet (BCF) at the end of 2023 to 62 BCF at the end of 2024, reflecting upward revisions from development and technical adjustments that more than offset modest declines elsewhere. This growth underscores a strategic shift toward the Asia Pacific/Middle East as a higher‑priority component of ConocoPhillips' global reserves portfolio, indicating that the company is increasingly relying on this region to bolster its overall gas resource base amid evolving market dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 154,
          "pages": [
            152,
            153,
            154,
            155,
            156
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69572,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17633,
        "completion_tokens": 151,
        "total_tokens": 17784
      }
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's relationship with Corebridge evolved from consolidation to deconsolidation. In 2023, AIG held a controlling stake in Corebridge, which was reflected in its debt structure as part of Corebridge's borrowings (including $200M CRBGLH notes and $6.45B senior unsecured notes). By June 2024, AIG deconsolidated Corebridge, retaining a 22.7% equity interest accounted for under the equity method. This shift eliminated Corebridge debt from AIG's consolidated balance sheet, with AIG now recognizing only equity method income (e.g., $601M from Corebridge in 2024) and dividends from its retained stake. The debt structure transition involved AIG guaranteeing Corebridge debt (with reimbursement obligations) and transferring collateral responsibilities, but post-deconsolidation, AIG's direct debt exposure to Corebridge was replaced by equity method income and investment gains.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 91365,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23064,
        "completion_tokens": 225,
        "total_tokens": 23289
      }
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "From 2022 to 2024, NextEra Energy’s Special Use Funds strategy shows a clear shift toward greater fixed‑income exposure and reduced equity reliance. In 2022 the funds held roughly $2.1 billion of fixed‑income securities versus $2.3 billion of equity, but by 2024 the fixed‑income share rose to about $2.5 billion while equity holdings modestly declined to $2.6 billion, indicating a deliberate tilt toward more stable, interest‑rate‑sensitive assets. This reallocation suggests a conservative risk appetite focused on preserving capital and ensuring liquidity for storm‑damage and nuclear‑decommissioning obligations, while still maintaining enough equity to meet long‑term return objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61085,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15517,
        "completion_tokens": 173,
        "total_tokens": 15690
      }
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The risk associated with site infrastructure sharing has evolved from a general concern about customer consolidation and network sharing to a specific, technology‑driven threat tied to 5G. In 2022 the filing highlighted that extensive sharing of site infrastructure—including roaming, resale and RAN‑sharing arrangements that accompany advanced technologies such as 5G—could reduce new lease activity because carriers might deploy shared equipment instead of adding new equipment, or could decommission equipment on existing sites when portions of their networks become redundant. By 2024 this risk was framed more explicitly as “extensive sharing of site infrastructure through RAN sharing, roaming or resale arrangements among wireless service providers, including due to increases in advanced network technology such as 5G, as an alternative to leasing our communications sites, without compensation to us, may cause new lease activity to slow if carriers utilize shared equipment rather than deploy new equipment, or may result in the decommissioning of equipment on certain existing sites because portions of the customers' networks may become redundant.” Thus, the nature of the risk shifted from a broad competitive/consumer‑demand concern to a concrete, technology‑induced pressure on lease growth, and its magnitude intensified as 5G rollout progressed, making infrastructure sharing a more direct driver of slower lease renewals and new site acquisitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56112,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14264,
        "completion_tokens": 366,
        "total_tokens": 14630
      }
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Between 2022 and 2023, Chevron's investment in Angola LNG Limited decreased slightly from $2,258 million to $2,180 million, reflecting a modest reduction in its equity stake. The company continues to account for this investment using the equity method, recognizing its share of earnings (which turned negative in 2023 with an equity loss of $166 million) while also paying its share of income taxes directly, which are excluded from the equity‑in‑earnings figure. This structure and accounting approach remained consistent across the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56436,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14336,
        "completion_tokens": 136,
        "total_tokens": 14472
      }
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 remained a key large‑cabin, long‑range business jet in Gulfstream’s lineup, but its production and performance context shifted. In 2022 the G600 was still in service, with cumulative deliveries of about 150 aircraft by year‑end 2021 and ongoing production, while the newer G500 and G600 were described as faster, more fuel‑efficient, and with greater cabin volume than the models they replaced. By 2023 the company’s public disclosures showed the G600’s revenue contribution falling to 20% of consolidated revenue (down from 22% in 2022 and 21% in 2021), and the focus turned to newer models such as the G700 (expected service entry in early 2024) and the upcoming G800/G400. Thus, while the G600’s performance metrics (speed, range, fuel efficiency) continued to reflect its advanced design, its role evolved from a flagship new‑generation aircraft to a mature product supporting ongoing deliveries and service, as attention moved to newer ultra‑long‑range variants and the company emphasized expanding its overall fleet and service capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30751,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7909,
        "completion_tokens": 268,
        "total_tokens": 8178
      }
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's financial relationship with its franchisees shifted toward greater strategic collaboration and reduced direct financial risk. The Company increasingly structured franchise agreements to include co-investment in restaurant improvements and technology platforms, while retaining ownership of real estate and collecting rent and royalties based on sales. This model, emphasized in the 2024 filing, reflects a move away from direct ownership of restaurants toward a more asset-light, franchise-centric model where franchisees bear the capital burden for equipment and building, and the Company focuses on revenue from rent, royalties, and initial fees. The 2024 filing also notes that the Company's \"franchising is paramount\" to its business model, with 95% of restaurants franchised by 2024, and that it actively co-invests with franchisees to fund improvements while maintaining strict operational standards. This evolution prioritizes long-term brand value and predictable cash flow from franchise fees over direct operational control.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64031,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16226,
        "completion_tokens": 267,
        "total_tokens": 16493
      }
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, Altria's smokeable products net revenues declined 2.4% to $21,756 million, while operating income for that segment fell slightly to $10,670 million (down from $10,688 million in 2022). Overall operating income also slipped $372 million (3.1%) to $11,547 million, driven by higher general corporate expenses and amortization, despite modest growth in oral tobacco products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58355,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14807,
        "completion_tokens": 97,
        "total_tokens": 14905
      }
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo’s role within BMS’s strategy evolved from being a co-developed oncology product under the BMS–Ono alliance (where profits and development costs were shared equally for combination therapies and Ono received royalties outside Japan, South Korea, and Taiwan) to a broader commercial and pipeline asset integrated into BMS’s global operations. By 2024, Opdivo had received multiple regulatory approvals across new indications and geographies—including FDA approvals for Opdivo Qvantig (subcutaneous formulation), new first-line combinations (e.g., with cisplatin/gemcitabine in urothelial carcinoma), and expanded uses in NSCLC and urothelial cancer—solidifying its position as a cornerstone of BMS’s oncology portfolio. This expansion was supported by a more mature collaborative framework with Ono, which included adjusted governance around development cost sharing, milestone payments, and profit distribution, as well as the incorporation of Opdivo into BMS’s long-term commercial strategy beyond its initial co-promotion agreement. Additionally, the 2024 financial disclosures reflect Opdivo’s growing contribution to alliance revenues and net product sales, underscoring its increased strategic importance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 44405,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11336,
        "completion_tokens": 308,
        "total_tokens": 11645
      }
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "Between 2022 and 2024, AMT’s disclosures show a shift from referencing LIBOR‑based rates to using EURIBOR for its European‑denominated delayed‑draw term loans and from LIBOR to SOFR‑based or other benchmark rates for new USD facilities, while maintaining similar covenant structures (e.g., rating‑based margins, 1.125% spread, and comparable financial‑maintenance covenants). The 2022 filings emphasized LIBOR and EURIBOR spreads tied to debt‑rating levels, whereas the 2024 filing updates the benchmark language to reflect the transition away from LIBOR and specifies the current applicable margins over EURIBOR or SOFR, but the underlying covenant thresholds and rating‑linked margin mechanics remain essentially unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50320,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12810,
        "completion_tokens": 181,
        "total_tokens": 12991
      }
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald’s evolved its real estate and co‑investment strategy by deepening its reliance on conventional franchise ownership of land and buildings, while increasingly partnering with franchisees on capital projects. The 2022 filing emphasizes that the company typically owns or secures long‑term leases for restaurant sites and that franchisees fund equipment and décor, whereas the 2024 filing shows a heightened focus on co‑investing with franchisees to modernize restaurants and accelerate initiatives that align with consumer preferences. This shift reflects a move toward greater collaboration and shared investment to enhance store performance and brand value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53410,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13570,
        "completion_tokens": 172,
        "total_tokens": 13742
      }
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "Between 2022 and 2023, the 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective October 26 2022 (as disclosed in the 2022 filing) and subsequently referenced again in the 2023 filing where the plan’s shares available were updated to 589,927. This evolution reflects Altria’s ongoing practice of formally updating and re‑filing its director‑compensation framework to align with evolving governance standards and to provide clearer, more current disclosures of available shares and plan terms. Consequently, the changes indicate that Altria maintains a structured, transparent approach to director compensation, regularly revising its equity‑based plans to ensure they remain consistent with shareholder expectations and regulatory requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54631,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13900,
        "completion_tokens": 195,
        "total_tokens": 14096
      }
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "From 2022 to 2024, the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity has intensified, leading to increased infrastructure sharing and reduced need for new tower leases. This trend reflects growing competitive pressures that suppress new lease growth, as carriers increasingly utilize shared equipment and network consolidation to avoid paying for additional space on AMT's sites. Consequently, AMT anticipates that such practices will continue to slow new lease activity and constrain revenue expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56112,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14268,
        "completion_tokens": 139,
        "total_tokens": 14408
      }
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's deepened its strategic investment in franchisees through co‑investment programs and a $15 billion share‑repurchase authorization, while simultaneously raising operational expectations. The company emphasizes that franchisees must meet rigorous standards, reinvest capital, and align with initiatives such as the “Accelerating the Arches” strategy, digital transformation, and enhanced customer‑experience investments, all of which require ongoing financial commitment and operational collaboration from franchisees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55188,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14019,
        "completion_tokens": 137,
        "total_tokens": 14156
      }
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "Based on the provided SEC 10-K filings, NextEra Energy's investment strategy in equity securities within its Special Use Funds evolved significantly from 2022 to 2024. In 2022, the company reported unrealized losses of $1,028 million on equity securities held in these funds, but by 2024, it had shifted to substantial unrealized gains of $917 million (NEE total) and $668 million (FPL), reflecting a marked improvement in the performance and strategic allocation of these investments. This transition is further evidenced by the increased fair value of equity securities within Special Use Funds, rising from $2,349 million in 2023 to $2,614 million in 2024 for NEE, and from $863 million to $1,028 million for FPL, indicating a deliberate expansion and rebalancing toward higher-growth equity positions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 75772,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19157,
        "completion_tokens": 201,
        "total_tokens": 19358
      }
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, net revenues from smokeable products declined $720 million (3.2%) to $21,756 million, while operating income from that segment fell $18 million (0.2%) to $10,670 million. Overall, consolidated operating income decreased $372 million (3.1%) to $11,547 million, driven primarily by higher general corporate expenses and amortization, partially offset by improved results in the oral tobacco segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58133,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14752,
        "completion_tokens": 104,
        "total_tokens": 14856
      }
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between fiscal 2022 and 2023, Accenture’s share purchase activity shifted from a larger open‑market program to a more diversified approach that included both open‑market purchases and other employee‑related programs. In fiscal 2022 the company bought 12.2 million Class A shares for $4.11 billion, of which 9.6 million were acquired through its publicly announced open‑market program and the remainder via employee share‑withholding and other plans. By fiscal 2023 the total shares purchased fell to 15.6 million (including both Class A shares and Accenture Canada Holdings exchangeable shares) but the open‑market component was reduced, reflecting a broader use of the $3 billion additional repurchase authority and a focus on treasury‑share replenishment for employee equity awards rather than large-scale market buying. Consequently, the utilization of Class A ordinary shares for open‑market purchases declined, while the overall share‑repurchase program continued to fund both market purchases and employee‑benefit‑related share issuances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33025,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8482,
        "completion_tokens": 261,
        "total_tokens": 8743
      }
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants remained tied to debt instruments bearing interest at LIBOR or EURIBOR plus a 1.125% margin, with maturities extending through 2025–2027. The structure of these covenants did not undergo substantive changes, though the underlying debt mix shifted toward senior unsecured notes and term loans (e.g., 0.400%–1.250% notes, 2021 USD Delayed Draw Term Loans), all governed by identical covenants requiring compliance with financial reporting, leverage ratios, and restrictions on additional indebtedness. The core covenants governing the 2021 Multicurrency Credit Facility, 2021 Credit Facility, and 2021 Term Loan remained unchanged, ensuring consistent operational constraints across all debt instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48350,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12323,
        "completion_tokens": 187,
        "total_tokens": 12511
      }
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Based on the provided SEC filings, Disney+ Hotstar's subscriber base grew from approximately 36 million paid subscribers in Disney+ Hotstar (as of September 28 2024) to about 123 million paid Disney+ subscribers overall (including Disney+ Hotstar) by September 28 2024, reflecting the consolidation of Star+ into Disney+ in Latin America and broader international expansion. This consolidation strengthened Disney’s international streaming strategy by unifying its general‑entertainment offering under a single Disney+ brand, expanding the addressable market in Latin America and other regions, and enabling a more scalable, integrated DTC platform that can leverage a larger subscriber base to drive advertising and subscription revenue globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46614,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11890,
        "completion_tokens": 186,
        "total_tokens": 12076
      }
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The number of employees covered under collective labor agreements remained essentially unchanged from 2022 to 2023, with approximately 21 agreements covering about 3,000 employees expected to be renegotiated in 2022 (2022 data) and 20 agreements covering roughly 2,100 employees planned for negotiation in 2024 (2023 data), indicating the company's strategy of proactively managing labor costs through routine, non-disruptive contract renegotiations rather than significant workforce changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38688,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9899,
        "completion_tokens": 123,
        "total_tokens": 10022
      }
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "Based on the provided document pages, there is no information related to NextEra Energy's investments in U.S. Government and municipal bonds or their evolution from 2022 to 2024. The document focuses on pension plans, employee retirement benefits, derivative instruments, and other financial disclosures, but does not contain any discussion of bond investments or their valuation changes over these years. Therefore, the question cannot be answered using the provided information.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60827,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15431,
        "completion_tokens": 120,
        "total_tokens": 15551
      }
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo’s role in Bristol‑Myers Squibb’s portfolio expanded markedly through new therapeutic approvals and a shift toward a more diversified manufacturing strategy. The company secured multiple FDA and EU approvals for Opdivo in new indications—including neoadjuvant NSCLC, urothelial carcinoma, and combinations with Yervoy and chemotherapy—while also obtaining subcutaneous formulation (Opdivo Qvantig) and accelerated approvals for related assets. To support this growth, BMS increasingly relies on both internal capacity (e.g., its Devens bulk‑biologics site) and third‑party manufacturers, establishing back‑up sources and inventory buffers for Opdivo’s active ingredient, thereby enhancing supply‑chain resilience and reducing dependence on a single supplier. This dual‑source approach underpins the drug’s expanding market presence and reinforces its strategic importance across the company’s oncology pipeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57654,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14642,
        "completion_tokens": 235,
        "total_tokens": 14877
      }
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Disney's relationship with National Geographic magazine has evolved from being a distinct publishing unit within the Entertainment segment to being fully integrated under the broader Disney portfolio. In 2023, National Geographic magazine was still reported as part of the Content Sales/Licensing activities under Entertainment, reflecting its historical role as a branded publication. By 2024, the company's strategic focus shifted toward consolidating its entertainment and media assets, particularly with the announcement of the Star India joint venture and the broader restructuring of its direct-to-consumer and linear networks businesses. This strategic positioning reflects Disney's effort to streamline its content portfolio and leverage National Geographic's brand within its global entertainment ecosystem, rather than operating as a standalone magazine business. The magazine's operations are now embedded within Disney's broader content licensing and publishing activities, with no separate financial disclosure for the publication itself.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42542,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10864,
        "completion_tokens": 262,
        "total_tokens": 11127
      }
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "PayPal’s 2023 filing describes its transaction‑management databases as supporting “approximately 150 currencies” and enabling consumers to “send payments in approximately 200 markets around the world,” whereas the 2024 filing expands this capability to “approximately 140 currencies” for holding balances and still references “approximately 200 markets” for payments, indicating a modest shift from a focus on a broad, multi‑currency footprint to a more streamlined emphasis on a slightly reduced number of currencies while maintaining global reach. This evolution reflects a move toward consolidating currency support while preserving the platform’s worldwide payment accessibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53642,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13641,
        "completion_tokens": 170,
        "total_tokens": 13812
      }
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The interest rate on NEECH’s Series K Debentures was reset to **6.051 % per annum** in March 2023 (up from the prior 4.255 % rate set in September 2022). This increase reflects NEE’s strategy of leveraging the equity‑unit structure to refinance maturing debt at higher rates, signaling a deliberate shift toward higher‑cost, longer‑dated financing as market rates rise.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 101280,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 25546,
        "completion_tokens": 92,
        "total_tokens": 25639
      }
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil's application of the unit-of-production depreciation method has evolved in response to changes in proved reserves and asset life assumptions, particularly through updated reserve estimates and adjustments to depreciation practices. In 2023, the company emphasized using the most recent SEC pricing for reserve determinations to ensure equitable cost allocation, especially when reserves are substantially de-booked, and continued to apply straight-line depreciation for assets with shorter lives than underlying reserves. The 2023 Environmental Expenditures section notes that capital expenditures for environmental initiatives are expected to account for approximately 47% of total spending in 2024, reflecting a strategic shift toward lower-emission projects that may influence future asset life assessments and depreciation approaches. This evolution aligns with the Corporation's broader focus on integrating environmental costs into asset management, as seen in its impairment assessments that factor in long-term emission-reduction plans and greenhouse gas pricing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48403,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12332,
        "completion_tokens": 270,
        "total_tokens": 12603
      }
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Between 2023 and 2024, Netflix has shifted from relying heavily on third‑party production partners toward a more vertically integrated model, scaling its own studios and acquiring complementary businesses to produce original programming in‑house. This strategic emphasis reflects a deliberate move to reduce dependence on external partners while expanding internal production capacity to meet growing content demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54993,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13979,
        "completion_tokens": 104,
        "total_tokens": 14083
      }
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Between 2022 and 2023, Mastercard's Cyber and Intelligence Solutions evolved from being part of broader \"other revenues\" (which included cyber and intelligence solutions fees, data analytics, loyalty programs, and payment-related services) to a more distinct strategic focus within its value-added services portfolio. In the 2023 filing, the company explicitly highlighted cyber and intelligence solutions as a dedicated revenue stream under \"Other revenues,\" emphasizing its role in fraud prevention, transaction security, and leveraging secure consumer/merchant data—aligning with its broader mission to \"make payments safer, simpler, and more accessible.\" This strategic positioning reflects a deliberate expansion of its digital security offerings beyond foundational network services, driven by growing demand for cyber resilience in global payments ecosystems. The 2023 filing also notes that revenue from these solutions is part of the $1.3 billion in estimated consideration for unsatisfied performance obligations related to value-added services, projecting recognition through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45403,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11562,
        "completion_tokens": 273,
        "total_tokens": 11835
      }
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "From 2023 to 2024, Tesla's energy storage business continued to rely on lithium-ion battery technology derived from its automotive operations, with Megapack serving utility-scale projects and Powerwall targeting residential and small commercial markets. Production challenges persist in scaling battery cell manufacturing, particularly for proprietary cells, while strategic dependencies remain on suppliers for key components and raw materials like lithium and nickel. The company emphasizes software-driven optimization and integration with its solar and charging networks to enhance deployment efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45884,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11692,
        "completion_tokens": 152,
        "total_tokens": 11844
      }
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "From 2023 to 2024, NextEra Energy Capital Holdings’ floating‑rate debenture program shifted toward larger issuances and shorter maturities. In 2023 it issued $2 billion of floating‑rate debentures due 2026 and $600 million of floating‑rate notes due 2026, while in 2024 it issued $3.8 billion of floating‑rate debentures with maturities from 2026 to 2054 and an additional $600 million of floating‑rate debentures due 2026. Consequently, the principal amount of floating‑rate debt rose from $2.2 billion (2023) to $3.8 billion (2024), and the maturity profile moved to include longer‑dated issues (up to 2054) alongside the near‑term 2026 notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 120731,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 30415,
        "completion_tokens": 161,
        "total_tokens": 30576
      }
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel’s supply‑chain responsibility strategy shifted from a primarily compliance‑focused, audit‑driven model toward a broader, collaborative approach that expands both the scope of supplier engagement and the emphasis on industry‑wide initiatives.  The 2023 disclosures highlight direct supplier audits, capacity‑building programs, and early‑stage industry coalitions (e.g., responsible‑minerals and transparency efforts), whereas the 2024 filing shows a deliberate expansion of those programs—linking supplier‑level sustainability metrics to executive compensation, scaling engagement with indirect suppliers, and deepening participation in cross‑industry frameworks such as the Responsible Business Alliance and the “Alliance for Global Inclusion.”  This evolution reflects a move from isolated risk mitigation to an integrated, value‑creating partnership model that seeks to embed diversity, climate, and human‑rights goals throughout the entire supply chain.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50032,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12740,
        "completion_tokens": 245,
        "total_tokens": 12985
      }
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "The characterization of assumptions underlying the standardized measure of discounted future cash flows has evolved from explicitly referencing first‑day‑of‑the‑month average prices in 2022 to emphasizing that such averages represent discrete points in time that can cause significant year‑to‑year variability in cash flows in 2023, while still applying the same 10 % discount factor and using year‑end costs and legislated tax rates. This shift underscores a more cautious framing of price assumptions, acknowledging greater sensitivity to price fluctuations despite the continued use of the same methodological structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 85432,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21611,
        "completion_tokens": 155,
        "total_tokens": 21767
      }
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, Mastercard expanded its digital identity solutions through enhanced integration with open banking capabilities, enabling secure, consent-centric data sharing across financial institutions. This integration strengthened fraud prevention via AI-driven tools like SafetyNet and biometric verification (e.g., fingerprint, facial recognition), while extending reach to over 95% of U.S. deposit accounts and 3,000 European banks. The company also broadened its digital identity platform to include device intelligence, behavioral biometrics, and transaction fraud data, improving payment approval rates and enabling seamless cross-border transactions through its open banking network.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 34516,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8858,
        "completion_tokens": 175,
        "total_tokens": 9034
      }
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Between 2023 and 2024, Tesla’s Solar Roof strategy shifted from broad expansion to a more controlled, efficiency‑focused rollout. 2023 filings note ongoing challenges with installation speed and cost‑competitiveness, while 2024 disclosures highlight tighter integration with Powerwall, streamlined design iterations, and a reliance on in‑house solar‑inverter and power‑electronics expertise to improve performance and reduce manufacturing complexity.  Consequently, production hurdles have persisted, and the product’s growth now depends heavily on these engineering refinements and on partnerships with real‑estate developers rather than on large‑scale channel sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45884,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11693,
        "completion_tokens": 167,
        "total_tokens": 11860
      }
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "Based on the provided SEC 10-K filings, NextEra Energy's use of Pledge Agreements has evolved with new agreements executed in 2024. In the 2023 filing (pages 114-118), the most recent Pledge Agreement referenced was dated September 1, 2022, involving NextEra Energy, Inc. as the pledgor and The Bank of New York Mellon as the pledgee/collateral agent for debt securities. The 2024 filing (pages 121-125) confirms the execution of two new Pledge Agreements on June 1, 2024, and October 1, 2024, both involving NextEra Energy, Inc. as pledgor with The Bank of New York Mellon serving as both Purchase Contract Agent and Collateral Agent. These 2024 agreements represent the latest evolution in the company's use of Pledge Agreements, expanding on the prior 2022 structure to support new debt issuances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 121,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 123,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 102513,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 25852,
        "completion_tokens": 200,
        "total_tokens": 26052
      }
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "From 2023 to 2024, Intel’s Edge AI strategy shifted from a focus on foundational hardware and ecosystem building to accelerated software and partnership execution. In 2023, Intel emphasized launching AI-optimized platforms like the 13th Gen Core processors with OpenVINO 2023.1 and expanding its edge AI software stack, while 2024 saw concrete progress through deeper ecosystem integration—highlighting collaborations with Ericsson, Nokia, Cisco, Dell, HPE, and Microsoft to deploy software-defined, AI-enabled edge infrastructure. Critically, Intel’s 2024 disclosures confirm the commercialization of its edge AI vision, with the Intel Xeon D-1800 and D-2800 processors (optimized for edge/5G) and the Intel Core Ultra \"AI PC\" platform (featuring NPU for on-device AI) now driving adoption. This evolved from 2023’s groundwork into a 2024 where software platforms (e.g., OpenVINO, edge-native frameworks) and partnerships became the primary engines for scaling Edge AI, moving beyond hardware announcements to tangible deployments in industrial, telecom, and enterprise edge use cases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44305,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11300,
        "completion_tokens": 271,
        "total_tokens": 11572
      }
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The 1.75% senior notes due August 2030 remained unchanged at $1.25 billion in both 2023 and 2024, reflecting no new issuance or repayment of that specific tranche during the period. Consequently, its composition and value stayed the same year‑over‑year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 168,
          "pages": [
            166,
            167,
            168,
            169,
            170
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 161,
          "pages": [
            159,
            160,
            161,
            162,
            163
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32197,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8282,
        "completion_tokens": 63,
        "total_tokens": 8345
      }
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix introduced and expanded its ad-supported subscription plan as a lower-priced option to attract price-sensitive members and broaden market reach, while maintaining its core focus on growing membership through compelling content and flexible pricing. This strategy aligns with its objective of increasing global membership growth—particularly in competitive markets—by offering tiered plans that cater to diverse consumer preferences, ultimately supporting revenue expansion and long-term profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49573,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12617,
        "completion_tokens": 133,
        "total_tokens": 12750
      }
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Tesla's approach to the Semi has evolved from pilot production in Nevada to active production at its Texas facility, with the vehicle now listed as \"Active\" in its production status table alongside Cybertruck and Cybercab. The company emphasizes scaling manufacturing capacity for newer models like the Semi to leverage its next-generation platform and battery cell innovations, aiming to improve performance, reduce costs, and expand affordability while integrating it into its broader strategy of vertical integration and AI-driven automation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36489,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9338,
        "completion_tokens": 136,
        "total_tokens": 9474
      }
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024—evidenced by the addition of new agreements with executives like Brian Bolster (May 6 2024), Nicole Daggs (January 1 2024), and Mark Lemasney (January 1 2023)—demonstrates a deliberate strategy to secure senior leadership continuity. By formalizing retention terms for an increasing number of key executives, the company underscores its emphasis on preserving institutional knowledge and ensuring stable, long‑term executive stewardship as it advances its strategic growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 123,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 125,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 94375,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23836,
        "completion_tokens": 144,
        "total_tokens": 23980
      }
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "Intel's xPU strategy shifted from a broad, diversified portfolio (including Optane, IPU, and other accelerators) toward a more focused emphasis on AI and data center workloads, as evidenced by its 2024 advisory group to expand the x86 ecosystem and its prioritization of AI-driven product development. This strategic pivot reflects a move away from earlier, less successful initiatives (like Optane) and toward leveraging xPU products—particularly GPUs and AI accelerators—to address the growing demand for AI computing, while maintaining its core x86 foundation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 52848,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13431,
        "completion_tokens": 140,
        "total_tokens": 13572
      }
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Netflix's advertising technology approach has evolved through significant organizational and infrastructure investments between 2023 and 2024, particularly in response to the growing complexity of its business and the strategic importance of advertising. The company has prioritized building dedicated advertising infrastructure, including developing its own ad technology stack, measurement tools, and sales organization, while also expanding partnerships with third-party service providers for ad delivery and management. This infrastructure development is critical to supporting its new ad-supported subscription tier, which requires robust analytics, targeting capabilities, and integration with existing streaming systems. Concurrently, Netflix has emphasized ESG considerations and regulatory compliance around advertising practices, recognizing that data privacy regulations (like GDPR and CPRA) and evolving industry standards for ad measurement and targeting directly impact its ability to attract advertisers and maintain member trust. The company explicitly states that its advertising revenue growth depends on developing the technology and infrastructure to demonstrate ad value to marketers, alongside managing risks related to third-party policy changes and regulatory shifts in advertising data collection.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62686,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15896,
        "completion_tokens": 330,
        "total_tokens": 16227
      }
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Tesla’s free Supercharging incentives are now accounted for as distinct performance obligations that are recognized over the vehicle’s expected ownership life (or on a usage/expiration basis for limited incentives), rather than being expensed immediately. Revenue from these services is recorded on a straight‑line basis over the performance period, and any deferred revenue related to FSD, connectivity, free Supercharging and over‑the‑air updates is amortized as the services are delivered. This contrasts with earlier periods where such incentives were often treated as marketing expenses or recognized upon vehicle delivery. Consequently, the company now capitalizes and amortizes the value of free Supercharging over time, affecting both revenue timing and the presentation of deferred revenue on the balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50589,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12870,
        "completion_tokens": 205,
        "total_tokens": 13075
      }
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "Between 2023 and 2024, NextEra Energy’s approach to issuing Series O Junior Subordinated Debentures reflects a strategic shift toward more flexible, long-dated financing with variable-rate features. In 2023, the company issued Series O Debentures with a 4.45% fixed coupon due in 2026 (via a May 2023 filing), while in 2024, it issued new Series O Debentures with a floating rate tied to SOFR plus a spread, maturing in 2026 but structured under updated indenture terms to support future refinancing and liquidity. This evolution indicates a move away from fixed-rate, long-term subordinated debt toward more adaptable, market-responsive financing to manage interest rate risk and support capital efficiency amid shifting rate environments. The change underscores NextEra’s broader strategy to optimize its capital structure with scalable, debt instrument flexibility while maintaining strong credit metrics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 137673,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 34665,
        "completion_tokens": 227,
        "total_tokens": 34892
      }
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "ExxonMobil's impairment assessment framework has evolved to explicitly incorporate long-term oil supply dynamics through its consideration of OPEC investment activities and production policies as key factors influencing future commodity prices and reserve economics. Specifically, the Corporation explicitly identifies \"OPEC investment activities and production policies also have an impact on world oil supplies\" as a critical supply-side driver affecting long-term price assumptions used in impairment testing, particularly when evaluating whether prolonged low prices or market shifts (such as those potentially driven by OPEC's strategic decisions) indicate potential asset impairment. This reflects a shift from viewing temporary price volatility as non-impairing to recognizing that structural supply changes, including OPEC's actions, can significantly alter the long-term price environment underpinning asset recoverability assessments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 41352,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10569,
        "completion_tokens": 236,
        "total_tokens": 10805
      }
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "From 2023 to 2024, Netflix’s ad‑supported plan has become a more central part of its growth strategy, with the company highlighting it as a key lever for attracting new subscribers and expanding its pricing options. The 2024 filing emphasizes a broader rollout of the ad tier, integration of advertising technology, and a focus on monetizing multi‑household usage, whereas the 2023 filing treated the ad‑supported offering as an emerging, still‑testing revenue stream. This shift reflects a strategic emphasis on scaling the ad‑supported subscription plan as a core component of Netflix’s future business model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40209,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10277,
        "completion_tokens": 152,
        "total_tokens": 10430
      }
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon’s shipping strategy shifted from aggressive price and speed incentives in 2022–2023 to a stronger focus on fulfillment efficiency and cost control by 2024. While shipping offers (e.g., Prime fast delivery) remained central to customer value, rising costs from network expansion, labor constraints, and carrier rates prompted investments in operational efficiencies—such as optimizing fulfillment networks and reducing per-unit shipping expenses—to mitigate cost pressures, even as sales growth slowed. This reflects a strategic pivot toward sustainable profitability over pure volume-driven shipping incentives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48406,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12326,
        "completion_tokens": 154,
        "total_tokens": 12480
      }
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Duke Energy's utilization and reporting of the Master Retirement Trust evolved between 2023 and 2024 with a shift in asset allocation targets: for the RCBP pension and 401(h) accounts, the target allocation moved to 35% liability-hedging and 65% return-seeking assets in 2024 (up from 35% liability-hedging and 65% return-seeking in 2023, though actual allocations remained near 35% liability-hedging and 65% return-seeking), while the DELPP target shifted to 80% liability-hedging and 20% return-seeking assets (up from 80% liability-hedging and 20% return-seeking in 2023, with actual allocations at 79% liability-hedging and 21% return-seeking in 2023). Disclosure practices remained consistent, with the Trust maintaining its diversified portfolio approach and reporting fair value measurements using Level 1, 2, and 3 inputs as detailed in the filings, though the 2024 target allocations explicitly emphasized reduced volatility through adjusted risk profiles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 218,
          "pages": [
            216,
            217,
            218,
            219,
            220
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 228,
          "pages": [
            226,
            227,
            228,
            229,
            230
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66419,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16835,
        "completion_tokens": 241,
        "total_tokens": 17076
      }
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "Between 2022 and 2024, Google's cost structure with Network Partners shifted toward higher TAC (Traffic Acquisition Costs) as a percentage of ad revenue, driven by increased reliance on third-party network partners for ad inventory. Payment obligations to these partners remained tied to ad performance metrics (e.g., impressions, clicks), with costs rising due to expanded network participation and competitive pricing pressures, though the exact evolution is inferred from 2023–2024 trends showing elevated TAC costs in Google Services operating expenses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44347,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11313,
        "completion_tokens": 139,
        "total_tokens": 11453
      }
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, the fair value changes and settlements related to offsetting swap positions did not result in significant gains or losses recorded in the consolidated income statement. The document indicates that gains or losses on fair value hedging relationships and cash flow hedges were reclassified from AOCI to income, but these were primarily driven by foreign currency exchange contracts and interest rate contracts, not by offsetting swap positions. Specifically, the reclassification amounts for cash flow hedges (e.g., $213 million in revenue and $(10) million in interest expense for 2023) were tied to designated hedges, not to the settlement of offsetting swaps. Additionally, the \"Net Amounts if Right of Offset had been Applied\" column in the balance sheet tables shows minimal net fair value positions ($92 million for assets and $26 million for liabilities in 2023), but these reflect the potential offsetting of derivative contracts, not the financial impact of settlements in the income statement. No specific gains or losses from offsetting swaps were reported in the income statement for 2023 or 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 159,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 38518,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9865,
        "completion_tokens": 282,
        "total_tokens": 10148
      }
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures—highlighted by its inclusion in the \"ITEM 11. EXECUTIVE COMPENSATION\" section and detailed description of its features, matching contributions, and deferred compensation options—indicates a more central role for this plan in the company's director compensation strategy compared to 2023, where it was referenced but less emphasized. This shift reflects a deliberate focus on enhancing long-term director alignment with shareholder interests through structured, performance-linked deferred compensation mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 245,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 239,
          "pages": [
            237,
            238,
            239,
            240,
            241
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 113278,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 28550,
        "completion_tokens": 150,
        "total_tokens": 28701
      }
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "American Express has refined its value proposition by emphasizing differentiated premium services, expanded digital capabilities, and targeted rewards programs to meet evolving customer expectations, particularly among Millennial and Gen Z consumers. The company has intensified focus on enhancing cardmember benefits, expanding merchant coverage, and leveraging data-driven personalization to counter competitive pressures from Visa, Mastercard, and emerging fintech rivals, while adapting to shifting spending behaviors post-pandemic. This strategic evolution aims to sustain premium brand positioning and drive engagement amid intensifying competition and changing consumer preferences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51738,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13164,
        "completion_tokens": 172,
        "total_tokens": 13336
      }
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Exxon Mobil's long-term debt financing approach remained consistent between 2022 and 2024, with the company continuing to issue low-coupon notes through its commercial paper program and maintaining a stable composition of long-term debt instruments. The 2024 filing confirms the ongoing presence of its 0.524% Notes due 2028 (XOM28), 0.835% Notes due 2032 (XOM32), and 1.408% Notes due 2039 (XOM39A) in its registered securities, indicating no material shift in the structure or tenor of its long-term debt. This continuity reflects ExxonMobil's strategy of leveraging its strong credit profile to secure cost-effective financing while maintaining a conservative capital structure, as evidenced by its $5 billion debt assumption in the Pioneer acquisition and sustained focus on financial discipline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12386,
        "completion_tokens": 200,
        "total_tokens": 12586
      }
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express deepened its strategic focus on commercial payments and corporate solutions, emphasizing product differentiation through enhanced card value propositions, accounts payable expense management tools, and innovative financing and banking services for business customers. The company expanded its integrated payments platform to strengthen merchant acceptance, leverage data analytics, and deepen partnerships—particularly with Delta Air Lines—while reinforcing its \"spend-centric\" model to drive higher spending among corporate cardholders. This evolution reflects a targeted shift toward tailored corporate products that combine premium benefits, digital innovation, and expanded financial solutions to meet evolving business customer needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30535,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7857,
        "completion_tokens": 194,
        "total_tokens": 8052
      }
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Between 2022 and 2024, Amazon's financial relationship with AWS Services intensified markedly, with AWS revenue growing from $90.8 billion in 2023 to $107.6 billion in 2024—a 19% year‑over‑year increase—and its operating cash flow expanding alongside broader company cash generation (operating cash flow rose to $115.9 billion in 2024). This growth underscores a strategic shift: AWS has become an increasingly central pillar of Amazon’s revenue mix (now 17% of consolidated sales) and a key driver of free cash flow, prompting the company to allocate ever‑larger capital expenditures toward AWS‑related infrastructure while still emphasizing long‑term sustainable cash generation across its retail and cloud businesses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56502,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14348,
        "completion_tokens": 180,
        "total_tokens": 14528
      }
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "The scope of trend analyses used to evaluate historical consistency of regulatory asset balances shifted from a general historical consistency review in 2023 to a more detailed, forward-looking assessment in 2024 that incorporated recent regulatory orders, commission-approved amortization schedules, and specific storm and fuel cost precedents to judge recoverability. In 2024, auditors also compared recorded balances against independently developed expectations and performed targeted procedures on coal ash-related asset retirement obligations, reflecting a deeper integration of regulatory process knowledge into the trend analysis.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54717,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13901,
        "completion_tokens": 159,
        "total_tokens": 14061
      }
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Costco's strategy regarding private-label penetration evolved from a defensive posture in 2022 to a more proactive approach in 2023 in response to cost and pricing pressures. In 2022, the company noted that \"merchandise costs in 2022 were impacted by inflation higher than what we have experienced in recent years\" and described strategies like \"working with our suppliers to share in absorbing cost increases\" and \"passing cost increases on to our members\" to protect margins, while acknowledging that \"holding prices steady despite cost increases\" negatively impacted gross margin. By 2023, the focus shifted toward leveraging private-label items as a core growth driver, with management explicitly stating that \"increasing the penetration of our private-label items\" was part of their strategy to \"adapt our business to these changes\" and maintain competitive pricing without sacrificing margins. This shift was reinforced by the 2023 MD&A highlighting that gross margin pressure from core merchandise was partially offset by \"warehouse ancillary and other businesses\" (including private-label categories), and the 2024 highlights noted that gross margin percentage increased due to \"warehouse ancillary and other businesses, largely e-commerce and gasoline,\" which included private-label offerings. Thus, Costco moved from managing cost pressures through price adjustments and supplier negotiations to actively expanding private-label product penetration as a strategic lever to sustain sales growth and margin resilience amid persistent inflation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 82947,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20957,
        "completion_tokens": 388,
        "total_tokens": 21345
      }
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Based on the provided document pages, the financial outlook for Paxlovid has evolved significantly between 2023 and 2024. In 2023, Paxlovid revenues were heavily driven by government contracts and EUA use, with $1.279 billion in total revenues and a major revenue reversal of $3.5 billion recorded in Q4 2023 due to expected returns of EUA-labeled inventory. By 2024, Paxlovid revenues increased to $5.716 billion, reflecting the transition to commercial market sales in the U.S. starting November 2023, with commercial pricing and copay assistance programs replacing government distribution. The document notes that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized through 2028 as part of ongoing commercialization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 98647,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24877,
        "completion_tokens": 205,
        "total_tokens": 25082
      }
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "American Express has extended its Reasonable and Supportable (R&S) Period for estimating credit loss reserves from a shorter historical horizon to a longer, more forward-looking period—specifically incorporating multi-year economic forecasts and longer-term loss rate assumptions—reflecting a strategic shift toward greater conservatism and forward-looking risk assessment between 2022 and 2024. This evolution indicates a more proactive and nuanced approach to financial risk management, emphasizing forward-looking economic scenarios and longer-term loss projections to better align reserve estimates with anticipated credit market conditions rather than relying solely on historical loss patterns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42068,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10763,
        "completion_tokens": 175,
        "total_tokens": 10938
      }
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon's debt financing strategy has consistently utilized structured note offerings to fund operations and acquisitions, with the 0.800% Note due 2025 representing a key component of its long-term financing. The note was initially issued in 2020 (as referenced in the 2020 Exhibit 4.5 filing) and remains outstanding through 2024, reflecting the company's reliance on low-cost, long-dated debt instruments. This approach aligns with Amazon's broader capital structure management, which emphasizes maintaining investment-grade credit metrics while leveraging the bond market for liquidity. The 2024 filing (Exhibit 4.5) confirms the note's continued presence in its debt profile, underscoring a stable and predictable financing strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44928,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11448,
        "completion_tokens": 184,
        "total_tokens": 11633
      }
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The Twenty-third Supplemental Indenture was originally disclosed in the 2022 filing (as part of the 2022 Form 8‑K dated March 1, 2022) and then re‑appeared in the 2024 filing (as part of the 2024 Form 8‑K dated March 14, 2024). Its repeated inclusion in both annual reports indicates that the indenture remains an active, ongoing component of Duke Energy’s debt structure rather than a historical artifact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 249,
          "pages": [
            247,
            248,
            249,
            250,
            251
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 252,
          "pages": [
            250,
            251,
            252,
            253,
            254
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 78228,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19791,
        "completion_tokens": 101,
        "total_tokens": 19893
      }
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "The repurchase activity for Class C Capital Stock increased from $50.2 billion in 2022 to $62.0 billion in 2023 and then slightly declined to $62.0 billion in 2024, with $50.2 billion repurchased in 2022, $62.2 billion in 2023, and $62.0 billion in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58465,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14838,
        "completion_tokens": 63,
        "total_tokens": 14901
      }
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "The American Express Company Salary/Bonus Deferral Plan was amended and restated effective January 1 2023, as disclosed in the 2022 Form 10‑K (Exhibit 10.17). This amendment updated the plan’s terms and documentation, and the plan continued to be referenced in subsequent filings, including the 2024 Form 10‑K where it appears as part of the company’s ongoing compensation disclosures (e.g., Exhibit 10.13 and related amendments). No further substantive changes to the plan’s treatment or documentation are indicated between the 2022 and 2024 filings beyond these routine updates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 165,
          "pages": [
            163,
            164,
            165,
            166,
            167
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 171,
          "pages": [
            169,
            170,
            171,
            172,
            173
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42507,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10851,
        "completion_tokens": 145,
        "total_tokens": 10996
      }
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Between 2022 and 2024, Starbucks' interest rate swap exposure shifted from a $5.8 million net loss in accumulated other comprehensive income (AOCI) at the end of fiscal 2022 to a $3.1 million net loss expected to be reclassified into earnings within 12 months in the most recent fiscal 2024 disclosure, reflecting a reduction in the magnitude of the liability. The outstanding maturity of the related interest‑rate swap contracts also declined from 0 months in 2022 to 0 months in 2024, indicating that the swaps are now fully rolled off or re‑classified, resulting in a markedly smaller balance‑sheet liability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18732,
        "completion_tokens": 153,
        "total_tokens": 18885
      }
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "Between 2022 and 2024, Duke Energy’s Directors’ Savings Plan shifted from an **Amended and Restated version dated January 1, 2014** (referenced in the 2022 filing) to an **Amendment effective December 16, 2021** (referenced in the 2024 filing). This amendment modifies deferral rules and matching contributions, reflecting a more structured governance approach to director compensation and emphasizing formalized deferral mechanisms. The evolution indicates Duke Energy’s intent to tighten oversight of director remuneration while maintaining flexibility through plan amendments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 258,
          "pages": [
            256,
            257,
            258,
            259,
            260
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 239,
          "pages": [
            237,
            238,
            239,
            240,
            241
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 72435,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18345,
        "completion_tokens": 144,
        "total_tokens": 18490
      }
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023, Costco's Kirkland Signature brand positioning shifted toward greater strategic emphasis on private-label growth, particularly through expanded sales penetration and margin optimization. The 2023 filing explicitly states the company \"expects to continue to increase the sales penetration of our private-label items\" and notes Executive members—who drive disproportionate Kirkland sales—represented 57% of paid members in the U.S. and Canada and 22% internationally, with their sales contributing ~71% of worldwide net sales. This reflects a deliberate evolution from Kirkland's traditional value-focused positioning to a more integrated, high-margin growth lever, while maintaining its core differentiation through \"high quality... generally lower than national brands\" and alignment with member demand. The risk disclosures also highlight heightened supplier dependency and market volatility as key challenges to sustaining this trajectory.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44880,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11433,
        "completion_tokens": 240,
        "total_tokens": 11673
      }
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "From 2022 to 2024 the Asia Pacific/Middle East proved‑reserve base showed a clear upward trend.  In 2022 the region held about 2,109 billion cubic feet of natural‑gas reserves and 1,058 million barrels of natural‑gas‑liquids; by the end of 2024 those figures had risen to roughly 3,162 billion cubic feet of gas and 1,112 million barrels of NGLs.  The growth was driven primarily by extensions and discoveries in the Lower 48 unconventional plays (especially the Permian Basin) and by purchases—most notably the 2024 acquisition of Marathon Oil, which added reserves in both the Lower 48 and Africa—as well as ongoing revisions that added several hundred billion cubic feet of gas and tens of millions of barrels of NGLs.  Consequently, the volume of proved reserves in the Asia Pacific/Middle East region expanded markedly over the three‑year period, with both gas and NGL components increasing substantially.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 167,
          "pages": [
            165,
            166,
            167,
            168,
            169
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 79039,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19989,
        "completion_tokens": 227,
        "total_tokens": 20217
      }
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F evolved from a leased fleet to a phased acquisition strategy focused on modernization and fuel efficiency. As of May 31, 2022, FedEx operated 114 owned Boeing 767F aircraft, with no leased 767Fs, and had committed to purchasing 38 additional 767Fs through 2025 (including 14 in 2023 and 14 in 2024), as detailed in the 2022 10-K's Aircraft Purchase Commitments table. By 2024, the company continued this modernization effort, with updated commitments showing 11 767F deliveries scheduled for 2025 and 3 for 2026, reflecting a strategic shift toward acquiring newer, more efficient aircraft to replace older models like the MD-11 and support long-term operational cost savings, as evidenced by the $1.3 billion in aircraft purchase deposits and progress payments noted in the 2022 filing and the $611 million in deposits referenced in the 2024 10-K.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40607,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10376,
        "completion_tokens": 230,
        "total_tokens": 10606
      }
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks' inventory value increased significantly, rising from $2,176.6 million in 2022 to $2,605.8 million in 2024, driven by higher coffee (both unroasted and roasted) and other merchandise balances. Concurrently, the company invested in expanding its roasting infrastructure, adding new facilities such as a 1,957,000‑sq‑ft roasting and distribution center in York, PA, and upgrading equipment at locations like the Minden, NV site, supporting greater roasting capacity and supply‑chain resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42567,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10859,
        "completion_tokens": 130,
        "total_tokens": 10990
      }
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "PepsiCo's 2.750% Senior Notes due 2025 were initially issued in March 2020 (as referenced in the 2020 8‑K filing) and later re‑authorized in February 2023 through the Board of Directors’ resolutions that also covered other senior note series. This evolution reflects the 2020 issuance and the subsequent 2023 Board approval that reaffirmed the terms of the 2.750% notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16636,
        "completion_tokens": 92,
        "total_tokens": 16728
      }
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "From 2022 to 2024 FedEx’s planned utilization of the B777F aircraft increased markedly: the 2022 purchase‑commitment table shows only 2 B777Fs scheduled for delivery in 2023 and 4 in 2024, while the 2024‑2025 commitments list 2 B777Fs for 2025 and 2 for 2026, and the 2024 aircraft‑commitment table adds 2 B777Fs to the 2025 schedule. This expansion reflects a strategic shift toward a newer, more fuel‑efficient fleet to replace older aircraft and generate long‑term operating savings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39428,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10081,
        "completion_tokens": 121,
        "total_tokens": 10202
      }
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "From 2022 to 2024, Starbucks’ foreign‑currency‑related derivative gains in AOCI fell sharply—from $55.3 million in 2022 to $11.5 million in 2024—reflecting lower foreign‑exchange volatility and the reclassification of $9.5 million of gains into earnings. This decline shows the company’s hedging program is effectively reducing its exposure to foreign‑currency fluctuations, as fewer gains remain deferred and more are realized in earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65781,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16689,
        "completion_tokens": 110,
        "total_tokens": 16799
      }
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "PepsiCo's engagement with the 2.625% Senior Notes due 2026 has evolved through the addition of new series and related indentures in its 2023 and 2024 disclosures. In the 2023 filing (PEP_10k_2023.pdf, pages 128–132), the company referenced the 2.625% Senior Notes due 2026 as part of its broader debt instrument framework, with specific board resolutions authorizing their terms (page 4.65). By the 2024 filing (PEP_10k_2024.pdf, pages 128–132), PepsiCo expanded its disclosures to include updated terms for the 2.625% Senior Notes due 2026 within a comprehensive list of debt authorizations (page 4.65), while also introducing new global notes under a February 2024 indenture (pages 4.70–4.75), reflecting ongoing refinements to its debt structure and governance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16636,
        "completion_tokens": 191,
        "total_tokens": 16827
      }
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "From 2022 to 2024 Cisco’s reliance on overcoming technical hurdles has shifted from primarily product‑development challenges to a broader set of strategic investments that underpin its growth agenda. In 2022 the focus was on “technical hurdles” that could delay new product introductions and market adoption, but by 2024 the company explicitly ties those hurdles to its long‑term investments in areas such as AI, cloud, cybersecurity and end‑to‑end security architectures, noting that delayed or insufficient returns on these investments could harm operating results. This evolution reflects a move from merely clearing technical obstacles to embedding those obstacles within a larger portfolio of strategic priorities and product‑development timelines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 55469,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14098,
        "completion_tokens": 188,
        "total_tokens": 14287
      }
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Based on the provided financial disclosures, Google Ad Manager's role in driving Google Network revenues grew significantly between 2022 and 2023. Specifically, Google Network revenues increased by $8.6 billion from 2020 to 2021 (as noted in the 2021 financial results), and the 2023 financials show continued strength in this segment with operating cash flow heavily reliant on advertising products, including those delivered through Ad Manager. The document explicitly states that Google Network revenues were driven by \"strength in AdMob, Google Ad Manager, and AdSense\" in 2021, and the 2023 financials reflect sustained growth in advertising revenue streams, confirming Ad Manager's critical role in monetizing Google's network properties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44851,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11444,
        "completion_tokens": 186,
        "total_tokens": 11630
      }
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Starbucks’ foreign‑currency‑related derivative liabilities (the “Foreign currency – other” line in the AOCI table) declined from **$55.3 million** of net gains in 2022 to **$11.5 million** of net gains in 2024, a reduction of **$43.8 million** (≈ 79 %). This represents the magnitude of the change in those derivative liabilities over the two‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18725,
        "completion_tokens": 97,
        "total_tokens": 18822
      }
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo issued its 4.600% Senior Notes due 2045 in February 2023 (4.650% Senior Notes due 2053) and again in July 2024 (4.800% Senior Notes due 2034), reflecting a strategic extension of debt maturities to manage interest costs and diversify funding sources. This evolution underscores PepsiCo's focus on maintaining a flexible, long-term debt structure while capitalizing on favorable market conditions to secure low-cost financing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16637,
        "completion_tokens": 108,
        "total_tokens": 16745
      }
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "ConocoPhillips has significantly expanded its natural gas reserves and production in the Asia Pacific/Middle East region through strategic acquisitions (notably Marathon Oil in 2024) and targeted development drilling, particularly in unconventional plays like the Permian Basin. This expansion is reflected in the 2024 reserve figures showing substantial growth in Asia Pacific/Middle East reserves (from 50 million barrels of NGLs and 48 billion cubic feet of gas at end-2023 to 62 million barrels of NGLs and 62 billion cubic feet of gas at end-2024), indicating a clear strategic pivot toward increasing its presence and resource base in this high-growth region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 173,
          "pages": [
            171,
            172,
            173,
            174,
            175
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74215,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18783,
        "completion_tokens": 166,
        "total_tokens": 18949
      }
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Alphabet's non-advertising revenue strategy evolved from being a modest contributor to a more strategically emphasized revenue stream. In the 2023 filing, Google Play is explicitly listed alongside hardware and YouTube non-advertising as a dedicated non-advertising revenue source within Google Services, reflecting its growing importance. The 2022 filing similarly identifies Google Play as generating revenue from app and in-app purchases, but the 2023 filing underscores its expanded role by integrating it into the broader \"products and services beyond advertising\" category alongside YouTube Premium and hardware, indicating a deliberate shift to highlight its contribution to diversifying revenue beyond ads. This strategic emphasis aligns with Alphabet's long-term focus on investing in platforms like Google Play to drive sustainable, non-advertising growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49057,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12487,
        "completion_tokens": 226,
        "total_tokens": 12714
      }
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "The projected utilization of the Cessna SkyCourier 408 has increased from 11 aircraft scheduled for delivery in 2023 to 17 aircraft for 2025, reflecting FedEx’s strategic commitment to expanding its regional delivery network and replacing older, less fuel‑efficient aircraft with newer, more efficient models. This growing reliance on the SkyCourier underscores FedEx’s intent to strengthen its last‑mile and regional logistics capabilities while supporting long‑term cost‑saving initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39428,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10087,
        "completion_tokens": 123,
        "total_tokens": 10210
      }
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "Between 2022 and 2023, AIG’s expected loss ratio methods continued to be applied primarily to the most recent accident years, with segmentation refined to separate automobile-related claims (short‑tail) from non‑automobile lines (including construction defects and mass‑tort exposures). The analysis further divided non‑automobile claims by attachment‑point bands to reflect how higher attachment points affect reporting delays. For the latest three accident years, expected loss ratios were derived from older years’ ultimate loss ratios adjusted for rate changes, inflation, and market trends, while COVID‑19‑related disruptions were considered where identifiable. This approach maintained the same methodological structure but increased reliance on expected loss ratios for newer business and incorporated more granular segmentation of casualty lines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 263,
          "pages": [
            261,
            262,
            263,
            264,
            265
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 260295,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 65300,
        "completion_tokens": 213,
        "total_tokens": 65513
      }
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "The classification and reporting of unallocated products shifted from being grouped under “Others” (which included products not allocated to Men’s, Women’s, NIKE Kids’ and Jordan Brand) in the 2022 filing to being explicitly separated within the new consumer‑centric construct of Men’s, Women’s, NIKE Kids’ and Jordan Brand beginning in fiscal 2022, with unisex products now placed in Men’s and Jordan Brand revenues reported separately. This re‑classification was part of the Consumer Direct Acceleration strategy and was reflected in the fiscal 2022 and subsequent fiscal 2023/2024 financial tables.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43253,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11045,
        "completion_tokens": 150,
        "total_tokens": 11195
      }
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolved from its initial issuance in March 2020 (referenced in 2020 8-K filings) to a more prominent role in its debt management strategy by 2024, as evidenced by its inclusion in the Board of Directors' resolutions authorizing new term authorizations for multiple note series, including the 3.500% Senior Notes due 2025. This reflects a strategic approach to refinancing and managing debt maturities, ensuring continuity in funding while optimizing the company's overall debt profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16638,
        "completion_tokens": 136,
        "total_tokens": 16774
      }
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, ConocoPhillips’ capital expenditures in the Lower 48 region increased markedly, rising from $1.88 billion in 2022 to $3.13 billion in 2023 and then to $3.13 billion again in 2024 (the 2024 figure reflects the consolidated amount that includes the Lower 48 segment).  At the same time, the company revised its outlook for future cash inflows tied to proved reserves in the Lower 48, reducing the projected future cash inflows from $195.6 billion (2022) to $164.3 billion (2024) after accounting for lower commodity prices and updated cost assumptions, while the discounted future net cash‑flow value for the segment fell from $55.9 billion (2022) to $38.7 billion (2024).  These adjustments reflect a downward revision of expected cash receipts and a corresponding reduction in the present‑value of future cash flows for the Lower 48 operations over the three‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 158,
          "pages": [
            156,
            157,
            158,
            159,
            160
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60167,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15272,
        "completion_tokens": 223,
        "total_tokens": 15495
      }
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Comcast's financial commitments to Atairos were reduced from up to $5 billion to up to $4.5 billion, with annual capital calls capped at $400 million and a separate $40 million annual management‑fee commitment, while its economic interest remains approximately 86 % of residual returns and it must absorb roughly 99 % of losses. The 2023 amendment extended the investment term to 16.5 years and clarified capital‑recycling rules, but the governance structure remains unchanged: Atairos is a VIE that Comcast does not consolidate, retaining only consent rights and no voting control. In contrast, the 2024 proxy filing shows that the Fourth Amended and Restated Shareholders Agreement (dated April 15 2022) and its June 2 2023 amendment continue to govern the relationship, preserving the same VIE treatment and the absence of control over key economic activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57151,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14519,
        "completion_tokens": 215,
        "total_tokens": 14734
      }
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "Between the 2022 and 2023 filings, FedEx's projected utilization of the Cessna SkyCourier 408 increased significantly—from 11 aircraft expected for delivery in 2023 to 17 aircraft for 2025 and 14 for 2026, reflecting a strategic shift toward greater reliance on this turboprop for regional and feeder‑lane operations. This expansion contrasts with the modest or static commitments for larger jets, indicating that the SkyCourier is being positioned as a key component of FedEx’s cost‑effective, high‑frequency network rather than as a supplemental asset, underscoring its growing strategic role relative to other aircraft types.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39812,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10187,
        "completion_tokens": 157,
        "total_tokens": 10344
      }
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "From 2022 to 2024, Nike's approach to the Air Max product line evolved with a stronger emphasis on technological innovation and greater transparency in revenue reporting. The company continued to highlight Air Max innovations (e.g., Air Max 270, Air Max 2090) while integrating them into its broader product strategy, though specific revenue figures for Air Max were not disclosed in the provided 10-K filings. Revenue transparency improved through detailed segment reporting in Note 15 (Accumulated Other Comprehensive Income) and Note 16 (Revenues), which broke down sales by geography, product line, and distribution channel, but did not isolate Air Max-specific revenue. Technological advancements remained a core focus, with Air Max technologies continuing to drive product differentiation and marketing narratives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56457,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14337,
        "completion_tokens": 205,
        "total_tokens": 14542
      }
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "From 2023 to 2024, Comcast’s capital‑expenditure strategy shifted toward greater investment in Epic Universe, with theme‑park capital spending rising to support the new Universal Studios park.  In 2023 the company allocated roughly $8.2 billion to Connectivity & Platforms, while 2024 saw continued spending on scalable infrastructure and line extensions, plus an increased focus on theme‑park projects—including $8.3 billion of total capex in 2024, a portion of which was earmarked for Epic Universe.  This reflects a thematic‑park development priority that now emphasizes expanding Universal’s global footprint (e.g., Epic Universe) alongside traditional network upgrades.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41433,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10591,
        "completion_tokens": 168,
        "total_tokens": 10759
      }
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Based on the provided 10-K filings, FedEx's utilization of ATR 72-600F aircraft evolved as follows between 2022 and 2023 planning periods: In 2022, the company had 6 ATR-72 600F aircraft in its fleet (as shown in the May 31, 2022 fleet table on page 39 of FDX_10k_2022.pdf), and its purchase commitments table (page 40) projected 6 deliveries of the ATR 72-600F for 2023. By 2023 planning, the company's commitments table (page 41 of FDX_10k_2022.pdf) showed 6 ATR 72-600F aircraft scheduled for delivery in 2023, maintaining the same quantity but reflecting the ongoing commitment to this aircraft type as part of its fleet modernization strategy. The 2023 10-K (pages 115-119) does not show a change in the aircraft type's utilization but confirms the continued presence of ATR 72-600F in the fleet composition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39812,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10177,
        "completion_tokens": 203,
        "total_tokens": 10380
      }
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Nike's approach to estimating product return reserves evolved from $269 million in 2021 to $194 million in 2022, reflecting a deliberate reduction in the reserve balance as part of its broader revenue‑recognition methodology. This decline indicates that the company is adjusting its estimates of future returns—likely due to improved demand forecasting, tighter inventory controls, or changes in return‑policy assumptions—thereby affecting the timing and amount of revenue recognized.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53599,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13631,
        "completion_tokens": 121,
        "total_tokens": 13752
      }
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "The Cessna SkyCourier 408 fleet plan shows 11 aircraft scheduled for delivery in 2023, increasing to 12 in 2024 and 12 in 2025 before declining to 14 in 2026, indicating a strategic shift toward larger, more fuel-efficient aircraft (B777F/B767F) for long-haul operations while maintaining a reduced but steady SkyCourier commitment for regional package delivery. This reflects FedEx's strategic reliance on the SkyCourier for specific regional needs but its broader fleet modernization prioritizing larger aircraft to replace older models and achieve long-term fuel savings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39326,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10072,
        "completion_tokens": 143,
        "total_tokens": 10215
      }
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard’s real-time account-based payments infrastructure has expanded its operational scale significantly, now supporting real-time clearing and settlement infrastructure in 13 markets as of December 31 2023, and enabling instant account‑to‑account payments for consumers, businesses, governments and merchants worldwide.  The company has reinforced this capability with a multi‑layered security framework that embeds privacy‑by‑design, AI governance and robust fraud‑scoring, tokenization and other real‑time risk controls across its distributed, peer‑to‑peer network, ensuring both scalability and integrated protection for all ecosystem participants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54324,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13808,
        "completion_tokens": 164,
        "total_tokens": 13972
      }
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Between 2022 and 2024, Nike's use of foreign exchange forwards and options evolved in three key ways: First, the notional amount of outstanding foreign currency derivatives designated as cash flow hedges decreased from $18.5 billion (as of May 31, 2022) to $16.2 billion (as of May 31, 2024), reflecting a strategic reduction in hedge volume. Second, the company continued to manage foreign currency exposure through its factory currency adjustment program, where embedded derivatives were created upon factory purchase order acceptance for non-functional currency exposures, with the total notional amount of embedded derivatives remaining stable at approximately $584 million. Third, the company maintained its hedging policy of entering contracts 12-24 months in advance and hedging up to 100% of exposures, with approximately $231 million of deferred net gains expected to be reclassified to net income over the next 12 months as of May 31, 2024. These derivatives continue to be used to mitigate foreign currency risks in product costs, revenues, and other transactions, with effective hedge results flowing through the same income statement lines as the underlying exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65162,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16518,
        "completion_tokens": 295,
        "total_tokens": 16813
      }
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "Between 2022 and 2023, Puffs remained classified within the Baby, Feminine & Family Care segment in both years, with no change in its category classification. The segment's net sales were flat (0% growth), and Puffs contributed to the segment's overall performance, which saw low single-digit organic sales growth in Baby, Feminine & Family Care. The classification itself did not evolve during this period, as Puffs continued to be grouped under this segment in both the 2022 and 2023 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12926,
        "completion_tokens": 123,
        "total_tokens": 13050
      }
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax remained within the Baby, Feminine & Family Care segment, which held 25% of net sales and 23% of net earnings in both years. Its categorization as part of the Feminine Care sub-category (alongside Always and Always Discreet) was unchanged, with Tampax consistently positioned as a leading global brand in this category, maintaining over 20% global market share. The document does not indicate any structural repositioning or reclassification of Tampax within P&G's portfolio during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12936,
        "completion_tokens": 131,
        "total_tokens": 13067
      }
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Oracle's strategy shifted toward cloud and license offerings, with cloud services and license support revenues growing 5% year-over-year in fiscal 2022 (6% constant currency) and representing 84% of total revenue in fiscal 2023. This growth drove a 5% increase in total research and development expenses (5% constant currency), reflecting strategic investment in cloud infrastructure and R&D to support future growth, while cloud and license business margins remained stable at 67% (slightly down from 68% in fiscal 2022 due to expense growth outpacing revenue gains).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53432,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13592,
        "completion_tokens": 142,
        "total_tokens": 13734
      }
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell’s investment in private funds for its non-U.S. pension plans remained relatively stable in fair value hierarchy classification. The non-U.S. private fund investments were classified as Level 3 assets, with balances increasing from $33 million (2021) to $36 million (2022) and then to $74 million (2023), reflecting ongoing investments and market adjustments. These holdings were consistently categorized under Level 3 in the fair value hierarchy, indicating they were not traded on active markets and required significant management judgment for valuation. The Company continued to use Level 3 classifications for private fund investments in both U.S. and non-U.S. plans, with non-U.S. private funds specifically reported as Level 3 in the fair value tables for 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57599,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14636,
        "completion_tokens": 200,
        "total_tokens": 14836
      }
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "The 2014 USD Notes (3.375% Senior Notes due April 2024) were fully retired in early 2024 when the company paid off the $1 billion principal maturing in April 2024.  In 2024 the company issued new long‑term debt, including $1 billion of 2034 notes, $750 million of 2028 notes and $1.15 billion of 2032 notes plus $1.10 billion of 2035 notes (the “2024 USD Notes”), raising a net $3.96 billion of proceeds.  These actions reduced short‑term debt (the 2014 notes and the INR term loan) and increased total long‑term debt to $18.2 billion, with the next maturity of $750 million of principal scheduled for March 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50931,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12954,
        "completion_tokens": 153,
        "total_tokens": 13107
      }
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "Based on the provided SEC filings, Lowe's treatment of officer indemnification agreements shows a clear evolution in governance continuity and risk management. The 2022 filing (10-K) includes Form 10.23 (\"Form of Lowe's Companies, Inc. Officer Indemnification Agreement\") as a current exhibit, while the 2024 filing (10-K) adds Form 10.24 (\"Form of Lowe's Companies, Inc. 2021 Restricted Stock Award Agreement\") and Form 10.25 (\"Form of Lowe's Companies, Inc. 2021 Performance Share Unit Award Agreement\") under new exhibit numbers, indicating updated governance documentation. This reflects a systematic approach to executive risk management, with consistent renewal and modernization of officer protection frameworks—evidenced by the 2023 amendment to the Severance Plan (10.28) and the 2023 credit agreement updates—demonstrating sustained governance continuity without structural changes to indemnification terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 36559,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9377,
        "completion_tokens": 229,
        "total_tokens": 9607
      }
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "Based on the provided 10-K filings, Always Discreet's market share and category positioning within the adult incontinence segment remained consistent between 2022 and 2023. In the 2022 filing (page 17), P&G described Always Discreet as holding \"over 10% market share in the key markets in which we compete\" within the adult incontinence category, positioning it as a global market leader behind Pampers. The 2023 filing (page 18) similarly states Always Discreet maintains \"over 10% market share in the key markets in which we compete\" in the adult incontinence category, confirming no significant change in its market share position or category leadership role between the fiscal years ending June 30, 2022 and June 30, 2023. The company continued to emphasize its leadership in feminine care (including Always Discreet) as part of its broader market positioning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12935,
        "completion_tokens": 216,
        "total_tokens": 13151
      }
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Between 2022 and 2023, Oracle's strategic positioning of Engineered Systems shifted from a standalone hardware business to a tightly integrated component of its cloud transformation narrative, particularly through deeper alignment with Oracle Cloud Infrastructure (OCI). The 2023 10-K emphasizes that Engineered Systems—such as Exadata, Exadata Cloud@Customer, and Oracle Roving Edge Infrastructure—are now explicitly positioned as core enablers for OCI, serving as pre-integrated, optimized platforms that accelerate cloud migration, hybrid deployment, and multi-cloud architectures. This evolution underscores a strategic pivot where hardware is no longer a standalone revenue stream but a critical enabler of Oracle's cloud services, reinforcing the narrative that Oracle's cloud transformation is built on a foundation of engineered systems designed for performance, security, and seamless integration across on-premise, OCI, and hybrid environments. Consequently, the hardware business now directly supports and validates Oracle's cloud positioning, with Engineered Systems acting as a key differentiator in OCI's value proposition for enterprise customers seeking to modernize infrastructure while leveraging Oracle's cloud services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47427,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12095,
        "completion_tokens": 309,
        "total_tokens": 12405
      }
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "The disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan remained consistent between the 2022 and 2023 10-K filings, both confirming that the 2020 Stock Plan is the successor to the 2011 Stock Plan and that it authorized 17.5 million new shares for award grants. However, the 2023 filing expanded the stock option activity details, including updated figures for shares granted, exercised, and expired under the 2020 Plan (e.g., 3.69 million shares granted in 2023 versus 1.56 million in 2022), while maintaining the same structural description of the plan's purpose and succession.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45052,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11482,
        "completion_tokens": 152,
        "total_tokens": 11634
      }
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell's allocation strategy toward private funds shifted significantly between 2022 and 2023, with private fund investments increasing from $1,105 million (2022) to $1,265 million (2023) in U.S. plans and from $65 million (2022) to $115 million (2023) in non-U.S. plans, while also expanding the use of private fund investments in non-U.S. plans from $36 (Level 2) to $41 (Level 3) and increasing the total fair value of private fund investments from $1,105 million to $1,265 million. This expansion, particularly the $160 million increase in U.S. private fund investments and the $50 million rise in non-U.S. private fund investments, indicates a strategic shift toward greater allocation to alternative investments, likely reflecting a deliberate capital deployment priority to enhance long-term returns amid evolving market conditions and to diversify the portfolio beyond traditional fixed income and equity holdings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62257,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15793,
        "completion_tokens": 231,
        "total_tokens": 16024
      }
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B-2 Common Stock transitioned from having no outstanding shares to 120 million shares issued and outstanding (as reflected in the 2024 equity tables), while its as-converted share count increased from 0 to 186 million. This evolution was directly tied to the January 2024 exchange offer where Class B-1 shares were retired and converted into Class B-2 and Class C shares, with the Class B-2 conversion rate adjustments having double the impact of Class B-1 adjustments. The shares were issued as part of Visa's restructuring of its Class B common stock, which included redenomination to Class B-1 and new exchange mechanisms, and the Class B-2 shares now participate in the same dividend and conversion rights as other classes, though they remain subject to transfer restrictions until U.S. litigation is resolved.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65336,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16561,
        "completion_tokens": 210,
        "total_tokens": 16771
      }
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The Target Circle loyalty program liability increased from $72 million in 2021 (reported in the 2022 10‑K) to $19 million in 2024 (reported in the 2024 10‑K), reflecting a decline in deferred revenue from the program. This reduction indicates that Target has scaled back or restructured its Circle rewards, likely shifting away from the earlier 1 % rewards model toward a more limited or differently structured loyalty offering.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41770,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10666,
        "completion_tokens": 107,
        "total_tokens": 10773
      }
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes increased from $1,111 million at the end of 2022 to $1,111 million at the end of 2023 (the table shows identical values, indicating no material change), suggesting that market conditions and investor perception of the notes remained stable over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44119,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11261,
        "completion_tokens": 76,
        "total_tokens": 11337
      }
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, Visa’s equity structure underwent significant changes related to its Class B common stock. In May 2024, the company executed a Class B-1 common stock exchange offer, accepting 241 million shares of Class B-1 common stock tendered, and in exchange issued approximately 120 million shares of Class B-2 common stock and 48 million shares of Class C common stock. This exchange modified the composition and classification of its equity, introducing new classes of common stock and adjusting the outstanding shares of each class. Additionally, in July 2024, Visa released $2.7 billion of as-converted value from its Series B and C preferred stock and issued 99,264 shares of Series A preferred stock in connection with the eighth anniversary of the Visa Europe acquisition, further evolving its equity structure. These transactions reflect a strategic reorganization of share classes to facilitate future conversions and align with corporate governance and capital management objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58585,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14868,
        "completion_tokens": 251,
        "total_tokens": 15119
      }
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "From 2022 to 2024, Lowe's expanded its focus on Rough Plumbing within its product classification, integrating it under the broader \"Building Products\" category (which includes Rough Plumbing as a subcategory) and increasing its sales contribution—from 31.5% of total sales in 2021 to 32.4% in 2022—reflecting growing strategic emphasis on this segment. Additionally, Lowe's enhanced its service offerings around Rough Plumbing through its installation services and protection plans, supporting project-based sales, while maintaining its classification as part of the single home improvement retail segment with no structural business reclassification.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45910,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11697,
        "completion_tokens": 162,
        "total_tokens": 11860
      }
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "The Class B‑2 common stock was created only after the Class B‑1 exchange offer was completed in May 2024, when Visa issued roughly 120 million new Class B‑2 shares (and 48 million Class C shares) in exchange for the tendered Class B‑1 shares, which were then retired.  This issuance introduced a new class of stock that will be subject to conversion‑rate adjustments that are twice as impactful as those for Class B‑1, and it reflects Visa’s strategy of restructuring its capital structure to accommodate the resolution of U.S. litigation and to provide a vehicle for future equity‑based transactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67872,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17196,
        "completion_tokens": 150,
        "total_tokens": 17346
      }
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "Between 2022 and 2024, the financial liability associated with the Target Circle program decreased significantly, from $170 million in 2022 to $19 million in 2024 (as reflected in the 2024 Form 10-K's gift card and loyalty program liabilities). This reduction indicates that the Target Circle program has matured and become more stable, with a smaller deferred revenue obligation reflecting lower future reward redemption costs. The decline suggests the program's growth has stabilized rather than expanding rapidly, as the liability associated with unredeemed rewards and program benefits has diminished substantially over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34298,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8800,
        "completion_tokens": 161,
        "total_tokens": 8961
      }
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVIDIA’s 2024 10‑K shows that concerns about pollution limits and related regulatory constraints have grown rather than receded.  In the “Climate change” section the filing notes that new or proposed regulations on carbon taxes, fuel/energy taxes, pollution limits and sustainability‑related disclosure “could result in greater direct costs… and greater indirect costs… that could harm our business.”  The company also warns that climate‑related laws may force changes to manufacturing processes, increase capital expenditures, and raise compliance and energy costs.  By contrast, the 2023 filing contains only a brief mention of climate‑related risks and does not discuss potential regulatory cost impacts.  Thus, exposure to and concern about pollution‑related regulations has clearly expanded between 2023 and 2024, with a direct focus on how such rules could affect NVIDIA’s operations and the data‑center expansion of its customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64832,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16438,
        "completion_tokens": 234,
        "total_tokens": 16673
      }
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "Between 2023 and 2024, the composition of the company's Guaranteed Senior Notes underwent specific changes: the Japanese subsidiary issued approximately $500 in new Guaranteed Senior Notes in November 2023, which were later partially repaid ($77 in July 2024), and the parent company retired $1,000 of 2.750% Senior Notes using cash and short-term investments on May 18, 2024. Fair value inputs for these instruments remained consistent with prior reporting—Level 2 for U.S. Senior Notes and Level 3 for the Japanese subsidiary's notes—though the carrying value of long-term debt decreased from $6,484 (2023) to $5,919 (2024), reflecting repayments and maturities. The fair value of the remaining long-term debt was approximately $5,412 at the end of 2024, down from $5,738 in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31494,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8102,
        "completion_tokens": 195,
        "total_tokens": 8297
      }
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024 Netflix’s streaming‑service investment continued to expand, with the company reporting higher spending on technology and development ($2.27 bn in 2021, up 24% YoY) and on marketing ($2.55 bn in 2021, up 14% YoY) to support “improvements to our streaming service,” while also increasing personnel‑related costs across all functional areas.  The 2024 filing notes that the Board authorized an additional $15 bn stock‑repurchase program and that cash, cash equivalents and restricted cash fell to $6.06 bn (down 27% YoY), reflecting the heavy use of cash for content acquisitions, marketing, streaming‑delivery infrastructure and debt repayments.  Cyber‑risk disclosures highlight a dedicated security organization led by a VP with 30 years’ experience, regular penetration testing, bug‑bounty programs, and third‑party audits, but also warn that any significant breach or service disruption could materially harm the business.  Overall, Netflix’s risk exposure to streaming‑service enhancements grew in scope—driven by larger technology and development budgets, higher personnel costs, and intensified cybersecurity monitoring—while its financial position showed tighter cash reserves and greater reliance on debt financing to fund continued content and infrastructure investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58423,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14842,
        "completion_tokens": 324,
        "total_tokens": 15166
      }
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Based on the provided SEC filings, the evolution of The Bank of New York Mellon Corporation's approach to restricted stock unit (RSU) agreements and executive compensation strategy is evident in the progression of documentation from 2023 to 2024. The 2023 filings (Exhibits 10.23–10.26) detail the formal adoption of RSU agreements under the 2023 Long-Term Incentive Plan, while the 2024 filings (Exhibits 10.28–10.29) reflect a strategic refinement, including the amendment of the Executive Severance Plan (Exhibit 10.30) and the introduction of updated 2024 RSU agreements that likely incorporate enhanced lifecycle management practices. This evolution underscores a deliberate shift toward greater alignment of equity compensation with long-term performance metrics and executive retention goals, as evidenced by the structured updates to RSU terms and severance provisions in consecutive filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44759,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11441,
        "completion_tokens": 225,
        "total_tokens": 11666
      }
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes issued in November 2023 (maturing April 15, 2029) had a gross carrying amount of $750 million and a net carrying amount of $743 million as of January 28, 2024; by February 2, 2025 the gross amount remained $750 million but the net amount increased slightly to $744 million after amortization of the $3.4 million discount. Their maturity timeline places the principal repayment in fiscal 2029, with scheduled principal payments of $750 million in fiscal 2025, $1,750 million in fiscal 2026, and $30,250 million thereafter.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52213,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13275,
        "completion_tokens": 136,
        "total_tokens": 13411
      }
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "The issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolved as follows: In November 2023 the subsidiary issued four Guaranteed Senior Notes totaling approximately $500 million with fixed rates of 1.400%‑2.120% and maturities extending to 2033‑2043. In July 2024 the subsidiary repaid $77 million of those notes, and on May 18 2024 the parent company retired the $1,000 million balance of its own 2.750% Senior Notes, leaving the Japanese‑subsidiary notes as the remaining long‑term debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33259,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8530,
        "completion_tokens": 130,
        "total_tokens": 8660
      }
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "The risk from competitors developing after‑market parts for DHR’s products has grown modestly from 2022 to 2023, now being highlighted as a specific concern under “Business and Strategic Risks” in the 2023 filing. While the earlier 2022 filing only mentioned competition generally, the 2023 document explicitly notes that “Competitors may also develop after‑market services and parts for our products which may detract from our sales,” indicating that such competitive pressure has become a more material factor that could erode DHR’s market share and negatively affect its revenue and financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45313,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11564,
        "completion_tokens": 151,
        "total_tokens": 11715
      }
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix evolved its membership plans by expanding pricing flexibility and introducing new features to address slowing subscriber growth and macroeconomic pressures. The company implemented price increases across most markets (notably raising the U.S. standard plan from $13.99 to $15.49 in early 2023), introduced a lower-cost ad-supported tier (launched in late 2022), and tested regional pricing variations to improve affordability in key markets. These changes aimed to counteract intense competition from rivals like Disney+ and Max, mitigate subscriber churn amid inflation, and offset rising content costs—particularly as production delays from the pandemic slowed revenue growth relative to fixed content expenses. The ad-supported plan, now available in over 100 countries, specifically targeted price-sensitive users while maintaining revenue growth through higher ARPU (average revenue per user).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58361,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14825,
        "completion_tokens": 231,
        "total_tokens": 15056
      }
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Boeing’s approach to in‑orbit incentive payments has remained consistent in structure—recognizing revenue during the construction period based on the estimated net present value of future in‑orbit fees—but the risk profile and financial recognition have shifted. In 2023 the company disclosed that many of its development contracts now include in‑orbit incentive payments that are contingent on long‑term satellite performance, exposing Boeing to potential refunds and loss of revenue if the spacecraft fails to meet specifications. Consequently, while the timing of revenue recognition has not changed, the exposure to financial risk has increased, leading to greater reliance on reach‑forward loss accounting and more frequent reassessment of the collectability of these incentive payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 31868,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8188,
        "completion_tokens": 198,
        "total_tokens": 8386
      }
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "The Directors' Code of Conduct was first made publicly accessible on BNY Mellon’s website in 2023 (via the “code-of-conduct.pdf” link) and remained available in 2024 through the same URL, with an explicit statement that any amendments or waivers to the code—including those affecting directors—would be disclosed on the website. No new version or separate posting was noted for 2024; the 2023 disclosure continued to serve as the current reference.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35180,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9003,
        "completion_tokens": 112,
        "total_tokens": 9115
      }
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, Mobileye Drive™ evolved from a development-stage platform into a production-deployed solution for Level 4 autonomy. It expanded its commercial deployments, including Robotaxi services in Germany (via SIXT) and Tel Aviv, secured design wins with OEMs like Geely and Polestar, and advanced its hardware roadmap with the EyeQ5 and EyeQ6L/H SoCs—designed for scalable, cost-efficient autonomous driving—while continuing to leverage its REM mapping and True Redundancy™ technologies to support broader ADAS and AV applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31766,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8148,
        "completion_tokens": 136,
        "total_tokens": 8284
      }
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "From 2022 to 2024, the structure of AT&T’s preferred equity in Tower Holdings evolved from a fixed-rate, reset‑every‑five‑year preferred interest (Class A‑1 at 5.0% and Class A‑2 at 4.75% with a $6,000 aggregate value) to a dual‑class redesign effective November 2024. The 2019 Tower preferred interests were amended to create Fixed‑Rate Class A Limited Membership Interests that now pay a higher 5.90% distribution and will transition over five years to Floating‑Rate Class A Limited Membership Interests tied to SOFR + 250 bps (potentially $525 by 2028). Redemption rights remain, with call options beginning in November 2029 (fixed rate) and anytime for the floating rate, and failure to pay distributions does not restrict cash movements or share repurchases. This restructuring reflects a shift toward higher, market‑linked rates and a staged move to floating‑rate exposure while preserving the original redemption and liquidation protections.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49956,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12699,
        "completion_tokens": 237,
        "total_tokens": 12936
      }
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The investment approach for Level 3 assets in the Balanced Index Fund remained unchanged – it is valued using a market approach based on quoted market prices of identical instruments (Level 1).  Unrealized gains/(losses) for Level 3 assets held at year‑end increased from a $90 decline in 2022 to a $14 gain in 2023, with specific gains of $2 on corporate fixed‑income, $6 on mortgage‑backed and asset‑backed securities, and $3 on other fixed‑income securities in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44176,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11264,
        "completion_tokens": 117,
        "total_tokens": 11381
      }
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "BNY Mellon’s forward‑looking disclosures in the 2024 filing show a more pronounced focus on accounting‑related risk factors—highlighting how new or revised accounting standards could materially affect its reported financial condition, results of operations, cash flows and other financial data. This shift underscores that evolving accounting frameworks have become a central element of the firm’s strategic planning and risk‑management priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34770,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8930,
        "completion_tokens": 112,
        "total_tokens": 9042
      }
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "The 2023 10‑K highlights that heightened store‑safety and cybersecurity risks—particularly the rise in organized retail crime and increasingly sophisticated cyber threats—could strain store operations, increase security‑related costs, and potentially diminish the associate experience.  In contrast, the 2022 filing emphasized engagement‑focused initiatives such as culture‑driven recognition programs, associate‑engagement surveys, and development opportunities that were credited with maintaining high associate commitment.  Consequently, while the 2022 narrative celebrated a supportive, values‑centric workplace, the 2023 disclosures suggest that new safety and cybersecurity pressures may offset those gains by adding operational stress and uncertainty for employees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53495,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13606,
        "completion_tokens": 193,
        "total_tokens": 13799
      }
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "The learning curve's impact on cost and production estimates has evolved from a significant risk driver in 2022 to a more managed factor in 2023, with reduced emphasis on its direct influence on program profitability and risk management. In 2022, the 777X program's accounting quantity adjustments and production delays (linked to learning curve challenges) triggered a $6.5 billion reach-forward loss and delayed certification, while the 787 program's production issues caused $3.5 billion in losses due to abnormal costs. By 2023, the company reported that the 777X program had \"near break-even gross margins\" at December 31, 2023, and the 787's rework costs were being managed within a $2 billion cumulative abnormal production cost estimate, indicating that learning curve-related risks were being addressed through revised production rates and quality controls rather than causing new major losses. However, the document still identifies the learning curve as a risk factor for future program profitability, particularly for the 777X and 787, noting that \"adverse changes to revenue and/or cost estimates\" could trigger earnings charges if margins shift by 1%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38591,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9878,
        "completion_tokens": 291,
        "total_tokens": 10169
      }
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "The treatment of the Dividend Reinvestment Plan (DRP) remained consistent in both the 2023 and 2024 SEC filings, with no material changes to its structure or disclosure. However, the 2024 filing (Item 9B) explicitly notes that certain officers and directors participate in the DRP and may elect to have shares withheld to cover taxes or exercise prices, which may involve Rule 10b5-1 plans or other trading arrangements, whereas the 2023 filing (Item 9B) only generally references such participation without specifying the trading mechanisms. The core DRP disclosure itself was not materially altered between the two filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35586,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9133,
        "completion_tokens": 156,
        "total_tokens": 9290
      }
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "From fiscal 2021 through fiscal 2023, The Home Depot’s investment in an interconnected shopping experience grew markedly, with capital spending on the initiative rising from $2.6 billion in fiscal 2021 to $3.2 billion in fiscal 2023. The company deepened integration across its digital and physical channels by expanding BOPIS, BORIS, BOSS and curb‑side pickup options, rolling out mobile‑enabled store navigation and real‑time inventory tools (e.g., hdPhone, Sidekick, Computer Vision), and enhancing its e‑commerce platforms and mobile apps to deliver personalized, location‑based offers and seamless order fulfillment. These changes collectively tailor the shopping journey to each customer’s intent and location, improving convenience, speed and overall experience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44295,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11308,
        "completion_tokens": 192,
        "total_tokens": 11500
      }
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "The financial relationship between DHR and Aldevron evolved significantly between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures. In 2022, DHR spent approximately $582 million on acquisitions (net of cash acquired), including $389 million of goodwill, and incurred $28 million in transaction-related costs for the Aldevron Acquisition. By 2023, DHR's acquisition activity shifted focus, with the $5.6 billion acquisition of Abcam representing a major strategic move, while the $9.6 billion Aldevron Acquisition (completed in 2021) continued to drive integration costs and goodwill amortization. Capital expenditures related to Aldevron's operations increased substantially, with DHR estimating $1.5 billion in 2022 capital spending to expand manufacturing capacity for products tied to Aldevron's capabilities, including pandemic-related testing and biopharma demand. The 2023 financial statements reflect ongoing integration costs, including $68 million in non-recurring fair value adjustments to inventory and preacquisition share-based payment settlements related to the Abcam Acquisition, alongside continued capital investment to scale Aldevron's operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46949,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11964,
        "completion_tokens": 303,
        "total_tokens": 12267
      }
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, Telco LLC’s preferred interests grew from an initial $2,000 issuance in September 2020 to $7,250 by the end of 2024, reflecting subsequent $5,250 of additional preferred interests (Class A‑2 and A‑3) issued in April 2023 and a planned $2,250 Class A‑4 issuance expected in early 2025. The distribution rates were reset as follows: the original Telco Class A‑1 interests carry a 4.25 % annual preferred distribution with a reset every seven years; the 2023‑issued Class A‑2/A‑3 interests carry a higher 6.85 % annual distribution, also resetting every seven years (next reset November 1 2027); and the forthcoming Class A‑4 interests will pay a 5.94 % annual distribution, resetting every four years beginning November 1 2028. All of these preferred interests are callable at their issue price after seven years (or earlier under specified events) and may be redeemed by the holders upon certain contingent events, with redemption prices based on accrued distributions and a fixed floor.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49956,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12721,
        "completion_tokens": 251,
        "total_tokens": 12972
      }
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "Between 2022 and 2024, AIG's use of Expected Loss Ratio Methods expanded across more lines of business, particularly in U.S. Property, U.S. Special Risk, and program business, where it is now applied to determine reserves for the latest accident year alongside ground‑up claim projections. The rationale for this expansion is to improve reserve adequacy for low‑frequency/high‑severity exposures (e.g., aviation, aerospace, marine, and certain casualty lines) and to better capture emerging trends such as inflation, rate changes, and the increasing proportion of non‑admitted coverages, while still combining these estimates with loss development methods for older accident years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 288962,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 72470,
        "completion_tokens": 170,
        "total_tokens": 72640
      }
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "Target's owned brands strategy has shifted from a focus on expanding the breadth and depth of its portfolio (highlighted in 2023 as \"strengthening our owned brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships\") to a more integrated, customer-centric approach in 2024. The 2024 filing emphasizes leveraging owned brands to \"delight with newness, style, and value\" while explicitly tying them to broader strategic pillars like \"Target Circle 360\" membership benefits (e.g., same-day delivery access) and omnichannel fulfillment, signaling a move toward deeper integration of owned brands into the customer experience rather than just portfolio growth. This evolution reflects a strategic emphasis on using owned brands to drive loyalty, enhance the digital shopping journey, and support sustainability goals, rather than solely expanding the number of brands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 25246,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6530,
        "completion_tokens": 229,
        "total_tokens": 6760
      }
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's inclusion of both the 0.875% Notes due 2030 and the newly issued 2.900% Notes due 2030 in its 2024 filing indicates a strategic shift toward longer-term, higher-yield financing amid rising interest rates, reflecting a more aggressive debt management approach to lock in capital at current market levels while maintaining flexibility. This suggests the company is capitalizing on investor demand for relatively attractive yields in a higher-rate environment, positioning itself to fund operations and investments with a more stable long-term capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52951,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13470,
        "completion_tokens": 141,
        "total_tokens": 13611
      }
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "Based on the provided 10-K filings, AT&T's long-term debt composition evolved between 2022 and 2024 through the addition of new long-term notes and the continued presence of existing instruments. Specifically, the 4.000% Global Notes due June 1, 2049 (identified as T 49A in the 2024 filing) remained part of AT&T's long-term debt structure, as evidenced by its inclusion in the 2024 list of registered securities. Additionally, the company added new long-term debt instruments during this period, including the AT&T Inc. 2.400% Global Notes due March 15, 2024 (T 24A) and other newer maturities such as the 1.800% Global Notes due September 5, 2026 (T 26D) and 2.900% Global Notes due December 4, 2026 (T 26A), reflecting a strategic shift toward issuing longer-dated, fixed-rate notes to manage the debt maturity profile. The 2022 filing (T_10k_2022.pdf) does not explicitly detail the 2049 notes or these newer additions, but the 2024 filing confirms the 4.000% 2049 notes were outstanding and part of the ongoing issuance of new long-term debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42122,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10759,
        "completion_tokens": 262,
        "total_tokens": 11021
      }
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The Heritage AspenTech acquisition generated $56 million of intangible amortization in 2022, $258 million in 2023 and $560 million in 2024, while restructuring costs related to the deal rose from $75 million in 2022 to $72 million in 2023 and $228 million in 2024, reflecting higher integration and exit‑related expenses in the later year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37271,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9544,
        "completion_tokens": 84,
        "total_tokens": 9629
      }
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG’s workers’ compensation reserve methodology has evolved from relying heavily on traditional loss development factors to incorporating more expected loss ratio and Bornhuetter‑Ferguson approaches, especially for the most recent accident years and for excess‑of‑deductible (large deductible) business. The company now segments guaranteed‑cost and excess‑of‑deductible policies by state, industry subset, deductible size and whether claims are handled internally or by third‑party administrators, and it applies distinct development patterns to these groups. This segmentation, together with the increased proportion of large‑deductible accounts that report more slowly, has led AIG to place greater weight on expected loss ratios for newer years and to adjust its tail‑factor estimates to reflect longer medical development and emerging claim trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 260,
          "pages": [
            258,
            259,
            260,
            261,
            262
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 259353,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 65078,
        "completion_tokens": 213,
        "total_tokens": 65291
      }
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "Target’s cybersecurity approach has expanded its Cyber Fusion Center operations and deepened external collaboration since 2023. In the 2024 filing, the company emphasizes a more integrated threat‑intelligence program, broader use of industry‑leading tools and internal testing (penetration testing, vulnerability scanning, attack simulation), and increased investment in talent through its Cyber Plus Institute. It also highlights formal collaboration with external organizations to share threat intelligence, best practices, and to advance capabilities across industries, reflecting a more coordinated and outward‑facing response strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43284,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11057,
        "completion_tokens": 160,
        "total_tokens": 11217
      }
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Based on the provided SEC 10-K filings, Eli Lilly's financial relationship with Baqsimi evolved significantly between 2023 and 2024 through revenue recognition and contractual arrangements. In 2023, Baqsimi generated $645.7 million in U.S. revenue and $31.9 million internationally, contributing to a total of $677.6 million, which was a major factor in the 20% consolidated revenue growth. The 2024 filing confirms Baqsimi's revenue was included in the \"Other products\" category, with the company recognizing revenue from the sale of Baqsimi rights as part of its collaboration and other arrangements, though specific 2024 revenue figures for Baqsimi are not detailed separately in the provided pages. The document notes that Baqsimi revenue was part of the $1.45 billion from the olanzapine portfolio sale in 2023, indicating the contractual transfer of rights contributed to revenue recognition, but no subsequent Baqsimi-specific revenue is reported for 2024 beyond the initial sale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47957,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12213,
        "completion_tokens": 246,
        "total_tokens": 12460
      }
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T expanded its preferred‑interest structure by issuing additional cumulative preferred interests in Telco LLC (including a $5.25 billion issuance in April 2023 and a planned $2.25 billion Class A‑4 issuance in early 2025) and by issuing $2 billion of Series B preferred interests in Mobility II.  In April 2023 AT&T also repurchased the remaining $5.4 billion of Mobility Preferred Interests, using proceeds from the Telco LLC issuance to fund the buy‑back.  These actions reflect a shift toward managing capital through the growth of Tower Holdings and Telco LLC preferred interests while retiring the older Mobility Preferred Interests.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56033,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14254,
        "completion_tokens": 165,
        "total_tokens": 14419
      }
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "Emerson's relationship with AspenTech evolved from a 57% ownership stake and AspenTech's stock-based compensation plans (including RSUs and performance units) to a proposed full acquisition at $240 per share ($15.3B market cap) in November 2024, while simultaneously exploring a sale of its Safety & Productivity segment. This transformation had significant financial impacts: gross margin increased 1.8 percentage points to 50.8% in 2024 due to the Test & Measurement acquisition (which added 9.5% to sales) and higher pricing, though partially offset by $231 million in acquisition-related inventory step-up amortization that negatively impacted margins by 1.3 percentage points. Additionally, Emerson's stock compensation expense in 2024 included $58 million in integration-related expenses from the NI acquisition (with $43 million reported as restructuring costs), and the company reserved 4 million shares for future equity compensation under its plans as of September 30, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46771,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11921,
        "completion_tokens": 246,
        "total_tokens": 12167
      }
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "Between 2022 and 2024, AIG's Japan pension plans saw a significant increase in their weighted average discount rate, rising from 1.09% (as reported for 2020) to 2.87% (for 2021) and further to 2.85% (for 2023) and 2.87% (for 2024), reflecting the application of country-specific Mercer yield curves. This change aligns with the broader trend in AIG's non-U.S. pension plans, where the discount rate for Japan specifically increased from 1.00% in 2020 to 2.85% in 2023 and 2.87% in 2024, as detailed in the 2024 Form 10-K disclosures. The weighted average discount rate for these plans was explicitly referenced as 0.52% for 2021 and 0.56% for 2020 in the 2021 filing, but the 2024 data shows a clear upward trajectory in the discount rate applied to Japan's pension obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 183,
          "pages": [
            181,
            182,
            183,
            184,
            185
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70746,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17927,
        "completion_tokens": 194,
        "total_tokens": 18121
      }
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "The 2022 10‑K framed competitive pressures as “intensifying competition from local companies that may have a substantial advantage because of their greater understanding of, and focus on, the local customer, as well as their more established local brand names,” emphasizing the risk of losing market share due to local competitors. In contrast, the 2023 filing broadened the language to describe “the inability to hire, train, retain, and manage sufficient required personnel may limit our international growth” and highlighted “different employee/employer relationships and the existence of works councils and labor unions,” shifting the narrative from purely market‑driven competition to a more systemic view of external conditions—including regulatory constraints, talent shortages, and geopolitical factors—that collectively shape the competitive environment. This evolution reflects a move from describing competition as a market‑entry challenge to portraying it as part of a broader set of structural and operational risks arising from evolving global market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49832,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12690,
        "completion_tokens": 269,
        "total_tokens": 12959
      }
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Target's exposure to port security risks has evolved from a general mention of supply‑chain disruptions tied to broader geopolitical and weather‑related events in 2023 to a more specific focus on the impact of port congestion, labor disputes and tariff‑related trade policy changes in 2024.  In the 2023 filing the discussion of port security appears only as part of a wider “political or financial instability, currency fluctuations, pandemic, labor unrest, transport capacity and costs, inflation, port security, weather conditions, natural disasters, geopolitical conflicts, terrorist attacks, armed conflicts, or other events” that could affect foreign trade.  By 2024 the language is sharper: it highlights “periodic closings and ship diversions, conflicts, labor disputes, and congestion disrupting railways, trucking, waterways, and ports around the world, including at California ports where we receive a significant portion of the products we source from outside the U.S.”  This shift reflects a geographic tightening on West Coast ports and a direct link to the company’s reliance on imported merchandise, especially from China, and to the operational impact of heightened port security and related supply‑chain volatility on inventory availability and costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51177,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13014,
        "completion_tokens": 317,
        "total_tokens": 13331
      }
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved through significant acquisition-related amortization and restructuring costs. In 2024, amortization of intangibles tied to the Heritage AspenTech acquisition increased to $258 (from $97 in 2023), while restructuring costs related to the combined entity rose sharply to $228 (from $72 in 2023), reflecting integration expenses and workforce reductions. These costs were explicitly included in the pro forma results and restructuring expense tables, with the $228 in 2024 restructuring costs encompassing $43 of integration-related stock compensation attributable to the NI acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39055,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9992,
        "completion_tokens": 168,
        "total_tokens": 10160
      }
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "Based on the provided document pages, AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024 as follows:\n\n1.  **Weight Given to Expected Loss Ratio Methods**: The Expected Loss Ratio method was given more weight for **more recent accident years** (e.g., 2021, 2022, 2023, 2024) across key lines of business like D&O, E&O, EPLI, and professional liability. This is explicitly stated in the \"Reserving Process and Methodology\" section (2021 Form 10-K, p. 267), which notes: \"Expected loss ratio methods are given more weight in the more recent accident years.\"\n\n2.  **Application Across Lines of Business**: The method was applied with specific weighting based on business characteristics:\n    *   For **D&O, E&O, EPLI, and professional liability** (including cyber and M&A coverage), Expected Loss Ratio methods were weighted more heavily for recent accident years, while loss development methods were weighted more heavily for mature accident years.\n    *   For **commercial D&O**, frequency estimates incorporated claims dismissal rates, and severity trends were analyzed using capped/excess layer approaches.\n    *   For **fidelity exposures**, Expected Loss Ratio methods were weighted for recent accident years, supplemented by claim department estimates for M&A exposure.\n    *   For **U.S. Excess Casualty**, Expected Loss Ratio methods were used for recent accident years, though loss development patterns were noted to lag significantly due to the line's nature.\n\n3.  **Impact of Recent Events**: The methodology explicitly accounts for disruptions from events like the **COVID-19 pandemic**, with adjustments made to standard projection techniques where appropriate to reflect changes in claims frequency, severity, and reporting patterns. The 2024 Form 10-K (p. 148) states: \"Recent COVID-19 related events have caused disruption in claims frequency and severity as well as reporting patterns. Where appropriate, and identifiable, adjustments have been made to standard projection techniques.\"\n\n4.  **Methodological Consistency**: The use of Expected Loss Ratio methods was consistent with the broader reserving approach described in the 2024 Form 10-K (p. 148), which states that the company uses a combination of methods (including Expected Loss Ratio) and selects the \"best estimate\" from a range of indications generated by various methods. The weight given to Expected Loss Ratio increased for newer accident years as more data became available.\n\n**In summary**: Between 2022 and 2024, AIG increasingly relied on Expected Loss Ratio methods for **newer accident years** (2021-2024) across its key liability lines (D&O, E&O, EPLI, professional liability), while continuing to use loss development methods for **mature accident years**. This weighting was explicitly tied to the nature of the business (low frequency/high severity, impact of external factors like COVID-19) and the need to reflect current trends in loss costs and market conditions. The methodology remains dynamic, with adjustments made for emerging risks and changes in underlying assumptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 270,
          "pages": [
            268,
            269,
            270,
            271,
            272
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 273698,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 68658,
        "completion_tokens": 772,
        "total_tokens": 69431
      }
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Based on the provided SEC 10-K filings, Amazon's monetization strategy for its film groups evolved significantly between 2022 and 2023, as evidenced by changes in capitalized video and music content costs and associated expenses. Specifically, the total capitalized costs of video and music content increased from $16.7 billion to $17.4 billion, while total video and music expenses rose from $16.6 billion to $18.9 billion. This indicates a strategic shift toward greater investment in content acquisition and production, with a heavier emphasis on monetization through Prime memberships and direct revenue generation, as reflected in the expanded use of capitalized assets and higher expense recognition tied to content utilization. The weighted average remaining life of capitalized video content also slightly increased to 3.5 years, suggesting longer-term monetization horizons for new releases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48616,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12382,
        "completion_tokens": 225,
        "total_tokens": 12607
      }
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, PMI's stake in RBH remained held but was ultimately impaired. In 2024, PMI recorded a $2,316 million non-cash impairment charge on its investment in RBH, reflecting a decline in the estimated fair value of the investment, which was determined to be lower than its carrying value. This impairment was identified as a key indicator of the investment's deterioration, particularly amid unresolved settlement allocations in the Canadian tobacco litigation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 29834,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7682,
        "completion_tokens": 118,
        "total_tokens": 7801
      }
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "Based on the disclosures in the 2023 and 2024 10-K filings (pages 51–55), the sensitivity of LLY’s net product revenue to changes in sales return, rebate, and discount liabilities remained consistent in magnitude but reflected updated figures. Specifically, a 5% change in the consolidated sales return, rebate, and discount liability would result in a revenue impact of approximately $600 million as of December 31, 2024, compared to $615 million as of December 31, 2023. This indicates a marginal decrease in sensitivity, though the underlying risk profile and exposure remained unchanged, with no material impact on earnings or cash flows from hypothetical 10% interest rate or currency fluctuations. The increase in absolute liability balances (e.g., from $8,214.1M in 2023 to $10,667.5M in 2024) reflects higher accruals driven by volume growth in managed care, Medicare, and Medicaid programs, but the proportional sensitivity to revenue changes stayed within a similar range.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43689,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11156,
        "completion_tokens": 245,
        "total_tokens": 11401
      }
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "From 2022 to 2024, Bulk shipments have continued to be a major contributor to Union Pacific’s freight revenues, accounting for roughly 32% of total freight revenue in 2024 (up from 30% in 2022).  Revenue from Bulk grew 12% year‑over‑year in 2021 and remained strong in 2022, driven by a 5% volume increase, higher core pricing and fuel surcharge gains, and favorable mix (e.g., strong grain demand and coal shipments boosted by higher natural‑gas prices).  Consequently, Bulk’s revenue contribution has risen modestly each year, moving from about $6.6 billion in 2021 to an estimated $7.3 billion in 2022 and continuing to expand in 2024 as the company leverages its network to capture additional grain, fertilizer, food‑refrigerated and coal traffic.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43180,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11008,
        "completion_tokens": 187,
        "total_tokens": 11196
      }
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "The interest rate on IBM's 2028 notes remained at 0.300% in both 2023 and 2024, as shown in the debt tables of the 2023 and 2024 10-K filings. This stability indicates IBM is maintaining a conservative debt strategy with low, fixed-rate obligations, avoiding the need to refinance at potentially higher market rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52951,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13452,
        "completion_tokens": 79,
        "total_tokens": 13531
      }
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024 AT&T’s capital‑structure strategy shifted markedly: the company fully retired the original “Mobility preferred interests” (the 7 % cumulative preferred membership interests issued in 2018) by repurchasing the remaining 213 million units in April 2023, reclassifying the liability and settling the balance at fair value.  In parallel, AT&T introduced new preferred‑interest structures—most notably the 2019 Tower Holdings preferred interests that were reset in November 2024 to Fixed‑Rate and Floating‑Rate Class A Limited Membership Interests, and the expanded Telco LLC preferred interests (Class A‑4 issued in October 2024) that carry a 5.94 % initial distribution and reset every four years.  These newer instruments provide AT&T with additional long‑term, non‑dilutive capital while preserving flexibility to call or redeem them under predefined conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61801,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15685,
        "completion_tokens": 219,
        "total_tokens": 15905
      }
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon’s characterization of the competitive threat from websites shifted from a general acknowledgment of intense competition—highlighting factors like local companies’ understanding of customers and brand strength—to a more specific focus on structural and regulatory challenges in international markets, particularly China and India. In 2022, the discussion emphasized competition through evolving business models and the advantage of local players, while the 2023 filing underscores heightened risks tied to regulatory restrictions, foreign ownership limitations, and compliance with local laws, indicating a shift toward viewing competition as increasingly constrained by geopolitical and regulatory environments rather than just market dynamics. This evolution reflects a deeper concern about operational sustainability in key international markets amid tightening governmental controls.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49832,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12689,
        "completion_tokens": 229,
        "total_tokens": 12918
      }
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "From 2022 through 2024, PMI’s strategic reliance on KT&G’s heat‑not‑burn (HNB) products grew markedly.  After the 2020 global collaboration agreement, PMI obtained exclusive rights to commercialize KT&G’s HNB portfolio (e.g., LIL Mini, LIL Plus, LIL HYBRID, LIL Vapor) outside South Korea, and by 2024 these licensed KT&G HNB products accounted for a substantial share of PMI’s smoke‑free revenue—over $14 billion in 2024 alone.  This partnership has become a cornerstone of PMI’s smoke‑free portfolio, positioning KT&G’s HNB offerings as the primary vehicle for PMI’s reduced‑risk product strategy in markets where combustion‑free products are taxed more favorably and regulated as separate categories.  Consequently, PMI’s growth and long‑term viability in the reduced‑risk segment are now closely tied to the success of KT&G’s HNB products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43555,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11118,
        "completion_tokens": 210,
        "total_tokens": 11329
      }
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Between 2022 and 2024, IBM’s PWCC Plan (the PricewaterhouseCoopers Consulting Acquisition Long-Term Performance Plan) continued to be used exclusively for funding awards to former PwCC employees who joined IBM after the acquisition, with no expansion of its scope to cover senior executives or broader employee groups. The plan’s administration remained consistent with prior years, governed by the same terms as the 2001 Plan, including administration by the Executive Compensation and Management Resources Committee, and it was not subject to shareholder approval. The 2024 disclosures confirm its ongoing use but show no significant evolution in administration or scope beyond its original post-acquisition purpose.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 36007,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9222,
        "completion_tokens": 179,
        "total_tokens": 9402
      }
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "AT&T’s Mobility Preferred Interests were fully retired in April 2023 after a series of repurchases that began with a $2.6 billion cash redemption of 105 million interests in October 2022 and culminated in the $5.414 billion purchase of the remaining 213 million interests in April 2023.  This move eliminated the $7 billion of cumulative preferred equity that had been recorded as a liability and later as non‑controlling interest, freeing up cash and reducing the company’s mezzanine‑equity burden.  The shift reflects AT&T’s broader strategy of streamlining its capital structure—moving away from complex, high‑cost preferred‑equity instruments toward a simpler mix of debt and equity that supports its focus on core wireless and wireline growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13051,
        "completion_tokens": 190,
        "total_tokens": 13241
      }
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "IBM's exposure to stock exchange regulations for its debt securities has remained consistent in focus but shifted toward newer regulatory considerations. While the 2022 filing highlights generic market risks tied to interest rate volatility, exchange controls, and credit rating changes affecting debt securities, the 2024 filing retains this framework but adds emphasis on evolving regulatory landscapes, including potential impacts from climate-related disclosures and global compliance complexities. Neither document indicates a material change in regulatory exposure, but the 2024 filing expands on environmental and cybersecurity-related regulatory risks that could indirectly influence market perception of IBM's debt. Thus, the core regulatory risks persist, with heightened attention to broader compliance obligations rather than structural shifts in exchange rules.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 37836,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9679,
        "completion_tokens": 218,
        "total_tokens": 9897
      }
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "Based on the provided SEC 10-K filings, Disney's financial relationship with A&E (A+E Networks) evolved significantly from 2022 to 2024, particularly regarding equity income contribution. In 2022, A+E contributed $56 million to Disney's equity income (as noted in the 2022 filing's \"Restructuring and impairment charges\" footnote referencing a $56 million gain from an A+E content license agreement termination), but by 2023 and 2024, A+E's equity income contribution declined sharply to $575 million in 2024 (down from $782 million in 2023), driven by lower income from A+E due to strategic shifts in content monetization and increased impairments. This decline reflects Disney's broader move away from licensing linear channel content toward direct-to-consumer (DTC) distribution, which negatively impacted A+E's revenue streams and thus its equity income contribution to Disney.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 32611,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8368,
        "completion_tokens": 220,
        "total_tokens": 8588
      }
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations rose from $16.9 billion at the end of 2022 to $18.0 billion at the end of 2023, reflecting net issuances of $6.25 billion in securitized debt during 2023. This increase shows that Capital One is actively expanding its securitization program and relying more on long‑term, asset‑backed funding to support its loan portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47990,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12224,
        "completion_tokens": 93,
        "total_tokens": 12317
      }
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Disney's scripted programming strategy has shifted decisively toward direct-to-consumer (DTC) distribution, particularly through Disney+ and its international variants (Disney+ Hotstar, Star+), as evidenced by the consolidation of Disney+ services (including the merger of Disney+ and Star+ in Latin America by June 2024) and the planned U.S. ESPN+ integration on Disney+ by early 2025. This strategic pivot has driven a deliberate reduction in reliance on traditional linear channel licensing, especially internationally, where the company explicitly states its \"increased focus on DTC distribution... is expected to negatively impact the International Channels business\" as it transitions monetization from linear channel licensing to DTC platforms. Consequently, while Disney's general entertainment channels (e.g., Disney Channel, Freeform, FX) and sports channels (e.g., ESPN, Star) remain significant, their scripted content is now primarily leveraged to feed DTC services rather than traditional broadcast or cable networks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39233,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10041,
        "completion_tokens": 257,
        "total_tokens": 10299
      }
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "From 2022 to 2023, Tesla’s accounts receivable balance rose sharply—from $627 million in 2021 to $46 million in 2020 and then to $627 million again by year‑end 2021—reflecting timing differences in customer payments, especially for regulatory‑credit sales and long‑term government rebates that can take up to a year to collect. At the same time, the company’s ability to scale production of energy‑storage products depended on overcoming supply‑chain constraints, expanding manufacturing capacity, and managing inventory valuations; any delays or cost increases in obtaining components or ramping up production could materially affect future earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49269,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12550,
        "completion_tokens": 162,
        "total_tokens": 12713
      }
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "The role of syrups in Coca-Cola's business model has shifted toward greater integration with bottling partners and fountain retailers, particularly through the adoption of an incidence-based concentrate pricing model that ties syrup pricing to bottler pricing, channels, and package mix. This model, which treats variable consideration (including syrup-related incentives) as part of net operating revenue, requires careful estimation of customer sales volumes, inventories, and pricing allowances to recognize revenue only when control transfers—typically upon shipment to bottlers, with revenue for consolidated partners deferred until finished products are sold to third parties. Additionally, syrup sales to bottling partners (both consolidated and unconsolidated) are structured to align with the Company's strategy of shared value and flexible growth, while fountain syrup sales to retailers are part of its North America operations, reflecting a broader shift toward embedding syrup within a holistic, volume-driven ecosystem rather than standalone concentrate sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48439,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12333,
        "completion_tokens": 268,
        "total_tokens": 12602
      }
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "From fiscal 2022 to fiscal 2024 Disney’s investment in Other Mortgage‑ and Asset‑Backed Securities (MBS & ABS) declined sharply: the fair‑value amount of “Other mortgage‑ and asset‑backed securities” fell from $84 million (as part of the Level 2 portfolio) in 2022 to $166 million in 2024, while the overall proportion of these securities within the total fair‑value hierarchy also dropped – they represented roughly 1 % of total plan assets in 2022 and about 1 % in 2024, reflecting a decreasing share relative to the broader fair‑value hierarchy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 107,
          "pages": [
            105,
            106,
            107,
            108,
            109
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54786,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13938,
        "completion_tokens": 137,
        "total_tokens": 14075
      }
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, the Skunk Works' advanced development programs shifted focus from near-term F-35 modernization and F-22 upgrades toward next-generation capabilities like hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility systems, while maintaining efforts on classified programs and network-enabled technologies to accelerate 21st Century Security initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48402,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12322,
        "completion_tokens": 103,
        "total_tokens": 12425
      }
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "From 2022 to 2023, Tesla shifted its Powerwall strategy from a focus on scaling production and integrating with solar offerings to emphasizing cross‑selling with residential solar and improving installation efficiency, while also stressing the need for greater battery‑cell supply to meet rising demand. Production emphasis moved toward integrating Powerwall with new manufacturing capabilities (e.g., structural battery packs) and expanding its role in grid‑stability services, reflecting a broader integration strategy that ties the product to both vehicle and energy‑storage ecosystems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42117,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10749,
        "completion_tokens": 147,
        "total_tokens": 10896
      }
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Between 2022 and 2024, Gilead's strategic positioning around Biktarvy evolved from being one of several key HIV products (alongside Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla) to a more central, flagship component of its HIV portfolio, emphasized for its once-daily single-tablet regimen and role in both treatment and prevention. The 2024 10-K highlights Biktarvy's continued prominence in the HIV franchise, contributing significantly to product sales and benefiting from revenue share arrangements (e.g., with Janssen for cobicistat, emtricitabine, and TAF in Symtuza). However, this growth is tempered by heightened commercial risks: increased competition from generics and alternative regimens, pricing pressures from government programs like the Inflation Reduction Act, and reliance on a narrow set of HIV products that face patent cliffs and market share erosion. The document underscores that Biktarvy's success is critical to Gilead's HIV revenue stability, but its long-term dominance is not guaranteed amid evolving treatment paradigms and regulatory shifts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47754,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12168,
        "completion_tokens": 276,
        "total_tokens": 12444
      }
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "The U.S. Retrospective Responsibility Plan’s composition remained unchanged between 2022 and 2023, continuing to rely on the same mechanisms—including the U.S. litigation escrow agreement, the conversion feature of class B common stock, indemnification obligations, the interchange judgment sharing agreement, the loss sharing agreement, and the omnibus agreement—to address potential liability from U.S. covered litigation. No new mechanisms were introduced in 2023; the plan’s structure and referenced agreements were consistent across the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52216,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13287,
        "completion_tokens": 138,
        "total_tokens": 13425
      }
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy’s strategic importance to Gilead has diminished as its patent protection remains robust but faces growing competition and regulatory shifts. While the document confirms Biktarvy’s U.S. patent expiration is projected for 2033 (with regulatory exclusivity extending to 2032) and its European patent has expired, the company’s risk disclosures highlight heightened vulnerability to HIV product dependency—citing \"market share gains by competitive products, including generics\" and the potential obsolescence of tenofovir alafenamide-based regimens if treatment paradigms shift. This risk is amplified by Gilead’s explicit warning that \"a substantial portion of our revenue\" comes from HIV products, making Biktarvy’s declining patent exclusivity a critical strategic vulnerability despite its current market dominance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 41788,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10677,
        "completion_tokens": 210,
        "total_tokens": 10888
      }
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Based on the provided document pages, there is no indication of any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023. The documents discuss AT&T's transactions with DIRECTV, FirstNet, and related financial arrangements, but do not reference Illinois Bell Telephone Company or any changes to its financial guarantees during this period. The only relevant financial guarantee discussion involves Crown Castle tower assets accounting (pages 133-137 of T_10k_2022), which pertains to a separate transaction and does not involve Illinois Bell. No documentation or references to Illinois Bell's financial guarantees appear in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10498,
        "completion_tokens": 176,
        "total_tokens": 10675
      }
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C‑to‑Class A conversion rate between 2022 and 2023 signals that the dilution effect on Class A voting power will remain unchanged in any major transaction. Because the conversion rate does not shift, holders of Class A stock can expect roughly the same proportion of voting influence to be eroded by the conversion of Class C (and Class B) securities, meaning that any significant corporate action will continue to dilute their voting strength by the same predictable amount.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44430,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11343,
        "completion_tokens": 124,
        "total_tokens": 11467
      }
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla shifted its Solar Roof production focus from a broad residential rollout to a more targeted, utility‑scale and retrofit‑oriented approach, emphasizing integration with energy storage and leveraging tax incentives to offset costs. The company increasingly relied on external partners and financing mechanisms—such as PPAs, loans, and state incentives—to expand deployment, while its strategic dependency moved toward collaborations with utilities and channel partners for installation and customer acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45587,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11613,
        "completion_tokens": 133,
        "total_tokens": 11746
      }
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model shifted toward greater integration with finished beverage production, particularly through expanded use in fountain systems and direct sales to retailers. While concentrate operations still accounted for 58% of net operating revenues in 2023 (up from 56% in 2022), the document emphasizes that syrups—especially fountain syrups—are critical to both concentrate operations (which supply bottlers) and finished product operations (which generate higher revenue but lower margins). This evolution underscores syrups' dual role as both an input for bottling partners and a direct revenue stream through fountain sales, reinforcing their importance in the Company's strategy to drive volume growth and leverage its bottling network.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44586,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11376,
        "completion_tokens": 199,
        "total_tokens": 11576
      }
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "The company's operational focus on Africa/Eurasia has remained a consistent geographic segment within its Oral, Personal and Home Care division, with Africa/Eurasia reporting $1,045 million in net sales in 2021 (up from $981 million in 2020) and $203 million in operating profit in 2021 (down slightly from $206 million in 2020). This reflects a modest growth in sales but a relatively stable contribution to overall segment profitability. The 2024 reporting structure continues to treat Africa/Eurasia as one of five key operating segments for the Oral, Personal and Home Care business, maintaining its strategic emphasis on emerging markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35961,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9220,
        "completion_tokens": 160,
        "total_tokens": 9381
      }
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Johnson & Johnson’s Orthopaedics business showed modest global sales growth, with worldwide revenue rising 4.1% to $8.942 billion in 2023 versus $8.587 billion in 2022, driven by a 3.8% increase in U.S. sales (to $5.525 billion) and a 4.6% rise in international sales (to $3.417 billion). The company continued to emphasize enabling technologies, expanding its portfolio of hip, knee, trauma, spine, sports and surgery solutions, and highlighted strong performance in advanced and general orthopaedic categories that supported the overall segment’s growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50365,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12824,
        "completion_tokens": 139,
        "total_tokens": 12963
      }
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa’s U.S. litigation escrow account grew from $894 million to $1,449 million, reflecting additional deposits and payments related to the Interchange multidistrict litigation. The scope of “U.S. covered litigation” remained defined as matters settled or substantially resolved, plus specific MDL 1720 cases and certain opt‑out actions after October 22 2015, with liability allocation governed by the loss‑sharing agreement that apportions judgments or settlements between Visa and Mastercard on a 66.6667%/33.3333% basis. In Europe, the retrospective responsibility plan continued to rely on conversion‑rate adjustments to the series B and C preferred stock rather than an escrow account, releasing $3.5 billion of as‑converted value in 2022 and adjusting the “right to recover for covered losses” accordingly.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53290,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13557,
        "completion_tokens": 208,
        "total_tokens": 13766
      }
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, Colgate-Palmolive significantly reduced its holdings in Guaranteed Investment Contracts (GICs) within its pension plan assets, decreasing from $51 million (2021) to $30 million (2024) in the international allocation and eliminating GICs entirely from the U.S. portfolio. This shift reflects a strategic move toward more liquid and potentially higher-returning assets, as evidenced by increased allocations to fixed income securities (from $75 million to $75 million in international but with a notable rise in Level 2 fixed income) and equity investments, while reducing reliance on the low-yield, principal-protected GICs. The reduction suggests a deliberate de-risking of the pension portfolio, prioritizing assets with better alignment with long-term liability matching and return objectives amid evolving market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39495,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10101,
        "completion_tokens": 212,
        "total_tokens": 10314
      }
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "The Mastercard Developer Platform has evolved from a general API hub into a strategic engine for digital asset integration and new payment flows. By 2024, it enabled seamless incorporation of blockchain capabilities (via Multi-Token Network™ and crypto onboarding/offboarding), supported virtual card solutions for B2B payments, and provided standardized APIs for emerging services like disbursements, remittances, and real-time payments—all designed to simplify integration for partners building next-generation financial technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45839,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11697,
        "completion_tokens": 134,
        "total_tokens": 11831
      }
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "The company's investment in U.S. common stocks within its pension plans has been reduced to zero since 2020, as evidenced by the 2020 sale of 739,869 shares to bring the holding to zero and no purchases in 2021 or 2024. This indicates a strategic shift away from holding its own stock in pension assets, aligning with a more diversified and potentially less volatile asset allocation focused on broader equity indices, fixed income, and alternative investments as reflected in the target allocations (e.g., 21-26% equity in U.S. plans, increasing to 26% in 2024) and the absence of Company stock in the portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33265,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8545,
        "completion_tokens": 153,
        "total_tokens": 8698
      }
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney’s cruise‑ship strategy shifted from modest expansion to a more aggressive capital‑investment plan.  In the 2022 filing the company highlighted cruise‑ship growth as part of its broader Parks & Experiences capital spend, but by the 2023 filing it disclosed a dedicated “significant capital investment” program that includes new vessels and fleet expansion, reflecting a clear strategic focus on the cruise segment.  At the same time, Disney emphasized operational‑risk considerations—citing the need to manage construction timelines, regulatory approvals, and the inherent volatility of the cruise market—while also noting that these investments are subject to macro‑economic pressures, cost‑inflation and the uncertainty of consumer demand.  Consequently, the company is allocating more capital to cruise‑ship development while closely monitoring execution risk and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 51248,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13037,
        "completion_tokens": 228,
        "total_tokens": 13265
      }
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard's use of short-duration foreign exchange derivative contracts to manage daily settlement risk has evolved significantly between 2022 and 2024, shifting from a primarily operational hedge to a more structured risk management practice. While the 2022 10-K described these contracts as short-term tools limited to \"a few days\" of exposure, the 2024 filings show they are now actively managed with notional amounts of $3.951 billion in cash flow hedges and $2.511 billion in net investment hedges as of December 31, 2024, reflecting a more deliberate and scalable approach to mitigating currency volatility during the brief settlement window. This evolution underscores a strategic expansion in how the company quantifies and mitigates daily FX risk, moving from passive monitoring to proactive, hedged management of its settlement exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61367,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15582,
        "completion_tokens": 212,
        "total_tokens": 15794
      }
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce's strategic relationship with enterprise cloud companies has evolved through deeper ecosystem integration and targeted investment focus. The company has increasingly leveraged its strategic investment portfolio—particularly in enterprise cloud startups and system integrators—to strengthen platform capabilities and expand its solution ecosystem, as evidenced by its continued investments in companies that enhance its AI, data, and industry-specific offerings. Simultaneously, Salesforce has intensified its focus on AI-driven platform services like Agentforce and Data Cloud, embedding these capabilities across its core offerings to drive cross-selling and deeper customer engagement, while simultaneously restructuring its workforce to optimize operational efficiency and support this strategic shift. This evolution reflects a clear pivot toward prioritizing integrated, AI-powered ecosystem partnerships as a core growth lever.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59851,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15188,
        "completion_tokens": 240,
        "total_tokens": 15429
      }
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "The company’s approach to accrual rates for vendor funding programs remained consistent in methodology—using historical purchase trends, volumes and negotiated agreements to set accrual rates—but the sensitivity to projected purchase volumes was reduced in fiscal 2024. In fiscal 2023, accrual rates were adjusted throughout the year based on actual versus projected purchase volumes, especially for programs with graduated funding tied to volume thresholds. By fiscal 2024, the company noted that amounts accrued could be impacted if actual purchase volumes differed from projections, but it did not highlight significant changes to the core methodology, indicating a more stable or less volume-sensitive approach compared to the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41170,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10523,
        "completion_tokens": 185,
        "total_tokens": 10708
      }
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "The strategic relationship between Lilly and Boehringer Ingelheim regarding Jardiance has evolved from a collaborative partnership into a legally entangled dynamic, particularly in the context of patent litigation and regulatory challenges. While the original partnership, established in 2011, focused on the joint development and commercialization of Jardiance for diabetes and cardiovascular indications, tensions emerged as generic competition approached. In November 2018, Boehringer Ingelheim initiated patent litigation in the U.S. District Court of Delaware to block generic manufacturers from launching generic versions of Jardiance prior to patent expiration, alleging infringement under the Hatch-Waxman Act. This legal action, which has been stayed but not resolved, reflects Boehringer Ingelheim’s active enforcement of its intellectual property rights to protect the commercial viability of Jardiance. Although Lilly is not a direct party to this litigation, the dispute underscores a growing dependency on Boehringer Ingelheim’s legal strategy to defend the product’s market exclusivity. The partnership’s legal involvement intensified in 2023 when the U.S. government, under the Inflation Reduction Act, selected Jardiance for price negotiation, triggering a 66% discount from list price effective in 2026. This regulatory shift, coupled with ongoing patent challenges, has created a complex environment where Boehringer Ingelheim’s legal actions are critical to safeguarding the product’s revenue stream, while Lilly’s commercial interests remain intertwined with its partner’s defensive maneuvers. The collaboration, once symbiotic, now requires careful navigation of legal and regulatory risks to maintain market access for Jardiance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48077,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12253,
        "completion_tokens": 438,
        "total_tokens": 12691
      }
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "From 2022 to 2023, Disney’s capital investment strategy toward cruise ships shifted from halting new shipbuilding during the pandemic to advancing a dedicated shipbuilding program, reflecting a broader realignment of its Parks & Experiences business. This evolution is underscored by the company’s focus on developing its Lighthouse Point destination on Eleuthera—scheduled to open as a Disney Cruise Line destination in 2024—and expanding cruise-related infrastructure, signaling a strategic pivot to reinvest in cruise ship growth as part of its long-term Parks & Experiences expansion plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47891,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12196,
        "completion_tokens": 148,
        "total_tokens": 12345
      }
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Mastercard Foundry’s role in fostering innovation has expanded significantly from 2022 to 2024, shifting from early-stage experimentation to strategic integration of emerging technologies and fintech partnerships. In 2022, it focused on foundational innovation (e.g., blockchain exploration, AI-driven security, and virtual card solutions), while by 2024, it actively drove commercialization of key initiatives like VCN adoption, Alias-Based Remittances, and blockchain-based payment rails via the Mastercard Mul-Token Network™, alongside acquisitions (e.g., CipherTrace, Recorded Future) to enhance crypto compliance and fraud intelligence. This evolution reflects a move from \"exploring\" to \"enabling\" innovation across the payments ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45839,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11689,
        "completion_tokens": 186,
        "total_tokens": 11875
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "The collaboration with Boehringer Ingelheim has evolved from early‑stage research to a more mature, regulatory‑focused partnership, highlighted by multiple Breakthrough Therapy and Fast Track designations for joint assets such as tirzepatide and empagliflozin.  However, pricing pressures have intensified, especially with the 2022 Inflation Reduction Act’s Medicare price‑setting provisions that target drugs like Jardiance (co‑developed with Boehringer Ingelheim), leading to anticipated revenue erosion and heightened pressure on pricing and reimbursement for their joint portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51253,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13045,
        "completion_tokens": 146,
        "total_tokens": 13191
      }
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "The CH‑53K King Stallion heavy‑lift helicopter is highlighted in Lockheed Martin’s Rotary and Mission Systems (RMS) segment as a key growth pillar under the company’s 21st Century Security strategy, with RMS noting that the CH‑53K program—along with radar surveillance systems—represents a major area of expansion for the segment. This positioning continued through 2024, as the company’s MD&A references the CH‑53K alongside other RMS programs (e.g., Aegis, LCS, MH‑60) and underscores its role in future modernization and production phases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48004,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12226,
        "completion_tokens": 135,
        "total_tokens": 12361
      }
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The expansion of Lilly’s diabetes portfolio—highlighted by co‑commercialized products such as Jardiance, Trajenta, Basaglar and the newer SGLT‑2/GLP‑1 combos—reflects a deliberate shift toward higher‑margin, cardio‑renal indications and away from pure insulin dependence. This strategic focus underscores Lilly’s intent to dominate the diabetes market through differentiated, cardiovascular‑protective therapies rather than simply competing on insulin price, aligning with its broader emphasis on innovative, high‑value oncology, immunology and neuroscience products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50725,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12912,
        "completion_tokens": 141,
        "total_tokens": 13054
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "The JASSM program’s production activity drove a $1.4 billion increase in MFC backlog in 2023 and continued to lift backlog further in 2024, supporting higher sales of $1.2 billion for tactical and strike‑missile programs. However, profit‑booking adjustments turned negative – MFC recorded a $1.1 billion drop in operating profit in 2024 due to $1.4 billion of losses on a classified JASSM contract and lower favorable profit adjustments – indicating that while the program sustains robust order flow, its contribution to earnings is being offset by cost overruns and adverse profit adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46128,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11762,
        "completion_tokens": 148,
        "total_tokens": 11911
      }
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPMorgan's credit risk evaluation for Business Banking Loans has shifted from a focus on **delinquency rates and loan portfolio composition** (e.g., tracking 30-149 and 150+ days past due for early distress signals) to a greater emphasis on **geographic distribution, loan-to-value (LTV) ratios, and refreshed FICO scores** as primary indicators of borrower stress. This evolution reflects a more nuanced approach to identifying early signs of distress, particularly in residential real estate and business banking portfolios, where geographic economic trends and borrower creditworthiness (via FICO and LTV) now complement traditional delinquency metrics to flag at-risk loans sooner.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 242,
          "pages": [
            240,
            241,
            242,
            243,
            244
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47694,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12159,
        "completion_tokens": 171,
        "total_tokens": 12330
      }
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Based on the provided SEC 10-K filings, Target Corporation's SPP II plan terms remained consistent between 2022 and 2023 filings, with no material changes documented in the compensation disclosures. The 2023 filing (pages 65-69) continues to reference the same SPP II plan description as the 2022 filing (also pages 65-69), indicating the company maintained its existing executive compensation framework without significant revisions to this specific plan. This consistency suggests Target's executive compensation structure emphasizes stability in its long-term incentive plans, particularly for its SPP II program, which appears to be a core component of its executive reward system without recent modifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 26733,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6909,
        "completion_tokens": 178,
        "total_tokens": 7088
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "Based on the provided document pages, the financial obligations related to the Incyte collaboration (Olumiant) evolved from 2022 to 2024 as follows: In 2022, milestone payments of $260.0 million and $210.0 million were capitalized as intangible assets upon regulatory approvals and a sales-based milestone, with Incyte eligible for up to $100.0 million in additional success-based regulatory milestones and $100.0 million in potential sales-based milestones through 2024. By 2024, Incyte remained eligible for these same milestone payments, but the collaboration terms were updated to include an additional royalty for COVID-19 treatment exceeding a specified sales threshold, while the core milestone structure and potential future payments to Incyte (up to $100 million each for regulatory and sales milestones) remained unchanged. (Note: The document does not indicate any reduction or evolution in the *potential* future milestone payments themselves from 2022 to 2024; the $100 million caps for both regulatory and sales milestones were still in effect as of December 31, 2021, and the 2024 context confirms these remain the forward-looking obligations.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40011,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10229,
        "completion_tokens": 289,
        "total_tokens": 10519
      }
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Based on the segment reporting and asset balance disclosures in the provided 10-K filings, Cisco's financial exposure in the APJC region remained relatively stable between fiscal 2022 and fiscal 2023, with revenue increasing slightly from $7,706 million to $8,027 million. However, the company's long-lived assets in the APJC region declined significantly from $1,244 million to $997 million, indicating a reduction in physical infrastructure exposure, while the overall segment revenue contribution from APJC grew modestly from 15.5% to 15.6% of total revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40805,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10424,
        "completion_tokens": 140,
        "total_tokens": 10564
      }
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "The strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance evolved significantly from 2022 to 2024 in response to regulatory changes, particularly the U.S. Inflation Reduction Act (IRA). In August 2023, HHS selected Jardiance as one of the first ten drugs subject to government-set pricing starting in 2026, with a 66% discount off the 2023 Medicare Part D list price. This regulatory shift, part of broader IRA provisions requiring price negotiations for drugs approved under NDAs after nine years, directly impacted Jardiance's revenue trajectory by accelerating expected price erosion and reimbursement pressures. The collaboration, which involves shared development and commercialization of Jardiance (including formulations like Glyxambi and Synjardy), was explicitly cited in the 2021 financial disclosures as being subject to these regulatory changes, foreshadowing the 2023 announcement that would shape its future commercial strategy through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41072,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10494,
        "completion_tokens": 245,
        "total_tokens": 10739
      }
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "GM’s 2022 filing emphasizes the financial and reputational risks of product‑safety recalls—particularly for global platforms such as the Chevrolet Bolt EV—by warning that recall costs and brand damage could materially affect profitability, while also highlighting heightened cybersecurity and data‑privacy threats that could undermine customer trust. In the 2023 filing, this focus expands to stress that evolving regulatory pressures on EV/AV technologies and increasingly stringent data‑privacy laws amplify those risks, noting that any safety‑related incident or breach could trigger costly recalls, regulatory penalties and lasting reputational harm, thereby reinforcing the company’s caution as it pushes deeper into electric and autonomous vehicles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56460,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14358,
        "completion_tokens": 188,
        "total_tokens": 14546
      }
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "The Guaranteed Senior Notes issued by Costco's Japanese subsidiary were initially recorded at fair value using Level 3 inputs in 2022 and remained part of the company's long-term debt structure through 2024. By 2024, the subsidiary had repaid $77 of these notes, and the remaining balance was included in the consolidated long-term debt figures, reflecting a strategic shift toward reducing reliance on this specific financing mechanism while maintaining access to capital through other debt instruments. This evolution indicates a broader long-term financing strategy focused on optimizing capital structure through targeted debt repayments and leveraging diverse funding sources, including senior notes and subsidiary-specific instruments, to support ongoing operational and strategic needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 29783,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7675,
        "completion_tokens": 198,
        "total_tokens": 7874
      }
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023 Cisco’s available‑for‑sale debt investments fell from $15,206 million to $11,947 million—a decline of $3,259 million (≈21%). This reduction reflects the company’s active capital‑allocation strategy, which uses cash to fund stock‑repurchase programs, dividend payments, acquisitions and other investments rather than holding large balances of low‑yielding securities. Consequently, the shrinkage signals that Cisco is deliberately reallocating capital toward growth initiatives and shareholder returns instead of maintaining a larger portfolio of debt investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49171,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12518,
        "completion_tokens": 149,
        "total_tokens": 12667
      }
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "From 2023 to 2024, JPMorgan Chase’s exposure to system‑damage risks has continued to rise, driven by a growing volume and sophistication of third‑party vendor attacks and increasingly complex data‑recovery challenges. The firm notes that attacks from hostile nation‑states, cyber‑criminals and hacktivists are becoming more frequent and advanced, and that any breach—whether caused directly by JPMorgan or by a vendor or connected market infrastructure—can trigger widespread operational disruption, loss of confidential data, costly remediation, regulatory fines and reputational harm. Consequently, the company’s reliance on external vendors and interconnected systems has amplified both the likelihood and potential impact of such incidents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52108,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13253,
        "completion_tokens": 186,
        "total_tokens": 13439
      }
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco has advanced its private-label growth strategy through significant operational investments by 2024, including the expansion of its private-label merchandise offerings and the optimization of warehouse operations to support increased sales of these items. The company has emphasized increasing comparable sales growth through strategic pricing and merchandise mix adjustments, particularly in its core categories, while leveraging its membership model to drive higher penetration of private-label products across its U.S., Canadian, and international operations. These efforts are aligned with its broader goal of enhancing profitability through controlled cost structures and targeted investments in private-label private-label merchandise development.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 80369,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20308,
        "completion_tokens": 189,
        "total_tokens": 20498
      }
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "UnitedHealth Group’s approach to Medicaid managed‑care bidding remained fundamentally the same in 2022 and 2023, but the company highlighted that bid accuracy increasingly depends on assumptions about enrollment, utilization, medical‑cost trends and competitive bid levels. In both years it warned that material errors in these assumptions—such as unexpected changes in Medicaid eligibility, utilization spikes or lower‑than‑expected bids from rivals—could cause significant adverse impacts on its results of operations, financial position and cash flows. Consequently, while the bidding methodology did not change, the firm emphasized tighter scrutiny of those underlying assumptions and the associated risks in its 2023 disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59361,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15070,
        "completion_tokens": 183,
        "total_tokens": 15254
      }
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "From 2022 to 2023, MetLife’s investment in Municipal securities (classified as fixed‑maturity securities AFS) declined in fair‑value hierarchy level: in 2022 the municipal holdings were reported at $13.7 billion (≈70.4% of total AFS) with a Level‑3 fair‑value amount of $13.7 billion, whereas in 2023 the municipal exposure fell to $14.2 billion (≈4.6% of total AFS) and the Level‑3 classification was reduced to $12 million, indicating a substantial downgrade from Level‑3 to lower levels in the fair‑value hierarchy. Consequently, the valuation hierarchy classification for MetLife’s municipal holdings shifted markedly downward, moving from a predominantly Level‑3 classification in 2022 to a minimal Level‑3 balance (≈$12 million) by the end of 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70656,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17882,
        "completion_tokens": 188,
        "total_tokens": 18071
      }
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "Microsoft's Office 365 licensing approach has evolved to emphasize subscription-based models with greater flexibility, particularly through the Microsoft Customer Agreement and Microsoft Online Subscription Agreement, which replaced older volume licensing structures. These agreements allow customers to subscribe monthly or annually without long-term commitments, offering scalable access to cloud services and software updates. The shift includes integrating Office 365 subscriptions with Software Assurance benefits under unified agreements, enabling usage-based billing and simplified management for organizations of all sizes. This transition reflects a strategic move toward cloud-centric, consumption-driven revenue models that prioritize recurring revenue and customer retention over perpetual licenses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 33454,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8587,
        "completion_tokens": 202,
        "total_tokens": 8790
      }
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "Between 2022 and 2023, MET's Level 3 Fixed Maturity Securities AFS declined from $58 million to $2 million, reflecting a substantial reduction in the company’s exposure to illiquid, Level 3 assets. This shrinkage indicates a more conservative investment strategy, emphasizing greater liquidity and lower risk in the portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 307,
          "pages": [
            305,
            306,
            307,
            308,
            309
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63750,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16166,
        "completion_tokens": 81,
        "total_tokens": 16247
      }
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Microsoft's strategic positioning of Office 365 has evolved from a standalone cloud productivity suite to a central pillar within its broader cloud services portfolio, particularly through deeper integration with Azure and Dynamics 365. The company increasingly bundles Office 365 subscriptions with AI-driven capabilities (e.g., Copilot), shifting revenue recognition to ratable over the subscription period and emphasizing recurring revenue. This strategy directly counters competitive pressures from AI-driven offerings by embedding generative AI features into Office 365, enhancing its value proposition while maintaining its role as a key driver of Microsoft's cloud growth and ecosystem lock-in.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45493,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11615,
        "completion_tokens": 175,
        "total_tokens": 11791
      }
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's handling of credit-related impairments remained consistent in methodology but reflected updated portfolio assessments. The company continued to evaluate available-for-sale debt securities for credit-related impairment by comparing fair value to amortized cost, considering issuer credit quality, cash flow expectations, and market conditions, without recording material allowances. While no significant credit losses were recognized in either year, the 2023 assessment incorporated new data from a larger portfolio (e.g., $18,004 million in unrealized losses across 13,000 positions), though the core evaluation framework—focusing on collectability of principal and interest rather than market-driven valuation declines—remained unchanged. The permanent repeal of the Health Insurance Tax in 2021 also influenced year-over-year comparability but did not alter the impairment methodology itself.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54575,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13875,
        "completion_tokens": 234,
        "total_tokens": 14109
      }
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "From 2022 to 2023, the allocation of Fixed Maturity Securities AFS in MET’s pension and other postretirement benefit plans shifted slightly toward higher actual allocations in both categories. In 2022, Fixed Maturity Securities AFS represented 85% of U.S. pension plan assets (actual 84%) and 95% of U.S. other postretirement benefit assets (actual 95%). By 2023, the actual allocation rose to 82% for U.S. pension benefits and 94% for U.S. other postretirement benefits, reflecting a modest increase in the relative weight of fixed maturity securities within the overall asset mix. This evolution indicates a continued emphasis on fixed income holdings, with slight adjustments in target and actual allocations across the two benefit categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 305,
          "pages": [
            303,
            304,
            305,
            306,
            307
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66048,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16736,
        "completion_tokens": 186,
        "total_tokens": 16922
      }
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's shifted its Kitchens & Bath category from a standalone merchandising focus to a more integrated component of its broader \"Total Home\" strategy, emphasizing installation services and omnichannel customer experiences. This evolution reflects its growing strategic importance, as Kitchens & Bath now represent a key category within the Home Décor segment (accounting for 35.3% of net sales in 2022), supporting Lowe's goal of providing end-to-end home solutions and driving professional customer penetration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43538,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11117,
        "completion_tokens": 133,
        "total_tokens": 11250
      }
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Between 2022 and 2024, Mondelez International’s strategic focus on Cheese & Grocery evolved from being a relatively minor, ancillary category to a more intentional growth pillar within its broader snacking portfolio. While historically Cheese & Grocery was mentioned only in passing (e.g., “cheese & grocery and powdered beverages”), the 2024 MD&A explicitly highlights it as one of the “adjacent, locally relevant categories” the company is leveraging to accelerate consumer‑centric growth, alongside chocolate, biscuits and baked snacks. This shift signals a deliberate prioritization of higher‑margin, grocery‑adjacent categories—particularly cheese and grocery products—to diversify revenue streams and capture long‑term snacking demand beyond traditional sweet snack lines. Consequently, Cheese & Grocery is now positioned as a key strategic lever for sustained growth, reflecting Mondelez’s intent to expand its presence in the savory, grocery‑oriented segment of the snack market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 136,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46718,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11913,
        "completion_tokens": 246,
        "total_tokens": 12160
      }
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "Abbott's presentation of its enteral feeding product lineup shows a shift in how Jevity is positioned relative to Freego™ products between the 2022 and 2023 10-K filings. In the 2022 filing (page 3), Jevity is listed alongside other enteral products like Glucerna 1.2 Cal and Osmolite under the Nutritional Products segment, with Freego™ specifically identified as an \"enteral pump\" used in institutional settings. By the 2023 filing (page 5), Freego™ is no longer described as an \"enteral pump\" but instead appears as a standalone product name within the same enteral feeding category, while Jevity remains listed among the core products (e.g., Jevity, Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite, Oxepa). The 2023 filing consolidates the description of enteral products without explicitly labeling Freego™ as a pump, indicating a repositioning where Freego™ is now presented as a distinct product line rather than a pump-type device, while Jevity continues to be grouped with other enteral nutritional formulas. This change reflects a subtle shift in emphasis from describing Freego™ by its functional category (pump) to presenting it as a branded product alongside Jevity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44840,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11437,
        "completion_tokens": 294,
        "total_tokens": 11731
      }
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MetLife’s fixed‑maturity securities classified as “Municipals” showed a decline in amortized cost from $11,761 million to $11,761 million (no change) but the gross unrealized gain fell sharply from $2,464 million to $2,464 million (no change) while the gross unrealized loss remained minimal (13 → 13). More importantly, the “Municipals” line in the Fixed Maturity Securities AFS by sector table shows that the amortized cost for this sector dropped from $10,982 million (2020) to $11,761 million (2021) and then to $11,761 million (2021 again), while the estimated fair value decreased from $13,722 million to $14,212 million and then to $14,212 million, indicating a modest reduction in fair‑value exposure. This reduction in fair‑value exposure, coupled with the stable classification of municipals within the AFS portfolio, suggests that MetLife is trimming lower‑yielding, higher‑risk municipal holdings to limit credit‑risk concentration, thereby strengthening its credit‑risk management strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66891,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16955,
        "completion_tokens": 255,
        "total_tokens": 17211
      }
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Abbott’s interest rate hedge contracts remained at roughly $2.9 billion of notional value in both 2022 and 2023, but the composition shifted as $700 million of those hedges matured in 2023 and were replaced by new swaps, leaving about $2.2 billion of active contracts at year‑end 2023. These fair‑value swaps convert a portion of the company’s fixed‑rate debt to a variable rate, allowing Abbott to manage interest‑rate exposure and effectively “reset” the fixed‑rate portion of its debt portfolio each year. Consequently, the company’s fixed‑rate debt exposure was reduced and its interest‑expense volatility was limited, while the fair‑value adjustments to the hedged debt offset the market movements of the swaps.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56275,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14296,
        "completion_tokens": 179,
        "total_tokens": 14475
      }
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M’s fixed‑rate debt issuance shifted toward longer‑dated notes with maturities extending to 2025‑2050, while it continued to refinance maturing obligations through registered notes and medium‑term notes, often swapping portions of its fixed‑rate exposure to floating rates via interest‑rate swaps. Repayment activity accelerated in 2022‑2023 as the company retired Eurobonds, floating‑rate medium‑term notes and older fixed‑rate issues, and by 2024 it had repaid roughly $1.1 billion of medium‑term notes that matured, maintaining a strategy of replacing near‑term maturities with higher‑coupon, longer‑term fixed‑rate debt to manage interest‑rate risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 57955,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14715,
        "completion_tokens": 169,
        "total_tokens": 14884
      }
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, Schwab’s capital structure saw a shift toward greater reliance on debt issuances and reduced equity financing. In 2023, the company issued $6.85 billion of senior unsecured notes (including $1.2 billion in May 2023 and $1.35 billion in August 2023), while in 2024 it redeemed all outstanding floating‑rate senior notes and did not issue new long‑term debt, instead drawing on existing credit facilities and maintaining liquidity through cash generated by operations and brokerage deposits. Consequently, long‑term borrowings rose to $26.1 billion at year‑end 2023 (up from $20.8 billion in 2022), but the company’s overall funding mix increasingly emphasized debt capital markets and retained earnings rather than equity issuances, reflecting a strategic focus on managing capital costs and returning excess capital to shareholders through dividends and share repurchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52016,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13236,
        "completion_tokens": 223,
        "total_tokens": 13459
      }
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "From 2022 to 2024, Coca-Cola's contingent payment obligations related to fairlife evolved as follows: In 2020, the company recorded a $270 million liability for the fair value of contingent consideration tied to fairlife achieving financial targets through 2024, using a Monte Carlo model. By 2021, fairlife met its 2020 targets, triggering a $100 million milestone payment, and the company continued to remeasure the remaining contingent liability quarterly. As of 2024, the liability was remeasured using updated projections, with changes recorded in income until the final 2025 payment. This ongoing remeasurement indicates fairlife's performance was tracked against targets, but the contingent liability's adjustments reflect evolving expectations of its financial results, not necessarily sustained outperformance. The company's goodwill allocation to fairlife (assigned to North America) and the contingent consideration mechanism underscore that fairlife's success was tied to achieving specific financial milestones, though the liability's remeasurement suggests performance was volatile and required continuous assessment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53168,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13522,
        "completion_tokens": 282,
        "total_tokens": 13805
      }
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) has evolved from a complementary offering to a core growth driver, with significant investments in cloud services and infrastructure positioning it as a major global competitor. The company has increasingly integrated OCI into its enterprise IT solutions strategy, emphasizing cloud-based deployment models and hybrid cloud adoption to meet enterprise demands, while maintaining its traditional license and hardware businesses as complementary offerings. This shift is reflected in its financial disclosures showing accelerated growth in cloud and license revenues (up 6-7% constant currency in fiscal 2022) and sustained investment in cloud infrastructure to capture market share against competitors like AWS and Microsoft Azure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52329,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13317,
        "completion_tokens": 198,
        "total_tokens": 13516
      }
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "The allowance for credit losses on bank loans decreased from 0.18% of total year-end loans in 2022 to 0.09% in 2023, reflecting a reduction in projected loss rates and improved credit quality metrics, particularly for First Mortgages and HELOCs. This decline was driven by lower nonaccrual loan balances and a reduced allowance requirement, consistent with the company's updated macroeconomic outlook and decreased loss rate projections as of December 31, 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 146,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59281,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15042,
        "completion_tokens": 115,
        "total_tokens": 15158
      }
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's operational structure in the Asia Pacific & Latin America (APLA) region remained part of its broader geographic segmentation, with APLA continuing to be one of four key Nike Brand operating segments (alongside North America, Europe, Middle East & Africa, and Greater China). The 2024 10-K filing indicates that APLA contributed $6,729 million in revenue in 2024, up slightly from $6,431 million in 2023, reflecting modest growth in the region. While the company did not highlight a structural reorganization of APLA operations, it emphasized ongoing efforts to strengthen direct-to-consumer (DTC) capabilities and supply chain resilience, including investments in digital platforms and localized brand engagement. Strategic emphasis in APLA aligned with global priorities—focusing on innovation, sustainable manufacturing, and deepening consumer connections through athlete and community partnerships—without indicating a fundamental shift in operational emphasis compared to prior years. The region continued to support Nike’s global brand strategy, particularly in emerging markets and high-growth economies across Latin America and Southeast Asia.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54382,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13827,
        "completion_tokens": 298,
        "total_tokens": 14125
      }
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Abbott expanded its U.S. Pediatric Nutritional business by growing Pedialyte sales within the broader U.S. Pediatric Nutritionals portfolio, which increased 10% in 2021 (vs. 5.8% in 2020), driven by continued growth in Pedialyte, Similac and PediaSure. This growth supported the segment's overall 7.7% sales increase (excluding foreign exchange), while international pediatric nutritional sales declined slightly due to market dynamics in China and Southeast Asia. The company also expanded its nutritional portfolio with new products like Ensure and Glucerna in adult nutrition markets, further diversifying its offerings beyond pediatric nutrition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47982,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12227,
        "completion_tokens": 162,
        "total_tokens": 12389
      }
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "From 2022 to 2023, RTX significantly reduced its exposure to the 7.100% notes due 2027, repaying $6 million of principal (down from $141 million outstanding at the end of 2022 to $135 million at year‑end 2023) and recording $649 million of debt‑extinguishment costs in 2021 related to early repayments. This targeted repayment, alongside the broader refinancing activity that retired higher‑coupon notes and increased long‑term debt issuance, reflects a strategy of actively managing and lowering the company’s overall debt profile and interest expense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43007,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10975,
        "completion_tokens": 138,
        "total_tokens": 11113
      }
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Nike’s Converse segment experienced a sharp revenue decline of 15% on a currency‑neutral basis, driven by weak wholesale and direct‑to‑consumer sales in North America and Western Europe. This revenue drop translated into a 30% decrease in Converse’s earnings before interest and taxes, reflecting lower sales and margin pressure from unfavorable currency shifts, reduced full‑price ASPs and higher promotional activity. Consequently, Converse’s strategic positioning weakened, with its revenue share shrinking and profitability under strain, while Nike’s overall footwear and apparel segments continued to grow modestly.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50088,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12740,
        "completion_tokens": 164,
        "total_tokens": 12905
      }
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "From 2022 to 2024, Coca-Cola’s financial risk assessment regarding digital evolution has shifted from a general acknowledgment of digital disruption to a strategic imperative tied directly to sales growth and margin improvement. In 2022, digital transformation was framed as a priority to enhance customer engagement and operational efficiency, but by 2024, the company explicitly links successful digitization to its ability to \"increase sales and improve margins\" and avoid adverse financial impacts. The 2024 filing emphasizes that failure to digitize operations—through data, AI, automation, and personalized digital experiences—could directly undermine revenue growth and margin expansion, reflecting a more urgent and integrated view of digital evolution as a core driver of financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 58253,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14790,
        "completion_tokens": 200,
        "total_tokens": 14991
      }
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Oracle has steadily increased its R&D spending—$7.2 billion in FY22, $7.5 billion in FY23 and $7.9 billion in FY24—reflecting a clear priority on cloud‑focused innovation.  At the same time, the company has shifted the mix of its offerings toward cloud services and license‑support revenues, which now represent roughly 71 % of total revenue, while positioning these cloud solutions as the preferred, lower‑cost alternative to traditional on‑premise software and hardware deployments.  This strategic emphasis is underscored by Oracle’s repeated statements that the proportion of cloud services and license‑support revenue will continue to grow and that customers are increasingly migrating their on‑premise workloads to Oracle Cloud.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12425,
        "completion_tokens": 192,
        "total_tokens": 12617
      }
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "Based on the provided document excerpts, the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan has evolved as follows:\n\n1.  **Status:** The Norwest Corporation Directors' Formula Stock Award Plan **no longer issues new awards or deferrals**. The document explicitly states: \"No future stock awards or deferrals may be made under this plan\" (in the \"Material Features of Equity Compensation Plans Not Approved by Shareholders\" section describing the Norwest Corporation Directors' Formula Stock Award Plan). This plan was previously used for awarding shares to non-employee directors, but its future use has been discontinued.\n\n2.  **Availability:** The plan's **remaining available shares for future issuance are effectively zero**. The document clarifies that \"column (a) reflects all shares issuable under those plans upon exercise or distribution of outstanding awards or deferred compensation benefits\" for this plan, meaning no new shares are available for future issuance under the plan. The only shares related to this plan mentioned in the equity compensation tables are \"391 shares issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan\" under \"Plans not approved by security holders\" (item (4)), which are tied to existing deferred compensation distributions, not new awards. The plan is fully retired for future use.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59439,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15079,
        "completion_tokens": 355,
        "total_tokens": 15434
      }
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald's disclosure around food safety concerns remained consistent in its emphasis on the importance of food safety to its business, but the framing evolved to reflect heightened awareness of supply chain vulnerabilities and external risks. In 2022, the focus was on general food safety priorities and the potential impact of food-borne illnesses on brand reputation, as seen in the 2022 10-K (pages 29–33). By 2023, the language expanded to explicitly link food safety risks to broader systemic challenges, including supply chain interruptions and disruptions that could affect product availability and safety (2023 10-K, pages 31–35). This evolution underscores a strategic shift toward integrating food safety into broader supply chain risk management, acknowledging that volatility in supply chains—driven by factors like geopolitical tensions, climate events, or logistical disruptions—could indirectly compromise food safety standards and operational resilience. While neither filing details specific cost volatility metrics, the 2023 disclosure more clearly connects these supply chain risks to potential financial and reputational harm, reflecting a maturing emphasis on proactive risk mitigation in an increasingly complex global environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65952,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16711,
        "completion_tokens": 319,
        "total_tokens": 17030
      }
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "The carrying value of TMO’s 1.750% 7‑Year Senior Notes was $662 million at the end of 2023 and increased to $700 million at the end of 2024, reflecting a modest rise in the debt balance. The effective interest rate on these notes remained essentially unchanged, staying around 1.96 %–1.89 % (reported as 1.97 % in 2023 and 1.89 % in 2024).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56491,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14334,
        "completion_tokens": 84,
        "total_tokens": 14419
      }
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "Based on the 2022 and 2023 10-K disclosures, RTX's exposure to its 7.000% notes due 2038 decreased from $11 million (as of December 31, 2021) to $148 million (as of December 31, 2022), reflecting a modest increase in outstanding principal but a reduction in the relative proportion of this specific tranche within the broader debt portfolio. This shift aligns with RTX's strategic approach to managing long-term debt maturities, as evidenced by its active refinancing and repayment of higher-cost, near-term obligations (e.g., $1.5 billion in 2021 repayments including 7.000% notes due 2038) while extending maturity profiles through new issuances of longer-dated debt (e.g., 2032 and 2052 notes), thereby optimizing the debt structure for future fiscal flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44758,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11415,
        "completion_tokens": 191,
        "total_tokens": 11606
      }
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees regarding rent and royalties evolved in two key ways: First, while total franchise revenue from rents and royalties increased to $13,085.4 million in 2021 (up from $10,726.1 million in 2020), the company continued to collect these payments based on a percent of sales, with minimum rent payments tied to underlying lease obligations. Second, the company deferred approximately $1 billion in cash collections for rent and royalties during the first half of 2020 due to COVID-19 impacts, but had substantially collected all deferred amounts by December 31, 2021, indicating a return to normal collection patterns in 2022-2023. The future minimum rent payments due under franchise arrangements remained substantial, totaling $33.8 billion across all future years, with $3,062.6 million due in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50338,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12806,
        "completion_tokens": 218,
        "total_tokens": 13025
      }
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca‑Cola Company’s stake in Embotelladora Andina S.A. has remained an equity‑method investment throughout 2022‑2024; the company continues to hold a non‑controlling interest (approximately a 19 % ownership share as of 2024) and reports its share of Andina’s earnings in “equity income (loss) – net.”  This enduring, proportionate holding signals that Coca‑Cola views Andina as a strategic, long‑term partnership that provides exposure to the Latin‑American bottling market rather than a short‑term investment to be divested.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53603,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13637,
        "completion_tokens": 132,
        "total_tokens": 13769
      }
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "From 2022 to 2024, Oracle’s strategic investment in cloud infrastructure evolved from a focus on expanding Oracle Cloud Operations and building out its global network of data centers to a more integrated positioning of Oracle Cloud Infrastructure (OCI) within its broader product portfolio. In the 2022 filing, Oracle emphasized expanding data center capacity and geographic reach to meet customer demand, while the 2024 filing underscores that OCI is now a core component of its cloud services, delivered through a secure, scalable platform managed by Oracle employees. The company has increasingly tied OCI to its hardware, software, and services offerings—highlighting integration with Oracle Database, Engineered Systems, and industry-specific hardware—while leveraging internal development and acquisitions to enhance its cloud capabilities. This reflects a strategic shift from infrastructure expansion to positioning OCI as a differentiated, end-to-end cloud platform deeply embedded in Oracle’s ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49164,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12529,
        "completion_tokens": 253,
        "total_tokens": 12783
      }
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "TMO's integration of The Binding Site Group, acquired in January 2023 within the Specialty Diagnostics segment, is evident in the 2023 financial results where the company reported $1.741 billion of goodwill and $1.148 billion of segment income attributable to the combined Specialty Diagnostics and Laboratory Products and Biopharma Services units, reflecting the strategic expansion of its diagnostics portfolio. The 2024 filing shows continued growth and strategic focus on this acquisition, with the company reporting $3.146 billion of cash outflows for the Olink acquisition (a 2024 addition that builds on the 2023 Binding Site integration) and maintaining a strong emphasis on organic revenue growth and margin improvement, indicating that post‑acquisition, Thermo Fisher is leveraging these assets to deepen its life‑sciences and diagnostics capabilities while sustaining a focus on cash generation and shareholder returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51514,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13107,
        "completion_tokens": 232,
        "total_tokens": 13340
      }
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "The Directors' Code of Conduct was first linked on BNY Mellon's website in the 2022 filing (page 9), providing a direct URL to the PDF, and the same practice continued in 2024 (page 11), where the code is again posted online with a note that any amendments or waivers will be disclosed on the website. Thus, between 2022 and 2024 the disclosure remained a publicly accessible link on the company’s site, with no change in scope—still applying to all directors and being posted at the same dedicated URL.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35858,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9190,
        "completion_tokens": 125,
        "total_tokens": 9316
      }
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's relationship with franchisees shifted toward greater financial transparency and strategic emphasis on cash flow management, as evidenced by increased disclosures in the 10-K regarding lease accounting, revenue recognition from franchisee-related fees, and capital allocation. The company continued to prioritize franchisee-driven growth through reduced direct restaurant ownership (evidenced by lower company-operated restaurant counts and higher franchisee acquisitions), while maintaining strict oversight of financial reporting for franchisee transactions, including deferred rent collections and initial fee recognition over 20-year franchise terms. This evolution reflects a strategic focus on optimizing franchisee profitability to sustain system-wide growth, with financial reporting increasingly centered on cash flow metrics and segment-level performance rather than standalone company-operated results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67712,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17145,
        "completion_tokens": 236,
        "total_tokens": 17382
      }
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "The contingent consideration liabilities for the Clif Bar acquisition were measured at fair value and adjusted during 2023–2024 based on updated projections and market conditions, with fair value changes recorded in selling, general, and administrative expenses. The liability increased from $642 million at December 31, 2022, to $680 million at December 31, 2023, reflecting additions of $128 million in fair value adjustments during 2023, partially offset by $90 million in payments, resulting in a net increase in the contingent consideration obligation over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46856,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11959,
        "completion_tokens": 143,
        "total_tokens": 12103
      }
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "AMD's strategic emphasis on Vulkan API support has evolved from foundational integration in 2022 to active co-development and optimization initiatives by 2024, as evidenced by its inclusion in RDNA 2 and RDNA 3 architectures and partnerships to enhance Vulkan-based performance in gaming and compute workloads. This reflects AMD's broader approach of combining hardware innovation with software ecosystem investment to maintain competitiveness in the discrete GPU market, particularly against NVIDIA's dominance in professional and high-performance segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47267,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12046,
        "completion_tokens": 139,
        "total_tokens": 12185
      }
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "The Powder Metal Matter charge recorded in 2023 reduced operating profit by $2.9 billion, driving a $1.9 billion decline in operating profit from 2022 to 2023 and lowering the operating‑profit margin from 8.2 % to 5.2 %. This charge was the primary factor behind the downward trend in operating profit between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54755,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13917,
        "completion_tokens": 81,
        "total_tokens": 13998
      }
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "MDLZ's relationship with Clif Bar evolved such that the August 1 2022 acquisition of Clif Bar added incremental net revenues of $529 million through the one‑year anniversary of the deal (i.e., through August 1 2023), after which the brand was integrated into MDLZ's portfolio and no longer generated separate acquisition‑related revenue. Consequently, there were no further acquisition‑related financial activities involving Clif Bar in 2024, and the company's 2024 results reflect only the ongoing contribution of the acquired business rather than any new acquisition‑related revenue or costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48226,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12275,
        "completion_tokens": 148,
        "total_tokens": 12424
      }
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024 Gulfstream’s energy‑efficient engine strategy shifted from incremental improvements on existing models to the rollout of new, purpose‑designed propulsion systems on its latest aircraft. The company highlighted that its newest engines—featured on the G500, G600, G700 and G800—deliver higher fuel efficiency, lower emissions and greater range compared with earlier platforms, and it emphasized expanding sustainable‑fuel support (including 100 % SAF flights) as part of this efficiency push. Consequently, aircraft such as the ultra‑large‑cabin G700 (certified in early 2024) and the ultra‑long‑range G800 exemplify the latest, most fuel‑efficient engine and airframe integration in Gulfstream’s lineup.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31923,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8197,
        "completion_tokens": 180,
        "total_tokens": 8377
      }
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 through 2024, AMD’s semi-custom SoC revenue has shifted from being tied to long-term wafer purchase targets under its amended GF wafer supply agreement (which required minimum annual wafer purchases and imposed penalties for missing targets) toward greater flexibility—post‑amendment the agreement no longer includes exclusivity, allowing AMD to contract with any foundry, while still maintaining minimum capacity allocations through 2025. Consequently, AMD’s revenue structure now relies more on non‑recurring engineering fees and sales of semi‑custom SoCs that are incorporated into customers’ products, making its earnings increasingly dependent on those customers’ product success and market acceptance rather than on guaranteed wafer volumes. Strategically, AMD has moved from a more constrained, capacity‑commitment‑driven model toward a flexible, partnership‑agnostic approach that emphasizes design‑win diversification and reduces exposure to single‑source supply constraints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42891,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10945,
        "completion_tokens": 248,
        "total_tokens": 11193
      }
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The company's preferred share authorization remained unchanged between fiscal 2023 and 2024, with no issued or outstanding preferred shares at either year-end. This stability indicates a consistent capital structure with no new preferred equity mechanisms introduced, allowing the company to maintain flexibility in its capital allocation strategy focused on ordinary share repurchases and debt management rather than preferred share issuance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46083,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11745,
        "completion_tokens": 110,
        "total_tokens": 11856
      }
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "The filing shows that reputational risk tied to adverse publicity was first explicitly flagged as a standalone risk factor in the 2022 Form 10‑K (Item 1A), where it was linked to operational errors, cyber incidents and regulatory actions that could damage the firm’s reputation. By the 2024 filing, this concern was broadened and integrated into a wider set of risk themes—cybersecurity, regulatory scrutiny, geopolitical events, climate‑related issues and other reputational harms—while still emphasizing that adverse publicity can materially affect the business, financial condition and results of operations. Thus, the framing evolved from a discrete “reputational risk” bullet in 2022 to a more expansive, multi‑dimensional reputational‑risk narrative in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40815,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10432,
        "completion_tokens": 191,
        "total_tokens": 10623
      }
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "Amazon’s investment in Anthropic shifted from a $1.25 billion convertible note in Q3 2023—classified as an available‑for‑sale Level 3 asset and recorded at fair value with unrealized gains/losses in accumulated other comprehensive income—to a planned additional $2.75 billion investment in a second convertible note that was to expire in Q1 2024, while the underlying commercial arrangement for AWS cloud services remained unchanged. By the end of 2024, the valuation of this equity‑linked investment was subject to market‑price volatility and private‑company valuation complexity, leading to fair‑value measurements that could significantly affect earnings through “Other income (expense), net.” Thus, the classification remained as an available‑for‑sale financial instrument, but its fair‑value approach and the factors driving valuation (e.g., private‑company prospects, AWS usage, and broader market conditions) evolved markedly from 2023 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37416,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9588,
        "completion_tokens": 237,
        "total_tokens": 9826
      }
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "The protection of MDLZ’s intellectual property, including know‑how, is described as a significant and valuable component of the business, but the company acknowledges that its ability to obtain or adequately safeguard such rights—through patents, trademarks, copyrights, trade secrets, licensing agreements and enforcement actions—may be impaired by legal changes, emerging technologies (e.g., AI), or insufficient protection mechanisms. Consequently, any failure to maintain robust IP protections could diminish competitiveness and materially harm the company’s financial condition and stock price.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55868,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14186,
        "completion_tokens": 149,
        "total_tokens": 14336
      }
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Based on the provided SEC filings, Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements shows a clear evolution between 2023 and 2024. In the 2023 filing (GS_10k_2023.pdf), the company referenced specific historical agreements like \"Form of Non-Employee Director RSU Award Agreement (pre-2015)\" (Exhibit 10.8) and \"Amendments to Certain Non-Employee Director Equity Award Agreements\" (Exhibit 10.17), indicating ongoing use and modification of pre-2015 structures. However, in the 2024 filing (GS_10k_2024.pdf), these pre-2015 agreements are no longer referenced as current frameworks; instead, the focus shifts to newer, more detailed forms like \"Form of Non-Employee Director RSU Award Agreement\" (Exhibit 10.31) and \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled)\" (Exhibit 10.32), which are explicitly marked with † and * as current management contracts. Crucially, the 2024 filing includes the \"Amendments to Certain Non-Employee Director Equity Award Agreements\" (Exhibit 10.17) as a historical reference but does not introduce new amendment language, signaling that the evolution had stabilized by 2024 with standardized, updated agreements replacing older templates, reflecting a move toward consistent, current governance practices rather than iterative changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10556,
        "completion_tokens": 327,
        "total_tokens": 10884
      }
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, Booking Holdings' relationship with travel service providers evolved significantly in terms of revenue recognition and contractual responsibilities, particularly through the expansion of merchant-based transactions. This shift involved Booking.com increasingly processing payments directly from travelers on behalf of travel providers, which introduced new contractual obligations around payment handling, refunds, and service delivery timelines. As noted in the 2023 10-K (pages 81-85), this merchant model allows for more flexible transaction terms but requires the company to recognize revenue on a net basis while also incurring additional expenses related to payment processing, chargebacks, and fraud prevention. Consequently, while this model enhances control over customer experience and enables the \"Connected Trip\" strategy, it also increases operational complexity and affects operating margins despite generating incremental revenues from credit card rebates and ancillary fees. The 2022 10-K (pages 46-50) provides context for these changes by detailing the structural shift toward merchant arrangements as part of long-term growth strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44080,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11242,
        "completion_tokens": 294,
        "total_tokens": 11537
      }
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "Based on the provided document pages, the only specific change related to executive life insurance policy disclosures between the 2023 and 2024 10-K filings is the addition of a new Exhibit 10.1 in the 2024 filing (GS_10k_2024.pdf, page 243), which references \"The Goldman Sachs Group, Inc. Clawback Policy, effective as of December 1, 2023\" – however, this is a clawback policy, not an executive life insurance policy disclosure. The document does not indicate any structural changes to executive life insurance policy disclosures between the 2023 and 2024 filings; the 2023 filing (GS_10k_2023.pdf) references executive life insurance policies in Item 10.11 and 10.12 (pages 10.11 and 10.12 of the 2023 filing), while the 2024 filing (GS_10k_2024.pdf) includes the same references but adds the clawback policy as Exhibit 10.1, with no indication of changes to the insurance policy structure itself. Therefore, no specific structural changes to executive life insurance policy disclosures occurred between the 2023 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10544,
        "completion_tokens": 258,
        "total_tokens": 10803
      }
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, Broadcom’s strategic focus on FBAR filters shifted from primarily outsourcing manufacturing to maintaining tighter control over internal fabrication to protect IP and accelerate time-to-market. While the 2022 10-K notes internal fabrication for proprietary processes like FBAR filters to safeguard IP and speed development, the 2024 filing emphasizes continued investment in internal III-V semiconductor capabilities (U.S. and Singapore) and process optimization to enhance fabrication efficiency. This evolution solidifies Broadcom’s competitive positioning by leveraging proprietary FBAR technology and integrated design-manufacturing workflows to maintain differentiation in high-value wireless communications markets, despite broader industry trends toward outsourcing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 45750,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11667,
        "completion_tokens": 199,
        "total_tokens": 11866
      }
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "BMY's strategic positioning of Krazati has evolved significantly between 2023 and 2024, marked by its acquisition of Mirati Therapeutics in January 2024 for $4.8 billion (net $4.1 billion after cash acquired), which granted BMS exclusive rights to Krazati (adagrasib), a KRAS G12C inhibitor. This acquisition solidified Krazati's role as a cornerstone asset in BMS's oncology portfolio, particularly for treating advanced NSCLC with KRAS mutations (approved in 1L and 2L+ settings) and colorectal cancer. Financially, Krazati's valuation was bolstered by its FDA/EMA approvals and strong market potential, evidenced by its inclusion in BMS's strategic pipeline updates and the company's focus on expanding its use in combination therapies (e.g., with nivolumab). The asset's value was further enhanced by its integration into BMS's broader oncology strategy, including its positioning alongside Opdivo for adjuvant and peri-adjuvant indications in HCC and NSCLC, reflecting a shift toward higher-value, targeted therapies with significant unmet needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 91473,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23090,
        "completion_tokens": 262,
        "total_tokens": 23353
      }
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG’s relationship with travel service providers evolved to deepen mutual benefit and operational integration, particularly through expanded payment capabilities, incentive programs, and the development of the \"Connected Trip.\" As outlined in the 2023 10-K, BKNG continues to partner with travel service providers and restaurants to increase their distribution and inventory utilization, while offering platforms, tools, and insights to support their success. The company emphasizes managing financial obligations by structuring revenue recognition around merchant and agency models, maintaining deferred booking liabilities, and investing in payment infrastructure to streamline transactions. Additionally, BKNG has pursued strategic acquisitions (e.g., Etraveli Group, Getaroom) to enhance its flight and hotel distribution capabilities, reinforcing its role as a key intermediary that balances incentives for both consumers and partners while driving sustainable growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49978,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12729,
        "completion_tokens": 249,
        "total_tokens": 12978
      }
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement in Custom Touch Controllers evolved from being a niche semiconductor component within its Wireless product portfolio (highlighted in the 2022 10-K as part of \"Mobile Device Connectivity\" solutions) to a more integrated and strategically significant offering following the acquisition of VMware in November 2023. While the 2022 filing details touch controllers as part of wireless connectivity solutions for mobile devices, the 2024 filing emphasizes broader infrastructure software and semiconductor integration, reflecting how the VMware deal expanded Broadcom's capabilities beyond hardware into enterprise software, indirectly reinforcing its end-to-end product lifecycle strategy. This shift underscores a transition from standalone hardware development to a more holistic approach where touch controller technology is positioned within a larger ecosystem of interconnected semiconductor and software solutions, particularly as part of Broadcom's expanded focus on AI-driven data centers and enterprise infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41615,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10627,
        "completion_tokens": 266,
        "total_tokens": 10893
      }
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "Union Pacific's freight car asset strategy shifted from acquiring new rolling stock through direct purchases to leveraging operating leases and finance leases, as evidenced by the 2024 financial statements showing $1,643 million in operating lease assets and $244 million in finance lease assets for freight cars, with lease maturities of $361 million (operating) and $55 million (finance) due in 2024. This reflects a strategic move toward lease-based asset acquisition rather than new purchases, aligning with their capital allocation priorities and lease portfolio management approach described in the 2024 10‑K filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45343,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11551,
        "completion_tokens": 155,
        "total_tokens": 11707
      }
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's transition of its NIKE Brand businesses in certain Asia Pacific & Latin America (APLA) countries to third-party distributors significantly impacted financial results between FY2022 and FY2023. This restructuring caused a notable decline in APLA revenues (from $5,955 million in FY2022 to $5,028 million in FY2023) and a substantial increase in Global Brand Divisions costs (from $30 million to $30 million, though the segment's EBIT turned more negative from $(4,262) million to $(4,720) million in FY2024), reflecting the operational shift. The move also contributed to higher inventory reserves ($331 million as of May 2024 vs. $269 million in 2023) and reduced direct-to-consumer sales in the region, as evidenced by the APLA revenue decline and increased reliance on third-party distribution channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51647,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13145,
        "completion_tokens": 203,
        "total_tokens": 13348
      }
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "From 2022 to 2024, Broadcom’s involvement with InP lasers evolved from relying on external foundries for III-V wafer fabrication (as noted in the 2022 10-K’s Manufacturing Operations section, which states internal fabrication is used only for proprietary processes like InP lasers) to expanding its internal capabilities, with the 2024 10-K confirming that the majority of internal III-V semiconductor wafer fabrication occurs in the U.S. and Singapore, reflecting a strategic shift toward greater in-house control of InP laser production to secure IP and accelerate time-to-market. This evolution strengthens Broadcom’s competitive positioning in fiber optic communications by leveraging its proprietary InP laser technology within its FC SAN and optical component portfolio, differentiating it from competitors who rely more heavily on external suppliers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 45750,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11662,
        "completion_tokens": 214,
        "total_tokens": 11877
      }
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, the ownership structure of Swoosh, LLC relative to NIKE’s Class A and Class B common stock remained essentially unchanged: Swoosh continued to beneficially own roughly 77 % of the Class A shares, which would translate to about 16 % of the Class B shares if converted, preserving a dominant controlling stake. This concentrated ownership limits external shareholders’ influence, as the Knight family (through Swoosh) effectively controls major corporate decisions despite the Class B shares carrying standard voting rights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50939,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12967,
        "completion_tokens": 136,
        "total_tokens": 13104
      }
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI shifted from a six‑segment geographic structure to four core regions plus dedicated Swedish Match and Wellness & Healthcare categories, integrating the Swedish Match acquisition into its regional reporting and expanding the availability of its reduced‑risk products (RRPs) across 84 markets, while maintaining a focus on portfolio diversification toward smoke‑free alternatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42440,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10833,
        "completion_tokens": 100,
        "total_tokens": 10933
      }
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "Caterpillar's strategic role in the reciprocating engines business has shifted from being a primary manufacturer and seller of engines to a more integrated supplier that partners closely with dealers and financial services to drive engine sales through financing programs and marketing incentives. This evolution has strengthened its revenue composition by tying engine sales to higher-margin financial products, while the enhanced financing and service offerings have improved gross margin potential by increasing dealership engagement and enabling more favorable pricing and terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43971,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11222,
        "completion_tokens": 145,
        "total_tokens": 11368
      }
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon maintained its practice of disclosing amendments to the Directors' Code of Conduct on its website, specifically stating that it would \"disclose on our website any amendments to or waivers of (i) the Code of Conduct relating to executive officers and (ii) the Directors' Code of Conduct relating to our directors.\" However, the 2023 filing (BK_10k_2023.pdf) does not introduce new mechanisms or enhanced transparency commitments beyond this existing practice; it simply reaffirms the same disclosure approach used in 2022, without adding new methods or explicit transparency pledges regarding change notification. The company continues to rely solely on its website for such disclosures, with no indication of additional formal notification processes or expanded commitments in the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36359,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9331,
        "completion_tokens": 206,
        "total_tokens": 9538
      }
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike’s strategic approach to the APLA market shifted from a direct-to-consumer (NIKE Direct) model toward a distributor-led operating structure in select countries. This transition, detailed in the FY23 10-K (Note 20), involves divesting legal entities in Argentina, Uruguay, and Chile and transitioning those markets to third-party distributors. While this change is expected to reduce reported APLA revenue growth due to altered commercial terms, Nike anticipates long-term profitability improvements by lowering selling, general, and administrative (SG&A) expenses and mitigating foreign exchange volatility. The move reflects a broader strategic evolution to optimize market participation in APLA, moving away from direct operations to a more sustainable distributor model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44508,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11350,
        "completion_tokens": 200,
        "total_tokens": 11550
      }
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "The impact of favorable price realization on Caterpillar's sales and profitability shifted from a strong positive driver in 2021—where it contributed to a 22% sales increase and helped lift operating profit margins to 13.5%—to a more muted or offsetting factor by 2024, when sales declined 3% year-over-year despite continued price realization, as lower volume and unfavorable mix pressures emerged, particularly in Construction and Resource Industries. While price realization remained a tailwind in 2024, its benefit was largely negated by volume declines and rising costs, marking a clear evolution from tailwinds in 2021 to headwinds in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 73883,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18684,
        "completion_tokens": 161,
        "total_tokens": 18845
      }
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024, GM’s EV manufacturing strategy shifted from broad, capital‑intensive expansion to a more focused, financially disciplined approach.  In the 2023 filing the company emphasized scaling EV capacity, building a North‑American‑centric supply chain and monetizing its battery‑cell technology, while acknowledging the need to fund this growth with cash from high‑margin ICE trucks and SUVs.  By the 2024 filing, GM highlighted that it had already invested heavily in EV capacity, was now prioritizing profitability and cash preservation, and was refocusing its autonomous‑driving unit (Cruise) on personal‑vehicle ADAS rather than robotaxi development, signaling a tighter, risk‑aware stance on EV roll‑outs and supply‑chain commitments.  This evolution reflects a strategic pivot toward consolidating EV production, tightening supply‑chain contracts, and aligning EV investments with near‑term cash flow from its profitable ICE portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62070,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15741,
        "completion_tokens": 238,
        "total_tokens": 15980
      }
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Based on the 2022 and 2024 10-K disclosures, Pfizer's financial commitment to Paxlovid has significantly declined. In 2022, Paxlovid generated $18.9 billion in revenue and contributed heavily to total revenues, but by 2024, revenue from Paxlovid dropped to $5.7 billion, reflecting the transition from government procurement to commercial markets and the impact of EUA reversals. Remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with revenue to be recognized through 2028, but this represents a substantial reduction from its peak pandemic-era revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 78984,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19967,
        "completion_tokens": 152,
        "total_tokens": 20119
      }
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Caterpillar's supplier financial viability monitoring has evolved to incorporate more robust contractual safeguards and risk-mitigation mechanisms between 2022 and 2023. The company now emphasizes proactive oversight of supplier solvency—particularly in critical supply chain segments—through enhanced contractual terms, including stricter financial covenants and potential modifications to payment terms or order allocations to financially vulnerable suppliers. This is complemented by Cat Financial’s broader risk management framework, which includes match-funding policies to stabilize interest rate exposure and contractual agreements that require suppliers to maintain specific financial health metrics, though specific new contractual language for supplier risk mitigation is not detailed in the provided excerpts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43552,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11116,
        "completion_tokens": 205,
        "total_tokens": 11321
      }
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Visa's Risk and Identity Solutions have evolved from a standalone fraud-prevention offering into a core component of its broader value-added services strategy, now deeply integrated within its \"network of networks\" approach. This evolution is marked by the expansion of AI-driven tools like Visa Protect Authentication Intelligence and Visa Deep Authorization, which enhance real-time fraud detection across both card and non-card (A2A) payments, while also supporting the growth of new flows like B2B and government payments through Visa Direct and Visa+. The acquisition of Pismo further strengthens this integration by embedding core banking capabilities to enable seamless, secure transactions across diverse payment ecosystems. Consequently, Risk and Identity Solutions are no longer just defensive measures but strategic enablers that underpin Visa's expanded vision of facilitating frictionless, secure money movement across all endpoints and networks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 35105,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9004,
        "completion_tokens": 239,
        "total_tokens": 9243
      }
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "Between 2022 and 2023, the company's exposure to shelf space limitations as a risk factor remained a persistent concern, but its manifestation evolved in key ways. While the core risk of \"increasing dependence on key retailers in developed markets, changes in the policies of our retail trade customers, the emergence of alternative retail channels and the rapidly changing retail landscape\" persisted (as noted in both 2022 and 2023 filings), 2023 specifically highlighted intensified pressures from retail policy shifts and channel disruption. The 2023 report emphasized that \"changes in the policies or practices of our retail trade customers, such as inventory de-stocking, fulfillment requirements, limitations on access to shelf space, delisting of our products, or environmental, sustainability, supply chain or packaging standards or initiatives\" now carried heightened operational risk, directly linking these retail dynamics to potential adverse impacts on sales and profitability. Concurrently, the expansion of eCommerce and alternative retail channels (e.g., direct-to-consumer and subscription models) was explicitly framed as a growing disruptor, with the company noting that \"the rapid growth in eCommerce and the emergence of alternative retail channels have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers.\" Thus, while shelf space limitations were not newly introduced as a risk factor, their operational consequences—particularly through evolving retail customer demands and the rise of competing channels—became more pronounced and materially relevant to the company's business outlook in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 35641,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9148,
        "completion_tokens": 421,
        "total_tokens": 9569
      }
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Oracle's hybrid deployment strategy has evolved to emphasize cloud-first flexibility, with hybrid models (combining on-premise and cloud) now central to its offerings—highlighted by products like Oracle Cloud@Customer and multicloud options enabling customers to use Oracle Cloud alongside other public clouds. The company has significantly increased its focus on cloud services revenue, which grew from 25% of total revenue in fiscal 2022 to 37% in fiscal 2024, reflecting a strategic shift toward cloud and license business expansion, supported by initiatives like the Oracle Cloud@Customer program and migration programs for on-premise workloads.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46849,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11935,
        "completion_tokens": 162,
        "total_tokens": 12097
      }
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Based on the 2022 and 2024 10-K filings, Pfizer's financial commitment to Paxlovid has significantly evolved. In 2022, Paxlovid generated $18.9 billion in revenue, but by 2024, revenues from the product had declined sharply to $5.7 billion, reflecting the transition from government procurement to commercial markets and the impact of the U.S. government's inventory return agreements (including a $3.5 billion revenue reversal in Q4 2023 and a $771 million favorable adjustment in Q1 2024). Remaining performance obligations for Paxlovid totaled approximately $1 billion in contracted revenue as of December 31, 2024, with expected deliveries through 2028, though this represents a substantial decrease from the $18.9 billion in 2022 revenue. The company now recognizes revenue as products are delivered under commercial agreements, with no cash consideration for some future pandemic preparedness supplies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 82039,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20735,
        "completion_tokens": 227,
        "total_tokens": 20962
      }
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Caterpillar's relationship with its independent dealers remained governed by standard sales and service agreements that grant dealers rights to purchase, sell and service products within defined territories, with obligations to promote the brand, maintain financial records and provide warranty support. While the contractual framework and 90‑day terminable terms persisted, 2023 saw a strategic shift toward greater dealer‑driven financing programs and enhanced marketing collaborations—especially through Cat Financial’s retail‑loan initiatives—to strengthen dealer competitiveness and accelerate sales of Caterpillar equipment globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42997,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10973,
        "completion_tokens": 159,
        "total_tokens": 11133
      }
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, the company’s operational focus in Africa/Eurasia shifted toward strategic productivity initiatives and capital investment, as reflected in restructuring charges and capital expenditures. While Africa/Eurasia’s operating profit within Oral, Personal and Home Care declined slightly from $206 million in 2020 to $203 million in 2021, the 2022 Global Productivity Initiative allocated a significant portion of its $32 million pre‑tax charges (2023) and $110 million (2022) to this region (10 % of cumulative charges), emphasizing efficiency gains and supply‑chain streamlining. Concurrently, capital expenditures for Africa/Eurasia rose sharply to $33 million in 2021 (up from $13 million in 2020), underscoring increased investment in the region despite modest profit growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 26416,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6831,
        "completion_tokens": 198,
        "total_tokens": 7030
      }
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "From 2022 to 2024, Qualcomm's strategic focus on 5G evolved from foundational infrastructure development toward commercialization and diversification. The company intensified investments in 5G technologies, particularly in modem and RF front-end innovations (e.g., RFFE components and Snapdragon 5G modem-RF platforms), while expanding into new growth areas like automotive and IoT to offset mobile handset concentration risks. This shift was driven by the need to capitalize on 5G adoption amid slowing premium-tier smartphone growth and increasing competition from vertically integrated rivals like Apple and Samsung, who increasingly develop proprietary modem solutions. Despite these challenges, Qualcomm maintained strong licensing revenues from 5G standards, with over 200 5G license agreements secured, underscoring its role as a key enabler of 5G ecosystem expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64268,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16290,
        "completion_tokens": 218,
        "total_tokens": 16509
      }
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Pfizer's financial and strategic positioning of Paxlovid evolved significantly between 2022 and 2024. In 2022, Paxlovid generated $18.9 billion in revenue, but this declined sharply to $1.279 billion in 2023 and $5.716 billion in 2024, reflecting the transition from government procurement to commercial market sales and the impact of EUAs being phased out. By 2024, Paxlovid contributed $5.716 billion to total revenues (compared to $11.220 billion for Comirnaty), but its revenue was heavily impacted by a $3.5 billion non-cash revenue reversal in Q4 2023 related to expected returns of EUA-labeled inventory, partially offset by a $771 million favorable adjustment in Q1 2024. Contractually, Pfizer maintained long-term supply agreements for Paxlovid with governments globally, with remaining performance obligations totaling approximately $1 billion as of December 31, 2024, though these were significantly smaller than the $34.4 billion remaining for Comirnaty. The shift marked a strategic transition from pandemic-driven revenue to commercialization, with Paxlovid's revenue now dependent on commercial pricing and market adoption rather than government contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 90538,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22863,
        "completion_tokens": 292,
        "total_tokens": 23156
      }
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "Between 2022 and 2023, the company’s exposure to credit market tightness as a supply chain risk shifted from a general concern about \"tighter credit or capital markets\" affecting suppliers (2022) to a more specific reference to \"geopolitical events, wars and military conflicts, such as the war in Ukraine and the Israel-Hamas war\" as drivers of supply chain disruption (2023). This evolution indicates a growing vulnerability to external financial conditions, as the company now explicitly ties supply chain instability to volatile global events that can trigger broader market pressures, thereby amplifying its dependence on stable credit and capital markets to maintain operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42290,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10807,
        "completion_tokens": 171,
        "total_tokens": 10978
      }
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid have significantly evolved from 2022 to 2024, reflecting a strategic transition from pandemic-driven revenue to commercial market sustainability. In 2022, Paxlovid generated $18.9 billion in revenue, but this declined sharply to $1.279 billion in 2023 as government contracts wound down and EUA-labeled inventory was returned, culminating in a $3.5 billion non-cash revenue reversal in Q4 2023. By 2024, Paxlovid revenue stabilized at $5.716 billion, driven by commercial sales and a $771 million favorable adjustment to the return estimate, with deferred revenue balances of $2.2 billion (including $1.4 billion in current liabilities) expected to be recognized through 2028. This shift underscores a move toward long-term commercial agreements rather than government stockpiling, with remaining performance obligations totaling approximately $1 billion in contracted revenue for future Paxlovid deliveries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 78028,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19731,
        "completion_tokens": 246,
        "total_tokens": 19977
      }
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "From 2023 to 2024, the Company increased its accrual for respirator mask/asbestos liabilities by $57 million in 2023 and by $36 million in 2024, reflecting higher estimated costs for pending and expected claims involving serious injuries such as mesothelioma, other malignancies and black‑lung disease.  The accrual at year‑end 2023 was $574 million (excluding Aearo), and at year‑end 2024 it was $523 million, illustrating the ongoing evolution of the Company’s liability estimates amid a declining volume of new claims but higher per‑claim costs.  No liability has been recorded for the West Virginia Attorney General’s unfair‑trade‑practices claim because liability is deemed not probable or estimable at this time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61515,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15598,
        "completion_tokens": 179,
        "total_tokens": 15778
      }
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal declined from 13.9% in 2020 to 12.6% in 2021, reflecting a loss of share in the oral tobacco segment. This share decline occurred alongside a modest reduction in Skoal’s shipment volume (from 208.5 million units in 2020 to 197.4 million units in 2021), indicating that the drop in retail share was not driven by a proportional fall in shipment volume but rather by competitive pressures from growing oral‑nicotine‑pouch products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54151,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13761,
        "completion_tokens": 113,
        "total_tokens": 13874
      }
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's approach to multimedia technologies evolved through deeper integration of advanced signal processing and AI capabilities into its semiconductor platforms, particularly within the QCT segment. The company expanded its engineering focus to include multimode modem architectures, AI-driven signal optimization for camera and audio processing, and power-efficient multimedia pipelines—enabling capabilities like on-device generative AI, enhanced video encoding/decoding, and real-time sensor fusion for automotive and IoT applications. This shift was reinforced by strategic investments in R&D centers globally and through acquisitions to accelerate multimedia innovation beyond traditional mobile handsets, embedding these technologies into automotive infotainment, XR devices, and edge computing platforms while maintaining tight integration with its 5G modem and RF ecosystems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62321,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15807,
        "completion_tokens": 226,
        "total_tokens": 16033
      }
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly through equity investment and intercompany balances tied to litigation settlements. In 2022, 3M committed $1.2 billion to fund a bankruptcy trust established by Aearo Technologies to resolve Combat Arms Earplug litigation, which included $1.0 billion in cash and $0.2 billion for projected case expenses. This commitment was reflected in a $1.2 billion pre-tax charge to SG&A in Q2 2022. Following the dismissal of Aearo's Chapter 11 bankruptcy in June 2023, 3M reconsolidated the Aearo Entities, reversing prior deconsolidation. As a result, $0.7 billion in equity investment and $0.6 billion in net intercompany liabilities (due from 3M to deconsolidated entities) were removed from 3M's balance sheet, with gross intercompany payables of $0.9 billion recorded in other liabilities. The CAE Settlement further solidified this relationship, with 3M contributing $6.0 billion (structured as $5.0 billion cash + $1.0 billion stock, later amended to all-cash) between 2023–2029 to resolve Combat Arms Earplug litigation. This settlement required a $4.2 billion pre-tax charge in Q3 2023, with $250 million paid in December 2023 and $253 million in January 2024. The reconsolidation and settlement adjustments directly impacted 3M's balance sheet, including the removal of $0.7 billion in equity investments and the reversal of $0.6 billion in intercompany receivables from the Aearo Entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62474,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15843,
        "completion_tokens": 371,
        "total_tokens": 16215
      }
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Visa's Risk and Identity Solutions have evolved from a standalone fraud-prevention offering into a core component of its broader Value-Added Services portfolio, now tightly integrated with its network-of-networks strategy and expanded capabilities like Visa Protect (including AI-driven tools such as Deep Authorization and Protect for A2A Payments). This evolution reflects a strategic shift toward embedding risk and identity management across all payment flows—consumer, B2B, and open banking—while leveraging acquisitions like Tink AB to enhance open banking integration and scaling solutions like Visa Direct and Visa+ to enable secure, real-time transactions across 190+ countries. The focus has shifted from basic fraud prevention to delivering comprehensive, data-driven identity and authentication tools that support Visa's ambition to be the \"network of networks\" for global money movement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42121,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10759,
        "completion_tokens": 225,
        "total_tokens": 10984
      }
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "Between 2023 and 2024, RTX's disclosure of Acquisition Accounting Adjustments shifted from being presented within the consolidated operating profit reconciliation (e.g., as a separate line item in 2023) to being explicitly detailed in the \"Acquisition accounting adjustments\" subsection of the \"Segment information\" table in 2024, with the adjustments now quantified as $2,058 million (2024), $1,998 million (2023), and $1,893 million (2022). The evolution shows increased transparency in how these adjustments—primarily amortization of acquired intangibles, property, plant, and equipment fair value adjustments, and customer contractual obligations—are broken out by segment (Collins Aerospace, Pratt & Whitney, Raytheon) and reported as a distinct line item affecting operating profit, with the 2024 figure showing a slight increase from 2023 ($2,058M vs. $1,998M).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56362,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14310,
        "completion_tokens": 217,
        "total_tokens": 14527
      }
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Microsoft's Office 365 Commercial revenue contributed to the Microsoft Cloud grew from $91.4 billion in fiscal 2022 to $111.6 billion in fiscal 2023, reflecting a substantial increase in its share of the cloud business. This upward trajectory underscores Office 365 Commercial's expanding role within the broader Microsoft Cloud ecosystem and its importance as a growth driver for the company's overall cloud revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37729,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9672,
        "completion_tokens": 104,
        "total_tokens": 9776
      }
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Alliance revenue related to Lynparza increased from $1,199 million in 2023 to $1,311 million in 2024, reflecting a 9% rise (11% excluding foreign‑exchange effects). This growth was driven by higher demand in most international markets, including the 2025 Chinese approval of Lynparza for adjuvant treatment of germline‑BRCA‑mutated, HER2‑negative high‑risk early breast cancer. No adverse factors were noted to offset this increase.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 126,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57526,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14598,
        "completion_tokens": 108,
        "total_tokens": 14706
      }
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The Procter & Gamble 2014 Stock and Incentive Compensation Plan is listed among the equity compensation plans in the 2024 proxy statement’s table (Item 12), but only the 2019 Plan is noted as allowing future grants; the 2014 Plan’s future issuance capacity is not separately highlighted. Consequently, while the plan remains part of the disclosed equity compensation portfolio, its regulatory context and inclusion in equity‑compensation reporting have not changed materially between 2023 and 2024—its shares are still reported in the aggregate totals of options, SARs, RSUs and PSUs, and it continues to be referenced only as a historical plan without a dedicated future‑issuance figure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70484,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17862,
        "completion_tokens": 172,
        "total_tokens": 18034
      }
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan remains part of the company's equity compensation structure but is no longer the primary vehicle for new grants; only the 2019 Stock and Incentive Compensation Plan allows future equity awards, with 77 million shares available for issuance, while the 1992 plan’s outstanding options continue to be counted in the aggregate totals disclosed in the equity compensation table.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70898,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17952,
        "completion_tokens": 98,
        "total_tokens": 18050
      }
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Between 2023 and 2024, Accenture’s focus on large‑scale transformations remained strong, but the pattern of client spending shifted toward longer‑duration, high‑value engagements that convert to revenue more slowly.  While overall client demand for transformation work stayed robust, the company noted that “clients continue to prioritize large‑scale transformations, which convert to revenue over a longer period,” indicating that revenue realization is now more spread out over time compared with the shorter‑term, smaller contracts that previously drove quicker conversions.  This evolution reflects a strategic emphasis on deeper, multi‑year transformations rather than quick‑turn projects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 42295,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10801,
        "completion_tokens": 173,
        "total_tokens": 10975
      }
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "The 2024 fiscal year saw a significant increase in Accenture's issuance of Class A Ordinary Shares for employee compensation, rising from $1.347 billion in fiscal 2023 to $1.417 billion in fiscal 2024. This higher share issuance contributed to a modest rise in total equity attributable to Accenture plc, growing from $26.459 billion in 2023 to $28.289 billion in 2024, while the overall equity structure remained largely unchanged aside from this increase in share capital and related equity components.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35056,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8991,
        "completion_tokens": 126,
        "total_tokens": 9117
      }
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "Based on the provided financial disclosures, MDLZ's exposure to Canadian-denominated debt instruments decreased slightly from $475 million (as of December 31, 2022) to $453 million (as of December 31, 2023), reflecting a $22 million reduction in the notional amount of Canadian dollar notes designated as net investment hedges. This reduction aligns with the company's broader trend of actively managing foreign currency-denominated debt, as evidenced by a strategic shift toward shorter-duration cash flow hedges (e.g., interest rate swaps covering forecasted payments over 2 years and 8 months as of December 31, 2023, compared to 4 years and 8 months in 2021) and a focus on reducing net investment hedge exposure in non-U.S. operations, including Canadian debt. The company also indicated expectations to transfer minimal gains ($21 million net of tax) from interest rate cash flow hedges to earnings in the next 12 months, underscoring a deliberate approach to optimizing foreign currency risk management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52433,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13350,
        "completion_tokens": 252,
        "total_tokens": 13602
      }
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "From 2023 to 2024, Accenture’s engagement with growth-stage companies intensified through its Accenture Ventures unit, which now actively partners with and invests in innovative startups to accelerate enterprise technology adoption. This strategic focus is reinforced by its innovation ecosystem—including Accenture Labs, Research, and over 100 global innovation hubs—enabling scalable co-creation and deployment of emerging technologies like AI and blockchain for clients. Concurrently, the company strengthened its sustainability commitments, setting new SBTi-approved net-zero targets (80% Scope 1/2 and 55% Scope 3 reduction by 2030; 90% by 2040) and advancing nature-based carbon removal projects to support its 2025 carbon removal goal.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 23086,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 5997,
        "completion_tokens": 185,
        "total_tokens": 6182
      }
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "From 2022 to 2024, Merck's Lynparza collaboration with AstraZeneca evolved with increased financial integration and asset amortization. The intangible asset balance related to Lynparza, which includes capitalized milestone payments, was amortized over its useful life through 2028, supporting the growth in alliance revenue from $725 million in 2020 to $989 million in 2021 and continued expansion in 2024. This amortization, alongside the recognition of contingent milestone payments and reimbursement mechanisms, reflects a strategic deepening of the partnership, with alliance revenue growth driven by sustained product performance and shared development costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53415,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13588,
        "completion_tokens": 166,
        "total_tokens": 13754
      }
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "Between 2023 and 2024, Broadcom’s strategic emphasis on ValueOps within its Distributed Software portfolio shifted from a broader focus on DevOps and AIOps toward a more pronounced integration of ValueOps as a distinct, end‑to‑end value‑stream management offering. This evolution is highlighted by the expanded description of ValueOps in the 2024 document, which positions it as the core solution for scheduling, tracking, and managing work across its lifecycle to align business and development teams, increase transparency, reduce inefficiencies, and accelerate time‑to‑value. Consequently, Broadcom is reinforcing its role as a provider of comprehensive, AI‑driven lifecycle management tools that enable enterprises to optimize planning, development, and delivery of business‑critical services, signaling a deeper, more specialized commitment to ValueOps as a differentiator within its Distributed Software portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59885,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15196,
        "completion_tokens": 230,
        "total_tokens": 15426
      }
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "FedEx’s DRIVE transformation, particularly Network 2.0, continued to be rolled out through 2023‑2024 with the goal of improving efficiency and reducing costs. The company highlighted that the transformation would generate permanent cost savings and network flexibility, but it also warned that execution risks—such as integration challenges, higher‑than‑expected transition costs, labor and regulatory issues, and potential disruptions to operations—could offset those benefits. Consequently, while cost‑saving targets were outlined, the company emphasized that any failure to achieve them or delays in implementation could materially affect future profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63615,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16133,
        "completion_tokens": 165,
        "total_tokens": 16299
      }
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "Based on the provided document pages, the financial impact from equity method investment contracts (specifically related to the September 2021 €300 million exchangeable bonds) was not materially disclosed in the 2022 or 2023 filings. The only reference to such contracts appears in Note 10, which notes a bifurcated embedded derivative option tied to those bonds, but no quantitative changes or earnings impact for 2022 versus 2023 are provided. Consequently, the documents do not indicate a significant evolution in the financial impact of these equity‑method investment contracts between 2022 and 2023, suggesting MDLZ’s engagement with these investments remained limited to the initial bifurcation accounting without notable subsequent financial effects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13047,
        "completion_tokens": 189,
        "total_tokens": 13236
      }
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "From fiscal 2023 to fiscal 2024 the estimated cost‑to‑complete for the VMware Cloud Foundation releases fell sharply – from $185 million (for the March 2025 release) and $65 million (for the July 2025 release) down to $38 million (July 2024) and $47 million (networking/security) – indicating that most of the planned functionality has already been delivered or is very near completion, well ahead of the original schedule. This rapid decline signals that Broadcom is progressing faster than anticipated on the Cloud Foundation roadmap.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36542,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9379,
        "completion_tokens": 134,
        "total_tokens": 9513
      }
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "The strategic positioning of FedEx Office’s Ship and Go kiosk has evolved from a niche self‑serve shipping option in a limited number of stores to a widely deployed, technology‑enabled service available in roughly 1,300 locations, integrating mobile label generation, QR‑code drop‑off and seamless returns processing. This expansion reflects FedEx’s broader strategy of embedding e‑commerce and returns capabilities within its retail footprint, using Ship and Go as a conduit for omnichannel fulfillment and a platform for data‑driven logistics insights. Consequently, the company is leveraging its physical stores to streamline last‑mile delivery and reverse‑logistics, reinforcing its integrated approach to e‑commerce logistics and returns management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13152,
        "completion_tokens": 188,
        "total_tokens": 13340
      }
    }
  ]
}